drug_name,sex,age,age_unit,indication,route,dosage_form,reaction,serious
BRAFTOVI,2,63,801,MALIGNANT MELANOMA,ORAL,Capsule,RETINOPATHY,1
OMNIPAQUE,1,43,801,NEUROENDOCRINE CARCINOMA,INTRAVENOUS,,ANAPHYLACTIC REACTION,1
LUMRYZ,1,,,NARCOLEPSY,ORAL,Extended-Release Oral Suspension,ABNORMAL BEHAVIOUR,2
LUMRYZ,2,,,NARCOLEPSY,ORAL,Extended-Release Oral Suspension,ILLNESS,2
LUMRYZ,1,,,NARCOLEPSY,ORAL,Extended-Release Oral Suspension,GASTRIC PH DECREASED,2
COSENTYX,2,62,801,PSORIASIS,SUBCUTANEOUS,Injection,ESCHERICHIA INFECTION,2
ZEPOSIA,2,48,801,MULTIPLE SCLEROSIS,ORAL,,THERAPEUTIC PRODUCT EFFECT DECREASED,2
LANTUS SOLOSTAR,2,87,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,DEMENTIA ALZHEIMER^S TYPE,1
SERTRALINE,2,7,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,CONGENITAL NYSTAGMUS,1
LINAGLIPTIN,2,64,801,TYPE 2 DIABETES MELLITUS,ORAL,Tablet,DUODENAL ULCER HAEMORRHAGE,1
MOUNJARO,2,68,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,ACCIDENTAL UNDERDOSE,2
CABOMETYX,1,76,801,RENAL CELL CARCINOMA,ORAL,Tablet,RENAL CELL CARCINOMA,1
CABOMETYX,1,,,NEUROENDOCRINE CARCINOMA METASTATIC,ORAL,Tablet,VISUAL IMPAIRMENT,2
OPSUMIT,1,50,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,HOSPITALISATION,1
ERIBULIN,2,67,801,BREAST CANCER,,Infusion,WHITE BLOOD CELL COUNT DECREASED,1
SAXENDA,2,63,801,OBESITY,SUBCUTANEOUS,Solution for injection,ARRHYTHMIA,1
DUPIXENT,1,41,801,ECZEMA,SUBCUTANEOUS,Solution for injection,ERYTHEMA,2
VENCLEXTA,2,66,801,CHEMOTHERAPY,ORAL,Tablet,MYELOSUPPRESSION,1
XOLAIR,2,70,801,IDIOPATHIC URTICARIA,SUBCUTANEOUS,Solution for injection in pre-filled syringe,OFF LABEL USE,2
NEXPLANON,2,,,CONTRACEPTION,SUBCUTANEOUS,Implant,VAGINAL HAEMORRHAGE,1
TALTZ,2,72,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,HYPOACUSIS,2
LIBTAYO,2,,,CERVIX CARCINOMA RECURRENT,INTRAVENOUS,Injection,METASTASES TO CENTRAL NERVOUS SYSTEM,1
MIRENA,2,45,801,INTRAUTERINE CONTRACEPTION,INTRAUTERINE,Intrauterine delivery system,DEVICE DISLOCATION,2
CITALOPRAM HYDROBROMIDE,2,64,801,DEPRESSION,ORAL,,ELECTROCARDIOGRAM QT PROLONGED,1
MOUNJARO,2,,,WEIGHT CONTROL,SUBCUTANEOUS,Solution for injection in cartridge,INTESTINAL ISCHAEMIA,1
TECENTRIQ,1,82,801,HEPATOCELLULAR CARCINOMA,INTRAVENOUS,Injection,PORTAL HYPERTENSION,1
LILETTA,2,28,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAUTERINE,,MUSCLE SPASMS,2
NUPLAZID,1,66,801,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,DEATH,1
DROXIDOPA,2,77,801,AUTONOMIC NERVOUS SYSTEM IMBALANCE,ORAL,,DEATH,1
COSENTYX,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,2
GAMUNEX-C,2,72,801,MYASTHENIA GRAVIS,,,ANAPHYLACTIC REACTION,1
DUPIXENT,2,58,801,ECZEMA,SUBCUTANEOUS,Solution for injection,PRODUCT PREPARATION ERROR,2
DUPIXENT,1,36,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
BOTOX,2,,,LIP COSMETIC PROCEDURE,INTRADERMAL,,INJECTION SITE BRUISING,2
MOUNJARO,2,52,801,WEIGHT CONTROL,SUBCUTANEOUS,Solution for injection in cartridge,RASH ERYTHEMATOUS,1
ORENCIA,2,59,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Solution for injection,GENERAL PHYSICAL HEALTH DETERIORATION,2
FABRAZYME,2,,,,INTRAVENOUS,Powder for concentrate for solution for infusion,PRODUCT STORAGE ERROR,2
IMATINIB,1,30,801,FIBROUS DYSPLASIA OF JAW,ORAL,,MUSCULAR WEAKNESS,2
LORAZEPAM,2,46,801,,INTRAMUSCULAR,Tablet,DRUG ABUSE,1
PLEGRIDY,2,40,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Unknown,ABORTION SPONTANEOUS,1
XPHOZAH,1,70,801,PRODUCT USED FOR UNKNOWN INDICATION,,Tablet,DEATH,1
BENLYSTA,1,,,SYSTEMIC LUPUS ERYTHEMATOSUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,PRODUCT DOSE OMISSION ISSUE,2
AYVAKIT,2,73,801,SYSTEMIC MASTOCYTOSIS,ORAL,Unknown,PNEUMONIA,1
SKYRIZI,1,33,801,CROHN^S DISEASE,SUBCUTANEOUS,,DEEP VEIN THROMBOSIS,1
DUPIXENT,1,65,801,NEURODERMATITIS,SUBCUTANEOUS,Solution for injection,COUGH,2
ALTUVIIIO,1,38,801,FACTOR VIII DEFICIENCY,,Powder and solvent for solution for injection,HAEMORRHAGE,2
TARPEYO,1,35,801,IGA NEPHROPATHY,ORAL,Prolonged-release capsule,WEIGHT INCREASED,2
HUMIRA,1,38,801,PRODUCT USED FOR UNKNOWN INDICATION,,Solution for injection in pre-filled pen,TUBERCULOSIS,1
SKYRIZI,2,19,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in pre-filled injector,INJECTION SITE URTICARIA,2
SKYRIZI,2,47,801,PSORIASIS,SUBCUTANEOUS,Injection,HOSPITALISATION,2
SKYRIZI,2,57,801,CROHN^S DISEASE,SUBCUTANEOUS,,COLECTOMY,1
BACLOFEN,1,,,MUSCLE SPASMS,ORAL,,DRUG INEFFECTIVE,2
DUPIXENT,2,70,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PRURITUS,2
SPRAVATO,2,,,DEPRESSION,NASAL,Nasal spray,PRODUCT DOSE OMISSION ISSUE,2
IQIRVO,2,,,PRIMARY BILIARY CHOLANGITIS,ORAL,Film-coated tablet,HEADACHE,2
CHILDREN CLARITIN ALLERGY,2,,,,ORAL,Syrup,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,2
TREMFYA,1,53,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Unknown,PRODUCT STORAGE ERROR,2
SKYRIZI,2,78,801,PSORIASIS,SUBCUTANEOUS,,HIP FRACTURE,1
SKYRIZI,1,72,801,CROHN^S DISEASE,SUBCUTANEOUS,,ARTHROPATHY,1
SKYRIZI,1,80,801,PSORIASIS,SUBCUTANEOUS,,BACK DISORDER,1
TREMFYA,2,,,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,DEVICE ISSUE,2
CLOZAPINE,1,69,801,SCHIZOPHRENIA,ORAL,Tablet,LOSS OF CONSCIOUSNESS,1
SKYRIZI,1,60,801,PSORIASIS,SUBCUTANEOUS,,KNEE OPERATION,1
SKYRIZI,2,34,801,PSORIASIS,SUBCUTANEOUS,,TUBERCULOSIS,1
ARIPIPRAZOLE,2,32,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,COMPLETED SUICIDE,1
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,,RASH,2
QINLOCK,1,49,801,GASTROINTESTINAL STROMAL TUMOUR,ORAL,Tablet,HYPERSOMNIA,2
SKYRIZI,1,74,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in pre-filled injector,INJECTION SITE HAEMORRHAGE,2
SPRAVATO,2,58,801,DEPRESSION,NASAL,Nasal spray,GASTROINTESTINAL HAEMORRHAGE,1
SILODOSIN,1,91,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,RENAL IMPAIRMENT,1
TREMFYA,1,39,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,CONSTIPATION,2
XELJANZ XR,2,63,801,ARTHRITIS,ORAL,Prolonged-release tablet,COUGH,2
SKYRIZI,2,86,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,LOSS OF CONSCIOUSNESS,1
LORAZEPAM,2,62,801,MAJOR DEPRESSION,INTRAMUSCULAR,,OVERDOSE,1
RIVASTIGMINE,2,92,801,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,Transdermal patch,DERMATITIS CONTACT,1
GLATIRAMER,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,RASH,2
TREMFYA,1,42,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,DEVICE DEPLOYMENT ISSUE,2
QINLOCK,1,80,801,GASTROINTESTINAL STROMAL TUMOUR,ORAL,Tablet,LACRIMATION INCREASED,2
SPRAVATO,2,33,801,PRODUCT USED FOR UNKNOWN INDICATION,NASAL,Nasal spray,AUTOSCOPY,2
AMPHETAMINE SULFATE,1,22,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,CARDIAC ARREST,1
SKYRIZI,1,71,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled injector,DYSSTASIA,1
BACLOFEN,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,DRUG INEFFECTIVE,2
CYCLOPHOSPHAMIDE,2,17,801,RHABDOMYOSARCOMA,INTRAVENOUS,,CARDIAC ARREST,1
CYCLOPHOSPHAMIDE,2,67,801,HORMONE RECEPTOR POSITIVE BREAST CANCER,INTRAVENOUS,Unknown,NEUTROPENIA,1
SKYRIZI,1,77,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,DEATH,1
TREMFYA,2,34,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,DEVICE LEAKAGE,2
SKYRIZI,1,78,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in pre-filled injector,INJECTION SITE MASS,2
EMPAGLIFLOZIN,1,68,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,CORONARY ARTERY DISEASE,1
CHILDREN CLARITIN ALLERGY,2,4,801,PROPHYLAXIS,ORAL,Syrup,PRODUCT USE ISSUE,2
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,,ILEAL STENOSIS,1
CYCLOPHOSPHAMIDE,2,17,801,LYMPHOCYTIC LEUKAEMIA,INTRAVENOUS,Powder for solution for injection/infusion,MYOCARDIAL INJURY,1
SKYRIZI,2,34,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,MENISCUS INJURY,1
SKYRIZI,2,55,801,CROHN^S DISEASE,SUBCUTANEOUS,,FAECALOMA,1
SKYRIZI,2,60,801,CROHN^S DISEASE,SUBCUTANEOUS,,MUSCLE SPASMS,1
SPRAVATO,2,20,801,DEPRESSION,NASAL,Nasal spray,HOSPITALISATION,1
SKYRIZI,1,66,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Solution for injection in pre-filled pen,PRECANCEROUS SKIN LESION,1
ELIQUIS,1,83,801,PRODUCT USED FOR UNKNOWN INDICATION,,Tablet,CEREBRAL INFARCTION,1
CANDESARTAN,2,84,801,HYPERTENSION,ORAL,,ACUTE KIDNEY INJURY,1
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,,GASTROENTERITIS,1
SPRAVATO,2,49,801,DEPRESSION,NASAL,Nasal spray,SUICIDE ATTEMPT,1
BREXPIPRAZOLE,2,,,MAJOR DEPRESSION,ORAL,Tablet,DYSARTHRIA,1
FILGRASTIM,2,56,801,HAEMATOPOIETIC STEM CELL MOBILISATION,INTRAVENOUS,Unknown formulation,RESPIRATORY FAILURE,1
SKYRIZI,2,76,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in pre-filled pen,HEADACHE,1
COBENFY,2,,,SCHIZOPHRENIA,ORAL,,HYPERTENSION,2
ARIPIPRAZOLE,1,52,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,MOVEMENT DISORDER,1
SKYRIZI,1,,,CROHN^S DISEASE,SUBCUTANEOUS,Intravenous infusion,VOMITING,2
TREMFYA,1,56,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,UNDERDOSE,2
TOPROL XL,2,,,CARDIAC DISORDER,ORAL,Tablet,LEUKAEMIA,1
SKYRIZI,2,29,801,CROHN^S DISEASE,SUBCUTANEOUS,,INTESTINAL OBSTRUCTION,1
EDOXABAN TOSYLATE,1,73,801,ATRIAL FIBRILLATION,ORAL,Tablet,EXFOLIATIVE RASH,1
SKYRIZI,1,,,CROHN^S DISEASE,SUBCUTANEOUS,,EYE OPERATION,1
ATENOLOL,1,43,801,HYPERTENSION,ORAL,,PRODUCT DISPENSING ERROR,1
ATTRUBY,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,RASH,2
COBENFY,1,64,801,SCHIZOPHRENIA,ORAL,,EATING DISORDER,1
TOLVAPTAN,1,,,BLOOD CREATININE INCREASED,ORAL,Tablet,MYOCARDIAL INFARCTION,1
SKYRIZI,2,61,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,HYPERSENSITIVITY,2
NOVORAPID,1,74,801,TYPE 2 DIABETES MELLITUS,,Solution for injection,CARDIAC VALVE DISEASE,1
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,VIRAL INFECTION,2
REXULTI,1,85,801,DEMENTIA ALZHEIMER^S TYPE,ORAL,Orodispersible tablet,URINARY RETENTION,1
SKYRIZI,2,76,801,PSORIASIS,SUBCUTANEOUS,,HEPATIC CYST,1
SKYRIZI,1,36,801,CROHN^S DISEASE,SUBCUTANEOUS,,CYST,1
COBENFY,2,,,SCHIZOPHRENIA,ORAL,Capsule,NAUSEA,2
SKYRIZI,1,43,801,CROHN^S DISEASE,SUBCUTANEOUS,,SEIZURE,1
TREMFYA,1,45,801,COLITIS ULCERATIVE,SUBCUTANEOUS,Solution for infusion,RASH,2
COBENFY,1,44,801,SCHIZOPHRENIA,ORAL,,AGITATION,2
GLATIRAMER,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,HYPERSENSITIVITY,2
SKYRIZI,2,73,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,,VARICOSE VEIN,1
LISINOPRIL,2,47,801,HYPERTENSION,ORAL,,ANGIOEDEMA,1
XYWAV,2,,,NARCOLEPSY,ORAL,Oral solution,SPINAL OPERATION,1
TREMFYA,2,37,801,PSORIASIS,SUBCUTANEOUS,,URINARY TRACT INFECTION,2
SPRAVATO,2,,,DEPRESSION,NASAL,Nasal spray,SURGERY,1
FLUOXETINE,2,17,801,ILL-DEFINED DISORDER,ORAL,"Capsule, hard",POOR QUALITY SLEEP,1
LEVOFLOXACIN,2,16,801,STAPHYLOCOCCAL INFECTION,INTRAVENOUS,Unknown,ARTHRALGIA,1
SKYRIZI,1,,,CROHN^S DISEASE,SUBCUTANEOUS,,SURGERY,1
TREMFYA,2,,,PSORIASIS,SUBCUTANEOUS,Unknown,EXFOLIATIVE RASH,2
ARIPIPRAZOLE,2,28,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,GAMBLING DISORDER,1
PREDNISOLONE,1,74,801,MANTLE CELL LYMPHOMA STAGE IV,ORAL,Unknown,ACUTE MYELOID LEUKAEMIA,1
ADAPALENE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,TOPICAL,Gel,DRUG INEFFECTIVE,2
TREMFYA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,PRODUCT DOSE OMISSION ISSUE,2
ADAPALENE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,TOPICAL,Gel,DRUG INEFFECTIVE,2
RITUXIMAB,1,63,801,CHRONIC LYMPHOCYTIC LEUKAEMIA,INTRAVENOUS,,LYMPHADENITIS VIRAL,2
TREMFYA,2,62,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Unknown,HERPES ZOSTER,1
ADAPALENE,1,15,801,ACNE,TOPICAL,Gel,DRUG INEFFECTIVE,2
SPRAVATO,1,73,801,DEPRESSION,NASAL,Nasal spray,KNEE OPERATION,1
AMPICILLIN,1,61,801,LISTERIA ENCEPHALITIS,INTRAMUSCULAR,Unknown,CONDITION AGGRAVATED,1
TREMFYA,2,45,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,PRODUCT DOSE OMISSION ISSUE,2
CONTRAVE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,NAUSEA,2
ARIPIPRAZOLE,2,,,PSYCHOTIC DISORDER,ORAL,Tablet,TRISMUS,1
SPRAVATO,1,75,801,DEPRESSION,NASAL,Nasal spray,ACUTE CORONARY SYNDROME,1
SKYRIZI,1,79,801,PSORIASIS,SUBCUTANEOUS,Injection,COVID-19,2
TREMFYA,1,39,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,SYNCOPE,1
SKYRIZI,1,62,801,CROHN^S DISEASE,SUBCUTANEOUS,,ATRIAL FIBRILLATION,1
CYCLOPHOSPHAMIDE,2,,,RETINOBLASTOMA,INTRAVENOUS,,MALIGNANT NEOPLASM PROGRESSION,1
SKYRIZI,2,80,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,KNEE OPERATION,1
MOUNJARO,2,45,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in cartridge,MYALGIA,1
HUMIRA,2,62,801,COLITIS ULCERATIVE,,Solution for injection in pre-filled pen,ARTHRITIS,1
ENSPRYNG,2,76,801,NEUROMYELITIS OPTICA SPECTRUM DISORDER,SUBCUTANEOUS,,PAIN IN EXTREMITY,2
LISINOPRIL,1,78,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,MALIGNANT NEOPLASM PROGRESSION,1
SKYRIZI,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,SURGERY,1
ARIPIPRAZOLE,2,21,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,MYASTHENIA GRAVIS,1
AFINITOR,2,69,801,PANCREATIC NEUROENDOCRINE TUMOUR,ORAL,Tablet,PANCREATIC NEUROENDOCRINE TUMOUR,1
SKYRIZI,1,20,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection,NAUSEA,1
QINLOCK,1,69,801,GASTROINTESTINAL STROMAL TUMOUR,ORAL,Tablet,SINUSITIS,2
EPIRUBICIN,2,41,801,BREAST CANCER,,,PAIN,1
SKYRIZI,1,,,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,ANAL ABSCESS,1
SKYRIZI,2,64,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in cartridge,FRACTURE PAIN,1
SPRAVATO,2,8,800,DEPRESSION,NASAL,Nasal spray,SEPSIS,1
AMPHETAMINE SULFATE,1,61,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,INTESTINAL ISCHAEMIA,1
TREMFYA,1,,,PSORIASIS,SUBCUTANEOUS,Solution for injection,LOWER RESPIRATORY TRACT INFECTION,1
SKYRIZI,1,43,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,CEREBROVASCULAR ACCIDENT,1
SPRAVATO,2,,,DEPRESSION,NASAL,Nasal spray,DRUG INEFFECTIVE,2
SKYRIZI,1,69,801,CROHN^S DISEASE,SUBCUTANEOUS,,GAIT INABILITY,1
LISINOPRIL,2,89,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ANGIOEDEMA,1
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,,ABORTION SPONTANEOUS,1
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,,TUBERCULOSIS,1
DALFAMPRIDINE,1,60,801,MULTIPLE SCLEROSIS,ORAL,,MULTIPLE SCLEROSIS,2
ERTAPENEM,2,82,801,OSTEOMYELITIS,INTRAMUSCULAR,,ENCEPHALOPATHY,1
SKYRIZI,2,77,801,CROHN^S DISEASE,SUBCUTANEOUS,,WRIST FRACTURE,1
SKYRIZI,1,58,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in cartridge,INTESTINAL RESECTION,1
SKYRIZI,1,27,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for infusion,CHOLECYSTECTOMY,1
TOLVAPTAN,1,,,CONGENITAL CYSTIC KIDNEY DISEASE,ORAL,Tablet,RENAL IMPAIRMENT,1
LENALIDOMIDE,1,74,801,CHRONIC KIDNEY DISEASE,ORAL,,PAIN,2
SKYRIZI,1,,,PSORIASIS,SUBCUTANEOUS,,MELANOCYTIC NAEVUS,2
TREMFYA,2,67,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,PRODUCT STORAGE ERROR,2
JARDIANCE,2,,,DIABETES MELLITUS,ORAL,,GLUCOSE URINE PRESENT,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DRY SKIN,2
JAKAFI,1,86,801,,ORAL,,GOUT,1
SKYRIZI,2,55,801,PSORIASIS,SUBCUTANEOUS,Injection,INFLUENZA,2
ADAPALENE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,TOPICAL,Gel,DRUG INEFFECTIVE,2
SKYRIZI,2,76,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection,CATARACT,1
VABYSMO,2,90,801,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,INTRAVITREAL,Injection,ATRIAL FIBRILLATION,1
QINLOCK,1,89,801,GASTROINTESTINAL STROMAL TUMOUR,ORAL,Tablet,GROIN PAIN,1
ARIPIPRAZOLE,1,24,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Suspension for injection,BLOOD FOLLICLE STIMULATING HORMONE DECREASED,1
SPRAVATO,1,,,DEPRESSION,NASAL,Nasal spray,HOSPITALISATION,1
SKYRIZI,1,70,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,HYPERTENSION,1
SKYRIZI,1,55,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection,HAEMORRHAGE,1
ARIPIPRAZOLE,2,54,801,HYPERPROLACTINAEMIA,ORAL,Tablet,BREAST PAIN,1
SKYRIZI,1,,,CROHN^S DISEASE,SUBCUTANEOUS,,SPEECH DISORDER,2
PROMACTA,2,,,IMMUNE THROMBOCYTOPENIA,ORAL,,COUGH,2
SKYRIZI,1,21,801,CROHN^S DISEASE,SUBCUTANEOUS,,ILEOSTOMY CLOSURE,1
EPIRUBICIN,2,47,801,BREAST CANCER,,,NEUTROPENIA,1
TREMFYA,1,59,801,PSORIASIS,SUBCUTANEOUS,,THERAPY INTERRUPTED,1
TADALAFIL,1,71,801,,ORAL,,ILLICIT PRESCRIPTION ATTAINMENT,2
TREMFYA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,DEVICE DEPLOYMENT ISSUE,2
ESMOLOL HYDROCHLORIDE,1,67,801,VASCULAR OPERATION,INTRAVENOUS,,RESPIRATORY ARREST,1
SPRAVATO,2,56,801,DEPRESSION,NASAL,Nasal spray,SURGERY,1
XGEVA,2,26,801,BONE GIANT CELL TUMOUR,SUBCUTANEOUS,Solution for injection,BONE GIANT CELL TUMOUR,1
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,Intravenous infusion,MYOCARDITIS,1
SKYRIZI,1,57,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in cartridge,INTESTINAL RESECTION,1
SPRAVATO,1,5,800,DEPRESSION,NASAL,Nasal spray,DEATH,1
BACLOFEN,1,62,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,COMPLETED SUICIDE,1
LACOSAMIDE,2,77,801,SEIZURE,ORAL,,BALANCE DISORDER,1
TREMFYA,2,49,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Solution for injection in pre-filled pen,DEVICE ISSUE,2
NOVORAPID,1,43,801,TYPE 2 DIABETES MELLITUS,,Solution for injection,GOUTY TOPHUS,1
SPRAVATO,2,,,MAJOR DEPRESSION,NASAL,Nasal spray,DRUG INEFFECTIVE,2
MAYZENT,1,45,801,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,ORAL,Film-coated tablet,INFECTION,1
ESCITALOPRAM,1,3,804,ADJUSTMENT DISORDER,ORAL,Tablet,SEIZURE,1
SKYRIZI,2,53,801,CROHN^S DISEASE,SUBCUTANEOUS,,SMALL INTESTINAL OBSTRUCTION,1
BORTEZOMIB,1,63,801,PLASMA CELL MYELOMA,INTRAVENOUS,Injection,PLASMA CELL MYELOMA RECURRENT,1
IBRANCE,2,79,801,BREAST CANCER STAGE IV,ORAL,Film-coated tablet,RESPIRATORY FAILURE,1
SKYRIZI,2,70,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in pre-filled injector,AORTIC ANEURYSM,1
SKYRIZI,2,72,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,BREAST CANCER,1
TRAZODONE HYDROCHLORIDE,1,54,801,BIPOLAR I DISORDER,ORAL,,CONDITION AGGRAVATED,1
INDOMETHACIN,2,5,804,PATENT DUCTUS ARTERIOSUS,ORAL,,NECROTISING COLITIS,1
FLUCONAZOLE,2,83,801,SYSTEMIC CANDIDA,ORAL,,HEPATIC CYTOLYSIS,1
INVEGA,1,21,801,SCHIZOPHRENIA,ORAL,Prolonged-release tablet,DYSDIADOCHOKINESIS,1
SKYRIZI,1,85,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in pre-filled injector,INJECTION SITE URTICARIA,2
EPIRUBICIN HYDROCHLORIDE,2,45,801,CHEMOTHERAPY,INTRAVENOUS,Powder for solution for injection,MYELOSUPPRESSION,1
TREMFYA,1,40,801,PSORIASIS,SUBCUTANEOUS,Unknown,DERMATITIS EXFOLIATIVE GENERALISED,1
COBENFY,2,59,801,SCHIZOPHRENIA,ORAL,,BRUXISM,2
SKYRIZI,2,74,801,CROHN^S DISEASE,SUBCUTANEOUS,,DEATH,1
CERTOLIZUMAB PEGOL,2,39,801,ANKYLOSING SPONDYLITIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,ANKYLOSING SPONDYLITIS,1
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE,1,77,801,HYPERTENSION,ORAL,,SPRUE-LIKE ENTEROPATHY,1
SKYRIZI,1,37,801,PSORIASIS,SUBCUTANEOUS,,CYST,1
SKYRIZI,1,,,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection,CHEMOTHERAPY,1
SPRAVATO,2,,,PRODUCT USED FOR UNKNOWN INDICATION,NASAL,Nasal spray,ANXIETY,2
LACOSAMIDE,2,85,801,SEIZURE,ORAL,Film-coated tablet,VIRAL INFECTION,1
BUSULFAN,2,,,IMMUNODEFICIENCY,INTRAVENOUS,Injection,PREMATURE MENOPAUSE,1
SPRAVATO,2,68,801,PRODUCT USED FOR UNKNOWN INDICATION,NASAL,Nasal spray,RASH PRURITIC,2
SKYRIZI,2,26,801,CROHN^S DISEASE,SUBCUTANEOUS,,BLOOD IRON DECREASED,1
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,,SKIN CANCER,1
AFINITOR,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,MOUTH ULCERATION,2
AMPICILLIN,2,,,ANTIBIOTIC PROPHYLAXIS,INTRAMUSCULAR,Unknown,AMNIOTIC CAVITY INFECTION,1
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in cartridge,GASTROINTESTINAL INFLAMMATION,1
BACLOFEN,2,75,801,MULTIPLE SCLEROSIS,ORAL,,DRUG INEFFECTIVE,1
TREMFYA,2,58,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,PAIN,2
ESTRADIOL\NORETHINDRONE ACETATE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Transdermal patch,HYPERSENSITIVITY,2
SKYRIZI,1,50,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,CEREBROVASCULAR ACCIDENT,1
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,,SPINAL FUSION SURGERY,1
TREMFYA,1,90,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,PNEUMONIA,1
DEXAMETHASONE SODIUM PHOSPHATE,2,68,801,PLASMA CELL MYELOMA,INTRAMUSCULAR,,MYELOSUPPRESSION,1
VARENICLINE,2,43,801,ADVERSE DRUG REACTION,ORAL,Unknown,MYOPIA,2
LACOSAMIDE,2,12,801,PARTIAL SEIZURES,ORAL,,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
QINLOCK,2,65,801,GASTROINTESTINAL STROMAL TUMOUR,ORAL,Tablet,INFECTION,2
SKYRIZI,2,42,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,,DEEP VEIN THROMBOSIS,1
XGEVA,1,33,801,BONE GIANT CELL TUMOUR,SUBCUTANEOUS,Unknown formulation,METASTASES TO LUNG,1
LORLATINIB,2,53,801,LUNG CANCER METASTATIC,ORAL,Film-coated tablet,HYPERTENSION,1
DILAUDID,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAMUSCULAR,Tablet,HYPERTENSION,2
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection,MALAISE,2
RITUXIMAB,1,63,801,DIFFUSE LARGE B-CELL LYMPHOMA,INTRAVENOUS,,SEPSIS,1
SKYRIZI,2,70,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in pre-filled injector,INTESTINAL RESECTION,1
COBENFY,1,46,801,SCHIZOPHRENIA,ORAL,Capsule,DECREASED APPETITE,2
TADALAFIL,1,44,801,SEXUAL DYSFUNCTION,ORAL,,HYPOACUSIS,1
SKYRIZI,1,,,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,MENTAL DISORDER,1
CYCLOPHOSPHAMIDE,2,,,ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES,INTRAVENOUS,Unknown,B-CELL APLASIA,1
SKYRIZI,2,74,801,PSORIASIS,SUBCUTANEOUS,,CARDIAC ABLATION,1
BUSULFEX,2,17,801,ACUTE MYELOID LEUKAEMIA,INTRAVENOUS,Injection,CARDIOTOXICITY,1
TADALAFIL,1,70,801,PULMONARY ARTERIAL HYPERTENSION,ORAL,Tablet,PULMONARY ARTERIAL HYPERTENSION,1
KOVALTRY,1,37,801,FACTOR VIII DEFICIENCY,,Powder and solvent for solution for injection,HAEMARTHROSIS,1
SKYRIZI,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,SUICIDE THREAT,1
DUPIXENT,2,8,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DRY SKIN,2
MEROPENEM,2,,,SEPSIS NEONATAL,INTRAVENOUS,,NEONATAL CHOLESTASIS,1
SKYRIZI,2,31,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in pre-filled injector,MALAISE,2
SPRAVATO,1,24,801,DEPRESSION,NASAL,Nasal spray,ADVERSE EVENT,1
SKYRIZI,2,63,801,PSORIASIS,SUBCUTANEOUS,Injection,UPPER RESPIRATORY TRACT INFECTION,2
CANDESARTAN,2,56,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,ASTHMA,1
LISINOPRIL,1,24,801,HYPERTENSION,ORAL,Tablet,AQUAGENIC WRINKLING OF PALMS,1
SKYRIZI,2,64,801,CROHN^S DISEASE,SUBCUTANEOUS,,BRONCHITIS,1
SKYRIZI,1,73,801,PSORIASIS,SUBCUTANEOUS,,HIP ARTHROPLASTY,1
SKYRIZI,1,,,DERMATITIS ATOPIC,SUBCUTANEOUS,,DRUG INEFFECTIVE,2
SKYRIZI,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,SPINAL FRACTURE,1
SPRAVATO,2,,,PRODUCT USED FOR UNKNOWN INDICATION,NASAL,Nasal spray,CROHN^S DISEASE,1
ATENOLOL,2,35,802,INFANTILE HAEMANGIOMA,ORAL,,THERAPY PARTIAL RESPONDER,1
SKYRIZI,1,,,PSORIASIS,SUBCUTANEOUS,,EYE OPERATION,1
DUPIXENT,1,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,THERAPEUTIC RESPONSE DECREASED,2
TADALAFIL,2,,,PULMONARY ARTERIAL HYPERTENSION,ORAL,,PNEUMONIA,1
SKYRIZI,1,71,801,PSORIASIS,SUBCUTANEOUS,,PNEUMONIA,1
LENACAPAVIR,1,59,801,HIV INFECTION,,Injection,RASH PAPULAR,1
ADAPALENE,2,,,RASH,TOPICAL,Gel,DRUG INEFFECTIVE,2
DEPAKOTE,1,80,801,EPILEPSY,ORAL,,FALL,1
METHOTREXATE SODIUM,1,15,801,DIFFUSE LARGE B-CELL LYMPHOMA,INTRA-ARTERIAL,Solution for injection,MUCOSAL INFLAMMATION,1
SKYRIZI,2,62,801,PSORIASIS,SUBCUTANEOUS,,CEREBROVASCULAR ACCIDENT,1
SKYRIZI,1,,,CROHN^S DISEASE,SUBCUTANEOUS,,LYMPHADENECTOMY,1
TREMFYA,2,,,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Solution for injection in pre-filled pen,NEEDLE ISSUE,2
SKYRIZI,1,41,801,CROHN^S DISEASE,SUBCUTANEOUS,,FATIGUE,1
RINVOQ,1,70,801,DERMATITIS ATOPIC,ORAL,Tablet,ROTATOR CUFF SYNDROME,1
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,,RENAL DISORDER,1
TOLVAPTAN,2,,,POLYURIA,ORAL,Tablet,CARDIAC FAILURE,1
TADALAFIL,1,69,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Film-coated tablet,PROSTATE CANCER,1
SKYRIZI,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,HYPERSENSITIVITY,2
EXEMESTANE,2,39,801,BREAST CANCER,ORAL,Coated tablet,DRUG-INDUCED LIVER INJURY,1
SKYRIZI,2,,,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Solution for injection in pre-filled pen,BREAST CANCER FEMALE,1
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,,NEOPLASM MALIGNANT,1
SPRAVATO,1,,,DEPRESSION,NASAL,Nasal spray,HOSPITALISATION,1
SKYRIZI,1,84,801,PSORIASIS,SUBCUTANEOUS,,ABSCESS LIMB,1
DOXORUBICIN,2,59,801,NON-HODGKIN^S LYMPHOMA,INTRAVENOUS,,ACUTE MYOCARDIAL INFARCTION,1
CONTRAVE,2,31,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,URTICARIA,2
SKYRIZI,2,52,801,CROHN^S DISEASE,SUBCUTANEOUS,,STOMA CREATION,1
DEPAKOTE,1,,,PETIT MAL EPILEPSY,ORAL,,OFF LABEL USE,2
SKYRIZI,1,,,PSORIASIS,SUBCUTANEOUS,,SKIN CANCER,1
LITFULO,2,60,801,ALOPECIA,ORAL,Capsule,URTICARIA,2
SKYRIZI,2,72,801,PSORIASIS,SUBCUTANEOUS,Injection,EAR INFECTION,2
OBINUTUZUMAB,2,54,801,FOLLICULAR LYMPHOMA,INTRAVENOUS,Injection,MYELOSUPPRESSION,1
TOLVAPTAN,1,71,801,OEDEMA,ORAL,Tablet,PERIPHERAL SWELLING,1
SKYRIZI,1,61,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in pre-filled injector,MALAISE,2
ISONIAZID,2,4,800,PULMONARY TUBERCULOSIS,ORAL,,TOXICITY TO VARIOUS AGENTS,1
CERTOLIZUMAB PEGOL,2,82,801,RHEUMATOID ARTHRITIS,SUBCUTANEOUS,,FALL,1
PALBOCICLIB,2,57,801,BREAST CANCER,ORAL,Capsule,MYELOSUPPRESSION,1
ADAPALENE,1,15,801,ACNE,TOPICAL,Gel,DRUG INEFFECTIVE,2
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,,BLOOD IRON DECREASED,1
CYCLOPHOSPHAMIDE,1,55,801,CHRONIC LYMPHOCYTIC LEUKAEMIA,INTRAVENOUS,,NOCARDIOSIS,1
SKYRIZI,2,67,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Solution for injection in pre-filled pen,OVARIAN CANCER,1
RIFAMPIN,1,48,801,TUBERCULOSIS,INTRAVENOUS,Unknown,TREATMENT FAILURE,1
FENTANYL,1,2,803,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,Unknown,PREMATURE BABY,1
PYZCHIVA,2,,,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in pre-filled syringe,HAEMATOCHEZIA,1
SKYRIZI,2,74,801,PSORIASIS,SUBCUTANEOUS,,SPINAL OPERATION,1
TREMFYA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Unknown,ADVERSE EVENT,2
SKYRIZI,2,66,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in pre-filled injector,INJECTION SITE BRUISING,2
SKYRIZI,1,55,801,PSORIASIS,SUBCUTANEOUS,,HIP SURGERY,1
TREMFYA,2,63,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,ASPARTATE AMINOTRANSFERASE INCREASED,1
METHYLPREDNISOLONE SODIUM SUCCINATE,1,,,CEREBELLAR ATAXIA,INTRAMUSCULAR,Injection,DRUG INEFFECTIVE,1
NUPLAZID,2,,,PARKINSON^S DISEASE,ORAL,Capsule,VOMITING,2
AMBRISENTAN,1,81,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,DEATH,1
REVLIMID,1,78,801,PLASMA CELL MYELOMA,ORAL,Capsule,CONSTIPATION,2
SKYRIZI,1,,,PSORIASIS,SUBCUTANEOUS,,HIP ARTHROPLASTY,1
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in pre-filled injector,INJECTION SITE HAEMORRHAGE,2
CYCLOPHOSPHAMIDE,2,0,804,ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES,INTRAVENOUS,,B-CELL APLASIA,1
SKYRIZI,1,61,801,CROHN^S DISEASE,SUBCUTANEOUS,,FEELING ABNORMAL,1
HYDROXYCHLOROQUINE,1,23,801,SYSTEMIC LUPUS ERYTHEMATOSUS,ORAL,,THERAPY NON-RESPONDER,1
TREMFYA,2,48,801,PSORIASIS,SUBCUTANEOUS,Injection,NASOPHARYNGITIS,2
QINLOCK,2,61,801,GASTROINTESTINAL STROMAL TUMOUR,ORAL,Tablet,DISEASE PROGRESSION,2
SKYRIZI,2,38,801,CROHN^S DISEASE,SUBCUTANEOUS,,ILEOSTOMY,1
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,,SMALL INTESTINAL OBSTRUCTION,1
VTAMA,1,42,801,PSORIASIS,TOPICAL,,INFLUENZA LIKE ILLNESS,1
DUPIXENT,2,72,801,ILLNESS,SUBCUTANEOUS,Solution for injection,ILLNESS,2
LITFULO,2,14,801,,ORAL,Capsule,NASOPHARYNGITIS,2
SKYRIZI,1,,,PSORIASIS,SUBCUTANEOUS,,COCHLEA IMPLANT,1
TREMFYA,2,36,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
SPRAVATO,2,45,801,DEPRESSION,NASAL,Nasal spray,SEIZURE,1
SKYRIZI,1,76,801,CROHN^S DISEASE,SUBCUTANEOUS,,MALIGNANT MELANOMA,1
TOLVAPTAN,2,,,CONGENITAL CYSTIC KIDNEY DISEASE,ORAL,Tablet,HAEMATOCHEZIA,1
ALLOPURINOL,2,72,801,HYPERURICAEMIA,INTRAVENOUS,Tablet,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
SKYRIZI,1,44,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection,HAEMORRHAGE,1
SKYRIZI,2,,,HIDRADENITIS,SUBCUTANEOUS,,HOSPITALISATION,1
TREMFYA,1,64,801,PSORIASIS,SUBCUTANEOUS,,INFLUENZA,1
SKYRIZI,1,73,801,COLITIS ULCERATIVE,SUBCUTANEOUS,,MACULAR OEDEMA,1
TREMFYA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for infusion,HYPOAESTHESIA,2
OPSUMIT,2,65,801,PULMONARY ARTERIAL HYPERTENSION,ORAL,Tablet,INFLUENZA,1
ARIPIPRAZOLE,1,43,801,BIPOLAR DISORDER,ORAL,Tablet,SLEEP APNOEA SYNDROME,1
QINLOCK,2,62,801,GASTROINTESTINAL STROMAL TUMOUR,ORAL,Tablet,MUSCLE SPASMS,2
COBENFY,2,37,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,ANGER,2
SKYRIZI,2,55,801,PSORIASIS,SUBCUTANEOUS,,ARTHROPATHY,1
SKYRIZI,1,57,801,PSORIASIS,SUBCUTANEOUS,,MEDICAL DEVICE BATTERY REPLACEMENT,1
TREMFYA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,DEVICE DEPLOYMENT ISSUE,2
ADRIACIN,2,63,801,PRODUCT USED FOR UNKNOWN INDICATION,,Solution for injection,DISEASE PROGRESSION,1
CEFIDEROCOL,1,76,801,VASCULAR GRAFT INFECTION,,Injection,POST PROCEDURAL HAEMORRHAGE,1
CONTRAVE,2,,,WEIGHT CONTROL,ORAL,Tablet,HYPERHIDROSIS,2
SKYRIZI,2,52,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,BREAST CANCER,1
SKYRIZI,1,,,CROHN^S DISEASE,SUBCUTANEOUS,,CHEMOTHERAPY,1
SKYRIZI,1,,,PSORIASIS,SUBCUTANEOUS,,CEREBROVASCULAR ACCIDENT,1
TREMFYA,1,43,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,PNEUMONIA,1
SKYRIZI,1,87,801,PSORIASIS,SUBCUTANEOUS,,LYMPHOEDEMA,1
VANCOMYCIN,1,70,801,SEPSIS,INTRAVENOUS,,DRUG INEFFECTIVE,1
SKYRIZI,2,68,801,PSORIASIS,SUBCUTANEOUS,,ROTATOR CUFF SYNDROME,1
MANNITOL,1,52,801,PERIARTHRITIS,RESPIRATORY (INHALATION),Solution for infusion,TREMOR,1
ADCETRIS,1,39,801,T-CELL LYMPHOMA,INTRAVENOUS,Powder for solution for injection,SEIZURE,1
EPIRUBICIN HYDROCHLORIDE,2,44,801,CHEMOTHERAPY,INTRAVENOUS,Powder for solution for injection,TRANSAMINASES INCREASED,1
TREMFYA,2,,,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,RESPIRATORY TRACT INFECTION,1
TREMFYA,2,65,801,PSORIASIS,SUBCUTANEOUS,Unknown,PRODUCT DOSE OMISSION ISSUE,2
DOXORUBICIN,1,9,800,DIFFUSE LARGE B-CELL LYMPHOMA,INTRAVENOUS,Unknown,PLASMA CELL MYELOMA,1
OZEMPIC,2,48,801,GLUCOSE TOLERANCE IMPAIRED,SUBCUTANEOUS,Solution for injection,RENAL ARTERY STENOSIS,1
CYCLOPHOSPHAMIDE,1,69,801,NON-HODGKIN^S LYMPHOMA,INTRAVENOUS,Unknown,IMMUNOSUPPRESSION,1
VERAPAMIL HYDROCHLORIDE,1,66,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,,COMPLETED SUICIDE,1
PYZCHIVA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Injection,FLATULENCE,1
TREMFYA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled syringe,PNEUMONIA,1
SKYRIZI,2,60,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,DEEP VEIN THROMBOSIS,1
COBENFY,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,BALANCE DISORDER,2
SKYRIZI,2,19,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,SYNCOPE,1
ADAPALENE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,TOPICAL,Gel,SKIN BURNING SENSATION,2
SKYRIZI,2,51,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,MYOCARDIAL INFARCTION,1
TREMFYA,1,82,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,DEVICE DEPLOYMENT ISSUE,2
SKYRIZI,2,69,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,,BLINDNESS,1
DEXAMETHASONE SODIUM PHOSPHATE,2,58,801,PLASMA CELL MYELOMA,INTRAMUSCULAR,,MYELOSUPPRESSION,1
VEDOLIZUMAB,1,,,CROHN^S DISEASE,SUBCUTANEOUS,Powder for solution for infusion,EAR INFECTION,1
COBENFY,1,39,801,SCHIZOPHRENIA,ORAL,,NAUSEA,2
SKYRIZI,1,40,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,CHOLELITHIASIS,1
VEDOLIZUMAB,1,24,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Infusion,HAEMATOCHEZIA,1
ADVATE,2,45,801,PRODUCT USED FOR UNKNOWN INDICATION,,Powder and solvent for solution for infusion,HAEMORRHAGE,1
KESIMPTA,1,,,,SUBCUTANEOUS,Solution for injection,MULTIPLE SCLEROSIS RELAPSE,1
IBRUTINIB,1,68,801,CHRONIC LYMPHOCYTIC LEUKAEMIA,ORAL,Unknown,ATRIAL FIBRILLATION,1
GOLD BOND ORIGINAL STRENGTH,2,78,801,PRODUCT USED FOR UNKNOWN INDICATION,,Powder,MESOTHELIOMA,1
DUPIXENT,1,66,801,ASTHMA,SUBCUTANEOUS,Solution for injection,DYSPNOEA,2
OTEZLA,2,76,801,,ORAL,Tablets,INTESTINAL OBSTRUCTION,2
ELIGARD,1,80,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,INTERCEPTED PRODUCT PREPARATION ERROR,2
AYVAKIT,2,54,801,MASTOCYTOMA,ORAL,Tablet,GASTROINTESTINAL DISORDER,2
BEOVU,1,61,801,DIABETIC RETINAL OEDEMA,INTRAVITREAL,Solution for injection in pre-filled syringe,CEREBRAL INFARCTION,1
XARELTO,1,60,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Film-coated tablet,HAEMOGLOBIN DECREASED,1
VERZENIO,2,50,801,BREAST CANCER,ORAL,Tablet,GINGIVITIS,2
BAVENCIO,2,65,801,TRANSITIONAL CELL CARCINOMA,INTRAVENOUS,,METASTASES TO LUNG,1
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION,2
NYVEPRIA,1,,,NEUTROPENIA,SUBCUTANEOUS,,PNEUMONIA,1
GENOTROPIN,1,10,801,,,Solution for injection,DRUG DOSE OMISSION BY DEVICE,2
ZEPOSIA,2,30,801,MULTIPLE SCLEROSIS,ORAL,Capsule,HYPOAESTHESIA,2
DARAPRIM,1,,,TOXOPLASMOSIS,ORAL,Tablet,ILLNESS,2
RUXIENCE,1,43,801,,INTRAVENOUS,Solution for infusion,RESPIRATORY DISTRESS,1
DUPIXENT,2,4,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
ZOLEDRONIC ACID,2,82,801,OSTEOPOROSIS,INTRAVENOUS,,MYOCARDIAL INFARCTION,1
CLARAVIS,2,25,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Capsule,ANXIETY,1
XOLAIR PFS,2,48,801,IDIOPATHIC URTICARIA,SUBCUTANEOUS,"INJECTION, SOLUTION",OFF LABEL USE,2
TRIUMEQ,1,59,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Film-coated tablet,PRODUCT DOSE OMISSION ISSUE,2
ELIGARD,1,73,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,INTERCEPTED PRODUCT PREPARATION ERROR,2
EVRYSDI,2,31,801,SPINAL MUSCULAR ATROPHY,ORAL,,ANAEMIA,1
BARICITINIB,1,64,801,RHEUMATOID ARTHRITIS,ORAL,,INTESTINAL PERFORATION,1
TYLENOL,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
NUPLAZID,1,82,801,PARKINSON^S DISEASE,ORAL,Capsule,SOMNOLENCE,2
LINACLOTIDE,2,,,DIVERTICULITIS,ORAL,,OFF LABEL USE,2
HUMIRA,2,,,PSORIASIS,,,BLINDNESS,1
TARPEYO,1,74,801,IGA NEPHROPATHY,ORAL,Prolonged-release capsule,FATIGUE,2
VELSIPITY,1,,,,ORAL,Film-coated tablet,COLITIS ULCERATIVE,1
OZEMPIC,1,,,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,HOSPITALISATION,1
MOUNJARO,1,73,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,EXTRA DOSE ADMINISTERED,2
XOLAIR,1,,,IDIOPATHIC URTICARIA,SUBCUTANEOUS,Direct auto-injector,OFF LABEL USE,2
MOUNJARO,1,73,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INCORRECT DOSE ADMINISTERED,2
RESTASIS,2,,,DRY EYE,OPHTHALMIC,,MULTIPLE USE OF SINGLE-USE PRODUCT,2
DUPIXENT,2,31,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,2,60,801,NEURODERMATITIS,SUBCUTANEOUS,Solution for injection,NAUSEA,2
DUPIXENT,2,38,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
VEKLURY,2,17,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Injection,CARDIAC ARREST,1
FINTEPLA,2,6,801,SEVERE MYOCLONIC EPILEPSY OF INFANCY,ORAL,Oral solution,SEIZURE,1
XELJANZ XR,2,60,801,,ORAL,Prolonged-release tablet,HEADACHE,2
FERRIC CITRATE ANHYDROUS,2,33,801,IRON DEFICIENCY ANAEMIA,,Tablet,PLATELET COUNT DECREASED,1
AYVAKIT,2,51,801,ADVANCED SYSTEMIC MASTOCYTOSIS,ORAL,Unknown,CHOLELITHIASIS,1
CARBIDOPA\LEVODOPA,1,72,801,PARKINSON^S DISEASE,,Intestinal gel,DEATH,1
XELJANZ XR,2,65,801,,ORAL,Prolonged-release tablet,NASOPHARYNGITIS,2
SPRYCEL,2,24,801,CHRONIC MYELOID LEUKAEMIA,ORAL,,MUSCULAR WEAKNESS,2
DUPIXENT,2,80,801,PEMPHIGOID,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
TYSABRI,2,,,MULTIPLE SCLEROSIS,INTRAVENOUS,Infusion,RASH,2
FINASTERIDE,1,46,801,ANDROGENETIC ALOPECIA,ORAL,,TINNITUS,1
SAXENDA,2,51,801,OBESITY,SUBCUTANEOUS,Solution for injection,MENISCUS INJURY,1
TEDUGLUTIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,PNEUMONIA,1
CABENUVA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,,Suspension for injection,OFF LABEL USE,2
NUZYRA,1,67,801,MYCOBACTERIAL INFECTION,INTRAVENOUS,Tablet,WRIST SURGERY,1
LUMIGAN,2,,,PRODUCT USED FOR UNKNOWN INDICATION,OPHTHALMIC,"Eye drops, solution",BLINDNESS,1
ERLEADA,1,95,801,HORMONE-DEPENDENT PROSTATE CANCER,ORAL,Film-coated tablet,NERVOUS SYSTEM DISORDER,2
METRELEPTIN,2,,,CONGENITAL GENERALISED LIPODYSTROPHY,SUBCUTANEOUS,Powder for solution for injection,ACUTE KIDNEY INJURY,1
DARZALEX,1,71,801,PLASMA CELL MYELOMA,INTRAVENOUS,Concentrate for solution for infusion,ACUTE KIDNEY INJURY,1
BEMPEDOIC ACID,2,,,LOW DENSITY LIPOPROTEIN INCREASED,ORAL,Film-coated tablet,PRODUCT DISPENSING ERROR,2
KESIMPTA,2,32,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,DISEASE PROGRESSION,1
LENALIDOMIDE,1,74,801,PLASMA CELL MYELOMA,ORAL,Capsule,GLAUCOMA,1
XOLAIR PFS,2,,,ASTHMA,SUBCUTANEOUS,Solution for injection in pre-filled syringe,ANAPHYLACTIC REACTION,1
QULIPTA,2,,,MIGRAINE,ORAL,,ABNORMAL DREAMS,2
LUPRON,1,93,801,PROSTATE CANCER,,Suspension for injection in pre-filled syringe,URINARY RETENTION,1
DUPIXENT,2,64,801,ASTHMA,SUBCUTANEOUS,Solution for injection,MIDDLE INSOMNIA,2
ZEPOSIA,1,64,801,COLITIS,ORAL,,DRUG INEFFECTIVE,2
REVLIMID,2,47,801,PLASMA CELL MYELOMA,ORAL,Capsule,HYPOAESTHESIA,2
GLECAPREVIR\PIBRENTASVIR,2,62,801,HEPATITIS C,,,LIP OEDEMA,1
CABOMETYX,2,,,RENAL CANCER,ORAL,Tablet,MUSCLE TWITCHING,2
CABOMETYX,1,,,RENAL CELL CARCINOMA,ORAL,Tablet,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,2
ZEPOSIA,2,46,801,COLITIS ULCERATIVE,ORAL,Capsule,HAEMORRHOIDS,2
ELIGARD,1,,,PROSTATE CANCER,SUBCUTANEOUS,Injection,DEMENTIA,1
KORSUVA,1,66,801,PRURITUS,INTRAVENOUS,"INJECTION, SOLUTION",CEREBRAL INFARCTION,1
HUMIRA,2,41,801,HIDRADENITIS,,Injection,INFLUENZA,2
DUPIXENT,1,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
TARPEYO,1,33,801,IGA NEPHROPATHY,ORAL,Prolonged-release capsule,PRODUCT DOSE OMISSION ISSUE,2
LUPKYNIS,2,,,LUPUS NEPHRITIS,ORAL,Softgel capsule,THERAPY INTERRUPTED,2
LUPKYNIS,2,38,801,LUPUS NEPHRITIS,ORAL,Softgel capsule,THERAPY INTERRUPTED,2
DUPIXENT,2,72,801,NEURODERMATITIS,SUBCUTANEOUS,Solution for injection,PRURITUS,2
MOUNJARO,1,63,801,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,INCORRECT DOSE ADMINISTERED,2
OCREVUS,2,40,801,RELAPSING-REMITTING MULTIPLE SCLEROSIS,INTRAVENOUS,Infusion,HERPES ZOSTER DISSEMINATED,1
ALPROLIX,1,50,801,FACTOR IX DEFICIENCY,,Powder and solvent for solution for injection,HAEMORRHAGE,2
DUPIXENT,1,53,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
LENACAPAVIR,1,,,HIV INFECTION,,Injection,INJECTION SITE MASS,1
VELSIPITY,1,66,801,,ORAL,Film-coated tablet,INFREQUENT BOWEL MOVEMENTS,2
DUPIXENT,2,44,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PRODUCT USE IN UNAPPROVED INDICATION,2
LUPKYNIS,2,,,LUPUS NEPHRITIS,ORAL,Softgel capsule,PRODUCT DOSE OMISSION ISSUE,2
CABOMETYX,2,,,RENAL CANCER,ORAL,Tablet,ADVERSE DRUG REACTION,2
NPLATE,2,57,801,IMMUNE THROMBOCYTOPENIA,SUBCUTANEOUS,Powder for injection,HYPERSENSITIVITY,2
OZEMPIC,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,MYOCARDIAL INFARCTION,1
CABOMETYX,1,,,METASTATIC RENAL CELL CARCINOMA,ORAL,Tablet,RENAL CELL CARCINOMA,1
CABOMETYX,1,,,RENAL CANCER,ORAL,Tablet,TOOTH DISORDER,2
CABOMETYX,1,,,RENAL CANCER,ORAL,Tablet,ADVERSE EVENT,2
AMOXICILLIN\CLAVULANATE POTASSIUM,1,71,801,C-REACTIVE PROTEIN INCREASED,,Film-coated tablet,RASH,1
DUPIXENT,2,61,801,NEURODERMATITIS,SUBCUTANEOUS,Solution for injection,NEURODERMATITIS,2
CABOMETYX,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,METASTASES TO LUNG,1
ORENCIA,2,80,801,OSTEOARTHRITIS,INTRAVENOUS,Injection,UNEVALUABLE EVENT,2
OXALIPLATIN,1,,,CHEMOTHERAPY,INTRAVENOUS,Infusion,TEMPERATURE INTOLERANCE,2
TEMODAR,1,37,801,METASTASES TO MENINGES,ORAL,Capsule,PRODUCT USE IN UNAPPROVED INDICATION,2
DUPIXENT,1,66,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,HOSPITALISATION,1
ENTYVIO,2,23,801,COLITIS ULCERATIVE,SUBCUTANEOUS,Powder for solution for infusion,HENOCH-SCHONLEIN PURPURA,1
INVEGA SUSTENNA,2,16,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAMUSCULAR,Injection,HOSPITALISATION,1
TYSABRI,1,,,MULTIPLE SCLEROSIS,INTRAVENOUS,Concentrate for solution for infusion,LYMPHOMA,1
DUPIXENT,2,18,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PRURITUS,2
TILDRAKIZUMAB,2,,,PRODUCT USED FOR UNKNOWN INDICATION,,,URINARY TRACT INFECTION,1
DUPIXENT,1,33,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ARTHRALGIA,2
DUPIXENT,2,21,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,MENTAL STATUS CHANGES,2
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,1,55,801,IMMUNODEFICIENCY COMMON VARIABLE,,Solution for infusion,ANAPHYLACTIC SHOCK,1
DUPIXENT,2,55,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,FOREIGN BODY SENSATION IN EYES,2
OMNITROPE,2,67,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,INCORRECT DOSE ADMINISTERED BY DEVICE,2
ALEMTUZUMAB,1,48,801,RELAPSING-REMITTING MULTIPLE SCLEROSIS,INTRAVENOUS,Solution for infusion,IMMUNE THROMBOCYTOPENIA,1
ALBUTEROL,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Inhaler,DRUG INEFFECTIVE,2
BENLYSTA,2,45,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,PAIN,2
HYLENEX RECOMBINANT,2,42,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,MUSCLE ATROPHY,1
XELJANZ XR,1,67,801,,ORAL,Prolonged-release tablet,GLAUCOMA,1
FLOMAX,1,79,801,PROSTATIC DISORDER,ORAL,,VISION BLURRED,2
DUPIXENT,2,73,801,PRURITUS,SUBCUTANEOUS,Solution for injection,EYE PRURITUS,2
OPSUMIT,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,PULMONARY ARTERIAL HYPERTENSION,1
WEGOVY,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,SYNCOPE,1
DUPIXENT,2,,,DERMATITIS ALLERGIC,SUBCUTANEOUS,Solution for injection,ECZEMA,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,SUICIDAL IDEATION,1
EZETIMIBE,2,55,801,BLOOD CHOLESTEROL INCREASED,ORAL,Unknown,DIZZINESS,2
EZETIMIBE,2,,,HYPERLIPIDAEMIA,ORAL,Unknown,MYALGIA,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
BENLYSTA,1,56,801,SYSTEMIC LUPUS ERYTHEMATOSUS,SUBCUTANEOUS,Powder for solution for infusion,PAIN,2
HUMIRA,2,71,801,PSORIASIS,,Solution for injection in pre-filled pen,STENT PLACEMENT,1
SYNAGIS,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAMUSCULAR,Injection,PNEUMONIA,1
OXALIPLATIN,1,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,,NEUROPATHY PERIPHERAL,1
DUPIXENT,1,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,RASH ERYTHEMATOUS,2
OPSUMIT,1,,,PULMONARY ARTERIAL HYPERTENSION,ORAL,,DEATH,2
DUPIXENT,2,33,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,1,80,801,NASAL POLYPS,SUBCUTANEOUS,Solution for injection,COVID-19,2
FENTANYL,1,,,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,Unknown,COVID-19,1
MIRENA,2,,,INTRAUTERINE CONTRACEPTION,INTRAUTERINE,Intrauterine delivery system,DEVICE DISLOCATION,2
CAPLYTA,2,,,BIPOLAR DISORDER,ORAL,Capsule,STOMATITIS,2
CAPLYTA,2,,,BIPOLAR DISORDER,ORAL,Capsule,AKATHISIA,2
KESIMPTA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,MATERNAL EXPOSURE TIMING UNSPECIFIED,2
DUPIXENT,1,29,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,FOOD ALLERGY,2
JARDIANCE,1,80,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,BALANOPOSTHITIS,1
ZOLEDRONIC ACID,1,68,801,PROSTATE CANCER METASTATIC,INTRAVENOUS,,PROSTATE CANCER METASTATIC,1
OLUMIANT,2,61,801,RHEUMATOID ARTHRITIS,ORAL,Film-coated tablet,LUNG ADENOCARCINOMA,1
DUPIXENT,1,48,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PRURITUS,2
ESTRADIOL TRANSDERMAL SYSTEM,2,,,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,Transdermal system,PRODUCT ADHESION ISSUE,2
MOUNJARO,2,66,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INJECTION SITE PAIN,2
FRUQUINTINIB,2,,,COLON CANCER,ORAL,,MYELOSUPPRESSION,1
AVONEX,2,,,MULTIPLE SCLEROSIS,INTRAMUSCULAR,Solution for injection in pre-filled syringe,VISUAL IMPAIRMENT,2
EUTHYROX,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,DEATH,1
CLOZARIL,2,,,SCHIZOPHRENIA,ORAL,Tablet,SCHIZOPHRENIA,1
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
OZEMPIC,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,BACK PAIN,1
MOUNJARO,2,80,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in cartridge,ELECTROLYTE IMBALANCE,1
MAVENCLAD,2,43,801,MULTIPLE SCLEROSIS,ORAL,,HEADACHE,2
HALOPERIDOL,1,,,SCHIZOPHRENIA,ORAL,Unknown,APGAR SCORE LOW,1
ZURZUVAE,2,29,801,,ORAL,,SOMNOLENCE,2
DUPIXENT,1,11,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
BASAGLAR,1,63,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Injection,HAEMORRHAGE,2
HUMIRA,1,,,RHEUMATOID ARTHRITIS,,Solution for injection in pre-filled pen,SPONDYLITIS,1
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
TRESIBA,2,41,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,THYROID MASS,1
BENLYSTA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,OFF LABEL USE,2
MENS ROGAINE EXTRA STRENGTH,2,,,PRODUCT USED FOR UNKNOWN INDICATION,,Cutaneous foam,HAIR TEXTURE ABNORMAL,2
ELIGARD,1,64,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,INTERCEPTED PRODUCT PREPARATION ERROR,2
TAVALISSE,1,,,IMMUNE THROMBOCYTOPENIA,ORAL,Tablet,DEATH,1
RIBOCICLIB,2,44,801,BREAST CANCER,ORAL,,HEPATITIS ACUTE,1
IMBRUVICA,1,,,CHRONIC LYMPHOCYTIC LEUKAEMIA,ORAL,Tablet,DEATH,1
CARBIDOPA\LEVODOPA,1,82,801,PRODUCT USED FOR UNKNOWN INDICATION,,"Modified-release capsule, hard",HEADACHE,2
CARBIDOPA\LEVODOPA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,,"Modified-release capsule, hard",HALLUCINATION,1
BASAGLAR,1,81,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Injection,HYPOACUSIS,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,SEXUAL DYSFUNCTION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,ADVERSE EVENT,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,BLOOD GLUCOSE DECREASED,2
OZEMPIC,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,BLINDNESS,1
XOSPATA,1,18,801,ACUTE MYELOID LEUKAEMIA,ORAL,Tablet,DEATH,1
ASPIRIN AND DIPYRIDAMOLE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Capsule,EXPOSURE VIA SKIN CONTACT,2
REVLIMID,2,51,801,PLASMA CELL MYELOMA,ORAL,,CARDIAC DISORDER,2
NUPLAZID,2,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,DRUG INEFFECTIVE,2
ABRILADA,1,71,801,HIDRADENITIS,,Solution for injection in pre-filled syringe,DEATH,1
YESCARTA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Suspension,HUMAN HERPESVIRUS 6 ENCEPHALITIS,1
ELIGARD,1,,,PROSTATE CANCER,SUBCUTANEOUS,Injection,METASTASES TO LYMPH NODES,1
TALTZ,2,60,801,PSORIASIS,SUBCUTANEOUS,Injection,INFLUENZA,2
PEDMARK,1,23,801,,INTRAVENOUS,Intravenous infusion,ASPARTATE AMINOTRANSFERASE INCREASED,1
FABHALTA,1,38,801,PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA,ORAL,Capsule,NEPHROLITHIASIS,1
BOSULIF,1,64,801,CHRONIC MYELOID LEUKAEMIA,ORAL,Film-coated tablet,HEADACHE,2
RILPIVIRINE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,,Prolonged-release suspension for injection,INJECTION SITE PAIN,2
DUPIXENT,2,8,801,ECZEMA,SUBCUTANEOUS,Solution for injection,ACCIDENTAL EXPOSURE TO PRODUCT,2
DUPIXENT,2,43,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,COVID-19,2
DUPIXENT,1,19,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,COVID-19,2
DUPIXENT,2,13,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ROAD TRAFFIC ACCIDENT,2
DUPIXENT,2,56,801,ASTHMA,SUBCUTANEOUS,Solution for injection,FATIGUE,2
DUPIXENT,1,1,801,ECZEMA,SUBCUTANEOUS,Solution for injection,ERYTHEMA,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,REBOUND ATOPIC DERMATITIS,2
DUPIXENT,2,23,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DRY EYE,2
ZENATANE,1,16,801,ACNE,ORAL,Capsule,AFFECTIVE DISORDER,2
DUPIXENT,2,22,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ACCIDENTAL EXPOSURE TO PRODUCT,2
HUMIRA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,,,PSORIASIS,2
LANTUS SOLOSTAR,1,50,801,TYPE 1 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
HUMIRA,2,66,801,COLITIS ULCERATIVE,,Solution for injection in pre-filled pen,PULMONARY THROMBOSIS,1
DEFINITY,2,25,801,ECHOCARDIOGRAM,INTRAVENOUS,"INJECTION, SUSPENSION",MATERNAL EXPOSURE DURING PREGNANCY,2
ROMOSOZUMAB,2,75,801,PRODUCT USED FOR UNKNOWN INDICATION,,Solution for injection,ATRIAL FIBRILLATION,1
TARPEYO,1,58,801,IGA NEPHROPATHY,ORAL,Prolonged-release capsule,PERIPHERAL SWELLING,2
HUMIRA,1,89,801,PSORIASIS,,Solution for injection in pre-filled pen,DEATH,1
PROMACTA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,DEATH,1
LENALIDOMIDE,2,77,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,"Capsule, hard",DEATH,1
XELJANZ XR,2,48,801,,ORAL,Prolonged-release tablet,CONDITION AGGRAVATED,2
NUPLAZID,1,88,801,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,PSYCHOTIC DISORDER,1
VYEPTI,2,58,801,MIGRAINE,INTRAVENOUS,Solution for infusion,KIDNEY INFECTION,1
RITUXAN,2,80,801,AUTOIMMUNE LUNG DISEASE,INTRAVENOUS,,OFF LABEL USE,2
BUPIVACAINE,2,57,801,PLASMA CELL MYELOMA,INFILTRATION,Solution for injection,AKATHISIA,1
LUMRYZ,2,,,,ORAL,Extended-Release Oral Suspension,CONCUSSION,2
NUPLAZID,2,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,HALLUCINATION,1
EXELON,2,89,801,DEMENTIA ALZHEIMER^S TYPE,TRANSDERMAL,Transdermal patch,DEPRESSED MOOD,1
DUPIXENT,1,,,ILL-DEFINED DISORDER,SUBCUTANEOUS,Solution for injection,LUNG NEOPLASM MALIGNANT,1
IMPLANON,2,19,801,CONTRACEPTION,,Implant,PORPHYRIA ACUTE,1
VICTOZA,2,,,POLYCYSTIC OVARIAN SYNDROME,SUBCUTANEOUS,Solution for injection,POLYCYSTIC OVARIAN SYNDROME,2
ALTUVIIIO,1,16,801,FACTOR VIII DEFICIENCY,,Powder and solvent for solution for injection,ANTI FACTOR VIII ANTIBODY POSITIVE,1
DUPIXENT,2,66,801,ASTHMA,SUBCUTANEOUS,Solution for injection,CANDIDA INFECTION,2
DUPIXENT,2,,,NASAL POLYPS,SUBCUTANEOUS,Solution for injection,NASAL POLYPS,2
DUPIXENT,1,4,801,DERMATITIS,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,2,51,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,REBOUND ATOPIC DERMATITIS,2
DUPIXENT,2,16,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PULMONARY CONGESTION,1
ACTEMRA,2,80,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,,OPTIC NERVE DISORDER,2
NEXPLANON,2,33,801,,SUBCUTANEOUS,Implant,VAGINAL HAEMORRHAGE,1
NGENLA,2,8,801,,SUBCUTANEOUS,Solution for injection in pre-filled pen,INJECTION SITE PAIN,2
DUPIXENT,1,25,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,INJECTION SITE SWELLING,2
CLOZAPINE,1,26,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,AGRANULOCYTOSIS,1
OXALIPLATIN,1,,,GASTRIC CANCER,INTRAVENOUS,,NEUROPATHY PERIPHERAL,1
RAYALDEE,2,,,,ORAL,Extended-release Capsule,CEREBROVASCULAR ACCIDENT,1
FENTANYL TRANSDERMAL SYSTEM,2,4,801,PRODUCT USED FOR UNKNOWN INDICATION,,,INTERCEPTED ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,2
OMALIZUMAB,1,74,801,CHRONIC SPONTANEOUS URTICARIA,SUBCUTANEOUS,Solution for injection in pre-filled syringe,BALANCE DISORDER,1
VEDOLIZUMAB,1,,,COLITIS ULCERATIVE,SUBCUTANEOUS,Solution for injection,LIVER FUNCTION TEST INCREASED,1
TRIPTORELIN,2,7,801,PRECOCIOUS PUBERTY,,Suspension for injection,GROWTH RETARDATION,1
FREMANEZUMAB,2,56,801,MIGRAINE,,,RASH PRURITIC,1
CIALIS,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,HEART RATE IRREGULAR,1
ACTEMRA ACTPEN,2,,,RHEUMATOID ARTHRITIS,SUBCUTANEOUS,Direct auto-injector,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
TRINTELLIX,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,NAUSEA,2
ATORVASTATIN,1,44,801,ADVERSE DRUG REACTION,,,DRY SKIN,1
ABACAVIR,2,66,801,HIV INFECTION,ORAL,,RENAL FAILURE,1
ELIGARD,1,,,PROSTATE CANCER,SUBCUTANEOUS,Injection,DEATH,1
PRAVASTATIN,2,74,801,HYPERCHOLESTEROLAEMIA,,Tablet,PAIN IN EXTREMITY,1
METFORMIN,2,77,801,TYPE 2 DIABETES MELLITUS,ORAL,,METABOLIC ACIDOSIS,1
MOUNJARO,2,66,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INJECTION SITE PAIN,2
HADLIMA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,FOOD ALLERGY,2
XELJANZ XR,2,75,801,,ORAL,Prolonged-release tablet,HYPERTENSION,2
DUVYZAT,1,32,801,,ORAL,,BLOOD TRIGLYCERIDES INCREASED,2
DUPIXENT,1,44,801,ECZEMA,SUBCUTANEOUS,Solution for injection,PRURITUS,2
DUPIXENT,1,14,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,INJECTION SITE REACTION,2
TRIHEXYPHENIDYL,2,,,SCHIZOPHRENIA,,,DRUG INTERACTION,1
DUPIXENT,2,32,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ERYTHEMA,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DRY SKIN,2
CARBIDOPA\LEVODOPA,2,86,801,PARKINSON^S DISEASE,,Solution for infusion,BRONCHITIS,1
VOLTAREN ARTHRITIS PAIN,2,76,801,ARTHRITIS,TOPICAL,Gel,DRUG INEFFECTIVE,2
XELJANZ,1,66,801,,ORAL,Tablet,NASOPHARYNGITIS,2
COMBIPATCH,2,51,801,MENOPAUSAL SYMPTOMS,,Transdermal patch,BREAST TENDERNESS,2
DUPILUMAB,2,34,801,EPIDERMOLYSIS BULLOSA,SUBCUTANEOUS,Solution for injection,LEUKOPENIA,1
UPTRAVI,2,70,801,PULMONARY ARTERIAL HYPERTENSION,ORAL,Tablet,PULMONARY CONGESTION,1
ARANESP,2,,,ANAEMIA,INTRAVENOUS,Solution for injection,DISABILITY,1
OPSUMIT,2,55,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,HOSPITALISATION,1
NUPLAZID,1,83,801,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,DEATH,1
SODIUM OXYBATE,2,,,NARCOLEPSY,ORAL,Oral solution,SURGERY,1
NURTEC ODT,2,76,801,MIGRAINE,ORAL,Orodispersible tablet,THERAPEUTIC PRODUCT EFFECT INCOMPLETE,2
VON WILLEBRAND FACTOR (RECOMBINANT),2,32,801,PRODUCT USED FOR UNKNOWN INDICATION,,,HEAVY MENSTRUAL BLEEDING,1
DUPIXENT,1,31,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,RASH,2
DUPIXENT,1,6,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,PRODUCT DOSE OMISSION IN ERROR,2
DUPIXENT,2,69,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PRURITUS,2
ELIGARD,2,41,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Injection,INTERCEPTED PRODUCT PREPARATION ERROR,2
ASPIRIN\LANSOPRAZOLE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,,Tablet,FOREIGN BODY IN THROAT,1
ERTAPENEM,1,83,801,CYSTITIS ESCHERICHIA,INTRAMUSCULAR,,CLOSTRIDIUM DIFFICILE INFECTION,1
DUPIXENT,2,,,ASTHMA,SUBCUTANEOUS,Solution for injection,GASTROENTERITIS VIRAL,2
SKYRIZI,2,50,801,PSORIASIS,SUBCUTANEOUS,,APPENDICECTOMY,1
OXALIPLATIN,1,48,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Concentrate for solution for infusion,PRURITUS,1
SKYRIZI,1,71,801,PSORIASIS,SUBCUTANEOUS,,DEATH,1
FINERENONE,1,64,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,HYPERKALAEMIA,1
BENAZEPRIL,1,,,,,Unknown,COUGH,2
NOVORAPID,2,65,801,TYPE 2 DIABETES MELLITUS,,Solution for injection,MYOCARDIAL INFARCTION,1
IMATINIB,2,77,801,CHRONIC MYELOID LEUKAEMIA,ORAL,,TUBULOINTERSTITIAL NEPHRITIS,1
VENETOCLAX,1,76,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,DEATH,1
COBENFY,2,18,801,SCHIZOAFFECTIVE DISORDER,ORAL,,DEATH,1
BRIVIACT,1,10,801,EPILEPSY,ORAL,,SELF-DESTRUCTIVE BEHAVIOUR,1
CYCLOSPORINE,1,50,801,CHRONIC SPONTANEOUS URTICARIA,ORAL,,BLINDNESS,1
SKYRIZI,2,,,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,,GAIT DISTURBANCE,1
DUPIXENT,2,61,801,ECZEMA,SUBCUTANEOUS,Solution for injection,ECZEMA,2
OMNIPAQUE,1,26,801,COMPUTERISED TOMOGRAM HEART,INTRAVENOUS,Solution for injection,URTICARIA,2
METHYLPREDNISOLONE SODIUM SUCCINATE,1,31,801,GRANULOMATOSIS WITH POLYANGIITIS,INTRAMUSCULAR,,HYPOGAMMAGLOBULINAEMIA,1
ABATACEPT,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Solution for infusion,GASTRITIS,1
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,,GALLBLADDER OPERATION,1
FLUOXETINE,2,16,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,POISONING DELIBERATE,1
SKYRIZI,1,72,801,PSORIASIS,SUBCUTANEOUS,,SURGERY,1
LENALIDOMIDE,2,79,801,PLASMA CELL MYELOMA,ORAL,,HOSPITALISATION,1
DUPIXENT,2,3,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ECZEMA,2
RITUXIMAB,1,69,801,NON-HODGKIN^S LYMPHOMA,INTRAVENOUS,,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
STELARA,1,73,801,PSORIASIS,INTRAVENOUS,Solution for injection,INFECTION,1
DUPIXENT,1,47,801,NASAL POLYPS,SUBCUTANEOUS,,OFF LABEL USE,2
CABENUVA,2,56,801,PRODUCT USED FOR UNKNOWN INDICATION,,Suspension for injection,PRODUCT DOSE OMISSION ISSUE,2
HIZENTRA,2,30,801,,,Injection,NEPHROLITHIASIS,1
XEMBIFY,2,73,801,IMMUNODEFICIENCY COMMON VARIABLE,,,INJECTION SITE URTICARIA,1
COSENTYX,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,ILLNESS,2
VEDOLIZUMAB,1,,,COLITIS ULCERATIVE,SUBCUTANEOUS,Powder for solution for infusion,HAEMATOCHEZIA,1
XIAFLEX,1,,,DUPUYTREN^S CONTRACTURE,,Injection,BURNING SENSATION,2
MOUNJARO,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in cartridge,DEPRESSED MOOD,1
DUPIXENT,2,63,801,PSORIASIS,SUBCUTANEOUS,Solution for injection,PRODUCT USE IN UNAPPROVED INDICATION,2
AUSTEDO XR,2,69,801,TARDIVE DYSKINESIA,ORAL,Extended release tablet,DEAFNESS,1
MAVENCLAD,2,,,MULTIPLE SCLEROSIS,ORAL,,ABDOMINAL PAIN,1
BASAGLAR,2,72,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Injection,BLOOD GLUCOSE INCREASED,2
LENALIDOMIDE,1,76,801,PLASMA CELL MYELOMA,ORAL,Capsule,NASOPHARYNGITIS,2
BENLYSTA,2,,,SYSTEMIC LUPUS ERYTHEMATOSUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,RASH,2
TEDUGLUTIDE,1,,,SHORT-BOWEL SYNDROME,SUBCUTANEOUS,Solution for injection,HERNIA,1
FRUZAQLA,2,44,801,COLORECTAL CANCER METASTATIC,ORAL,Capsule,DRUG INTOLERANCE,2
ELIGARD,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Injection,INTERCEPTED PRODUCT PREPARATION ERROR,2
FINGOLIMOD,1,48,801,MULTIPLE SCLEROSIS,ORAL,,LIVER DISORDER,1
ERYTHROMYCIN ETHYLSUCCINATE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,HYPERSENSITIVITY,2
HYFTOR,1,6,801,TUBEROUS SCLEROSIS COMPLEX,TOPICAL,Jelly,DRY SKIN,2
XELJANZ XR,2,66,801,RHEUMATOID ARTHRITIS,ORAL,Prolonged-release tablet,CONDITION AGGRAVATED,2
DUPIXENT,2,6,801,ECZEMA,SUBCUTANEOUS,Solution for injection,INJECTION SITE SWELLING,2
LILETTA,2,25,801,CONTRACEPTION,INTRAUTERINE,Intrauterine device,PROCEDURAL PAIN,2
ALECENSA,2,61,801,LUNG NEOPLASM MALIGNANT,ORAL,Capsule,MYALGIA,2
TAKHZYRO,2,,,ANGIOEDEMA,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
ELIGARD,1,,,PROSTATE CANCER,SUBCUTANEOUS,Injection,HIP FRACTURE,1
PROMACTA,1,60,801,IMMUNE THROMBOCYTOPENIA,ORAL,,PLATELET COUNT DECREASED,2
VASCEPA,1,75,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Capsule,POOR QUALITY PRODUCT ADMINISTERED,2
DUPIXENT,1,38,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ABDOMINAL DISCOMFORT,2
CARBIDOPA\LEVODOPA,1,87,801,PARKINSON^S DISEASE,,,DEAFNESS,1
RYBELSUS,2,51,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,VITREOUS DETACHMENT,1
OZEMPIC,2,69,801,,SUBCUTANEOUS,Solution for injection,HEPATIC STEATOSIS,1
CLARITIN,2,32,801,,ORAL,Tablet,HEADACHE,2
EUCRISA,2,46,801,,TOPICAL,Ointment,DRUG INEFFECTIVE,2
DUPIXENT,1,56,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,DYSPHAGIA,2
TRIPTORELIN PAMOATE,2,9,801,PRODUCT USED FOR UNKNOWN INDICATION,,,IDIOPATHIC INTRACRANIAL HYPERTENSION,1
EYLEA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVITREAL,Injection,DEATH,1
DIANEAL PD-2 PERITONEAL DIALYSIS SOLUTION WITH DEXTROSE,1,34,801,RENAL FAILURE,,Solution for peritoneal dialysis,ULTRAFILTRATION FAILURE,1
RITUXIMAB,1,74,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,,ABDOMINAL PAIN UPPER,1
PLENVU,2,,,PRODUCT USED FOR UNKNOWN INDICATION,,,ILL-DEFINED DISORDER,2
LEQEMBI,2,70,801,DEMENTIA ALZHEIMER^S TYPE,INTRAVENOUS,Solution for infusion,AMYLOID RELATED IMAGING ABNORMALITY-OEDEMA/EFFUSION,1
OMNITROPE,1,,,SHORT STATURE,SUBCUTANEOUS,Solution for injection,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
ABRILADA,2,32,801,CROHN^S DISEASE,,Solution for injection in pre-filled pen,ILEOCOLECTOMY,1
TALTZ,2,51,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Injection,BLOOD POTASSIUM ABNORMAL,2
DUPIXENT,2,5,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,INJECTION SITE REACTION,2
DUPIXENT,2,40,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,REBOUND ATOPIC DERMATITIS,2
DUPIXENT,1,60,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
LENALIDOMIDE,1,90,801,HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL,ORAL,,ABDOMINAL PAIN LOWER,1
SKYCLARYS,1,,,FRIEDREICH^S ATAXIA,ORAL,Capsule,CARDIOMYOPATHY,1
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
SUNOSI,2,,,NARCOLEPSY,ORAL,Unknown,MENSTRUATION DELAYED,2
ESTRADIOL TRANSDERMAL SYSTEM,2,,,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,Transdermal system,PRODUCT ADHESION ISSUE,2
ESTRADIOL TRANSDERMAL SYSTEM,2,,,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,Transdermal system,PRODUCT ADHESION ISSUE,2
SUNOSI,1,,,OBSTRUCTIVE SLEEP APNOEA SYNDROME,ORAL,Tablets,DRUG INEFFECTIVE,2
BOTOX COSMETIC,2,,,SKIN WRINKLING,INTRAMUSCULAR,,ADVERSE DRUG REACTION,2
DUPIXENT,1,61,801,NASAL POLYPS,SUBCUTANEOUS,Solution for injection,PARAESTHESIA,2
AMIODARONE,1,73,801,ATRIAL FIBRILLATION,,,DRUG INEFFECTIVE,1
EUCRISA,1,15,801,ECZEMA,TOPICAL,Ointment,CONDITION AGGRAVATED,2
LILETTA,2,32,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAUTERINE,,UNINTENTIONAL MEDICAL DEVICE REMOVAL,2
MOUNJARO,2,,,WEIGHT CONTROL,SUBCUTANEOUS,Solution for injection in cartridge,HAEMATEMESIS,1
FOSCARBIDOPA\FOSLEVODOPA,1,77,801,PARKINSON^S DISEASE,SUBCUTANEOUS,Solution for infusion,HIP FRACTURE,1
VENCLEXTA,2,,,ACUTE MYELOID LEUKAEMIA,ORAL,,HOSPICE CARE,1
DUPIXENT,2,79,801,ECZEMA,SUBCUTANEOUS,Solution for injection,PRODUCT DOSE OMISSION IN ERROR,2
TAMSULOSIN HYDROCHLORIDE,1,72,801,BENIGN PROSTATIC HYPERPLASIA,ORAL,,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
AMJEVITA,2,51,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,INJECTION SITE PAIN,2
DUPIXENT,1,4,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,1,4,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
SKYRIZI,2,40,801,CROHN^S DISEASE,SUBCUTANEOUS,,VOMITING,1
AMPICILLIN,1,5,800,,INTRAMUSCULAR,,TUBULOINTERSTITIAL NEPHRITIS,1
SPRAVATO,2,39,801,DEPRESSION,NASAL,Nasal spray,HOSPITALISATION,1
AMPHOTERICIN B,1,73,801,CRYPTOCOCCAL CUTANEOUS INFECTION,INTRAVENOUS,,FAILURE TO THRIVE,1
SKYRIZI,1,,,CROHN^S DISEASE,SUBCUTANEOUS,,CEREBROVASCULAR ACCIDENT,1
SKYRIZI,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,PROSTATE CANCER,1
SKYRIZI,2,,,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,,BLADDER CANCER,1
LORATADINE,2,17,801,,ORAL,,HEADACHE,2
PRIMIDONE,2,79,801,EPILEPSY,ORAL,,NEAR DEATH EXPERIENCE,1
PALFORZIA,1,4,801,FOOD ALLERGY,,Oral powder,POST-TUSSIVE VOMITING,2
SKYRIZI,1,65,801,PSORIASIS,SUBCUTANEOUS,,SKIN CANCER,1
TREMFYA,2,41,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,NEEDLE ISSUE,2
ADVIL,1,,,HEADACHE,ORAL,"Capsule, soft",DRUG EFFECTIVE FOR UNAPPROVED INDICATION,2
BORTEZOMIB,2,65,801,PLASMA CELL MYELOMA,INTRAVENOUS,Injection,PLASMA CELL MYELOMA RECURRENT,1
IBRANCE,2,71,801,,ORAL,Film-coated tablet,DIARRHOEA,2
FENTANYL,1,48,801,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,,TOXICITY TO VARIOUS AGENTS,1
LACOSAMIDE,2,,,SEVERE MYOCLONIC EPILEPSY OF INFANCY,ORAL,Unknown,MENTAL IMPAIRMENT,1
SPRAVATO,2,,,DEPRESSION,NASAL,Nasal spray,CONFUSIONAL STATE,2
SKYRIZI,1,,,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,LYMPHOCYTE COUNT INCREASED,1
TYSABRI,1,44,801,MULTIPLE SCLEROSIS,INTRAVENOUS,Concentrate for solution for infusion,SENSORY DISTURBANCE,2
NICODERM CQ,1,77,801,SMOKING CESSATION THERAPY,TRANSDERMAL,PATCH,URTICARIA,2
TRANEXAMIC ACID,2,67,801,HAEMORRHAGE,INTRAVENOUS,Solution for injection,ISCHAEMIC STROKE,1
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,,OVARIAN GERM CELL TERATOMA BENIGN,1
CETIRIZINE,2,24,801,RHINITIS ALLERGIC,ORAL,Unknown,MYDRIASIS,1
TREMFYA,1,29,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,DEVICE ISSUE,2
RINVOQ,1,23,801,COLITIS ULCERATIVE,ORAL,Prolonged-release tablet,MELANOCYTIC NAEVUS,1
PYZCHIVA,2,64,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in pre-filled syringe,CROHN^S DISEASE,1
CAMZYOS,2,50,801,HYPERTROPHIC CARDIOMYOPATHY,ORAL,Capsule,SINUSITIS,2
VARENICLINE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,MYOPIA,2
TADALAFIL,2,,,PULMONARY ARTERIAL HYPERTENSION,ORAL,,CARDIAC FAILURE CONGESTIVE,1
SKYRIZI,2,62,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,INCORRECT DOSE ADMINISTERED,2
LEVOFLOXACIN,1,44,801,OSTEOMYELITIS,INTRAVENOUS,,CHOLESTASIS,1
TADALAFIL,2,70,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,CHOLECYSTITIS INFECTIVE,1
BORTEZOMIB,2,,,PLASMA CELL MYELOMA,INTRAVENOUS,Powder for solution for injection,DIARRHOEA,1
AMLODIPINE,2,50,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,COMPLETED SUICIDE,1
VERAPAMIL HYDROCHLORIDE,2,73,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,,COMPLETED SUICIDE,1
SKYRIZI,1,72,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,MEDICAL DEVICE IMPLANTATION,1
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,,SURGERY,1
TOPAMAX,2,59,801,MIGRAINE,ORAL,,DRUG SCREEN POSITIVE,1
SOLU-MEDROL,2,13,801,PNEUMONIA MYCOPLASMAL,INTRAMUSCULAR,Powder for solution for injection,RASH,1
TREMFYA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,DEVICE DEPLOYMENT ISSUE,2
TREMFYA,2,52,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,DEVICE DEPLOYMENT ISSUE,2
OPSUMIT,2,8,800,PULMONARY ARTERIAL HYPERTENSION,ORAL,Tablet,SYSTEMIC SCLERODERMA,1
ETHAMBUTOL,2,77,801,CUTANEOUS TUBERCULOSIS,,,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,1
SKYRIZI,1,,,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,STAPHYLOCOCCAL SKIN INFECTION,1
TREMFYA,2,66,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,DEVICE ISSUE,2
SKYRIZI,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,GASTRIC OPERATION,1
TREMFYA,2,51,801,COLITIS ULCERATIVE,SUBCUTANEOUS,Solution for infusion,DRUG INEFFECTIVE,2
TOLVAPTAN,1,39,801,BLOOD OSMOLARITY DECREASED,ORAL,,HYPONATRAEMIA,1
TREMFYA,2,52,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,PNEUMONIA,1
SKYRIZI,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,NOROVIRUS INFECTION,1
AMPHETAMINE,1,32,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,DILATED CARDIOMYOPATHY,1
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,,GIANT CELL ARTERITIS,1
SKYRIZI,2,,,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Solution for injection in pre-filled syringe,PYREXIA,2
SKYRIZI,2,82,801,PSORIASIS,SUBCUTANEOUS,,POST-TRAUMATIC STRESS DISORDER,1
SKYRIZI,1,,,CROHN^S DISEASE,SUBCUTANEOUS,,HIP ARTHROPLASTY,1
RIFAMPIN,2,28,801,TUBERCULOSIS,INTRAVENOUS,Unknown,PSYCHOTIC DISORDER,1
TREMFYA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,DEVICE DEFECTIVE,2
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,,CATARACT,1
TECFIDERA,1,,,MULTIPLE SCLEROSIS,ORAL,Unknown,MULTIPLE SCLEROSIS,2
SKYRIZI,1,67,801,PSORIASIS,SUBCUTANEOUS,,TOE AMPUTATION,1
SKYRIZI,2,42,801,CROHN^S DISEASE,SUBCUTANEOUS,,DEVICE ISSUE,2
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,,CARDIAC OPERATION,1
TREMFYA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for infusion,BACK INJURY,1
TREMFYA,2,54,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,PRODUCT CONTAMINATION,2
SKYRIZI,2,71,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,,KNEE OPERATION,1
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,,HYSTERECTOMY,1
FLUCONAZOLE,1,90,801,FUNGAL INFECTION,ORAL,,TASTE DISORDER,2
CYCLOPHOSPHAMIDE,1,5,801,,INTRAVENOUS,,ADENOVIRUS INFECTION,1
SKYRIZI,2,19,801,CROHN^S DISEASE,SUBCUTANEOUS,,ABSCESS,1
BRAFTOVI,2,33,801,BRAIN NEOPLASM,ORAL,Capsule,SEIZURE,1
TREMFYA,1,,,COLITIS ULCERATIVE,SUBCUTANEOUS,Solution for infusion,MUSCLE SPASMS,2
LACOSAMIDE,2,,,SEIZURE,ORAL,Film-coated tablet,JAW FRACTURE,1
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,SURGERY,1
LENALIDOMIDE,1,70,801,PLASMA CELL MYELOMA,ORAL,,LEUKOCYTOSIS,1
SPRAVATO,2,44,801,DEPRESSION,NASAL,Nasal spray,BLOOD PRESSURE INCREASED,1
BENDAMUSTINE,1,66,801,B-CELL LYMPHOMA,INTRAVENOUS,,DRUG INEFFECTIVE,1
SPRAVATO,1,,,DEPRESSION,NASAL,Nasal spray,CARDIAC DISORDER,1
TOLVAPTAN,1,,,SWELLING,ORAL,Tablet,CARDIAC FAILURE,1
AMPHETAMINE SULFATE,1,51,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,INJURY,1
SKYRIZI,2,62,801,CROHN^S DISEASE,SUBCUTANEOUS,Intravenous infusion,GENERALISED OEDEMA,2
CYCLOPHOSPHAMIDE,2,58,801,BREAST CANCER FEMALE,INTRAVENOUS,Powder for solution for injection/infusion,PHARYNGEAL OEDEMA,1
AMPHETAMINE,2,48,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,DRUG ABUSE,1
TREMFYA,2,43,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,PERICARDITIS,1
SKYRIZI,2,77,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,LUNG DISORDER,2
TADALAFIL,1,57,801,PULMONARY ARTERIAL HYPERTENSION,ORAL,,SYNCOPE,1
SKYRIZI,2,32,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,LYMPHADENOPATHY,2
SKYRIZI,1,5,803,MATERNAL EXPOSURE TIMING UNSPECIFIED,SUBCUTANEOUS,,FOETAL EXPOSURE DURING PREGNANCY,2
BUSPIRONE HYDROCHLORIDE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Capsule,OBSESSIVE-COMPULSIVE DISORDER,2
ENSPRYNG,2,70,801,NEUROMYELITIS OPTICA SPECTRUM DISORDER,SUBCUTANEOUS,Injection,ATYPICAL MYCOBACTERIAL LOWER RESPIRATORY TRACT INFECTION,1
SKYRIZI,2,64,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,JOINT INJURY,1
EPIRUBICIN HYDROCHLORIDE,2,28,801,NEOPLASM,INTRAVENOUS,Powder for solution for injection,HEPATIC FUNCTION ABNORMAL,1
SKYRIZI,1,59,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,INTESTINAL OBSTRUCTION,1
SKYRIZI,2,60,801,PSORIASIS,SUBCUTANEOUS,,APPENDICECTOMY,1
ENSPRYNG,2,40,801,NEUROMYELITIS OPTICA SPECTRUM DISORDER,SUBCUTANEOUS,Injection,NEUROMYELITIS OPTICA SPECTRUM DISORDER,1
SKYRIZI,1,87,801,PSORIASIS,SUBCUTANEOUS,,DEATH,1
SKYRIZI,2,56,801,CROHN^S DISEASE,SUBCUTANEOUS,,STOMA CREATION,1
TREMFYA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled syringe,SKIN DISORDER,2
SKYRIZI,1,,,CROHN^S DISEASE,SUBCUTANEOUS,,LIVER FUNCTION TEST INCREASED,2
SKYRIZI,1,50,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in pre-filled injector,HERNIA,1
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,,DEATH,1
ADCETRIS,1,44,801,CHEMOTHERAPY,INTRAVENOUS,Powder for solution for injection,MYELOSUPPRESSION,1
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,,HERNIA,1
TREMFYA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Unknown,NASOPHARYNGITIS,2
PAXIL,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,ILLNESS,2
SPRAVATO,2,,,MAJOR DEPRESSION,NASAL,Nasal spray,MANIA,1
SPRAVATO,2,56,801,DEPRESSION,NASAL,Nasal spray,SLEEP TERROR,1
COBENFY,2,3,800,SCHIZOPHRENIA,ORAL,Capsule,INCREASED APPETITE,2
VYVANSE,1,62,801,ATTENTION DEFICIT HYPERACTIVITY DISORDER,ORAL,Capsule,VENOUS THROMBOSIS,1
SOLU-MEDROL,1,,,PREMEDICATION,INTRAMUSCULAR,Powder for solution for infusion,DRUG INEFFECTIVE,1
ARANESP,1,79,801,ANAEMIA,INTRAVENOUS,Solution for injection,CHEST PAIN,1
SKYRIZI,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,ATRIAL FIBRILLATION,1
TREMFYA,2,44,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,NEEDLE ISSUE,2
SKYRIZI,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,PHARYNGEAL DISORDER,1
IBRANCE,2,52,801,,ORAL,Film-coated tablet,HEADACHE,2
SKYRIZI,1,55,801,CROHN^S DISEASE,SUBCUTANEOUS,,CHOLECYSTECTOMY,1
SKYRIZI,1,,,PSORIASIS,SUBCUTANEOUS,,DEATH,1
SKYRIZI,1,48,801,PSORIASIS,SUBCUTANEOUS,,SPINAL OPERATION,1
LUMAKRAS,1,69,801,NON-SMALL CELL LUNG CANCER,ORAL,Unknown formulation,CARCINOEMBRYONIC ANTIGEN INCREASED,1
COBENFY,1,35,801,SCHIZOAFFECTIVE DISORDER,ORAL,Capsule,CONSTIPATION,2
TRANEXAMIC ACID,2,67,801,HAEMORRHAGE,INTRAVENOUS,Solution for infusion,ISCHAEMIC STROKE,1
VENCLEXTA,2,88,801,CHRONIC LYMPHOCYTIC LEUKAEMIA,ORAL,,LIMB INJURY,1
TREMFYA,1,31,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,PRODUCT STORAGE ERROR,2
ARIPIPRAZOLE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Suspension for injection,KIDNEY INFECTION,1
SKYRIZI,1,37,801,PSORIASIS,SUBCUTANEOUS,Solution for injection,STEVENS-JOHNSON SYNDROME,1
ARIPIPRAZOLE,1,35,801,DEPRESSION,ORAL,,CENTRAL SLEEP APNOEA SYNDROME,1
STIVARGA,1,57,801,GASTROINTESTINAL STROMAL TUMOUR,ORAL,Film-coated tablet,HYPERTENSION,1
SKYRIZI,1,,,CROHN^S DISEASE,SUBCUTANEOUS,,CLAVICLE FRACTURE,1
TOLVAPTAN,2,,,CONGENITAL CYSTIC KIDNEY DISEASE,ORAL,Tablet,HYPERTENSION,1
CEFTRIAXONE,2,42,801,TOOTHACHE,INTRAVENOUS,Powder for solution for infusion,DERMATITIS ALLERGIC,1
SKYRIZI,2,69,801,OSTEOPOROSIS,SUBCUTANEOUS,Injection,HEPATIC CIRRHOSIS,2
SKYRIZI,1,,,CROHN^S DISEASE,SUBCUTANEOUS,,INTESTINAL OBSTRUCTION,1
ARIPIPRAZOLE,1,24,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,AMNESIA,1
DALFAMPRIDINE,2,,,MULTIPLE SCLEROSIS,ORAL,,ROAD TRAFFIC ACCIDENT,1
PAXLOVID,2,55,801,COVID-19 TREATMENT,,Tablet,COVID-19,2
SKYRIZI,2,53,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in pre-filled injector,HYPERTENSION,1
QINLOCK,1,68,801,GASTROINTESTINAL STROMAL TUMOUR,ORAL,Tablet,PROSTATE CANCER,1
SKYRIZI,2,57,801,PSORIASIS,SUBCUTANEOUS,,TENDONITIS,1
TREMFYA,2,66,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Unknown,ADENOCARCINOMA OF THE CERVIX,1
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,,ILEAL ULCER,1
RITUXIMAB,1,24,801,DIFFUSE LARGE B-CELL LYMPHOMA,INTRAVENOUS,,CLOSTRIDIUM DIFFICILE INFECTION,2
ABIRATERONE ACETATE,1,88,801,PROSTATE CANCER,ORAL,,DEATH,1
TADALAFIL,1,,,ADVERSE DRUG REACTION,ORAL,,OCULAR HYPERTENSION,1
AMPHETAMINE,1,19,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,DEATH,1
SKYRIZI,2,31,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,PSORIASIS,2
SKYRIZI,1,32,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in pre-filled pen,INJECTION SITE HAEMORRHAGE,2
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,,IDIOPATHIC PULMONARY FIBROSIS,1
ANGELIQ,2,60,801,,ORAL,Film-coated tablet,UTERINE POLYP,1
TREMFYA,1,80,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Unknown,STENT PLACEMENT,1
ZITHROMAX,2,59,801,,ORAL,,WHEEZING,2
SKYRIZI,2,51,801,CROHN^S DISEASE,SUBCUTANEOUS,,RETINAL ARTERY OCCLUSION,1
SKYRIZI,2,35,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in pre-filled injector,DEVICE ISSUE,2
TREMFYA,2,45,801,COLITIS ULCERATIVE,SUBCUTANEOUS,Solution for infusion,ORAL HERPES,2
DUPIXENT,2,15,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PHARYNGITIS,2
FILGRASTIM,1,42,801,HAEMATOPOIETIC STEM CELL MOBILISATION,INTRAVENOUS,Unknown formulation,EPIDIDYMITIS,1
SPRAVATO,2,,,DEPRESSION,NASAL,Nasal spray,SINUS OPERATION,1
SKYRIZI,2,63,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for infusion,CROHN^S DISEASE,1
METHYLPREDNISOLONE SODIUM SUCCINATE,1,19,801,HEREDITARY OPTIC ATROPHY,INTRAMUSCULAR,Powder and solvent for solution for injection,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
SPRAVATO,2,61,801,DEPRESSION,NASAL,Nasal spray,SURGERY,1
QINLOCK,1,60,801,GASTROINTESTINAL STROMAL TUMOUR,ORAL,Tablet,HOSPITALISATION,1
SKYRIZI,2,53,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in cartridge,BACK INJURY,1
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,,BACK PAIN,1
SKYRIZI,1,66,801,ECZEMA,SUBCUTANEOUS,Solution for injection in pre-filled pen,RENAL FAILURE,1
RIFATER,1,22,801,TUBERCULOSIS,,Coated tablet,HEPATIC CYTOLYSIS,1
TREMFYA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,DRUG INEFFECTIVE,2
METHYLPREDNISOLONE SODIUM SUCCINATE,2,88,801,,INTRAMUSCULAR,Powder for solution for injection,HEPATITIS CHOLESTATIC,1
TREMFYA,1,74,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,PRODUCT DOSE OMISSION ISSUE,2
ZEPZELCA,1,54,801,PERITONEAL MESOTHELIOMA MALIGNANT,INTRAVENOUS,UNK,FEBRILE NEUTROPENIA,1
AGAMREE,1,9,801,DUCHENNE MUSCULAR DYSTROPHY,ORAL,Oral suspension,PYREXIA,2
SPRAVATO,1,,,DEPRESSION,NASAL,Nasal spray,CHEMOTHERAPY,1
RINVOQ,1,53,801,RHEUMATOID ARTHRITIS,ORAL,Tablet,CHOLELITHIASIS,1
RIBOCICLIB,2,66,801,BREAST CANCER,ORAL,,PNEUMONITIS,1
AMITRIPTYLINE HYDROCHLORIDE,2,73,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,COMPLETED SUICIDE,1
TREMFYA,2,30,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,ACCIDENTAL EXPOSURE TO PRODUCT,2
FILGRASTIM,2,37,801,CYCLIC NEUTROPENIA,INTRAVENOUS,Solution for injection,THROAT TIGHTNESS,1
TREMFYA,2,,,PSORIASIS,SUBCUTANEOUS,Solution for injection,PSYCHOTIC DISORDER,1
SKYRIZI,1,,,CROHN^S DISEASE,SUBCUTANEOUS,,SPINAL STENOSIS,1
POSACONAZOLE,1,44,801,MENINGITIS COCCIDIOIDES,ORAL,,HEPATIC FAILURE,1
TREMFYA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,PRODUCT STORAGE ERROR,2
SKYRIZI,2,78,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in pre-filled injector,CHRONIC KIDNEY DISEASE,1
SPRAVATO,1,52,801,DEPRESSION,NASAL,Nasal spray,JAW OPERATION,1
BACLOFEN,1,9,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,MUSCLE SPASMS,1
TREMFYA,2,,,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,DEVICE ISSUE,2
LISINOPRIL,2,32,801,HYPERTENSION,ORAL,Unknown,INTESTINAL ANGIOEDEMA,1
LISINOPRIL,1,42,801,HYPERTENSION,ORAL,,ACUTE KIDNEY INJURY,2
ARIPIPRAZOLE,1,52,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,MOVEMENT DISORDER,1
SKYRIZI,2,67,801,PSORIASIS,SUBCUTANEOUS,,CARTILAGE INJURY,1
LORAZEPAM,2,27,801,,INTRAMUSCULAR,,AMNESTIC DISORDER,1
COBENFY,2,33,801,SCHIZOPHRENIA,ORAL,Capsule,SECRETION DISCHARGE,2
RISPERDAL,1,48,801,"HALLUCINATION, AUDITORY",ORAL,,NEUROLEPTIC MALIGNANT SYNDROME,1
MEDROL,2,56,801,EAR INFECTION,ORAL,Tablet,ANGIOEDEMA,1
ADAPALENE,2,,,ACNE,TOPICAL,Gel,ACNE,2
ADAPALENE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,TOPICAL,Gel,DRUG INEFFECTIVE,2
EZETIMIBE,2,79,801,BLOOD CHOLESTEROL INCREASED,ORAL,,DIARRHOEA,1
MYOVIEW,2,,,CARDIAC IMAGING PROCEDURE,INTRAVENOUS,Kit for radiopharmaceutical preparation,DRUG INEFFECTIVE,2
COBENFY,2,26,801,SCHIZOPHRENIA,ORAL,,HEART RATE INCREASED,2
EPIRUBICIN HYDROCHLORIDE,2,47,801,BREAST CANCER FEMALE,INTRAVENOUS,Powder for solution for injection,NAUSEA,1
TREMFYA,2,53,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Solution for injection in pre-filled pen,PRODUCT DOSE OMISSION ISSUE,2
SPRAVATO,2,56,801,DEPRESSION,NASAL,Nasal spray,PATIENT UNCOOPERATIVE,1
VYEPTI,2,43,801,MIGRAINE,INTRAVENOUS,Solution for infusion,PRURITUS,2
SKYRIZI,1,,,PSORIASIS,SUBCUTANEOUS,,SPINAL STENOSIS,1
SKYRIZI,1,,,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in cartridge,HODGKIN^S DISEASE,1
SPRAVATO,2,,,PRODUCT USED FOR UNKNOWN INDICATION,NASAL,Nasal spray,NASAL CONGESTION,2
AXICABTAGENE CILOLEUCEL,1,54,801,DIFFUSE LARGE B-CELL LYMPHOMA,INTRAVENOUS,Suspension,HYPOGAMMAGLOBULINAEMIA,1
LITFULO,1,17,801,ALOPECIA AREATA,ORAL,Capsule,NASOPHARYNGITIS,2
SKYRIZI,2,77,801,CROHN^S DISEASE,SUBCUTANEOUS,,INTESTINAL OBSTRUCTION,1
SKYRIZI,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,ARTHRALGIA,2
SKYRIZI,1,,,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,MYOCARDIAL INFARCTION,1
TRANEXAMIC ACID,1,50,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,,STATUS EPILEPTICUS,1
SPRAVATO,2,53,801,DEPRESSION,NASAL,Nasal spray,MULTIPLE SCLEROSIS,1
XCOPRI,1,58,801,EPILEPSY,,,SEIZURE,1
TREMFYA,2,33,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,TYPE 1 DIABETES MELLITUS,1
OMALIZUMAB,2,21,801,CHRONIC SPONTANEOUS URTICARIA,SUBCUTANEOUS,,ANAPHYLACTIC SHOCK,1
SKYRIZI,2,61,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,,GASTRIC OPERATION,1
SKYRIZI,2,27,801,CROHN^S DISEASE,SUBCUTANEOUS,,FISTULA,1
SKYRIZI,1,53,801,PSORIASIS,SUBCUTANEOUS,,MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE,2
SKYRIZI,2,33,801,CROHN^S DISEASE,SUBCUTANEOUS,,PYODERMA GANGRENOSUM,1
LYBALVI,2,49,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Coated Bilayer Tablet,UNRESPONSIVE TO STIMULI,1
AMBRISENTAN,2,,,PULMONARY ARTERIAL HYPERTENSION,ORAL,,APPENDICITIS PERFORATED,2
SKYRIZI,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,PULMONARY OEDEMA,1
BLINCYTO,2,,,PHILADELPHIA CHROMOSOME POSITIVE,,Injection,CYTOKINE RELEASE SYNDROME,1
XELJANZ XR,2,56,801,,ORAL,Prolonged-release tablet,HYPERTENSION,2
SKYRIZI,1,40,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in cartridge,INTESTINAL OBSTRUCTION,1
ORENITRAM,2,43,801,PULMONARY ARTERIAL HYPERTENSION,ORAL,,RESPIRATORY FAILURE,1
TREMFYA,2,50,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,DEVICE DEFECTIVE,2
SKYRIZI,2,63,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,BRONCHITIS,2
DARATUMUMAB,2,,,PLASMA CELL MYELOMA,INTRAVENOUS,Concentrate for solution for infusion,DRUG INEFFECTIVE,1
SKYRIZI,2,37,801,CROHN^S DISEASE,SUBCUTANEOUS,,ABSCESS,1
OLANZAPINE,1,23,801,PSYCHOTIC DISORDER,ORAL,Unknown,DIABETES MELLITUS,1
TREMFYA,2,79,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,ACCIDENTAL EXPOSURE TO PRODUCT,2
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,Solution for injection,MENTAL DISORDER,1
SPRAVATO,1,6,800,DEPRESSION,NASAL,Nasal spray,MYOCARDIAL INFARCTION,1
TOLVAPTAN,1,,,CONGENITAL CYSTIC KIDNEY DISEASE,ORAL,Tablet,DIALYSIS,1
SKYRIZI,1,78,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for infusion,DRUG-INDUCED LIVER INJURY,1
SKYRIZI,1,,,PSORIASIS,SUBCUTANEOUS,,NECK SURGERY,1
QINLOCK,2,85,801,GASTROINTESTINAL STROMAL TUMOUR,ORAL,Tablet,ATRIAL FIBRILLATION,1
INSULIN GLARGINE,2,72,801,BLOOD GLUCOSE INCREASED,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
SPRAVATO,2,42,801,DEPRESSION,NASAL,Nasal spray,URINARY TRACT INFECTION,2
SKYRIZI,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,NEPHROLITHIASIS,1
SKYRIZI,1,55,801,PSORIASIS,SUBCUTANEOUS,,DEAFNESS,1
TREMFYA,2,19,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,PNEUMONIA,1
RITUXIMAB,2,73,801,DIFFUSE LARGE B-CELL LYMPHOMA,INTRAVENOUS,Injection,FEBRILE NEUTROPENIA,1
BEMPEDOIC ACID,2,64,801,BLOOD TRIGLYCERIDES INCREASED,ORAL,Film-coated tablet,ARTHRALGIA,2
TRANEXAMIC ACID,2,21,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,,SOPOR,1
LUPRON DEPOT,2,,,PROSTATE CANCER,,Injection,PROSTATE CANCER RECURRENT,1
SKYRIZI,2,40,801,PSORIASIS,SUBCUTANEOUS,,SALPINGITIS,1
SKYRIZI,1,48,801,CROHN^S DISEASE,SUBCUTANEOUS,,SURGERY,1
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,REBOUND ATOPIC DERMATITIS,2
LISINOPRIL,1,64,801,HYPERTENSION,ORAL,,ANGIOEDEMA,2
SKYRIZI,1,43,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in cartridge,COVID-19,1
SKYRIZI,1,58,801,ISCHAEMIC HEART DISEASE PROPHYLAXIS,SUBCUTANEOUS,,HAEMOGLOBIN ABNORMAL,1
SPRAVATO,2,,,DEPRESSION,NASAL,Nasal spray,HIP FRACTURE,1
DABIGATRAN ETEXILATE,1,70,801,,ORAL,,HAEMORRHAGE,1
SKYRIZI,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,SURGERY,1
FILGRASTIM,2,72,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Unknown formulation,SYNCOPE,1
SKYRIZI,1,45,801,PSORIASIS,SUBCUTANEOUS,,INFLUENZA VIRUS TEST POSITIVE,1
AMPHETAMINE SULFATE,2,31,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,ENVIRONMENTAL EXPOSURE,1
RINVOQ,2,41,801,ANKYLOSING SPONDYLITIS,ORAL,,ALOPECIA,1
LURBINECTEDIN,1,66,801,SMALL CELL LUNG CANCER,INTRAVENOUS,UNK,NEUTROPENIA,1
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,,DENTAL IMPLANTATION,1
QINLOCK,2,67,801,GASTROINTESTINAL STROMAL TUMOUR,ORAL,Tablet,NECK SURGERY,1
DALFAMPRIDINE,2,,,MULTIPLE SCLEROSIS,ORAL,,DRUG INEFFECTIVE,2
TADALAFIL,1,81,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,DEATH,1
SKYRIZI,2,55,801,CROHN^S DISEASE,SUBCUTANEOUS,,GASTROINTESTINAL DISORDER,1
REXULTI,1,82,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Orodispersible tablet,FRACTURE,1
DEPAKOTE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,CONSTIPATION,2
ENSPRYNG,2,75,801,NEUROMYELITIS OPTICA SPECTRUM DISORDER,SUBCUTANEOUS,Injection,PNEUMONIA,1
MANNITOL,1,82,801,ANGIOEDEMA,RESPIRATORY (INHALATION),Solution for infusion,DYSPNOEA,1
RIFAMPIN,1,32,801,TUBERCULOSIS,INTRAVENOUS,Unknown,DRUG RESISTANCE,1
SKYRIZI,1,71,801,PSORIASIS,SUBCUTANEOUS,,BLINDNESS,1
SKYRIZI,2,87,801,PSORIASIS,SUBCUTANEOUS,,HIP FRACTURE,1
LACOSAMIDE,1,45,801,EPILEPSY,ORAL,Film-coated Tablets,EPILEPSY,1
RIFAXIMIN,2,57,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,URTICARIA,2
SKYRIZI,1,35,801,CROHN^S DISEASE,SUBCUTANEOUS,,RASH,2
CEFTRIAXONE,2,72,801,CYSTITIS,INTRAVENOUS,,DRUG-INDUCED LIVER INJURY,1
AMPYRA,2,76,801,MULTIPLE SCLEROSIS,ORAL,Tablet,DEATH,1
BUPROPION,2,38,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,COMPLETED SUICIDE,1
SKYRIZI,1,78,801,COLITIS ULCERATIVE,SUBCUTANEOUS,,CLOSTRIDIUM DIFFICILE COLITIS,1
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,,ABSCESS,1
TREMFYA,1,56,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,DEVICE ISSUE,2
SKYRIZI,1,73,801,PSORIASIS,SUBCUTANEOUS,,GASTRIC HAEMORRHAGE,1
SKYRIZI,2,59,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,VOCAL CORD PARALYSIS,1
SKYRIZI,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,LUNG DISORDER,1
SPRAVATO,2,4,800,DEPRESSION,NASAL,Nasal spray,SUICIDAL IDEATION,1
SKYRIZI,2,66,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Solution for injection in pre-filled pen,INJECTION SITE DISCHARGE,2
SKYRIZI,1,,,PSORIASIS,SUBCUTANEOUS,,THROMBOSIS,1
CEFTRIAXONE,1,82,801,,INTRAVENOUS,,FEELING HOT,1
SKYRIZI,2,83,801,PSORIASIS,SUBCUTANEOUS,,MACULAR DEGENERATION,1
ABECMA,1,61,801,PLASMA CELL MYELOMA,INTRAVENOUS,Injection for infusion,PLASMA CELL MYELOMA,1
AMPICILLIN,1,7,801,PNEUMONIA,INTRAMUSCULAR,Injection,DRUG INEFFECTIVE,1
TREMFYA,2,36,801,COLITIS ULCERATIVE,SUBCUTANEOUS,Solution for injection in pre-filled pen,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,2
SKYRIZI,1,,,CROHN^S DISEASE,SUBCUTANEOUS,Injection,GASTROINTESTINAL OBSTRUCTION,1
SKYRIZI,1,37,801,CROHN^S DISEASE,SUBCUTANEOUS,,COLECTOMY,1
TREMFYA,2,57,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,DEVICE ISSUE,2
SPRAVATO,2,4,800,DEPRESSION,NASAL,Nasal spray,HYPOTENSION,1
TREMFYA,2,76,801,PALMOPLANTAR PUSTULOSIS,SUBCUTANEOUS,Unknown,DERMATITIS CONTACT,1
LACOSAMIDE,1,43,801,SEIZURE,ORAL,Film-coated tablet,CEREBRAL DISORDER,1
MOXIFLOXACIN,2,19,801,TUBERCULOSIS,INTRAVENOUS,,PRODUCT USE IN UNAPPROVED INDICATION,2
NUPLAZID,2,80,801,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Tablet,RENAL FAILURE,1
TREMFYA,2,,,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,PRODUCT TEMPERATURE EXCURSION ISSUE,2
SKYRIZI,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,KNEE OPERATION,1
VELCADE,1,53,801,PLASMA CELL MYELOMA,INTRAVENOUS,Injection,COVID-19,1
SATRALIZUMAB,2,,,NEUROMYELITIS OPTICA SPECTRUM DISORDER,SUBCUTANEOUS,,URINARY TRACT INFECTION,1
SKYRIZI,2,54,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,,SEIZURE,1
EXEMESTANE,2,62,801,BREAST CANCER,ORAL,Coated tablet,PRURITUS,1
CANDESARTAN CILEXETIL,2,57,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,SYNCOPE,1
SKYRIZI,2,69,801,CROHN^S DISEASE,SUBCUTANEOUS,,INTESTINAL OPERATION,1
RILPIVIRINE,1,40,801,HIV INFECTION,,Prolonged-release suspension for injection,BACTERIAL PROSTATITIS,1
SKYRIZI,1,45,801,CROHN^S DISEASE,SUBCUTANEOUS,,SYNCOPE,1
ARIPIPRAZOLE,2,26,801,TOURETTE^S DISORDER,ORAL,Tablet,THINKING ABNORMAL,1
AMPYRA,2,42,801,MULTIPLE SCLEROSIS,ORAL,Tablet,HEAD DISCOMFORT,2
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,Intravenous infusion,CARDIAC FAILURE CONGESTIVE,1
SKYRIZI,1,24,801,CROHN^S DISEASE,SUBCUTANEOUS,Intravenous infusion,GASTROINTESTINAL DISORDER,1
QINLOCK,1,88,801,GASTROINTESTINAL STROMAL TUMOUR,ORAL,Tablet,HOSPITALISATION,1
SKYRIZI,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,SKIN LACERATION,1
CEFTRIAXONE,2,22,801,INFLUENZA,INTRAVENOUS,Powder for solution for injection/infusion,ANAPHYLACTIC SHOCK,1
SOLU-MEDROL,2,45,801,PREMEDICATION,INTRAMUSCULAR,Powder for solution for injection,AGRANULOCYTOSIS,1
AXICABTAGENE CILOLEUCEL,2,68,801,DIFFUSE LARGE B-CELL LYMPHOMA,INTRAVENOUS,Suspension,DIFFUSE LARGE B-CELL LYMPHOMA,1
SKYRIZI,1,,,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,,NEOPLASM MALIGNANT,1
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,,INTESTINAL RESECTION,1
SKYRIZI,1,,,COLITIS ULCERATIVE,SUBCUTANEOUS,,BILIARY OBSTRUCTION,1
SKYRIZI,2,66,801,CROHN^S DISEASE,SUBCUTANEOUS,,NECK SURGERY,1
SKYRIZI,2,61,801,CROHN^S DISEASE,SUBCUTANEOUS,Infusion,DEEP VEIN THROMBOSIS,1
EVENITY,2,64,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,MYOCARDIAL INFARCTION,1
XGEVA,2,73,801,METASTASES TO BONE,SUBCUTANEOUS,Solution for injection,HYPERCALCAEMIA,2
TREMFYA,2,,,PSORIASIS,SUBCUTANEOUS,Unknown,CAROTID ARTERY STENOSIS,1
SPRAVATO,2,63,801,DEPRESSION,NASAL,Nasal spray,SEIZURE,1
VINCRISTINE SULFATE,1,76,801,DIFFUSE LARGE B-CELL LYMPHOMA,INTRAVENOUS,Solution for injection,NEUROPATHY PERIPHERAL,1
PYRAZINAMIDE,2,13,801,PULMONARY TUBERCULOSIS,ORAL,,CUTANEOUS VASCULITIS,1
SKYRIZI,1,31,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled injector,INJECTION SITE PAPULE,2
LACOSAMIDE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Film-coated tablet,CEREBROVASCULAR ACCIDENT,1
SKYRIZI,1,,,CROHN^S DISEASE,SUBCUTANEOUS,,INTESTINAL OBSTRUCTION,1
LITFULO,2,43,801,,ORAL,Capsule,INFECTION,2
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,,ANORECTAL OPERATION,1
TREMFYA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for infusion,MENSTRUATION IRREGULAR,2
COBENFY,2,52,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,MALAISE,2
DALFAMPRIDINE,2,66,801,MULTIPLE SCLEROSIS,ORAL,,DEATH,1
ATORVASTATIN,2,70,801,ILL-DEFINED DISORDER,,,RASH,1
ENSPRYNG,2,70,801,NEUROMYELITIS OPTICA SPECTRUM DISORDER,SUBCUTANEOUS,Injection,CHOLANGITIS ACUTE,1
CYTARABINE,2,16,801,PRECURSOR B-LYMPHOBLASTIC LYMPHOMA,INTRAVENOUS,Unknown,FEBRILE NEUTROPENIA,1
TREMFYA,2,,,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,CARDIAC DISORDER,1
SPRAVATO,1,42,801,DEPRESSION,NASAL,Nasal spray,IMMOBILE,1
LISINOPRIL,2,47,801,HYPERTENSION,ORAL,,ANGIOEDEMA,1
ABIRATERONE ACETATE,1,79,801,PROSTATE CANCER,ORAL,,PNEUMONIA,1
ZELBORAF,1,60,801,MALIGNANT MELANOMA,ORAL,Tablet,HAEMORRHAGE,2
SPRAVATO,1,38,801,DEPRESSION,NASAL,Nasal spray,EXPIRED PRODUCT ADMINISTERED,1
SKYRIZI,2,75,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Injection,BREAST CANCER FEMALE,1
SKYRIZI,2,35,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in pre-filled injector,INJECTION SITE VESICLES,2
TREMFYA,2,63,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled syringe,PRODUCT CONTAINER SEAL ISSUE,2
CYCLOSPORINE,1,72,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,NASOPHARYNGITIS,1
UDENYCA,2,63,801,COLON CANCER,SUBCUTANEOUS,,CROHN^S DISEASE,1
ADAPALENE,2,,,ACNE,TOPICAL,Gel,ACNE,2
COBENFY,1,,,SCHIZOPHRENIA,ORAL,Capsule,FLUSHING,1
SPRAVATO,2,,,PRODUCT USED FOR UNKNOWN INDICATION,NASAL,Nasal spray,FEELING ABNORMAL,2
SKYRIZI,1,29,801,CROHN^S DISEASE,SUBCUTANEOUS,,ABDOMINAL ADHESIONS,1
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,,SKIN CANCER,1
LISINOPRIL,1,64,801,HYPERTENSION,ORAL,,ANGIOEDEMA,1
CEFTRIAXONE,1,62,801,UROSEPSIS,INTRAVENOUS,Unknown,PANCREATITIS,1
ENSPRYNG,2,51,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Injection,BREAST CANCER,1
SKYRIZI,1,,,CROHN^S DISEASE,SUBCUTANEOUS,,NEPHROLITHIASIS,1
BLINATUMOMAB,2,13,801,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,,Unknown formulation,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
SKYRIZI,2,53,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,MYOCARDIAL INFARCTION,1
ADALIMUMAB-RYVK,1,34,801,COLITIS ULCERATIVE,SUBCUTANEOUS,Injection,WRONG TECHNIQUE IN DEVICE USAGE PROCESS,2
SKYRIZI,1,,,CROHN^S DISEASE,SUBCUTANEOUS,,GASTROINTESTINAL OBSTRUCTION,1
SKYRIZI,2,82,801,CROHN^S DISEASE,SUBCUTANEOUS,,PNEUMONIA,1
SKYRIZI,1,54,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,,SPINAL OPERATION,1
METOPROLOL TARTRATE,1,38,801,TACHYCARDIA,INTRAVENOUS,Unknown,HYPERKALAEMIA,1
SKYRIZI,2,50,801,PSORIASIS,SUBCUTANEOUS,,SKIN CANCER,1
FLUCONAZOLE,1,75,801,SKIN CANDIDA,ORAL,,CONDITION AGGRAVATED,2
SKYRIZI,1,20,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in needle-free injector,INJECTION SITE MASS,2
EXEMESTANE,2,56,801,,ORAL,Coated tablet,BONE PAIN,2
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,,LOSS OF CONSCIOUSNESS,1
TREMFYA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,DEVICE DEFECTIVE,2
AMPHETAMINE,2,30,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,SHOCK HAEMORRHAGIC,1
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,,CARDIAC DISORDER,1
SKYRIZI,1,70,801,CROHN^S DISEASE,SUBCUTANEOUS,,GASTROINTESTINAL DISORDER,1
TREMFYA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Unknown,PRODUCT DOSE OMISSION ISSUE,2
BLINATUMOMAB,2,5,801,B-CELL TYPE ACUTE LEUKAEMIA,,Unknown formulation,ADENOVIRUS INFECTION,1
SKYRIZI,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,GASTROINTESTINAL INFECTION,2
ABIRATERONE ACETATE,1,,,PROSTATE CANCER,ORAL,,CARDIAC FAILURE,1
SKYRIZI,2,53,801,CROHN^S DISEASE,SUBCUTANEOUS,,MEDICAL PROCEDURE,1
AMPYRA,1,,,GAIT DISTURBANCE,ORAL,Tablet,NO ADVERSE EVENT,2
GLATIRAMER,2,,,MULTIPLE SCLEROSIS,SUBCUTANEOUS,,NEOPLASM MALIGNANT,1
SKYRIZI,1,68,801,PSORIASIS,SUBCUTANEOUS,,NEOPLASM MALIGNANT,1
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,,KNEE OPERATION,1
SPRAVATO,2,,,DEPRESSION,NASAL,Nasal spray,PRODUCT PACKAGING QUANTITY ISSUE,2
BACLOFEN,1,4,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,STATUS EPILEPTICUS,1
ELTROMBOPAG OLAMINE,1,85,801,IMMUNE THROMBOCYTOPENIA,ORAL,Film-coated tablet,MYELOFIBROSIS,1
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,,CARBON MONOXIDE POISONING,1
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,,SKIN CANCER,1
SPRAVATO,2,61,801,DEPRESSION,NASAL,Nasal spray,MEDICAL PROCEDURE,1
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,Infusion,ABORTION SPONTANEOUS,1
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,,BLINDNESS,1
QINLOCK,2,81,801,GASTROINTESTINAL STROMAL TUMOUR,ORAL,Tablet,DEATH,1
CEFTRIAXONE,2,61,801,URINARY TRACT INFECTION,INTRAVENOUS,,PARAESTHESIA ORAL,1
DOXORUBICIN,1,32,801,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA,INTRAVENOUS,Unknown,HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS,1
VINORELBINE TARTRATE,2,79,801,DIFFUSE LARGE B-CELL LYMPHOMA,,,RENAL FAILURE,1
SPRAVATO,2,63,801,MAJOR DEPRESSION,NASAL,Nasal spray,"HALLUCINATION, VISUAL",1
VARENICLINE,1,49,801,EX-TOBACCO USER,ORAL,Unknown,HALLUCINATION,1
ALEMTUZUMAB,1,79,801,T-CELL PROLYMPHOCYTIC LEUKAEMIA,INTRAVENOUS,Concentrate for solution for infusion,NEUTROPENIA,1
TREMFYA,1,76,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,DEVICE LEAKAGE,2
QINLOCK,2,71,801,GASTROINTESTINAL STROMAL TUMOUR,ORAL,Tablet,SURGERY,1
QINLOCK,1,84,801,GASTROINTESTINAL STROMAL TUMOUR,ORAL,Tablet,BACTERAEMIA,1
SKYRIZI,1,,,PSORIASIS,SUBCUTANEOUS,,URTICARIA,2
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,,MENINGITIS,1
SKYRIZI,1,74,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in pre-filled injector,INJECTION SITE PAPULE,2
AMPYRA,2,,,MULTIPLE SCLEROSIS,ORAL,Tablet,BURNING SENSATION,2
AMITRIPTYLINE HYDROCHLORIDE,1,66,801,DEPRESSIVE SYMPTOM,ORAL,,DRUG INTERACTION,1
FUROSEMIDE,1,15,801,HYPERCALCAEMIA,ORAL,Injection,DRUG INEFFECTIVE,1
SKYRIZI,2,,,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,,SKIN CANCER,1
SPRAVATO,1,44,801,DEPRESSION,NASAL,Nasal spray,VOCAL CORD OPERATION,1
TREMFYA,1,53,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,DEVICE MALFUNCTION,2
SKYRIZI,2,19,801,CROHN^S DISEASE,SUBCUTANEOUS,,PAIN,1
SKYRIZI,1,55,801,PSORIASIS,SUBCUTANEOUS,,SHOULDER OPERATION,1
SKYRIZI,1,63,801,PSORIASIS,SUBCUTANEOUS,,SEIZURE,1
XOLAIR,2,63,801,CHRONIC SPONTANEOUS URTICARIA,SUBCUTANEOUS,Solution for injection in pre-filled syringe,BLOOD PRESSURE INCREASED,1
ADAPALENE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,TOPICAL,Gel,SKIN BURNING SENSATION,2
TREMFYA,2,70,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,LOWER RESPIRATORY TRACT INFECTION,1
SKYRIZI,1,,,CROHN^S DISEASE,SUBCUTANEOUS,,MENISCUS INJURY,1
ADAPALENE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,TOPICAL,Gel,THERAPEUTIC PRODUCT EFFECT INCOMPLETE,2
ELTROMBOPAG OLAMINE,1,,,APLASTIC ANAEMIA,ORAL,Film-coated tablet,HAEMORRHAGE,1
TREMFYA,2,61,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,PRODUCT DOSE OMISSION ISSUE,2
AMLODIPINE,1,,,ILL-DEFINED DISORDER,ORAL,TPP YC - please reclassify,GINGIVAL HYPERTROPHY,1
TREMFYA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,DEVICE DEPLOYMENT ISSUE,2
OCTREOTIDE,1,34,801,GASTRIC VARICES,INTRAVENOUS,Injection,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,Solution for infusion,PAIN,1
SKYRIZI,2,78,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,NOROVIRUS INFECTION,1
CEFTRIAXONE,2,53,801,PNEUMONIA,INTRAVENOUS,,DRUG INEFFECTIVE,1
ENSPRYNG,2,36,801,NEUROMYELITIS OPTICA SPECTRUM DISORDER,SUBCUTANEOUS,,MATERNAL EXPOSURE BEFORE PREGNANCY,1
SKYRIZI,1,61,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,HERNIA,1
SKYRIZI,1,,,MIGRAINE,SUBCUTANEOUS,,PELVIC FRACTURE,1
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,,NECK SURGERY,1
SKYRIZI,2,72,801,PSORIASIS,SUBCUTANEOUS,,MYASTHENIA GRAVIS,1
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection,DEATH,1
SKYRIZI,1,,,CROHN^S DISEASE,SUBCUTANEOUS,,SUDDEN HEARING LOSS,1
METOPROLOL,2,59,801,THYROTOXIC CRISIS,INTRAVENOUS,,DRUG INEFFECTIVE,1
SPRAVATO,1,56,801,DEPRESSION,NASAL,Nasal spray,SUICIDAL IDEATION,1
SKYRIZI,1,36,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in cartridge,SEIZURE,1
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,,LARGE INTESTINAL STENOSIS,1
ADAPALENE,1,15,801,PRODUCT USED FOR UNKNOWN INDICATION,TOPICAL,Gel,SKIN BURNING SENSATION,2
SKYRIZI,1,78,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,1
SOLU-MEDROL,1,43,801,GOUT,INTRAMUSCULAR,Powder for solution for injection,ABDOMINAL PAIN,1
SKYRIZI,2,69,801,CROHN^S DISEASE,SUBCUTANEOUS,,CHOLECYSTECTOMY,1
DAPTOMYCIN,2,48,801,BACTERAEMIA,INTRAVENOUS,,ENCEPHALOPATHY,1
TOLVAPTAN,1,,,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,ORAL,Tablet,SMALL CELL LUNG CANCER METASTATIC,1
METHYLPREDNISOLONE SODIUM SUCCINATE,1,56,801,ANTIINFLAMMATORY THERAPY,INTRAMUSCULAR,Powder for solution for injection,WHITE BLOOD CELL COUNT INCREASED,1
SKYRIZI,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,INTESTINAL OBSTRUCTION,1
BOTOX COSMETIC,2,50,801,SKIN WRINKLING,INTRAMUSCULAR,Solution for injection,BLEPHAROSPASM,2
SKYRIZI,1,,,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in pre-filled injector,STOMA COMPLICATION,1
BORTEZOMIB,1,61,801,PLASMA CELL MYELOMA,INTRAVENOUS,,PULMONARY MUCORMYCOSIS,1
BACLOFEN,1,31,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,DEATH,1
ARIPIPRAZOLE,2,28,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,PSYCHIATRIC DECOMPENSATION,1
TOLVAPTAN,2,,,CONGENITAL CYSTIC KIDNEY DISEASE,ORAL,Tablet,DIALYSIS,1
IBRANCE,2,55,801,,ORAL,Capsule,DYSGEUSIA,2
SPRAVATO,2,52,801,DEPRESSION,NASAL,Nasal spray,HYPERTHYROIDISM,1
SPRAVATO,2,,,PRODUCT USED FOR UNKNOWN INDICATION,NASAL,Nasal spray,ANXIETY,2
LENALIDOMIDE,1,78,801,DIFFUSE LARGE B-CELL LYMPHOMA,ORAL,,GENERAL PHYSICAL HEALTH DETERIORATION,1
CYCLOPHOSPHAMIDE,2,6,800,,INTRAVENOUS,Coated tablet,URINARY RETENTION,1
KISQALI,2,62,801,BREAST CANCER METASTATIC,ORAL,Tablet,LIVER FUNCTION TEST INCREASED,1
BOTOX,2,,,MIGRAINE,INTRADERMAL,,CHEMOTHERAPY,1
SKYRIZI,2,62,801,CROHN^S DISEASE,SUBCUTANEOUS,,SPINAL FRACTURE,1
VANCOMYCIN,2,37,801,INFECTION,INTRAVENOUS,Solution for infusion,MEDICATION ERROR,1
TREMFYA,2,,,URTICARIA,SUBCUTANEOUS,Solution for injection in pre-filled pen,DEVICE DEPLOYMENT ISSUE,2
AGAMREE,1,18,801,DUCHENNE MUSCULAR DYSTROPHY,ORAL,Oral suspension,INFUSION RELATED REACTION,1
REZLIDHIA,1,48,801,BRAIN NEOPLASM MALIGNANT,ORAL,Capsule,NEOPLASM,1
CEFTRIAXONE SODIUM,2,68,801,SKIN INFECTION,INTRAVENOUS,,ANAPHYLACTIC REACTION,1
REXULTI,2,36,801,DEPRESSION,ORAL,Tablet,HALLUCINATION,1
SKYRIZI,2,4,802,MATERNAL EXPOSURE TIMING UNSPECIFIED,SUBCUTANEOUS,,POSTNATAL GROWTH RESTRICTION,1
SPRAVATO,2,77,801,DEPRESSION,NASAL,Nasal spray,PULSE ABSENT,1
SKYRIZI,1,70,801,CROHN^S DISEASE,SUBCUTANEOUS,,GASTROINTESTINAL DISORDER,1
INSULIN GLARGINE,1,92,801,,SUBCUTANEOUS,Solution for injection,SYNCOPE,1
PIOGLITAZONE,1,73,801,,ORAL,,NEOPLASM MALIGNANT,2
CYCLOPHOSPHAMIDE,2,77,801,DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV,INTRAVENOUS,Unknown,ADRENAL MASS,1
SPRAVATO,1,,,DEPRESSION,NASAL,Nasal spray,COMPLETED SUICIDE,1
SKYRIZI,1,45,801,PSORIASIS,SUBCUTANEOUS,,NEPHRECTOMY,1
SKYRIZI,2,,,PSORIASIS,SUBCUTANEOUS,Suspension for injection,INJECTION SITE PAIN,2
SKYRIZI,2,32,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Solution for injection in pre-filled pen,PULMONARY OEDEMA,1
QINLOCK,1,80,801,GASTROINTESTINAL STROMAL TUMOUR,ORAL,Tablet,DEATH,1
TREMFYA,2,,,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Solution for injection in pre-filled pen,PSORIATIC ARTHROPATHY,1
SKYRIZI,2,67,801,CROHN^S DISEASE,SUBCUTANEOUS,,VESICAL FISTULA,1
SKYRIZI,2,53,801,CROHN^S DISEASE,SUBCUTANEOUS,,BRONCHITIS,1
SKYRIZI,2,49,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,THROMBOSIS,1
NUVARING,2,42,801,,VAGINAL,Vaginal Ring,PREGNANCY WITH CONTRACEPTIVE DEVICE,1
SKYRIZI,2,77,801,PSORIASIS,SUBCUTANEOUS,Solution for injection,DEATH,1
COBENFY,2,65,801,SCHIZOPHRENIA,ORAL,,DISTURBANCE IN ATTENTION,2
SKYRIZI,2,,,CROHN^S DISEASE,SUBCUTANEOUS,,SURGERY,1
DUPIXENT,2,47,801,DYSHIDROTIC ECZEMA,SUBCUTANEOUS,Solution for injection,DYSHIDROTIC ECZEMA,2
CLARITIN-D NOS,1,,,PRODUCT USED FOR UNKNOWN INDICATION,,Film-coated tablet,DIZZINESS,2
MIRENA,2,,,,INTRAUTERINE,Intrauterine delivery system,DEVICE DISLOCATION,2
HUMIRA,2,25,801,RHEUMATOID ARTHRITIS,,,NASOPHARYNGITIS,2
JEUVEAU,2,,,SKIN WRINKLING,INTRAMUSCULAR,Powder for solution for injection,DRUG EFFECT LESS THAN EXPECTED,2
DIMETHYL FUMARATE,1,60,801,MULTIPLE SCLEROSIS,ORAL,,HOT FLUSH,1
ABEMACICLIB,2,50,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,HEPATOTOXICITY,1
DUPIXENT,2,,,ASTHMA,SUBCUTANEOUS,Solution for injection,ARTHRITIS,2
DUPIXENT,1,,,ILLNESS,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
DUPIXENT,1,4,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
DUPIXENT,1,44,801,NASAL POLYPS,SUBCUTANEOUS,Solution for injection,ANOSMIA,2
ZURZUVAE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,HYPERSOMNIA,2
XOLAIR PFS,2,,,ASTHMA,SUBCUTANEOUS,Solution for injection in pre-filled syringe,ANAPHYLACTIC REACTION,1
ELFABRIO,2,24,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Solution for infusion,CHEST PAIN,1
AIMOVIG,2,75,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,FOOD ALLERGY,2
REVLIMID,1,58,801,PLASMA CELL MYELOMA,ORAL,,NEUROPATHY PERIPHERAL,1
LISTERINE COOL MINT ANTISEPTIC,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Mouth wash,NEOPLASM MALIGNANT,1
AUVELITY,1,,,MAJOR DEPRESSION,ORAL,Extended-release tablets,IMPAIRED DRIVING ABILITY,2
NUPLAZID,2,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,MALAISE,2
CEFEPIME HYDROCHLORIDE,1,67,801,PNEUMONIA,INTRAMUSCULAR,,STEVENS-JOHNSON SYNDROME,1
VALIUM,1,42,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,TOXICITY TO VARIOUS AGENTS,1
LENALIDOMIDE,2,58,801,PLASMA CELL MYELOMA,ORAL,Capsule,PRODUCT DOSE OMISSION ISSUE,2
MOUNJARO,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in cartridge,INSOMNIA,1
SIMPONI,2,65,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,PRODUCT DOSE OMISSION ISSUE,2
RILPIVIRINE,1,35,801,HIV INFECTION,,Prolonged-release suspension for injection,BLOOD HIV RNA INCREASED,2
REVLIMID,2,82,801,PLASMA CELL MYELOMA,ORAL,Capsule,HIP FRACTURE,1
TALTZ,1,57,801,SPONDYLOARTHROPATHY,SUBCUTANEOUS,Solution for injection in pre-filled pen,OFF LABEL USE,2
SKYCLARYS,1,33,801,FRIEDREICH^S ATAXIA,ORAL,Capsule,HAEMATURIA,1
CYCLOSPORINE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,"Emulsion, Ophthalmic",PRODUCT COLOUR ISSUE,2
INVANZ,2,79,801,CHOLECYSTITIS ACUTE,INTRAMUSCULAR,Powder for injection,DEMENTIA,1
LUMRYZ,2,,,NARCOLEPSY,ORAL,Extended-Release Oral Suspension,IRRITABILITY,2
INCLISIRAN,1,44,801,,SUBCUTANEOUS,,INJECTION SITE DISCOLOURATION,1
ORENCIA,2,71,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Solution for injection,ARTHRALGIA,2
LENALIDOMIDE,2,82,801,PLASMA CELL MYELOMA,ORAL,,DEATH,1
VERZENIO,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,RENAL FAILURE,1
VEDOLIZUMAB,1,,,CROHN^S DISEASE,SUBCUTANEOUS,Injection,FALL,1
CLOZAPINE,1,30,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,NEUTROPENIA,2
NUPLAZID,1,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,DRUG INEFFECTIVE,2
BENLYSTA,1,55,801,SYSTEMIC LUPUS ERYTHEMATOSUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,PRODUCT DOSE OMISSION ISSUE,2
AMLODIPINE,2,45,801,DIASTOLIC HYPERTENSION,ORAL,Tablet,OEDEMA PERIPHERAL,1
NEXPLANON,2,,,,SUBCUTANEOUS,Implant,HEAVY MENSTRUAL BLEEDING,1
COPAXONE,2,60,801,MULTIPLE SCLEROSIS,SUBCUTANEOUS,Injection,MULTIPLE SCLEROSIS RELAPSE,1
VICTOZA,2,,,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,HAEMORRHAGE,2
IMBRUVICA,2,76,801,CHRONIC LYMPHOCYTIC LEUKAEMIA,ORAL,Unknown,ESCHERICHIA URINARY TRACT INFECTION,1
LINZESS,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,DRUG INEFFECTIVE,2
DUPIXENT,2,57,801,NEURODERMATITIS,SUBCUTANEOUS,Solution for injection,BLISTER,2
DUPIXENT,1,56,801,ASTHMA,SUBCUTANEOUS,Solution for injection,ASTHMA,2
LANTUS SOLOSTAR,1,84,801,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,EXPIRED PRODUCT ADMINISTERED,2
MEPIVACAINE,2,28,801,LOCAL ANAESTHESIA,SUBMUCOSAL,,HYPERTENSION,1
HADLIMA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,COVID-19,2
FARICIMAB,2,64,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVITREAL,Injection,CONJUNCTIVITIS,1
VABYSMO,2,66,801,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,INTRAVITREAL,,HEADACHE,1
XELJANZ XR,2,53,801,RHEUMATOID ARTHRITIS,ORAL,Prolonged-release tablet,URINARY TRACT INFECTION,2
SAXENDA,2,,,WEIGHT CONTROL,SUBCUTANEOUS,Solution for injection,HYPERTENSION,2
DUPIXENT,2,76,801,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,SUBCUTANEOUS,Solution for injection,INJECTION SITE PAIN,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
CONCERTA,1,,,ATTENTION DEFICIT HYPERACTIVITY DISORDER,ORAL,Prolonged-release tablet,CONTUSION,1
OMALIZUMAB,2,31,801,ASTHMA,SUBCUTANEOUS,,ANAPHYLACTIC REACTION,1
NUPLAZID,2,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,HALLUCINATION,1
DUPIXENT,1,17,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ERYTHEMA,2
DUPIXENT,1,10,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,RASH PAPULAR,2
DUPIXENT,2,25,801,NASAL POLYPS,SUBCUTANEOUS,Solution for injection,NASAL POLYPS,2
OMNITROPE,1,13,801,GROWTH HORMONE DEFICIENCY,SUBCUTANEOUS,Solution for injection,INJECTION SITE HAEMORRHAGE,2
AZOPT,2,,,PRODUCT USED FOR UNKNOWN INDICATION,OPHTHALMIC,"Eye drops, suspension",BLINDNESS,1
ZOLPIDEM TARTRATE,2,84,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,DRUG USE DISORDER,1
MOUNJARO,2,70,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,FAECALOMA,2
TALTZ,2,58,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Injection,VERTIGO,2
PIQRAY,1,71,801,GASTRIC CANCER STAGE 0,ORAL,,DEATH,1
DELFLEX WITH DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM,2,80,801,END STAGE RENAL DISEASE,,Solution for peritoneal dialysis,PERITONITIS,1
AVONEX,2,,,MULTIPLE SCLEROSIS,INTRAMUSCULAR,Unknown,NERVOUSNESS,2
LEQVIO,2,,,HYPERCHOLESTEROLAEMIA,SUBCUTANEOUS,Solution for injection,BLOOD CHOLESTEROL INCREASED,1
TRODELVY,2,40,801,TRIPLE NEGATIVE BREAST CANCER,INTRAVENOUS,Powder for concentrate for solution for infusion,EPISTAXIS,1
REVLIMID,2,66,801,PLASMA CELL MYELOMA,ORAL,Capsule,PRODUCT DOSE OMISSION ISSUE,2
DUPIXENT,2,1,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
MIEBO,2,,,PRODUCT USED FOR UNKNOWN INDICATION,OPHTHALMIC,"Eye drops, solution",HYPOAESTHESIA EYE,2
OMNITROPE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,GASTROINTESTINAL DISORDER,1
ACTEMRA ACTPEN,1,68,801,RHEUMATOID ARTHRITIS,SUBCUTANEOUS,Direct auto-injector,DRUG INEFFECTIVE,2
ELIGARD,1,77,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,INTENTIONAL PRODUCT USE ISSUE,2
DUPIXENT,2,14,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ASTHMA,2
DUPIXENT,1,34,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
FOCALIN,1,9,801,ATTENTION DEFICIT HYPERACTIVITY DISORDER,ORAL,Unknown,HALLUCINATION,1
DUPIXENT,1,18,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DRY SKIN,2
FEZOLINETANT,2,,,MENOPAUSAL SYMPTOMS,ORAL,Tablet,THERAPEUTIC PRODUCT EFFECT DECREASED,2
MOUNJARO,2,65,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,INJECTION SITE REACTION,2
TYSABRI,2,52,801,MULTIPLE SCLEROSIS,INTRAVENOUS,Concentrate for solution for infusion,FURUNCLE,1
SACITUZUMAB GOVITECAN-HZIY,2,45,801,TRIPLE NEGATIVE BREAST CANCER,,Powder for concentrate for solution for infusion,DISEASE PROGRESSION,1
NIVOLUMAB\RELATLIMAB,1,,,PRODUCT USED FOR UNKNOWN INDICATION,,,SECONDARY ADRENOCORTICAL INSUFFICIENCY,2
XIFAXAN,2,79,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,DEATH,1
LENALIDOMIDE,2,79,801,PLASMA CELL MYELOMA,ORAL,,HAEMATURIA,1
DUPIXENT,1,,,ECZEMA,SUBCUTANEOUS,Solution for injection,INJECTION SITE SWELLING,2
DUPIXENT,2,63,801,TRANSIENT ACANTHOLYTIC DERMATOSIS,SUBCUTANEOUS,Solution for injection,PRURITUS,2
VENETOCLAX,2,49,801,CHRONIC LYMPHOCYTIC LEUKAEMIA,ORAL,Film-coated tablet,OXYGEN SATURATION DECREASED,1
WEGOVY,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,BLINDNESS UNILATERAL,1
OZEMPIC,2,52,801,WEIGHT CONTROL,SUBCUTANEOUS,Solution for injection,HAEMATEMESIS,1
NEXPLANON,2,,,,SUBCUTANEOUS,Implant,HEAVY MENSTRUAL BLEEDING,1
DEPO-PROVERA,2,,,CONTRACEPTION,INTRAMUSCULAR,Suspension for injection,MENINGIOMA,1
SYNAGIS,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAMUSCULAR,Injection,WEIGHT DECREASED,1
ACTEMRA,2,,,RHEUMATOID ARTHRITIS,INTRAVENOUS,Injection,HAEMORRHAGE,1
AMLODIPINE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,FALL,1
DUPIXENT,2,59,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ASTHMA,2
CLOZAPINE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,PSYCHIATRIC SYMPTOM,1
DUPIXENT,2,57,801,ASTHMA,SUBCUTANEOUS,Solution for injection,INFLUENZA,2
"DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE",2,,,ATTENTION DEFICIT HYPERACTIVITY DISORDER,,Tablet,FLATULENCE,2
GENOTROPIN,1,5,801,GROWTH HORMONE DEFICIENCY,,Solution for injection,INJECTION SITE HAEMATOMA,2
KESIMPTA,2,,,MULTIPLE SCLEROSIS,SUBCUTANEOUS,,MULTIPLE SCLEROSIS,1
DUPIXENT,1,,,ASTHMA,SUBCUTANEOUS,Solution for injection,ASTHMA,2
TECENTRIQ,2,66,801,LUNG CANCER METASTATIC,INTRAVENOUS,,ABDOMINAL PAIN UPPER,1
FINGOLIMOD,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,GLOMERULAR FILTRATION RATE DECREASED,1
ORENCIA,2,56,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Injection,CARDIAC DISORDER,2
PROMACTA,1,,,IMMUNE THROMBOCYTOPENIA,ORAL,,DYSPEPSIA,2
CLOPIDOGREL,1,59,801,STENOSIS,ORAL,,INSULIN AUTOIMMUNE SYNDROME,1
REVLIMID,1,53,801,PLASMA CELL MYELOMA,ORAL,,PYREXIA,1
TIKOSYN,2,,,,ORAL,"Capsule, hard",PRODUCT RESIDUE PRESENT,2
AXICABTAGENE CILOLEUCEL,2,41,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Suspension,COMPLETED SUICIDE,1
XELJANZ XR,1,72,801,,ORAL,Prolonged-release tablet,NEOPLASM MALIGNANT,1
AMLODIPINE,1,86,801,HYPERTENSION,ORAL,Tablet,PHOTOSENSITIVITY REACTION,1
REVLIMID,2,78,801,PLASMA CELL MYELOMA REFRACTORY,ORAL,Capsule,PLATELET COUNT DECREASED,2
RYBELSUS,2,58,801,TYPE 2 DIABETES MELLITUS,ORAL,Tablet,CARDIAC OPERATION,1
REVLIMID,1,74,801,PLASMA CELL MYELOMA,ORAL,Capsule,PNEUMONIA,1
XOFIGO,1,,,HORMONE-REFRACTORY PROSTATE CANCER,INTRAVENOUS,Solution for injection,ARTHRALGIA,1
ELIGARD,1,,,PROSTATE CANCER,SUBCUTANEOUS,Injection,EXERCISE TOLERANCE DECREASED,2
XELJANZ,1,28,801,COLITIS ULCERATIVE,ORAL,Tablet,DRUG INEFFECTIVE,2
AMLODIPINE,1,76,801,ADVERSE DRUG REACTION,ORAL,Tablet,POLLAKIURIA,1
NUPLAZID,1,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,PRODUCT USE ISSUE,2
MOUNJARO,2,49,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INCORRECT DOSE ADMINISTERED,2
STELARA,2,22,801,CROHN^S DISEASE,INTRAVENOUS,Solution for injection,FOOT OPERATION,1
TYLENOL,2,,,DYSMENORRHOEA,ORAL,Unknown,DRUG INEFFECTIVE,2
VEDOLIZUMAB,2,56,801,COLITIS ULCERATIVE,SUBCUTANEOUS,Powder for solution for infusion,HAEMATOCHEZIA,1
FRUZAQLA,1,6,800,COLORECTAL CANCER RECURRENT,ORAL,Capsule,NEPHROTIC SYNDROME,1
ZEPOSIA,1,41,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Capsule,BACK DISORDER,1
TRINTELLIX,2,,,PANIC ATTACK,ORAL,Tablet,MEMORY IMPAIRMENT,2
JIVI,1,31,801,,,Powder and solvent for solution for infusion,HAEMORRHAGE,1
GENOTROPIN,2,,,,,Solution for injection,ACCIDENTAL EXPOSURE TO PRODUCT,2
OXYCONTIN,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Prolonged-release tablet,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
DUPIXENT,2,8,801,DERMATITIS,SUBCUTANEOUS,Solution for injection,OCULAR HYPERAEMIA,2
MOUNJARO,2,62,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,EXTRA DOSE ADMINISTERED,2
GENOTROPIN,2,15,801,,,Solution for injection,INJECTION SITE PAIN,2
DUPIXENT,1,21,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
KESIMPTA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,LOWER RESPIRATORY TRACT INFECTION,1
NUPLAZID,2,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,HALLUCINATION,1
EYLEA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVITREAL,Injection,HOSPITALISATION,1
DUPIXENT,2,41,801,DERMATITIS ALLERGIC,SUBCUTANEOUS,Solution for injection,ILLNESS,2
DUPIXENT,2,58,801,NASAL POLYPS,SUBCUTANEOUS,Solution for injection,INFLUENZA,2
DUPIXENT,2,24,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
CARBIDOPA\LEVODOPA,2,77,801,PRODUCT USED FOR UNKNOWN INDICATION,,,URINARY TRACT INFECTION,1
SOOTHE HYDRATION,1,,,PRODUCT USED FOR UNKNOWN INDICATION,,"Eye drops, solution",CATARACT,1
CILTACABTAGENE AUTOLEUCEL,1,77,801,PLASMA CELL MYELOMA,INTRAVENOUS,Dispersion for infusion,ACUTE MYELOID LEUKAEMIA,1
TENOFOVIR DISOPROXIL FUMARATE,1,69,801,HEPATITIS B,ORAL,Unknown,LACTIC ACIDOSIS,1
EMTRICITABINE\TENOFOVIR DISOPROXIL,2,,,PRODUCT USED FOR UNKNOWN INDICATION,,,LOW BIRTH WEIGHT BABY,1
PARAGARD T 380A,2,31,801,CONTRACEPTION,INTRAUTERINE,Intrauterine,REPRODUCTIVE COMPLICATION ASSOCIATED WITH DEVICE,1
YASMIN,2,33,801,CONTRACEPTION,,Film-coated tablet,SUICIDAL IDEATION,1
SEMAGLUTIDE,2,54,801,OBESITY,SUBCUTANEOUS,,PANCREATITIS ACUTE,1
REVLIMID,1,59,801,PLASMA CELL MYELOMA,ORAL,,PERIORBITAL OEDEMA,2
ULTRAVIST,2,74,801,COMPUTERISED TOMOGRAM,INTRA-ARTERIAL,Solution for injection,URTICARIA,1
MIRALAX,1,,,COLONOSCOPY,ORAL,Powder for oral solution,PRODUCT PRESCRIBING ISSUE,2
FOSCARBIDOPA\FOSLEVODOPA,1,,,PARKINSON^S DISEASE,SUBCUTANEOUS,Solution for infusion,MOBILITY DECREASED,1
ABATACEPT,1,51,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Solution for injection,DEEP VEIN THROMBOSIS,1
HERCEPTIN,2,,,BREAST CANCER,INTRAVENOUS,Injection,HYPERTENSION,1
SERTRALINE,2,36,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,POLYMENORRHOEA,1
TALTZ,1,61,801,PSORIASIS,SUBCUTANEOUS,Injection,RESPIRATORY TRACT INFECTION,2
XARELTO,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Film-coated tablet,PERIPHERAL SWELLING,1
ADEMPAS,2,,,PULMONARY ARTERIAL HYPERTENSION,ORAL,,BENDOPNOEA,1
EYLEA,2,53,801,DIABETIC RETINAL OEDEMA,INTRAVITREAL,Injection,SWELLING FACE,2
UBRELVY,2,45,801,MIGRAINE,ORAL,,ANXIETY,2
DUPIXENT,2,48,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PRURITUS,2
TYRVAYA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,NASAL,,SYNCOPE,1
KESIMPTA,1,34,801,RELAPSING-REMITTING MULTIPLE SCLEROSIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,MULTIPLE SCLEROSIS RELAPSE,1
MEKINIST,2,,,HYPERTROPHIC CARDIOMYOPATHY,ORAL,,RASH,2
DUPIXENT,1,44,801,,SUBCUTANEOUS,Solution for injection,ACCIDENTAL EXPOSURE TO PRODUCT,2
DUPIXENT,2,66,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,COVID-19,2
DUPIXENT,1,77,801,NASAL POLYPS,SUBCUTANEOUS,Solution for injection,INJECTION SITE DISCOLOURATION,2
DUPIXENT,2,38,801,BENIGN FAMILIAL PEMPHIGUS,SUBCUTANEOUS,Solution for injection,PRODUCT USE IN UNAPPROVED INDICATION,2
DUPIXENT,1,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PRURITUS,2
ENTYVIO,2,6,801,CROHN^S DISEASE,SUBCUTANEOUS,Powder for solution for infusion,CROHN^S DISEASE,1
SERTRALINE,2,23,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,MYOPATHY,1
LUMAKRAS,1,79,801,K-RAS GENE MUTATION,ORAL,Tablet,LYMPHADENOPATHY,1
RYBREVANT,2,,,NON-SMALL CELL LUNG CANCER,INTRAVENOUS,Solution for injection,FLUSHING,2
CARBIDOPA\LEVODOPA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,,"Modified-release capsule, hard",DEATH,1
XELJANZ XR,2,53,801,,ORAL,Prolonged-release tablet,ILLNESS,2
MOUNJARO,1,,,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,INJECTION SITE HYPERSENSITIVITY,2
TYSABRI,2,63,801,MULTIPLE SCLEROSIS,INTRAVENOUS,Concentrate for solution for infusion,DEAFNESS UNILATERAL,1
DUPIXENT,2,71,801,ASTHMA,SUBCUTANEOUS,Solution for injection,INCORRECT DOSE ADMINISTERED,2
SIMPONI,1,69,801,RHEUMATOID ARTHRITIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,LOWER RESPIRATORY TRACT INFECTION,1
FULVESTRANT,2,,,BREAST CANCER METASTATIC,INTRAMUSCULAR,Unknown,RESPIRATORY FAILURE,1
KERENDIA,1,,,,ORAL,Film-coated tablet,HYPERKALAEMIA,1
LAMIVUDINE\ZIDOVUDINE,1,,,,,,GALLBLADDER OPERATION,1
DUPIXENT,1,38,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
MOUNJARO,1,65,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,ASTHENIA,2
TAVALISSE,2,,,IMMUNE THROMBOCYTOPENIA,ORAL,Tablet,BLOOD DISORDER,1
AIMOVIG,2,77,801,HEADACHE,SUBCUTANEOUS,Solution for injection,DEVICE DIFFICULT TO USE,2
KINERET,2,7,801,PARTIAL SEIZURES,SUBCUTANEOUS,,NAUSEA,2
MOUNJARO,2,51,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,PRODUCT STORAGE ERROR,2
VELTASSA,2,,,,ORAL,Powder for oral suspension,VOMITING,2
REVLIMID,1,76,801,PLASMA CELL MYELOMA,ORAL,Capsule,TOOTH DISORDER,1
CABOMETYX,2,,,CHONDROSARCOMA METASTATIC,ORAL,Tablet,OFF LABEL USE,2
CABOMETYX,1,,,HEPATIC CANCER,ORAL,Tablet,BLOOD PRESSURE FLUCTUATION,2
CABOMETYX,1,,,ILLNESS,ORAL,Tablet,DYSPHAGIA,2
ERIVEDGE,2,,,BASAL CELL CARCINOMA,ORAL,Capsule,MEMORY IMPAIRMENT,2
TERBINAFINE,2,50,801,ANTIFUNGAL TREATMENT,ORAL,,AGEUSIA,1
CIBINQO,1,24,801,DERMATITIS ATOPIC,ORAL,Tablet,DRUG INEFFECTIVE,2
INLYTA,1,81,801,,ORAL,Film-coated tablet,CONFUSIONAL STATE,1
MOUNJARO,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,NEOPLASM MALIGNANT,1
MOUNJARO,2,78,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,EXTRA DOSE ADMINISTERED,2
SERTRALINE,1,60,801,DEPRESSION,ORAL,,SLEEP TERROR,1
HYRIMOZ,2,52,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,RASH MACULAR,2
NUPLAZID,2,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,ADVERSE DRUG REACTION,2
ALEVE BACK AND MUSCLE PAIN,2,84,801,INTERVERTEBRAL DISC PROTRUSION,ORAL,Coated tablet,EXTRA DOSE ADMINISTERED,2
KERENDIA,2,,,,ORAL,Film-coated tablet,INSOMNIA,2
XIIDRA,2,,,DRY EYE,OPHTHALMIC,"Eye drops, solution",EYE PAIN,2
SUNOSI,2,50,801,OBSTRUCTIVE SLEEP APNOEA SYNDROME,ORAL,Tablets,NAUSEA,2
PREDNISOLONE,2,69,801,STILL^S DISEASE,ORAL,Unknown,DEATH,1
BASAGLAR,1,56,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Injection,INJURY ASSOCIATED WITH DEVICE,2
SPINRAZA,1,,,SPINAL MUSCULAR ATROPHY,INTRATHECAL,Unknown,NEOPLASM MALIGNANT,1
MARIBAVIR,1,,,CYTOMEGALOVIRUS INFECTION,ORAL,Tablet,BLOOD POTASSIUM ABNORMAL,2
XELJANZ XR,1,74,801,,ORAL,Prolonged-release tablet,PROSTATE CANCER,1
NUPLAZID,1,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,DELUSION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
CELEBREX,2,69,801,PAIN IN EXTREMITY,ORAL,Capsule,ASTHENIA,1
CANDESARTAN,1,,,HYPERTENSION,ORAL,Unknown,MYALGIA,1
TOCILIZUMAB,1,36,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,,LOCALISED OEDEMA,1
HUMIRA,2,31,801,RHEUMATOID ARTHRITIS,,Injection,INFLUENZA,2
ALEVE BACK AND MUSCLE PAIN,1,4,801,,ORAL,Coated tablet,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,2
FINTEPLA,2,5,801,LENNOX-GASTAUT SYNDROME,ORAL,Oral solution,SEIZURE,1
SPINRAZA,1,20,802,SPINAL MUSCULAR ATROPHY,INTRATHECAL,Unknown,DYSPHAGIA,2
RITUXIMAB,2,,,GLOMERULONEPHRITIS,INTRAVENOUS,,MUSCLE SPASMS,1
TAVNEOS,2,56,801,,ORAL,,ANEURYSM RUPTURED,1
TYLENOL 8 HR ARTHRITIS PAIN,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,DRUG INEFFECTIVE,2
REVLIMID,2,75,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,DRUG HYPERSENSITIVITY,2
TRAMADOL,2,19,801,PRODUCT USED FOR UNKNOWN INDICATION,,,INTENTIONAL PRODUCT MISUSE,1
VENCLEXTA,1,28,801,DIFFUSE LARGE B-CELL LYMPHOMA,ORAL,,DEATH,1
CIMZIA,2,46,801,ANKYLOSING SPONDYLITIS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,ANKYLOSING SPONDYLITIS,1
HYDROCODONE BITARTRATE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,DRUG INEFFECTIVE,2
PANTOPRAZOLE,1,75,801,,ORAL,,HYPOCALCAEMIA,1
MIRENA,2,57,801,HEAVY MENSTRUAL BLEEDING,INTRAUTERINE,Intrauterine delivery system,ENDOMETRIAL CANCER,1
MIRENA,2,,,INTRAUTERINE CONTRACEPTION,INTRAUTERINE,Intrauterine delivery system,DEVICE DISLOCATION,2
CARBIDOPA\LEVODOPA,2,80,801,PARKINSON^S DISEASE,,Intestinal gel,DEATH,1
VEDOLIZUMAB,1,,,COLITIS ULCERATIVE,SUBCUTANEOUS,Solution for injection,COLITIS ULCERATIVE,1
ZIAGEN,1,59,801,HIV INFECTION,ORAL,,PRODUCT DOSE OMISSION ISSUE,2
GENOTROPIN,1,,,,,Solution for injection in pre-filled pen,ACCIDENT,1
ORENCIA,2,72,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Solution for injection,JOINT SWELLING,2
SAXENDA,2,46,801,,SUBCUTANEOUS,Solution for injection,VOMITING,1
LA ROCHE POSAY LABORATOIRE DERMATOLOGIQUE EFFACLAR DUO ACNE TREATMENT,2,37,801,ACNE,TOPICAL,,RASH,1
TYMLOS,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Sub-cutaneous injection,BLOOD PRESSURE DECREASED,1
CARBIDOPA\LEVODOPA,2,75,801,PRODUCT USED FOR UNKNOWN INDICATION,,,LEUKAEMIA,1
COSENTYX,2,47,801,HIDRADENITIS,SUBCUTANEOUS,Injection,PNEUMONIA,2
DAPTOMYCIN,2,74,801,ENDOCARDITIS BACTERIAL,INTRAVENOUS,,HAEMOLYTIC ANAEMIA,1
ABRILADA,2,20,801,JUVENILE IDIOPATHIC ARTHRITIS,,Solution for injection in pre-filled pen,CYST RUPTURE,1
MOUNJARO,1,62,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,EXTRA DOSE ADMINISTERED,2
CLARITIN REDITABS,1,,,COLD URTICARIA,ORAL,Orodispersible tablet,DIARRHOEA,2
TAVNEOS,2,65,801,,ORAL,,INTERNAL HAEMORRHAGE,1
FRUQUINTINIB,1,,,COLON CANCER,ORAL,Capsule,DEATH,1
ZOLPIDEM,1,22,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,DRUG ABUSE,1
NEULASTA,2,51,801,PROPHYLAXIS,SUBCUTANEOUS,Solution for injection,LABORATORY TEST ABNORMAL,2
CERTOLIZUMAB PEGOL,2,52,801,ANKYLOSING SPONDYLITIS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,ANKYLOSING SPONDYLITIS,1
SERTRALINE,1,,,ANXIETY,ORAL,,ABNORMAL DREAMS,1
ZEASORB AF,2,,,,,,ASPHYXIA,1
LITHIUM,1,55,801,SCHIZOAFFECTIVE DISORDER,ORAL,,NEPHROGENIC DIABETES INSIPIDUS,1
MIRENA,2,,,INTRAUTERINE CONTRACEPTION,INTRAUTERINE,Intrauterine delivery system,DEVICE DISLOCATION,2
UBRELVY,2,61,801,MIGRAINE,ORAL,,ALOPECIA,2
ZEPOSIA,2,61,801,MULTIPLE SCLEROSIS,ORAL,,DRUG HYPERSENSITIVITY,2
ETONOGESTREL,2,,,,SUBCUTANEOUS,Implant,PREGNANCY WITH IMPLANT CONTRACEPTIVE,1
HUMIRA,1,23,801,SYNOVITIS,,Injection,LIMB INJURY,2
DUPIXENT,1,12,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,INJECTION SITE DISCOMFORT,2
BOTOX COSMETIC,2,,,MUSCLE HYPERTROPHY,INTRAMUSCULAR,,INJECTION SITE SWELLING,2
MOUNJARO,2,68,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,ACCIDENTAL UNDERDOSE,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
NUBEQA,1,,,PROSTATE CANCER,ORAL,,PYREXIA,1
VEDOLIZUMAB,1,,,COLITIS ULCERATIVE,SUBCUTANEOUS,Powder for solution for infusion,NEUROPATHY PERIPHERAL,1
TAMSULOSIN,1,69,801,BENIGN PROSTATIC HYPERPLASIA,,,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
ELOCTATE,1,32,801,,,Powder and solvent for solution for injection,GASTRIC ULCER HAEMORRHAGE,1
DUPIXENT,2,53,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,MYCOPLASMA INFECTION,1
REVLIMID,2,70,801,PLASMA CELL MYELOMA,ORAL,,NEUTROPENIA,1
MOUNJARO,2,79,801,BLOOD GLUCOSE DECREASED,SUBCUTANEOUS,Solution for injection in pre-filled pen,INCORRECT DOSE ADMINISTERED,2
VEDOLIZUMAB,1,,,COLITIS ULCERATIVE,SUBCUTANEOUS,Solution for injection,DEATH,1
OMALIZUMAB,2,38,801,CHRONIC SPONTANEOUS URTICARIA,SUBCUTANEOUS,,DYSPEPSIA,1
OCREVUS,2,,,MULTIPLE SCLEROSIS,INTRAVENOUS,,MATERNAL EXPOSURE BEFORE PREGNANCY,2
VOLTAREN ARTHRITIS PAIN,1,,,PRODUCT USED FOR UNKNOWN INDICATION,TOPICAL,Gel,ACCIDENTAL EXPOSURE TO PRODUCT,2
FENFLURAMINE HYDROCHLORIDE,2,24,802,SEVERE MYOCLONIC EPILEPSY OF INFANCY,,,FEBRILE CONVULSION,1
OMNITROPE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR,2
LIDODERM,2,,,OSTEOARTHRITIS,TOPICAL,Poultice or Patch,PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION,2
VENETOCLAX,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,DEATH,1
LEQVIO,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,LIVER FUNCTION TEST INCREASED,2
DUPIXENT,1,12,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
ZETIA,1,,,BLOOD CHOLESTEROL,ORAL,Tablet,MYOCARDIAL INFARCTION,1
EVENITY,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,APPENDICITIS,1
OTEZLA,2,,,PSORIASIS,ORAL,Tablet,THERAPY NON-RESPONDER,2
NUPLAZID,1,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,HALLUCINATION,1
METHOTREXATE SODIUM,1,10,801,ACUTE LYMPHOCYTIC LEUKAEMIA,INTRA-ARTERIAL,Solution for injection,LEUKOPENIA,1
TECVAYLI,2,,,PLASMA CELL MYELOMA,SUBCUTANEOUS,Solution for injection,CYTOKINE RELEASE SYNDROME,1
EPIDIOLEX,2,,,SEVERE MYOCLONIC EPILEPSY OF INFANCY,ORAL,Oral solution,HOSPITALISATION,1
REBYOTA,1,47,801,CLOSTRIDIUM COLITIS,RECTAL,Suspension,CLOSTRIDIUM DIFFICILE INFECTION,2
NEXLETOL,2,66,801,HYPERLIPIDAEMIA,ORAL,Film-coated tablet,PRURITUS,2
INVEGA SUSTENNA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAMUSCULAR,Injection,PRODUCT DOSE OMISSION ISSUE,2
OPSUMIT,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,EPISTAXIS,2
ORENCIA,2,58,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Solution for injection,MIGRAINE,2
SPIRIVA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,DYSPNOEA,2
DUPIXENT,1,35,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,ARTHRALGIA,2
DUPIXENT,2,55,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,1,51,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,INCORRECT DOSE ADMINISTERED,2
LEQEMBI,2,75,801,COGNITIVE DISORDER,INTRAVENOUS,Infusion,FEMUR FRACTURE,1
ELIGARD,1,73,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Injection,INTERCEPTED PRODUCT PREPARATION ERROR,2
TARPEYO,2,51,801,IGA NEPHROPATHY,ORAL,Prolonged-release capsule,NASOPHARYNGITIS,2
OMNIPAQUE,2,55,801,SKIN TEST,INTRAVENOUS,Solution for injection,PALLOR,1
EZETIMIBE,1,79,801,LOW DENSITY LIPOPROTEIN,ORAL,,NEUROPATHY PERIPHERAL,1
MAVENCLAD,2,,,MULTIPLE SCLEROSIS,ORAL,,ANAEMIA,1
ORENCIA,2,81,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,,FALL,1
SUTAB,2,59,801,COLONOSCOPY,ORAL,Tablet,DRUG INEFFECTIVE,2
CUBICIN,1,69,801,STAPHYLOCOCCAL INFECTION,,Injection,PRODUCT USE IN UNAPPROVED INDICATION,2
BENLYSTA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,NASOPHARYNGITIS,2
TECENTRIQ,1,75,801,LUNG ADENOCARCINOMA,INTRAVENOUS,Infusion,OFF LABEL USE,1
TECENTRIQ,1,77,801,LUNG CANCER METASTATIC,INTRAVENOUS,Infusion,PNEUMONIA VIRAL,1
AIMOVIG,1,,,MIGRAINE,SUBCUTANEOUS,Solution for injection,DRUG INEFFECTIVE,2
AGAMREE,1,6,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Oral suspension,MUSCULAR WEAKNESS,1
DEPO-PROVERA,2,31,801,,INTRAMUSCULAR,Suspension for injection,WRONG TECHNIQUE IN DEVICE USAGE PROCESS,2
ELIGARD,2,,,PRECOCIOUS PUBERTY,SUBCUTANEOUS,Injection,ANXIETY,2
DARZALEX FASPRO,2,3,800,PLASMA CELL MYELOMA,SUBCUTANEOUS,Solution for injection,CHILLS,2
REVLIMID,2,59,801,PLASMA CELL MYELOMA,ORAL,Capsule,INSURANCE ISSUE,2
DUPIXENT,2,17,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,SURGERY,2
VERZENIO,2,56,801,BREAST CANCER METASTATIC,ORAL,Tablet,MALIGNANT NEOPLASM PROGRESSION,1
OZEMPIC,2,61,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,KNEE ARTHROPLASTY,1
NUPLAZID,1,75,801,PARKINSON^S DISEASE,ORAL,Capsule,BLOOD PRESSURE INCREASED,1
ACTEMRA ACTPEN,1,6,801,DEMYELINATION,SUBCUTANEOUS,Direct auto-injector,OFF LABEL USE,2
MOUNJARO,2,62,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,NAUSEA,2
AMIKACIN,1,,,MYCOBACTERIUM AVIUM COMPLEX INFECTION,RESPIRATORY (INHALATION),,DISEASE PROGRESSION,1
DOXORUBICIN,2,36,801,CHEMOTHERAPY,INTRAVENOUS,Solution for injection/infusion,JOINT STIFFNESS,1
IMBRUVICA,2,,,WALDENSTROM^S MACROGLOBULINAEMIA,ORAL,,PULMONARY MASS,1
DEFINITY,2,77,801,ECHOCARDIOGRAM,INTRAVENOUS,,HEADACHE,2
DEFINITY,2,65,801,,INTRAVENOUS,,CONTRAST MEDIA REACTION,1
NUCYNTA,1,81,801,PAIN,ORAL,Unknown,URINARY RETENTION,1
ZOLEDRONIC ACID,2,48,801,METASTASES TO BONE,INTRAVENOUS,,PERIORBITAL INFLAMMATION,1
LANTUS SOLOSTAR,1,80,801,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,PRODUCT DISPENSING ERROR,2
LANTUS SOLOSTAR,2,65,801,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,SURGERY,2
DUPIXENT,1,62,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,INJECTION SITE PAIN,2
DUPIXENT,2,57,801,ECZEMA,SUBCUTANEOUS,Solution for injection,INJECTION SITE PAIN,2
DUPIXENT,2,40,801,NASAL POLYPS,SUBCUTANEOUS,Solution for injection,ALOPECIA,2
DUPIXENT,2,79,801,ECZEMA,SUBCUTANEOUS,Solution for injection,DYSPNOEA,2
DUPIXENT,1,71,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,LACRIMATION INCREASED,2
DUPIXENT,2,36,801,NASAL POLYPS,SUBCUTANEOUS,Solution for injection,NASOPHARYNGITIS,2
DUPIXENT,1,14,801,ECZEMA INFANTILE,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
DUPIXENT,1,,,ASTHMA,SUBCUTANEOUS,Solution for injection,ASTHMA,2
LENALIDOMIDE,1,81,801,PLASMA CELL MYELOMA,ORAL,,ANAEMIA,1
DUPIXENT,2,58,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
ELRANATAMAB,2,73,801,,,,CYTOKINE RELEASE SYNDROME,1
DUPIXENT,2,18,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,1,76,801,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,SUBCUTANEOUS,Solution for injection,AVIAN INFLUENZA,1
XELJANZ,1,85,801,RHEUMATOID ARTHRITIS,ORAL,,DEATH,1
AZTREONAM LYSINE,2,,,CYSTIC FIBROSIS,,"Inhalation vapour, liquid",PULMONARY HAEMORRHAGE,1
RILPIVIRINE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,,Prolonged-release suspension for injection,INJECTION SITE MASS,2
REVLIMID,2,66,801,PLASMA CELL MYELOMA,ORAL,Capsule,RASH,2
DUPIXENT,2,42,801,ASTHMA,SUBCUTANEOUS,Solution for injection,ASTHMA,2
JARDIANCE,2,86,801,TYPE 2 DIABETES MELLITUS,ORAL,,HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME,1
DEFINITY,2,59,801,ECHOCARDIOGRAM,INTRAVENOUS,"INJECTION, SUSPENSION",PAIN IN EXTREMITY,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PAIN,2
DUPIXENT,2,52,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,2,,,DERMATITIS ALLERGIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,2,,,ASTHMA,SUBCUTANEOUS,Solution for injection,NEUROPATHY PERIPHERAL,1
ADBRY,2,36,801,DERMATITIS ATOPIC,SUBCUTANEOUS,,DERMATITIS ATOPIC,2
VENCLEXTA,1,72,801,ACUTE MYELOID LEUKAEMIA,ORAL,Tablet,DEATH,1
PATADAY ONCE DAILY RELIEF,1,,,PRODUCT USED FOR UNKNOWN INDICATION,OPHTHALMIC,Eye drops,SINUSITIS,2
VYALEV,2,56,801,PARKINSON^S DISEASE,SUBCUTANEOUS,Injection,INFLAMMATION,2
NICOTINIC ACID,1,80,801,PRODUCT USED FOR UNKNOWN INDICATION,,,ACUTE HEPATIC FAILURE,1
LANADELUMAB,2,62,801,HEREDITARY ANGIOEDEMA,,Solution for injection,PORTAL HYPERTENSION,1
ORENCIA,1,81,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Solution for infusion,ABDOMINAL DISCOMFORT,2
AZATHIOPRINE,2,39,801,IMMUNE THROMBOCYTOPENIA,ORAL,,PULMONARY THROMBOSIS,1
DUPIXENT,1,64,801,ASTHMA,SUBCUTANEOUS,Solution for injection,HIP SURGERY,1
DUPIXENT,1,39,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,THERAPEUTIC RESPONSE DECREASED,2
SERTRALINE,1,63,801,ANXIETY,ORAL,,NIGHTMARE,1
VEOZAH,2,,,HOT FLUSH,ORAL,Tablet,NEOPLASM RECURRENCE,1
DUPIXENT,2,68,801,TRANSIENT ACANTHOLYTIC DERMATOSIS,SUBCUTANEOUS,Solution for injection,PRODUCT USE IN UNAPPROVED INDICATION,2
DOTAREM,2,13,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Solution for injection,THROAT IRRITATION,2
RILPIVIRINE,1,,,HIV INFECTION,,Prolonged-release suspension for injection,VIRAL LOAD INCREASED,2
PARAGARD T 380A,2,,,CONTRACEPTION,INTRAUTERINE,Intrauterine,DEVICE EXPULSION,2
DUPIXENT,1,74,801,,SUBCUTANEOUS,Solution for injection,EYE CONTUSION,2
DUPIXENT,2,66,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,INITIAL INSOMNIA,2
KYLEENA,2,,,,INTRAUTERINE,Intrauterine delivery system,RASH,2
TAMSULOSIN HYDROCHLORIDE,1,76,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,FIXED ERUPTION,1
LEQEMBI,1,80,801,DEMENTIA ALZHEIMER^S TYPE,INTRAVENOUS,Infusion,AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS,2
XOLAIR PFS,1,,,IDIOPATHIC URTICARIA,SUBCUTANEOUS,"INJECTION, SOLUTION",IDIOPATHIC URTICARIA,2
CARBIDOPA\LEVODOPA,1,82,801,PARKINSON^S DISEASE,,Intestinal gel,FALL,1
ELREXFIO,1,76,801,PLASMA CELL MYELOMA,SUBCUTANEOUS,Solution for injection,PYREXIA,1
DUPIXENT,1,39,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
TEDUGLUTIDE,2,,,SHORT-BOWEL SYNDROME,SUBCUTANEOUS,Solution for injection,MAST CELL ACTIVATION SYNDROME,1
ESTRADIOL TRANSDERMAL SYSTEM,2,,,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,Transdermal system,MENOPAUSAL SYMPTOMS,2
LOSARTAN,2,76,801,HYPERTENSION,ORAL,Tablet,HYPONATRAEMIC SEIZURE,1
LENALIDOMIDE,2,77,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,TREATMENT NONCOMPLIANCE,2
BAVENCIO,1,75,801,TRANSITIONAL CELL CARCINOMA,INTRAVENOUS,,DIPLOPIA,1
REVLIMID,1,69,801,PLASMA CELL MYELOMA,ORAL,Capsule,RESPIRATORY DISORDER,1
MOUNJARO,1,69,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INJECTION SITE ERYTHEMA,2
CLARITIN,2,,,,ORAL,Orodispersible tablet,BLOOD GLUCOSE INCREASED,2
COSENTYX,1,64,801,ANKYLOSING SPONDYLITIS,SUBCUTANEOUS,Injection,INFLUENZA,2
DUPIXENT,2,38,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PRODUCT DOSE OMISSION IN ERROR,2
LEQVIO,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,NASOPHARYNGITIS,2
OTEZLA,1,54,801,PSORIASIS,ORAL,Tablet,PSORIASIS,2
LUTATHERA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,,ALOPECIA,2
ROCURONIUM,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,,BRADYCARDIA,1
AUVELITY,1,40,801,MAJOR DEPRESSION,ORAL,Extended-release tablets,MALAISE,2
DUPIXENT,2,84,801,ASTHMA,SUBCUTANEOUS,Solution for injection,COUGH,2
DUPIXENT,2,58,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,RASH,2
HUMIRA,2,77,801,COLITIS ULCERATIVE,,Solution for injection in pre-filled pen,CEREBROVASCULAR ACCIDENT,1
ENZALUTAMIDE,1,65,801,PROSTATE CANCER,ORAL,Unknown,RENAL FAILURE,1
LUMRYZ,2,58,801,,ORAL,Extended-Release Oral Suspension,MIDDLE INSOMNIA,2
LUMRYZ,1,,,,ORAL,Extended-Release Oral Suspension,INSOMNIA,2
LUMRYZ,2,,,,ORAL,Extended-Release Oral Suspension,MEMORY IMPAIRMENT,2
VYALEV,2,,,PARKINSON^S DISEASE,SUBCUTANEOUS,Solution for infusion,TASTE DISORDER,2
IBRUTINIB,1,36,801,CHRONIC LYMPHOCYTIC LEUKAEMIA,ORAL,Tablet,TESTICULAR HAEMORRHAGE,1
DUPIXENT,1,57,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,2
DUPIXENT,1,11,801,ASTHMA,SUBCUTANEOUS,Solution for injection,URTICARIA,2
KESIMPTA,2,42,801,MULTIPLE SCLEROSIS,SUBCUTANEOUS,,HYPOAESTHESIA,1
ADBRY,1,28,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Injection,ECZEMA HERPETICUM,1
CLOZAPINE,1,63,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
ALREX,2,,,ROUTINE HEALTH MAINTENANCE,OPHTHALMIC,"Eye drops, suspension",EYE COLOUR CHANGE,2
ZEMAIRA,2,,,ALPHA-1 ANTITRYPSIN DEFICIENCY,,Infusion,DEATH,1
MULTIHANCE,2,57,801,MAGNETIC RESONANCE IMAGING,INTRAVENOUS,Solution for injection,DYSPHONIA,1
XOLAIR,2,43,801,URTICARIA,SUBCUTANEOUS,Direct auto-injector,PRODUCT DOSE OMISSION ISSUE,2
ELIGARD,1,69,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,INJECTION SITE HAEMORRHAGE,2
PAXLOVID,1,63,801,COVID-19 TREATMENT,,Tablet,COVID-19,2
HUMIRA,2,47,801,COLITIS ULCERATIVE,,Solution for injection in pre-filled pen,INJECTION SITE DISCHARGE,2
HUMIRA,2,46,801,PSORIATIC ARTHROPATHY,,Solution for injection in pre-filled pen,DIARRHOEA,1
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
LENACAPAVIR,1,,,HIV INFECTION,,Tablet,PNEUMONIA,1
CERTOLIZUMAB PEGOL,2,73,801,RHEUMATOID ARTHRITIS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,PNEUMONIA,1
CABOMETYX,1,68,801,CLEAR CELL RENAL CELL CARCINOMA,ORAL,Tablet,SCROTAL INFLAMMATION,1
XOLAIR,2,,,IDIOPATHIC URTICARIA,SUBCUTANEOUS,Direct auto-injector,LIP SWELLING,2
JEUVEAU,2,,,SKIN WRINKLING,INTRAMUSCULAR,Powder for solution for injection,ANXIETY,2
STELARA,2,,,PSORIASIS,INTRAVENOUS,Solution for injection in pre-filled syringe,PRODUCT DOSE OMISSION ISSUE,2
MOUNJARO,2,62,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INCORRECT DOSE ADMINISTERED,2
ROSUVASTATIN CALCIUM,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ATRIAL FIBRILLATION,1
OMVOH,1,25,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for infusion,DRUG INEFFECTIVE,2
KESIMPTA,1,78,801,MULTIPLE SCLEROSIS,SUBCUTANEOUS,,DEATH,1
HUMIRA,1,59,801,CROHN^S DISEASE,,,PNEUMONIA,1
BRIVARACETAM,1,,,SEIZURE,ORAL,Film-coated tablet,BLINDNESS,1
VYEPTI,2,55,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Solution for infusion,MIGRAINE,2
MOUNJARO,1,51,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,EXTRA DOSE ADMINISTERED,2
BOTOX COSMETIC,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAMUSCULAR,Injection,DRUG INEFFECTIVE,2
TYRVAYA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,NASAL,Nasal spray,EYE IRRITATION,2
FILSPARI,2,72,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,DIZZINESS,2
MOUNJARO,2,65,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,,RETINAL ARTERY OCCLUSION,1
MIRENA,2,43,801,,INTRAUTERINE,Intrauterine delivery system,DEVICE DISLOCATION,2
TYSABRI,2,,,MULTIPLE SCLEROSIS,INTRAVENOUS,Unknown,MALAISE,2
CRIZOTINIB,1,52,801,,ORAL,Capsule,DEATH,1
LEVULAN KERASTICK,2,,,PRECANCEROUS CONDITION,,Cutaneous solution,POOR QUALITY PRODUCT ADMINISTERED,2
EYLEA,1,,,MACULAR DEGENERATION,INTRAVITREAL,Injection,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
LENALIDOMIDE,2,79,801,FIBROMYALGIA,ORAL,Capsule,HEPATIC ENZYME INCREASED,2
MIRENA,2,44,801,INTRAUTERINE CONTRACEPTION,INTRAUTERINE,Intrauterine delivery system,DEVICE DISLOCATION,2
BOTOX COSMETIC,2,,,SKIN WRINKLING,INTRAMUSCULAR,Powder for injection,DRUG INEFFECTIVE,2
RYZODEG 70/30,1,55,801,TYPE 2 DIABETES MELLITUS,,Solution for injection,DIABETIC RETINOPATHY,1
OXYCONTIN,1,67,801,CANCER PAIN,ORAL,Prolonged-release tablet,CONSTIPATION,1
SKLICE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,TOPICAL,Lotion (Except Lotion For Eye),DRUG INEFFECTIVE,2
VEDOLIZUMAB,1,,,CROHN^S DISEASE,SUBCUTANEOUS,Powder for solution for infusion,DEATH,1
TRASTUZUMAB,2,,,UTERINE CANCER,INTRAVENOUS,Unknown formulation,UTERINE CANCER,1
BOSULIF,1,28,801,,ORAL,Film-coated tablet,PERIPHERAL SWELLING,2
ELIGARD,1,73,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,BLOOD PRESSURE INCREASED,1
BENLYSTA,2,55,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,PRODUCT DOSE OMISSION ISSUE,2
DUPIXENT,2,31,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
VEKLURY,1,62,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Injection,TENDON DISORDER,1
REVLIMID,2,73,801,PLASMA CELL MYELOMA,ORAL,Capsule,MALAISE,2
XOLAIR PFS,2,35,801,URTICARIA,SUBCUTANEOUS,Solution for injection in pre-filled syringe,OFF LABEL USE,2
GENOTROPIN,1,14,801,,,Solution for injection,DEVICE DELIVERY SYSTEM ISSUE,2
COSENTYX,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled syringe,PYREXIA,2
DUPIXENT,2,,,ASTHMA,SUBCUTANEOUS,Solution for injection,LOCALISED INFECTION,1
PULMOZYME,2,9,801,CONGENITAL BRONCHOMALACIA,RESPIRATORY (INHALATION),,RESPIRATORY FAILURE,1
DUPIXENT,1,5,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,VIRAL INFECTION,2
DUPIXENT,2,,,NEURODERMATITIS,SUBCUTANEOUS,Solution for injection,NEURODERMATITIS,2
IMODIUM MULTI-SYMPTOM RELIEF,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,INCORRECT DOSE ADMINISTERED,2
DUPIXENT,2,,,ASTHMA,SUBCUTANEOUS,Solution for injection,PNEUMONIA,1
COPAXONE,2,26,801,MULTIPLE SCLEROSIS,SUBCUTANEOUS,Injection,HAEMATEMESIS,1
REVLIMID,2,68,801,PLASMA CELL MYELOMA,ORAL,Capsule,FATIGUE,2
DUPIXENT,2,32,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,BLEPHAROSPASM,2
DUPIXENT,2,,,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,ACCIDENTAL EXPOSURE TO PRODUCT,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,2,24,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,NAUSEA,2
DUPIXENT,2,8,801,ASTHMA,SUBCUTANEOUS,Solution for injection,INFLUENZA,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,EYE IRRITATION,2
VYLEESI,2,58,801,LIBIDO DECREASED,SUBCUTANEOUS,Injection,PRURITUS,2
LANTUS SOLOSTAR,2,73,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,2
DUPIXENT,1,46,801,SEBORRHOEIC DERMATITIS,SUBCUTANEOUS,Solution for injection,ASTIGMATISM,2
AVASTIN,1,8,800,HEPATOCELLULAR CARCINOMA,INTRAVENOUS,Injection,ASCITES,1
INVEGA SUSTENNA,1,32,801,SCHIZOPHRENIA,INTRAMUSCULAR,Injection,MOVEMENT DISORDER,1
SPRYCEL,1,57,801,CHRONIC MYELOID LEUKAEMIA,ORAL,,PRODUCT DOSE OMISSION ISSUE,2
WEGOVY,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,HAEMATOCHEZIA,1
AVONEX,2,,,MULTIPLE SCLEROSIS,INTRAMUSCULAR,Solution for injection in pre-filled syringe,LOWER RESPIRATORY TRACT INFECTION,1
INLYTA,1,67,801,,ORAL,Film-coated tablet,FATIGUE,2
XOLAIR PFS,2,32,801,IDIOPATHIC URTICARIA,SUBCUTANEOUS,Solution for injection in pre-filled syringe,MATERNAL EXPOSURE BEFORE PREGNANCY,1
INGREZZA,2,25,801,TARDIVE DYSKINESIA,ORAL,Capsule,EYE MOVEMENT DISORDER,2
AYVAKIT,2,77,801,GASTROINTESTINAL STROMAL TUMOUR,ORAL,Unknown,DYSPNOEA,2
LENALIDOMIDE,1,82,801,PLASMA CELL MYELOMA,ORAL,Capsule,PAIN IN EXTREMITY,2
TABRECTA,2,91,801,LUNG NEOPLASM MALIGNANT,ORAL,,COVID-19,1
REVLIMID,1,86,801,,ORAL,,RASH,1
LILETTA,2,16,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAUTERINE,,DEVICE EXPULSION,2
DUPIXENT,2,69,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,1,9,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,SKIN REACTION,2
DUPIXENT,1,71,801,ASTHMA,SUBCUTANEOUS,Solution for injection,INJECTION SITE PAIN,2
MIRALAX,1,,,CONSTIPATION PROPHYLAXIS,ORAL,Powder for oral solution,PRODUCT PRESCRIBING ISSUE,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,RASH ERYTHEMATOUS,2
SERTRALINE,2,23,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,MYOPATHY,1
ILARIS,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,PRODUCT STORAGE ERROR,2
TYSABRI,2,24,801,MULTIPLE SCLEROSIS,INTRAVENOUS,Unknown,ILLNESS,2
DUPIXENT,1,32,801,NASAL POLYPS,SUBCUTANEOUS,Solution for injection,REBOUND EFFECT,2
PARAGARD T 380A,1,,,,INTRAUTERINE,Intrauterine,INJURY,1
LECANEMAB,1,80,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Infusion,BLOOD PRESSURE INCREASED,2
EPOPROSTENOL,1,,,PULMONARY HYPERTENSION,INTRAVENOUS,,DRUG INEFFECTIVE,1
SOMATROPIN,2,10,801,GROWTH HORMONE DEFICIENCY,SUBCUTANEOUS,Solution for injection,THERAPY INTERRUPTED,2
GENOTROPIN,2,1,801,HYPOPITUITARISM,,Solution for injection,DEVICE USE ERROR,2
CIBINQO,1,,,DERMATITIS ATOPIC,ORAL,Tablet,HEPATIC ENZYME INCREASED,2
KESIMPTA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,THROMBOSIS,1
PLUVICTO,1,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Solution for injection/infusion,VOMITING,2
RILPIVIRINE,2,29,801,HIV INFECTION,,Prolonged-release suspension for injection,INJECTION SITE SWELLING,2
ULTRAVIST,1,38,801,COMPUTERISED TOMOGRAM NECK,INTRA-ARTERIAL,Solution for injection,ANAPHYLACTIC SHOCK,1
XIAFLEX,1,,,DUPUYTREN^S CONTRACTURE,,Injection,DUPUYTREN^S CONTRACTURE,2
MOUNJARO,1,73,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,DRUG INTOLERANCE,2
OZEMPIC,2,66,801,OBESITY,SUBCUTANEOUS,Solution for injection,DEHYDRATION,1
LENALIDOMIDE,1,,,PLASMA CELL MYELOMA,ORAL,,NEUTROPHIL COUNT DECREASED,2
ZEPOSIA,2,26,801,MULTIPLE SCLEROSIS,ORAL,,LIVER FUNCTION TEST INCREASED,2
ALPROLIX,1,,,FACTOR IX DEFICIENCY,,Powder and solvent for solution for injection,HAEMORRHAGE,2
LANTUS SOLOSTAR,2,,,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,2
MULTAQ,2,82,801,SUPRAVENTRICULAR TACHYCARDIA,ORAL,,FALL,2
TECARTUS,1,,,ACUTE LYMPHOCYTIC LEUKAEMIA,INTRAVENOUS,Suspension,DEATH,1
STELARA,1,32,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Solution for injection in pre-filled syringe,DEVICE DEPLOYMENT ISSUE,2
HUMIRA,1,64,801,RHEUMATOID ARTHRITIS,,,MECHANICAL VENTILATION,1
KYLEENA,2,,,,INTRAUTERINE,Intrauterine delivery system,DEVICE EXPULSION,2
LENALIDOMIDE,2,73,801,PLASMA CELL MYELOMA,ORAL,Capsule,COVID-19,1
GANIRELIX ACETATE,2,29,801,ASSISTED REPRODUCTIVE TECHNOLOGY,SUBCUTANEOUS,Solution for injection,OVARIAN CYST RUPTURED,1
REVLIMID,2,75,801,PLASMA CELL MYELOMA,ORAL,,DIARRHOEA,2
WEGOVY,2,6,800,WEIGHT CONTROL,SUBCUTANEOUS,Solution for injection,DEATH,1
MIRENA,2,,,INTRAUTERINE CONTRACEPTION,INTRAUTERINE,Intrauterine delivery system,DEVICE DISLOCATION,1
ELIGARD,1,64,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,DYSPNOEA,2
CABOMETYX,1,,,THYROID CANCER,ORAL,Tablet,SKIN EXFOLIATION,2
TRODELVY,2,,,TRIPLE NEGATIVE BREAST CANCER,INTRAVENOUS,Powder for concentrate for solution for infusion,DISEASE PROGRESSION,1
IMODIUM MULTI-SYMPTOM RELIEF,2,,,DIARRHOEA,ORAL,Tablet,DRUG INEFFECTIVE,2
VYALEV,2,,,PARKINSON^S DISEASE,SUBCUTANEOUS,Solution for infusion,DROOLING,2
DUPIXENT,1,24,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,INJECTION SITE PAIN,2
DUPIXENT,1,63,801,ASTHMA,SUBCUTANEOUS,Solution for injection,SINUS OPERATION,2
DUPIXENT,1,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DRUG INEFFECTIVE,2
ATORVASTATIN,1,62,801,PRODUCT USED FOR UNKNOWN INDICATION,,,DRY MOUTH,1
ALPROLIX,1,12,802,FACTOR IX DEFICIENCY,,Powder and solvent for solution for injection,HAEMARTHROSIS,1
MOUNJARO,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,FOREIGN BODY SENSATION IN EYES,2
MOUNJARO,1,59,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,SMALL INTESTINAL OBSTRUCTION,1
TOUJEO MAX,1,,,,SUBCUTANEOUS,Solution for injection,DEVICE DISPENSING ERROR,2
EZETIMIBE,2,84,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,MUSCULAR WEAKNESS,1
KESIMPTA,2,,,MULTIPLE SCLEROSIS,SUBCUTANEOUS,,EXTRASYSTOLES,1
METHOTREXATE SODIUM,2,,,,INTRA-ARTERIAL,,LOSS OF CONSCIOUSNESS,1
QULIPTA,2,38,801,MIGRAINE,ORAL,,ABORTION SPONTANEOUS,1
FINGOLIMOD,2,56,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,CRYPTOCOCCOSIS,1
HUMIRA,1,,,RHEUMATOID ARTHRITIS,,Solution for injection in pre-filled pen,SURGERY,1
CABOMETYX,1,,,HEPATOCELLULAR CARCINOMA,ORAL,Tablet,BLOOD PRESSURE INCREASED,2
CABOMETYX,1,62,801,RENAL CELL CARCINOMA,ORAL,Tablet,OFF LABEL USE,2
CABOMETYX,1,,,RENAL CANCER,ORAL,Tablet,BLOOD TEST ABNORMAL,2
ARANESP,1,,,RENAL FAILURE,INTRAVENOUS,Solution for injection,HOSPITALISATION,1
ELIGARD,1,54,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Injection,INTERCEPTED PRODUCT PREPARATION ERROR,2
CARVYKTI,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Dispersion for infusion,SKIN LACERATION,2
ELRANATAMAB,1,74,801,PLASMA CELL MYELOMA REFRACTORY,,,NEUROPATHY PERIPHERAL,1
XELJANZ XR,1,67,801,,ORAL,Prolonged-release tablet,MYOCARDIAL INFARCTION,1
GLIVEC,1,,,CHRONIC MYELOID LEUKAEMIA,,,INFARCTION,1
GENOTROPIN,1,13,801,,,Solution for injection,DRUG DOSE OMISSION BY DEVICE,2
BOTOX,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRADERMAL,,FACIAL ASYMMETRY,2
LEUPLIN,1,75,801,PROSTATE CANCER RECURRENT,,Powder and solvent for solution for injection,EOSINOPHILIA,2
MAXIMUM STRENGTH PEPCID AC ICY COOL MINT,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,FEELING HOT,2
CLOZAPINE,2,67,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,HOSPITALISATION,1
PAXLOVID,2,51,801,COVID-19 TREATMENT,,Tablet,SYMPTOM RECURRENCE,2
LUPKYNIS,2,,,LUPUS NEPHRITIS,ORAL,Softgel capsule,HEART RATE INCREASED,2
LUPKYNIS,2,,,LUPUS NEPHRITIS,ORAL,Softgel capsule,HYPERTENSION,2
LUPKYNIS,2,,,LUPUS NEPHRITIS,ORAL,Softgel capsule,HYPERTENSION,2
LUPKYNIS,2,,,LUPUS NEPHRITIS,ORAL,Softgel capsule,MUSCLE SPASMS,2
COSENTYX,2,62,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,THROAT CLEARING,2
CARBIDOPA\LEVODOPA,2,72,801,PARKINSON^S DISEASE,,,DEATH,1
ALPROLIX,1,52,801,,,Powder and solvent for solution for injection,HAEMORRHAGE,2
DUPIXENT,2,,,ASTHMA,SUBCUTANEOUS,Solution for injection,INCORRECT DOSE ADMINISTERED,2
HEMLIBRA,1,,,FACTOR VIII DEFICIENCY,SUBCUTANEOUS,,ARTHRALGIA,2
HUMALOG MIX75/25,1,66,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Injection,ACCIDENTAL UNDERDOSE,2
ATEZOLIZUMAB,1,77,801,HEPATOCELLULAR CARCINOMA,INTRAVENOUS,,CARDIO-RESPIRATORY ARREST,1
PARAGARD T 380A,2,29,801,,INTRAUTERINE,Intrauterine,FEMALE STERILISATION,1
FENTANYL,2,51,801,GENERAL ANAESTHESIA,TRANSDERMAL,,PAROTID GLAND ENLARGEMENT,1
ELREXFIO,1,,,PLASMA CELL MYELOMA,SUBCUTANEOUS,Solution for injection,CYTOKINE RELEASE SYNDROME,1
CABOMETYX,1,,,METASTASES TO LIVER,ORAL,Tablet,GLOSSODYNIA,2
DOVATO,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Film-coated tablet,VIRAL LOAD INCREASED,2
FILSPARI,1,54,801,HAEMATURIA,ORAL,Tablet,PRODUCT USE IN UNAPPROVED INDICATION,2
BOSULIF,1,67,801,,ORAL,,HOSPITALISATION,2
DUPIXENT,2,58,801,ASTHMA,SUBCUTANEOUS,Solution for injection,ASTHMA,2
DUPIXENT,1,69,801,NEURODERMATITIS,SUBCUTANEOUS,Solution for injection,DIZZINESS,2
CABOMETYX,1,,,RENAL CANCER,ORAL,Tablet,MALIGNANT NEOPLASM PROGRESSION,1
CABOMETYX,1,8,800,RENAL CELL CARCINOMA,ORAL,Tablet,RENAL CELL CARCINOMA,1
ALLEGRA ALLERGY,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Film-coated tablet,INCORRECT PRODUCT ADMINISTRATION DURATION,2
ABILIFY ASIMTUFII,1,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAMUSCULAR,Suspension for injection,FATIGUE,2
NUBEQA,1,,,,ORAL,Film-coated tablet,MALIGNANT NEOPLASM PROGRESSION,1
LENALIDOMIDE,2,73,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Capsule,PRODUCT DISPENSING ERROR,2
DUPIXENT,1,18,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
CERTOLIZUMAB PEGOL,2,,,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Solution for injection in pre-filled pen,PSORIATIC ARTHROPATHY,1
ESTRADIOL TRANSDERMAL SYSTEM,2,,,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,Transdermal system,PRODUCT SUBSTITUTION ISSUE,2
LANTUS,2,75,801,,SUBCUTANEOUS,Solution for injection,BLOOD GLUCOSE INCREASED,2
DUPIXENT,1,8,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,ACCIDENTAL EXPOSURE TO PRODUCT,2
DUPIXENT,2,,,ECZEMA,SUBCUTANEOUS,Solution for injection,SKIN DEPIGMENTATION,2
LISOCABTAGENE MARALEUCEL,1,59,801,DIFFUSE LARGE B-CELL LYMPHOMA,,Injection for infusion,CYTOKINE RELEASE SYNDROME,1
AFRIN ORIGINAL NASAL,1,,,,,"Nasal spray, solution",DRUG DEPENDENCE,1
CRIZOTINIB,1,63,801,,ORAL,Capsule,DEATH,1
ADBRY,2,26,801,DERMATITIS ATOPIC,SUBCUTANEOUS,,RASH,2
ZEPOSIA,2,61,801,MULTIPLE SCLEROSIS,ORAL,,TREMOR,2
BOTOX COSMETIC,2,,,SKIN WRINKLING,INTRAMUSCULAR,,THERAPEUTIC PRODUCT EFFECT INCOMPLETE,2
MOUNJARO,2,54,801,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,INJECTION SITE HAEMORRHAGE,2
ALLOPURINOL,2,90,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,,PANCREATITIS ACUTE,1
MODAFINIL,1,79,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,DIABETES MELLITUS,1
REFRESH TEARS,2,,,DRY EYE,OPHTHALMIC,,THROMBOSIS,1
MOUNJARO,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,ALOPECIA,2
TALTZ,2,46,801,PSORIASIS,SUBCUTANEOUS,,UPPER RESPIRATORY TRACT INFECTION,2
PONATINIB,1,64,801,CHRONIC MYELOID LEUKAEMIA,,Tablet,CLOSTRIDIUM DIFFICILE INFECTION,1
AXICABTAGENE CILOLEUCEL,2,,,DIFFUSE LARGE B-CELL LYMPHOMA,INTRAVENOUS,Suspension,NERVOUS SYSTEM DISORDER,1
DUPIXENT,1,12,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
DUPILUMAB,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,SKIN PAPILLOMA,2
DUPIXENT,2,,,,SUBCUTANEOUS,Solution for injection,ONYCHOLYSIS,2
CARBIDOPA\LEVODOPA,1,81,801,PARKINSON^S DISEASE,,Intestinal gel,CARDIO-RESPIRATORY ARREST,1
ELIGARD,1,63,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
PARAGARD T 380A,2,27,801,CONTRACEPTION,INTRAUTERINE,Intrauterine,REPRODUCTIVE COMPLICATION ASSOCIATED WITH DEVICE,1
COSENTYX,2,,,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Solution for injection,DRUG DOSE OMISSION BY DEVICE,2
TAMOXIFEN,2,,,BREAST CANCER STAGE I,,Tablet,HAEMORRHAGE,1
TYLENOL 8HR,1,85,801,MYALGIA,ORAL,Tablet,INCORRECT DOSE ADMINISTERED,2
DUPIXENT,1,35,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PRURITUS,2
KESIMPTA,2,33,801,RELAPSING MULTIPLE SCLEROSIS,SUBCUTANEOUS,,ABORTION SPONTANEOUS,1
LENALIDOMIDE,2,67,801,PLASMA CELL MYELOMA,ORAL,Capsule,PRODUCT DOSE OMISSION ISSUE,2
HIZENTRA,2,80,801,IMMUNODEFICIENCY COMMON VARIABLE,,Injection,BLOOD PRESSURE INCREASED,1
BENLYSTA,2,49,801,SYSTEMIC LUPUS ERYTHEMATOSUS,SUBCUTANEOUS,,COVID-19,2
DUPIXENT,1,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,LACRIMATION INCREASED,2
REVLIMID,2,85,801,PLASMA CELL MYELOMA,ORAL,Capsule,CONSTIPATION,2
MONOFERRIC,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,,RASH,1
RISDIPLAM,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,PATELLA FRACTURE,1
TARPEYO,2,56,801,IGA NEPHROPATHY,ORAL,Prolonged-release capsule,RASH,2
XDEMVY,2,,,,OPHTHALMIC,,EYE PAIN,2
DUPIXENT,1,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,EYE PRURITUS,2
HERCEPTIN,2,53,801,BREAST CANCER METASTATIC,INTRAVENOUS,,BREAST CANCER METASTATIC,1
MOUNJARO,1,49,801,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,BLOOD GLUCOSE INCREASED,2
LINZESS,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,MUSCULOSKELETAL DISORDER,1
DUPIXENT,2,31,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,INJECTION SITE REACTION,2
ALLEGRA ALLERGY,2,84,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,PRODUCT PACKAGE ASSOCIATED INJURY,2
OMNITROPE,2,10,801,,SUBCUTANEOUS,Solution for injection,FLUSHING,2
OZEMPIC,2,60,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,HAEMATEMESIS,1
NEUPRO,2,,,PARKINSON^S DISEASE,TRANSDERMAL,Transdermal patch,LABILE BLOOD PRESSURE,2
DAPTOMYCIN,1,76,801,OSTEOMYELITIS,INTRAVENOUS,,RHABDOMYOLYSIS,1
BOSULIF,2,65,801,,ORAL,Film-coated tablet,OCULAR VASCULAR DISORDER,2
INBRIJA,2,83,801,PRODUCT USED FOR UNKNOWN INDICATION,RESPIRATORY (INHALATION),Inhalation powder,DYSPEPSIA,2
NEULASTA,1,78,801,NEUTROPENIA,SUBCUTANEOUS,Solution for injection,PRODUCT PREPARATION ERROR,2
DUPIXENT,1,53,801,PSORIASIS,SUBCUTANEOUS,Solution for injection,PRODUCT USE IN UNAPPROVED INDICATION,2
DUPIXENT,2,43,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
ERLEADA,1,85,801,PROSTATE CANCER,ORAL,Film-coated tablet,BREAST HYPERPLASIA,1
ENTYVIO,2,,,IMMUNE-MEDIATED ENTEROCOLITIS,SUBCUTANEOUS,,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
PLENVU,2,37,801,BOWEL PREPARATION,,,MATERNAL EXPOSURE DURING BREAST FEEDING,1
CIMZIA,1,29,801,ANKYLOSING SPONDYLITIS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,ANKYLOSING SPONDYLITIS,1
MOUNJARO,1,67,801,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,INFLUENZA,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,INJECTION SITE SWELLING,2
MAVENCLAD,2,,,MULTIPLE SCLEROSIS,ORAL,,WHITE BLOOD CELL COUNT DECREASED,1
PARAGARD T 380A,2,24,801,CONTRACEPTION,INTRAUTERINE,Intrauterine,REPRODUCTIVE COMPLICATION ASSOCIATED WITH DEVICE,1
NUPLAZID,1,82,801,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,PRODUCT USE ISSUE,2
ORENCIA,1,64,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Solution for injection,HEADACHE,2
TAVNEOS,1,26,801,,ORAL,,CARDIAC OPERATION,1
RITUXIMAB,1,36,801,THROMBOTIC THROMBOCYTOPENIC PURPURA,INTRAVENOUS,Solution for infusion,HEPATITIS E,1
GOLD BOND ORIGINAL STRENGTH,2,,,PRODUCT USED FOR UNKNOWN INDICATION,,Powder,MESOTHELIOMA,1
AMLODIPINE,1,45,801,PREHYPERTENSION,ORAL,Tablet,ERECTILE DYSFUNCTION,1
CLOZAPINE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,PNEUMONIA,1
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION,2
DUPIXENT,2,70,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,MOUTH SWELLING,2
DUPIXENT,1,,,NASAL POLYPS,SUBCUTANEOUS,Solution for injection,INJECTION SITE PAIN,2
DUPIXENT,2,8,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,1,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PHARYNGITIS STREPTOCOCCAL,2
DUPIXENT,1,,,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,SUBCUTANEOUS,Solution for injection,ASTHENIA,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
EYLEA HD,2,75,801,AGE-RELATED MACULAR DEGENERATION,INTRAVITREAL,Injection,BLINDNESS,1
KISQALI,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Film-coated tablet,HYPERTHYROIDISM,1
LUPKYNIS,2,,,LUPUS NEPHRITIS,ORAL,Softgel capsule,CEREBROVASCULAR ACCIDENT,1
ELIGARD,1,,,PROSTATE CANCER,SUBCUTANEOUS,Injection,METASTASES TO BONE,1
OZEMPIC,1,69,801,,SUBCUTANEOUS,Solution for injection,CATARACT OPERATION,1
CIMZIA,2,78,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection in pre-filled syringe,DEATH,1
MOUNJARO,1,67,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,NAUSEA,2
FINTEPLA,1,,,SEVERE MYOCLONIC EPILEPSY OF INFANCY,ORAL,Oral solution,SEIZURE,1
MOUNJARO,1,66,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,ARTHRALGIA,2
DUPIXENT,2,68,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,RASH MACULAR,2
NOVOLOG MIX 70/30,2,75,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Suspension for injection,CATARACT OPERATION,1
OZEMPIC,2,56,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,OPTIC ISCHAEMIC NEUROPATHY,1
VABYSMO,1,79,801,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,INTRAVITREAL,,DEATH,1
NOVOEIGHT,1,70,801,FACTOR VIII DEFICIENCY,,Powder and solvent for solution for injection,RENAL FAILURE,1
CARBIDOPA\LEVODOPA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,,"Modified-release capsule, hard",FALL,2
COSENTYX,2,67,801,AXIAL SPONDYLOARTHRITIS,SUBCUTANEOUS,Injection,VIRAL INFECTION,2
RECORLEV,2,,,CUSHING^S SYNDROME,ORAL,Tablet,HOSPITALISATION,1
XELJANZ,2,59,801,,ORAL,Tablet,SUICIDAL IDEATION,1
NUTROPIN,1,10,801,SHORT STATURE,,"INJECTION, SOLUTION",DEVICE MALFUNCTION,2
BENLYSTA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,PRODUCT DOSE OMISSION ISSUE,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,SUICIDAL IDEATION,1
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,SEXUAL DYSFUNCTION,2
BOTOX,2,50,801,SKIN WRINKLING,INTRADERMAL,,THERAPEUTIC RESPONSE SHORTENED,2
AVASTIN,2,59,801,OVARIAN CANCER,INTRAVENOUS,,DISEASE PROGRESSION,1
EDOXABAN TOSYLATE,1,65,801,CEREBROVASCULAR ACCIDENT PROPHYLAXIS,ORAL,Tablet,DRUG INEFFECTIVE,2
GENOTROPIN,1,13,801,GROWTH DISORDER,,Solution for injection,DRUG DOSE OMISSION BY DEVICE,2
DUPIXENT,2,54,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,EOSINOPHILIC OESOPHAGITIS,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,2,64,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
TALTZ,1,62,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,ORAL MUCOSAL BLISTERING,2
HUMIRA,2,,,RHEUMATOID ARTHRITIS,,Solution for injection in pre-filled pen,MUSCULOSKELETAL DISORDER,1
REGADENOSON,2,84,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Injection,DIZZINESS,2
ELIGARD,1,,,PROSTATE CANCER,SUBCUTANEOUS,Injection,ERYTHEMA,2
AMLODIPINE,1,,,HYPERTENSION,ORAL,Unknown,HAEMORRHAGE,1
HYDROCHLOROTHIAZIDE\LOSARTAN POTASSIUM,1,42,801,HYPOKALAEMIA,,,HYPOKALAEMIA,1
VEDOLIZUMAB,1,,,COLITIS ULCERATIVE,SUBCUTANEOUS,Solution for injection,COLITIS ULCERATIVE,1
AZTREONAM LYSINE,2,,,CYSTIC FIBROSIS,,"Inhalation vapour, liquid",INFLUENZA,1
MEKINIST,1,,,MALIGNANT MELANOMA,ORAL,,GAIT DISTURBANCE,2
TOCILIZUMAB,2,,,RHEUMATOID ARTHRITIS,INTRAVENOUS,Pre-filled Pen,ABDOMINAL PAIN UPPER,1
BOSULIF,1,75,801,CHRONIC MYELOID LEUKAEMIA,ORAL,Film-coated tablet,DEATH,1
DUPIXENT,2,76,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,MYALGIA,2
LO LOESTRIN FE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,,,COELIAC DISEASE,2
VICTOZA,1,74,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,DEPRESSION,1
IMDELLTRA,1,,,SMALL CELL LUNG CANCER,,Powder for solution for injection,AGEUSIA,2
XYZAL ALLERGY 24HR,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Film-coated tablet,HEADACHE,2
RECLAST,2,79,801,OSTEOPOROSIS,INTRAVENOUS,,INFLUENZA LIKE ILLNESS,1
LENALIDOMIDE,2,73,801,PLASMA CELL MYELOMA,ORAL,Capsule,INSURANCE ISSUE,2
ALDACTONE,1,75,801,CARDIAC FAILURE CONGESTIVE,ORAL,Tablet,URTICARIA,1
DUPIXENT,1,25,801,ASTHMA,SUBCUTANEOUS,Solution for injection,INFLUENZA LIKE ILLNESS,2
OZEMPIC,2,40,801,GLUCOSE TOLERANCE IMPAIRED,SUBCUTANEOUS,Solution for injection,ANXIETY,1
RENFLEXIS,1,34,801,CROHN^S DISEASE,INTRAVENOUS,Infusion,SMALL INTESTINAL OBSTRUCTION,1
MOUNJARO,1,87,801,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,MYALGIA,1
FENTANYL,1,30,801,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,,DRUG ABUSE,1
PALFORZIA,2,10,801,FOOD ALLERGY,,Sachet,GASTROINTESTINAL DISORDER,2
DUPIXENT,1,6,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,INCORRECT DOSE ADMINISTERED,2
LAGEVRIO,2,8,800,COVID-19 TREATMENT,ORAL,Capsule,DRUG INEFFECTIVE,2
REVLIMID,1,71,801,PLASMA CELL MYELOMA,ORAL,Capsule,DYSPNOEA,1
METHOTREXATE SODIUM,2,31,801,,INTRA-ARTERIAL,,VOMITING,2
COPAXONE,2,27,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,ASPHYXIA,1
NEULASTA,2,83,801,PROPHYLAXIS,SUBCUTANEOUS,Solution for injection,DEVICE ADHESION ISSUE,2
NUPLAZID,1,,,PARKINSON^S DISEASE,ORAL,Capsule,HALLUCINATION,1
LEQEMBI,1,,,DEMENTIA ALZHEIMER^S TYPE,INTRAVENOUS,Injection,INFUSION RELATED REACTION,1
DUPIXENT,2,60,801,ASTHMA,SUBCUTANEOUS,Solution for injection,RHINOVIRUS INFECTION,2
DUPIXENT,1,36,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,OCULAR HYPERAEMIA,2
TECFIDERA,2,33,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,ENDOCRINE DISORDER,1
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,INJECTION SITE URTICARIA,2
ACTEMRA ACTPEN,2,75,801,RHEUMATOID ARTHRITIS,SUBCUTANEOUS,Direct auto-injector,DRUG DELIVERY SYSTEM MALFUNCTION,2
EVENITY,2,54,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,HYPOAESTHESIA ORAL,1
OZEMPIC,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,HEPATITIS,1
MABTHERA,2,,,RELAPSING MULTIPLE SCLEROSIS,,,MULTIPLE SCLEROSIS RELAPSE,2
IMDELLTRA,1,,,SMALL CELL LUNG CANCER,,Powder for solution for injection,DYSPNOEA AT REST,1
ELIGARD,1,63,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,INTERCEPTED PRODUCT PREPARATION ERROR,2
IRINOTECAN,1,40,801,RECTAL ADENOCARCINOMA,,Unknown,DRUG INEFFECTIVE,1
ELIGARD,1,77,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,INJECTION SITE PAIN,2
LENALIDOMIDE,1,36,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,DRUG HYPERSENSITIVITY,2
METHOTREXATE SODIUM,2,5,801,ACUTE LYMPHOCYTIC LEUKAEMIA,INTRA-ARTERIAL,Solution for injection,PYREXIA,1
DUPIXENT,1,9,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,VITILIGO,2
HUMIRA,2,63,801,CROHN^S DISEASE,,Solution for injection in pre-filled pen,DIABETES MELLITUS,1
VENCLEXTA,1,,,ACUTE MYELOID LEUKAEMIA,ORAL,Tablet,DENGUE FEVER,1
JARDIANCE,1,9,800,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,CARDIAC FAILURE CONGESTIVE,1
RIBOCICLIB,2,,,BREAST CANCER METASTATIC,ORAL,Tablet,BREAST CANCER METASTATIC,1
LINZESS,2,68,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,GASTRIC BYPASS,1
COSENTYX,2,41,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,,DYSPEPSIA,1
LANTUS SOLOSTAR,1,72,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,ACCIDENTAL EXPOSURE TO PRODUCT,2
DUPIXENT,2,49,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DYSHIDROTIC ECZEMA,2
DUPIXENT,2,43,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,NEURODERMATITIS,2
AUSTEDO,2,88,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,DEATH,1
FENTANYL,2,9,802,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,,DEATH,1
ELRANATAMAB,1,71,801,PLASMA CELL MYELOMA,,,LUNG DISORDER,1
WOMENS ROGAINE UNSCENTED,2,68,801,ALOPECIA,TOPICAL,Cutaneous foam,ALOPECIA,2
DUPIXENT,1,37,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,1,18,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
RYBELSUS,1,70,801,TYPE 2 DIABETES MELLITUS,ORAL,Tablet,FOREIGN BODY IN THROAT,1
DUPIXENT,2,,,NEURODERMATITIS,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
HYRIMOZ,2,36,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,DEVICE USE ISSUE,2
LUTATHERA,2,52,801,TOXIC EPIDERMAL NECROLYSIS,INTRAVENOUS,,LEUKOPENIA,1
DEFINITY,2,,,ECHOCARDIOGRAM,INTRAVENOUS,"INJECTION, SUSPENSION",INCORRECT DRUG ADMINISTRATION RATE,2
FABRAZYME,1,59,801,FABRY^S DISEASE,INTRAVENOUS,Powder for concentrate for solution for infusion,WEIGHT DECREASED,2
DUPIXENT,2,39,801,ASTHMA,SUBCUTANEOUS,Solution for injection,ASTHMA,2
DUPIXENT,1,53,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
LANTUS SOLOSTAR,1,57,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
ARISTADA,1,45,801,SCHIZOPHRENIA,INTRAMUSCULAR,Prefilled syringe XTR injectable susp,NEEDLE ISSUE,2
HUMIRA,1,23,801,PRODUCT USED FOR UNKNOWN INDICATION,,,GASTROINTESTINAL DISORDER,1
FINASTERIDE,1,39,801,ALOPECIA,ORAL,,DEPRESSION SUICIDAL,1
VASCEPA,1,76,801,DIABETES MELLITUS,ORAL,Capsule,ABDOMINAL PAIN UPPER,2
TECFIDERA,2,,,MULTIPLE SCLEROSIS,ORAL,Prolonged-release capsule,IMPAIRED GASTRIC EMPTYING,1
PATADAY ONCE DAILY RELIEF,2,,,PRODUCT USED FOR UNKNOWN INDICATION,OPHTHALMIC,"Eye drops, solution",PRODUCT ODOUR ABNORMAL,2
ERELZI,2,83,801,PRODUCT USED FOR UNKNOWN INDICATION,,Unknown,DEATH,1
HUMIRA,1,,,CROHN^S DISEASE,,Solution for injection in pre-filled pen,INJECTION SITE DISCHARGE,2
SERTRALINE,1,27,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,URINARY RETENTION,1
BOTOX COSMETIC,2,,,SKIN WRINKLING,INTRAMUSCULAR,,OCULAR HYPERAEMIA,2
TECVAYLI,1,,,PLASMA CELL MYELOMA,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
LENALIDOMIDE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,"Capsules, Immediate Release",FULL BLOOD COUNT DECREASED,2
OZEMPIC,2,,,,SUBCUTANEOUS,Solution for injection,GASTRIC BYPASS,1
DUPIXENT,1,75,801,ECZEMA,SUBCUTANEOUS,Solution for injection,INCORRECT DOSE ADMINISTERED,2
SERTRALINE,1,63,801,ANXIETY,ORAL,Tablet,NIGHTMARE,1
PARAGARD T 380A,2,26,801,CONTRACEPTION,INTRAUTERINE,Intrauterine,DEVICE DISLOCATION,2
DUPIXENT,2,49,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
KESIMPTA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,PRODUCT STORAGE ERROR,2
XARELTO,1,82,801,THROMBOSIS PROPHYLAXIS,ORAL,Film-coated tablet,SUBDURAL HAEMATOMA,1
JARDIANCE,1,50,801,CARDIOMYOPATHY,ORAL,,FUNGAL INFECTION,2
MOUNJARO,1,43,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INCORRECT DOSE ADMINISTERED,2
ESTRADIOL TRANSDERMAL SYSTEM,2,,,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,Transdermal system,PRODUCT ADHESION ISSUE,2
NUPLAZID,1,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,ADVERSE DRUG REACTION,2
TARLATAMAB,1,60,801,SMALL CELL LUNG CANCER RECURRENT,,Investigational dosage form,DEATH,1
XDEMVY,2,64,801,DEMODEX BLEPHARITIS,OPHTHALMIC,,DYSPEPSIA,1
AVASTIN,1,45,801,NEUROENDOCRINE CARCINOMA OF THE SKIN,INTRAVENOUS,,NEUROENDOCRINE CARCINOMA OF THE SKIN,1
GENOTROPIN,1,14,801,,,Solution for injection,INJECTION SITE HAEMORRHAGE,2
TARPEYO,2,47,801,IGA NEPHROPATHY,ORAL,Prolonged-release capsule,INFLUENZA,2
NEXPLANON,2,,,CONTRACEPTION,SUBCUTANEOUS,Implant,PREGNANCY WITH IMPLANT CONTRACEPTIVE,1
TUKYSA,2,,,BREAST CANCER METASTATIC,ORAL,Film-coated tablet,RASH,1
VYEPTI,2,31,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Solution for infusion,URTICARIA,2
FRUZAQLA,2,6,800,COLON CANCER,ORAL,Capsule,COLON CANCER,1
VENCLEXTA,1,71,801,CHRONIC LYMPHOCYTIC LEUKAEMIA,ORAL,Tablet,DEATH,1
ATORVASTATIN,1,,,HYPERLIPIDAEMIA,,Film-coated tablet,ERECTILE DYSFUNCTION,1
AUVELITY,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,UNEVALUABLE EVENT,2
DIANEAL LOW CALCIUM PERITONEAL DIALYSIS SOLUTION WITH DEXTROSE,2,84,801,,,Solution for peritoneal dialysis,DEATH,1
BASAGLAR,1,62,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Injection,INJECTION SITE DISCOMFORT,2
MIRENA,2,,,,INTRAUTERINE,Intrauterine delivery system,DEVICE PHYSICAL PROPERTY ISSUE,2
SANDOSTATIN LAR DEPOT,1,44,801,ACROMEGALY,,,CHEST PAIN,1
DUPIXENT,2,,,NEURODERMATITIS,SUBCUTANEOUS,Solution for injection,CARDIAC VALVE DISEASE,2
PONATINIB,2,,,ACUTE LYMPHOCYTIC LEUKAEMIA,,Tablet,PANCREATITIS CHRONIC,1
CLOZAPINE,1,66,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,ADENOCARCINOMA,1
HUMIRA,1,83,801,RHEUMATOID ARTHRITIS,,,DEATH,1
KEPPRA,1,,,SEIZURE,INTRAVENOUS,Film-coated tablet,OVERDOSE,2
GENOTROPIN,2,13,801,TURNER^S SYNDROME,,Solution for injection,ARRHYTHMIA,1
MIRCERA,1,80,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Solution for injection in pre-filled syringe,DEATH,1
SIMPONI,2,58,801,RHEUMATOID ARTHRITIS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,RHEUMATOID ARTHRITIS,1
FINASTERIDE,2,29,801,ALOPECIA,ORAL,Unknown,MEDICATION ERROR,1
ACTEMRA,1,,,RHEUMATOID ARTHRITIS,INTRAVENOUS,Infusion,OROPHARYNGEAL PAIN,2
CONCERTA,2,27,801,ATTENTION DEFICIT HYPERACTIVITY DISORDER,ORAL,Prolonged-release tablet,HYPERTHYROIDISM,1
BRAFTOVI,2,,,,ORAL,,RASH PRURITIC,1
DUPIXENT,2,60,801,NEURODERMATITIS,SUBCUTANEOUS,Solution for injection,SKIN CANCER,1
LUMRYZ,1,42,801,,ORAL,Extended-Release Oral Suspension,MIDDLE INSOMNIA,2
LUMRYZ,2,,,NARCOLEPSY,ORAL,Extended-Release Oral Suspension,PRODUCT DOSE OMISSION ISSUE,2
KEPPRA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Oral solution,PRODUCT CONTAMINATION PHYSICAL,2
VTAMA,2,2,801,ECZEMA,TOPICAL,Cream,ECZEMA,2
LUPRON,1,,,PROSTATE CANCER,,Powder and solvent for suspension for injection in,DEATH,1
SUTENT,1,,,,ORAL,"Capsule, hard",DEATH,1
SIMPONI,2,,,COLITIS ULCERATIVE,SUBCUTANEOUS,Solution for injection in pre-filled pen,LOWER RESPIRATORY TRACT INFECTION,1
ELIGARD,1,73,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,INTERCEPTED PRODUCT PREPARATION ERROR,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
RIFADIN,1,73,801,LATENT TUBERCULOSIS,,Capsule,DIALYSIS,1
FILSPARI,1,36,801,IGA NEPHROPATHY,ORAL,Tablet,HEADACHE,2
CERTOLIZUMAB PEGOL,2,,,RHEUMATOID ARTHRITIS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,RHEUMATOID ARTHRITIS,1
NUPLAZID,1,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,PARKINSON^S DISEASE,1
CYCLOSPORINE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Eye drops,OCULAR DISCOMFORT,2
XELJANZ XR,2,69,801,,ORAL,Prolonged-release tablet,CONDITION AGGRAVATED,2
TRESIBA,2,65,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,CATARACT,1
DUPIXENT,2,,,PRURITUS,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
DUPIXENT,2,33,801,ASTHMA,SUBCUTANEOUS,Solution for injection,ANAPHYLACTIC REACTION,1
MOUNJARO,1,59,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INCORRECT DOSE ADMINISTERED,2
DUPIXENT,1,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,REBOUND ECZEMA,2
DUPIXENT,1,64,801,ASTHMA,SUBCUTANEOUS,Solution for injection,ASTHMA,2
KESIMPTA,2,39,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,PNEUMONIA,1
MOUNJARO,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INJECTION SITE REACTION,2
DUPIXENT,2,20,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ASTHENOPIA,2
COSENTYX,1,62,801,ANKYLOSING SPONDYLITIS,SUBCUTANEOUS,Solution for injection,GASTROINTESTINAL INFLAMMATION,1
CYTARABINE,2,49,801,NEOPLASM,INTRAVENOUS,Powder for solution for injection,DYSPNOEA,1
TYMLOS,1,32,801,OSTEOPOROSIS,SUBCUTANEOUS,,BACK PAIN,1
SERTRALINE,1,60,801,ANXIETY,ORAL,,NIGHTMARE,1
DUPIXENT,2,61,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ECZEMA,2
TAVNEOS,2,55,801,,ORAL,,HOSPITALISATION,1
AMLODIPINE,1,57,801,HYPERTENSION,ORAL,Tablet,BLOOD PRESSURE INCREASED,1
ENJAYMO,2,,,,INTRAVENOUS,Solution for infusion,APHONIA,2
VENCLEXTA,1,76,801,CHRONIC LYMPHOCYTIC LEUKAEMIA,ORAL,,COVID-19,1
HUMIRA,1,,,ANKYLOSING SPONDYLITIS,,Solution for injection in pre-filled pen,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
DUPIXENT,2,62,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PRODUCT DOSE OMISSION IN ERROR,2
SOMATULINE DEPOT,2,68,801,CARCINOID TUMOUR OF THE SMALL BOWEL,SUBCUTANEOUS,Solution for injection,DEATH,1
PARAGARD T 380A,2,,,,INTRAUTERINE,Intrauterine,INJURY ASSOCIATED WITH DEVICE,1
ALECENSA,1,,,LUNG NEOPLASM MALIGNANT,ORAL,,PAIN IN EXTREMITY,2
RISPERDAL,1,12,801,AFFECTIVE DISORDER,ORAL,Film-coated tablet,GYNAECOMASTIA,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DISCOMFORT,2
SPRYCEL,1,63,801,CHRONIC MYELOID LEUKAEMIA,ORAL,,DRUG INEFFECTIVE,1
PULMOZYME,2,26,801,CYSTIC FIBROSIS,RESPIRATORY (INHALATION),,DEATH,1
LENALIDOMIDE,1,65,801,PLASMA CELL MYELOMA,ORAL,Capsule,COVID-19,2
MIRENA,2,25,801,INTRAUTERINE CONTRACEPTION,INTRAUTERINE,Intrauterine delivery system,DEVICE DISLOCATION,2
VALSARTAN,1,86,801,HYPERTENSION,ORAL,,ACUTE KIDNEY INJURY,1
VERAPAMIL,1,50,801,PRODUCT USED FOR UNKNOWN INDICATION,,,SYNCOPE,1
VEDOLIZUMAB,2,,,COLITIS ULCERATIVE,SUBCUTANEOUS,Powder for solution for infusion,COLITIS ULCERATIVE,1
ELIGARD,2,,,PRECOCIOUS PUBERTY,SUBCUTANEOUS,Injection,INTENTIONAL PRODUCT USE ISSUE,2
COSENTYX,2,58,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Solution for injection,PAIN,2
TUKYSA,2,74,801,BREAST CANCER,ORAL,Film-coated tablet,DYSPNOEA,1
NYVEPRIA,1,60,801,,SUBCUTANEOUS,Solution for injection in pre-filled syringe,DEATH,1
DAPTOMYCIN,1,70,801,SEPSIS,INTRAVENOUS,Unknown,ACUTE PULMONARY OEDEMA,1
DUPIXENT,2,,,,SUBCUTANEOUS,Solution for injection,ACCIDENTAL EXPOSURE TO PRODUCT,2
DUPIXENT,1,21,801,ECZEMA,SUBCUTANEOUS,Solution for injection,ECZEMA,2
DUPIXENT,2,,,ASTHMA,SUBCUTANEOUS,Solution for injection,DRY EYE,2
VENCLEXTA,1,36,801,ACUTE MYELOID LEUKAEMIA,ORAL,Coated tablet,SEPTIC SHOCK,1
RYBELSUS,1,61,801,DIABETES MELLITUS,ORAL,Tablet,HAEMATOCHEZIA,1
HUMIRA,2,,,CROHN^S DISEASE,,Solution for injection in pre-filled pen,ECTOPIC PREGNANCY,1
OMNITROPE,1,,,GROWTH HORMONE DEFICIENCY,SUBCUTANEOUS,Solution for injection,PRODUCT SUBSTITUTION,2
ULTRAVIST,2,68,801,MYOCARDIAL ISCHAEMIA,INTRA-ARTERIAL,Solution for injection,HYPOTENSION,1
KEPPRA,2,,,SEIZURE,INTRAVENOUS,Film-coated tablet,ANGER,2
LUMRYZ,2,30,801,NARCOLEPSY,ORAL,Extended-Release Oral Suspension,ENURESIS,2
LUMRYZ,2,,,,ORAL,Extended-Release Oral Suspension,MIDDLE INSOMNIA,2
ZURZUVAE,2,19,801,PERINATAL DEPRESSION,ORAL,Capsule,FEELING ABNORMAL,2
CABOTEGRAVIR,1,48,801,PRODUCT USED FOR UNKNOWN INDICATION,,Suspension for injection,HYPERTENSION,2
GOLD BOND ORIGINAL STRENGTH,1,,,PRODUCT USED FOR UNKNOWN INDICATION,,Powder,MESOTHELIOMA,1
TEZSPIRE,2,53,801,ASTHMA,SUBCUTANEOUS,,HYPERSENSITIVITY,1
PRETOMANID,1,63,801,PULMONARY TUBERCULOSIS,ORAL,,DEATH,1
MOUNJARO,1,58,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INCORRECT DOSE ADMINISTERED,2
BASAGLAR,2,70,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Injection,HAEMORRHAGE,2
PATADAY ONCE DAILY RELIEF,1,34,801,SEASONAL ALLERGY,OPHTHALMIC,Eye drops,DRUG INEFFECTIVE,2
PATADAY ONCE DAILY RELIEF,2,79,801,HYPERSENSITIVITY,OPHTHALMIC,"Eye drops, solution",HYPERSENSITIVITY,2
PLUVICTO,1,,,PROSTATE CANCER,INTRAVENOUS,Solution for injection/infusion,DRUG INEFFECTIVE,2
DUPIXENT,2,28,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,SKIN FISSURES,2
HUMIRA,1,72,801,PRODUCT USED FOR UNKNOWN INDICATION,,Solution for injection in pre-filled pen,SURGICAL FAILURE,1
CARBIDOPA\LEVODOPA,1,56,801,PARKINSON^S DISEASE,,Solution for infusion,SKIN MASS,2
ORENCIA,2,67,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Solution for injection,GENERAL PHYSICAL HEALTH DETERIORATION,2
AUSTEDO XR,2,40,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Extended release tablet,DYSKINESIA,2
DUPIXENT,1,51,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DRY SKIN,2
OZEMPIC,2,,,RENAL DISORDER PROPHYLAXIS,SUBCUTANEOUS,Solution for injection,CHRONIC KIDNEY DISEASE,1
TECFIDERA,2,30,801,MULTIPLE SCLEROSIS,ORAL,Prolonged-release capsule,ABORTION SPONTANEOUS,1
AUSTEDO,1,75,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,DEATH,1
TRIUMEQ,1,64,801,HIV TEST,ORAL,Film-coated tablet,PRODUCT DOSE OMISSION ISSUE,2
XELJANZ XR,2,82,801,RHEUMATOID ARTHRITIS,ORAL,Prolonged-release tablet,FALL,1
DUPIXENT,1,66,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DEMENTIA,1
VERZENIO,2,76,801,BREAST CANCER FEMALE,ORAL,Tablet,DIARRHOEA,2
MOUNJARO,2,45,801,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,ACCIDENTAL UNDERDOSE,2
ESTRADIOL TRANSDERMAL SYSTEM,2,,,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,Transdermal system,PRODUCT ADHESION ISSUE,2
MOUNJARO,2,55,801,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,INJECTION SITE REACTION,2
DUPIXENT,1,40,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ECZEMA,2
DUPIXENT,1,,,CHRONIC SINUSITIS,SUBCUTANEOUS,Solution for injection,CHRONIC SINUSITIS,2
ABILIFY,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,LOSS OF CONSCIOUSNESS,1
DOTAREM,2,25,801,MAGNETIC RESONANCE IMAGING HEAD,INTRAVENOUS,Solution for injection,NASAL CONGESTION,2
VEVYE,1,45,801,PRODUCT USED FOR UNKNOWN INDICATION,OPHTHALMIC,"Eye drops, solution",EYE IRRITATION,2
CLOZARIL,1,73,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,DEATH,1
MOLNUPIRAVIR,1,68,801,,ORAL,,PRODUCT DISPENSING ISSUE,2
DUPIXENT,2,2,801,ECZEMA,SUBCUTANEOUS,Solution for injection,ECZEMA,2
GATTEX,2,15,801,GRAFT VERSUS HOST DISEASE,SUBCUTANEOUS,,OFF LABEL USE,2
CIBINQO,2,,,,ORAL,Tablet,DRUG INEFFECTIVE,2
CARISOPRODOL,2,78,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,SUSPECTED SUICIDE,1
ELURYNG,2,,,PRODUCT USED FOR UNKNOWN INDICATION,VAGINAL,Vaginal ring,DEVICE EXPULSION,2
JEUVEAU,2,4,800,SKIN WRINKLING,INTRAMUSCULAR,Powder and solvent for solution for injection,BRAIN FOG,2
BOSULIF,2,42,801,,ORAL,Film-coated tablet,CEREBROVASCULAR ACCIDENT,1
REVLIMID,1,73,801,PLASMA CELL MYELOMA,ORAL,Capsule,ASTHENIA,2
BASAGLAR,2,44,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Injection,INJECTION SITE PAIN,2
TRODELVY,2,67,801,TRIPLE NEGATIVE BREAST CANCER,INTRAVENOUS,Powder for concentrate for solution for infusion,RECTAL PERFORATION,1
SACUBITRIL\VALSARTAN,1,84,801,CARDIAC FAILURE,,Film-coated tablet,DIZZINESS,1
ELIGARD,1,72,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,INTERCEPTED PRODUCT PREPARATION ERROR,2
BRENTUXIMAB VEDOTIN,2,70,801,HODGKIN^S DISEASE,INTRAVENOUS,Powder for solution for injection,MYELOSUPPRESSION,1
DUPIXENT,2,29,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PRURITUS,2
NUCYNTA,2,,,BENIGN BONE NEOPLASM,ORAL,Tablet,ILEUS,1
DUPIXENT,1,,,NEURODERMATITIS,SUBCUTANEOUS,Solution for injection,DRUG INEFFECTIVE,2
KEPPRA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,,SOMNOLENCE,2
AFRIN ORIGINAL NASAL,2,,,,,"Nasal spray, solution",DRUG DEPENDENCE,1
MOUNJARO,2,52,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INCORRECT DOSE ADMINISTERED,2
LUMRYZ,1,,,NARCOLEPSY,ORAL,Extended-Release Oral Suspension,INSOMNIA,2
NEXPLANON,2,,,,SUBCUTANEOUS,Implant,VAGINAL HAEMORRHAGE,1
MIRENA,2,33,801,PAIN,INTRAUTERINE,Intrauterine delivery system,UTERINE PERFORATION,1
IMODIUM MULTI-SYMPTOM RELIEF,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,INCORRECT DOSE ADMINISTERED,2
RISPERDAL,1,27,801,SCHIZOPHRENIA,ORAL,,PAIN,1
BERINERT,2,36,801,HEREDITARY ANGIOEDEMA,,Injection,HEREDITARY ANGIOEDEMA,1
TRASTUZUMAB,2,37,801,BREAST CANCER,INTRAVENOUS,Powder for concentrate for solution for infusion,CHEST DISCOMFORT,1
ORENCIA,2,63,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Solution for injection,DRUG INEFFECTIVE,2
FLUTICASONE PROPIONATE\SALMETEROL XINAFOATE,1,,,BRONCHITIS,,Inhalation powder,WRONG TECHNIQUE IN DEVICE USAGE PROCESS,2
GENOTROPIN,1,16,801,,,Solution for injection,DEVICE LEAKAGE,2
XARELTO,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Film-coated tablet,CORONARY ARTERIAL STENT INSERTION,1
REVLIMID,2,71,801,PLASMA CELL MYELOMA,ORAL,Capsule,VOMITING,2
TRAZODONE,1,61,801,PRODUCT USED FOR UNKNOWN INDICATION,,UNK,TOXICITY TO VARIOUS AGENTS,1
QULIPTA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,ALOPECIA,2
DUPIXENT,1,54,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ACCIDENTAL EXPOSURE TO PRODUCT,2
NUPLAZID,1,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,CONDITION AGGRAVATED,2
MOUNJARO,1,47,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INCORRECT DOSE ADMINISTERED,2
CLOZARIL,1,,,SCHIZOPHRENIA,ORAL,,DEATH,1
ZENATANE,2,18,801,ACNE,ORAL,Capsule,MOOD SWINGS,2
LANTUS SOLOSTAR,1,67,801,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,DEVICE DISPENSING ERROR,2
DUPIXENT,2,20,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PRURITUS,2
COSENTYX,2,,,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,,PSORIATIC ARTHROPATHY,1
UBRELVY,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,SPINAL CORD OPERATION,1
MOUNJARO,2,24,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INCORRECT DOSE ADMINISTERED,2
MENS ROGAINE EXTRA STRENGTH,2,46,801,ALOPECIA,,Cutaneous foam,POOR QUALITY PRODUCT ADMINISTERED,2
DUPIXENT,2,58,801,,SUBCUTANEOUS,Solution for injection,ANAPHYLACTIC REACTION,1
DUPIXENT,1,15,801,NASAL POLYPS,SUBCUTANEOUS,Solution for injection,ERYTHEMA,2
DUPIXENT,2,44,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ALLERGY TO METALS,2
DUPIXENT,2,30,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,RASH PRURITIC,2
DUPIXENT,1,58,801,DERMATITIS ALLERGIC,SUBCUTANEOUS,Solution for injection,DRY SKIN,2
MOUNJARO,2,44,801,WEIGHT CONTROL,SUBCUTANEOUS,Solution for injection in cartridge,MYOCLONUS,1
DUPIXENT,2,24,801,DERMATITIS,SUBCUTANEOUS,Solution for injection,DRY SKIN,2
SAXENDA,2,58,801,WEIGHT CONTROL,SUBCUTANEOUS,Solution for injection,INFLUENZA,2
GAZYVA,2,70,801,DIFFUSE LARGE B-CELL LYMPHOMA,INTRAVENOUS,Infusion,GENERAL PHYSICAL HEALTH DETERIORATION,1
OZEMPIC,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,DISABILITY,1
TYSABRI,2,,,MULTIPLE SCLEROSIS,INTRAVENOUS,Infusion,PRODUCT DOSE OMISSION ISSUE,2
BOTOX,2,72,801,TORTICOLLIS,INTRADERMAL,Powder for solution for injection,DYSPHAGIA,2
KESIMPTA,2,,,RELAPSING-REMITTING MULTIPLE SCLEROSIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,LOWER RESPIRATORY TRACT INFECTION,1
DAPTOMYCIN,1,,,ENTEROCOCCAL INFECTION,INTRAVENOUS,,PRODUCT USE IN UNAPPROVED INDICATION,2
WEGOVY,2,62,801,OVERWEIGHT,SUBCUTANEOUS,Solution for injection,VISUAL IMPAIRMENT,1
FINTEPLA,2,20,801,SEVERE MYOCLONIC EPILEPSY OF INFANCY,ORAL,Oral solution,AORTIC VALVE INCOMPETENCE,1
METFORMIN,2,89,801,TYPE 2 DIABETES MELLITUS,ORAL,Unknown,LACTIC ACIDOSIS,1
BICTEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE,2,42,801,PRODUCT USED FOR UNKNOWN INDICATION,,Tablet,ILLNESS,1
DOTAREM,2,46,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Solution for injection,URTICARIA,2
ABEMACICLIB,2,42,801,BREAST CANCER METASTATIC,ORAL,Tablet,HAEMOGLOBIN DECREASED,1
LENALIDOMIDE,2,73,801,PLASMA CELL MYELOMA,ORAL,,PRODUCT USE ISSUE,2
OZEMPIC,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,CARPAL TUNNEL SYNDROME,1
CABOMETYX,2,,,RENAL CANCER,ORAL,Tablet,ADVERSE DRUG REACTION,2
CABOMETYX,2,40,801,ADRENOCORTICAL CARCINOMA,ORAL,Tablet,OFF LABEL USE,2
CABOMETYX,2,,,RENAL CANCER,ORAL,Tablet,DRUG INTOLERANCE,2
CLOZAPINE,1,63,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,NEUTROPHILIA,2
MIRALAX,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Powder for oral solution,INCORRECT DOSE ADMINISTERED,2
RITUXAN,1,68,801,B-CELL LYMPHOMA,INTRAVENOUS,,OFF LABEL USE,2
AIMOVIG,2,46,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,ACCIDENTAL EXPOSURE TO PRODUCT,2
ELIGARD,1,73,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,INJECTION SITE PAIN,2
LENALIDOMIDE,1,84,801,PLASMA CELL MYELOMA,ORAL,Capsule,PLATELET COUNT DECREASED,1
BRIVIACT,1,77,801,SEIZURE,ORAL,Tablet,DEMENTIA,1
DUPIXENT,2,59,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,ARTHRALGIA,2
MOUNJARO,1,64,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INCORRECT DOSE ADMINISTERED,2
FLUOXETINE,1,78,801,DEPRESSED MOOD,ORAL,"Capsule, soft",HALLUCINATION,1
DUPIXENT,1,5,801,,SUBCUTANEOUS,Solution for injection,HYPERSENSITIVITY,2
LUPKYNIS,2,,,LUPUS NEPHRITIS,ORAL,Softgel capsule,SURGERY,2
LUPKYNIS,2,39,801,LUPUS NEPHRITIS,ORAL,Softgel capsule,HYPERTENSION,1
LUPKYNIS,2,29,801,LUPUS NEPHRITIS,ORAL,Softgel capsule,SYSTEMIC LUPUS ERYTHEMATOSUS,1
CABOMETYX,1,,,RENAL CANCER,ORAL,Tablet,ABDOMINAL DISCOMFORT,2
CABOMETYX,1,,,METASTASES TO CENTRAL NERVOUS SYSTEM,ORAL,Tablet,DRUG INTOLERANCE,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
TOUJEO,2,68,801,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,PRODUCT DISPENSING ERROR,2
TAVNEOS,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Capsule,TRANSAMINASES ABNORMAL,2
CABOMETYX,1,,,RENAL CANCER,ORAL,Tablet,BLOOD GLUCOSE INCREASED,1
OMNITROPE,1,13,801,,SUBCUTANEOUS,Solution for injection,INCORRECT DOSE ADMINISTERED BY DEVICE,2
VONJO,2,65,801,MYELOFIBROSIS,ORAL,Capsule,HEPATIC CIRRHOSIS,1
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,HEADACHE,2
ALLEGRA ALLERGY,2,70,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,EAR SWELLING,2
BENLYSTA,2,,,SYSTEMIC LUPUS ERYTHEMATOSUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,INJURY ASSOCIATED WITH DEVICE,2
VYEPTI,2,33,801,MIGRAINE,INTRAVENOUS,Solution for infusion,DRUG INEFFECTIVE,2
LENALIDOMIDE,2,68,801,PLASMA CELL MYELOMA,ORAL,Capsule,FATIGUE,2
OMALIZUMAB,1,27,801,CHRONIC SPONTANEOUS URTICARIA,SUBCUTANEOUS,,FEAR OF INJECTION,1
MOUNJARO,2,,,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,FEELING COLD,2
POLIVY,1,56,801,DIFFUSE LARGE B-CELL LYMPHOMA,INTRAVENOUS,,DYSPNOEA,1
NIVOLUMAB\RELATLIMAB,1,,,PRODUCT USED FOR UNKNOWN INDICATION,,,SECONDARY ADRENOCORTICAL INSUFFICIENCY,2
HAEGARDA,2,18,801,HEREDITARY ANGIOEDEMA,,Injection,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
CLOZAPINE,2,62,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,HOSPITALISATION,1
STIOLTO RESPIMAT,2,,,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,RESPIRATORY (INHALATION),,DRY MOUTH,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
EZETIMIBE,2,,,HYPERCHOLESTEROLAEMIA,ORAL,Unknown,MYALGIA,2
FILSPARI,1,,,IGA NEPHROPATHY,ORAL,Tablet,HYPOTENSION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,HEART RATE INCREASED,2
DUPIXENT,1,61,801,NEURODERMATITIS,SUBCUTANEOUS,Solution for injection,CONJUNCTIVITIS,2
RITUXIMAB,2,,,RHEUMATOID ARTHRITIS,INTRAVENOUS,Concentrate for solution for infusion,PNEUMONIA,1
RHOPRESSA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,OPHTHALMIC,"Eye drops, solution",PRODUCT CLOSURE ISSUE,2
RITONAVIR,1,47,801,HIV INFECTION,ORAL,"Capsule, soft",OSTEONECROSIS,1
GENOTROPIN,1,14,801,,,Solution for injection,DRUG DOSE OMISSION BY DEVICE,2
ZOLPIDEM TARTRATE,1,42,801,,ORAL,,DRUG ABUSE,1
HAEGARDA,2,46,801,HEREDITARY ANGIOEDEMA,,Injection,HEREDITARY ANGIOEDEMA,1
LEVOTHYROXINE,2,54,801,HYPOTHYROIDISM,ORAL,,WEIGHT INCREASED,1
OXALIPLATIN,1,78,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,,LOSS OF CONSCIOUSNESS,1
PADCEV,1,8,800,TRANSITIONAL CELL CARCINOMA METASTATIC,INTRAVENOUS,Infusion,PANCREATIC CARCINOMA,1
TRAVOPROST,2,,,PRODUCT USED FOR UNKNOWN INDICATION,OPHTHALMIC,Eye drops,INTRAOCULAR PRESSURE INCREASED,2
ARESTIN,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,NAUSEA,2
SACITUZUMAB GOVITECAN-HZIY,2,52,801,BREAST CANCER,,Powder for concentrate for solution for infusion,DELIRIUM,1
FABHALTA,2,36,801,IGA NEPHROPATHY,ORAL,,NASOPHARYNGITIS,2
ABILIFY,2,38,801,IMPULSE-CONTROL DISORDER,ORAL,Tablet,CONDITION AGGRAVATED,1
OMNITROPE,2,59,801,HYPERPITUITARISM,SUBCUTANEOUS,Solution for injection,PNEUMONIA BACTERIAL,1
ESTRADIOL TRANSDERMAL SYSTEM,2,,,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,Transdermal system,PRODUCT ADHESION ISSUE,2
MOUNJARO,1,45,801,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,INTERCEPTED PRODUCT DISPENSING ERROR,2
HUMIRA,1,,,RHEUMATOID ARTHRITIS,,Solution for injection in pre-filled pen,ROTATOR CUFF SYNDROME,1
ZENATANE,2,40,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Capsule,ACNE,2
LENALIDOMIDE,1,78,801,PLASMA CELL MYELOMA,ORAL,Capsule,NASOPHARYNGITIS,2
DOXORUBICIN,1,22,801,SYNOVIAL SARCOMA METASTATIC,INTRAVENOUS,,DRUG INEFFECTIVE,1
DUPIXENT,1,70,801,NASAL POLYPS,SUBCUTANEOUS,Solution for injection,ABDOMINAL PAIN UPPER,2
DUPIXENT,1,,,NASAL POLYPS,SUBCUTANEOUS,Solution for injection,PALPITATIONS,2
FINERENONE,1,77,801,,ORAL,Film-coated tablet,BLOOD POTASSIUM INCREASED,1
TYSABRI,1,,,MULTIPLE SCLEROSIS,INTRAVENOUS,Unknown,ILLNESS,2
ADEMPAS,2,72,801,PULMONARY ARTERIAL HYPERTENSION,ORAL,Film-coated tablet,DEATH,1
JEUVEAU,1,,,PRODUCT USE IN UNAPPROVED INDICATION,INTRAMUSCULAR,Powder for solution for injection,SKIN DISCOLOURATION,2
HYRIMOZ,1,25,801,CROHN^S DISEASE,SUBCUTANEOUS,Solution for injection,HOSPITALISATION,1
GENOTROPIN,1,14,801,,,Solution for injection,DEVICE LEAKAGE,2
LUPRON,1,,,PROSTATE CANCER,,,BONE CANCER,1
DUPIXENT,2,48,801,NASAL POLYPS,SUBCUTANEOUS,Solution for injection,ANOSMIA,2
TALTZ,2,,,GUTTATE PSORIASIS,SUBCUTANEOUS,,DYSPAREUNIA,2
M-M-RVAXPRO,2,1,801,IMMUNISATION,,,PYREXIA,1
OZEMPIC,1,,,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,PREMATURE BABY,1
ELREXFIO,2,53,801,,SUBCUTANEOUS,Solution for injection,BRAIN OEDEMA,1
LANTUS SOLOSTAR,1,51,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
DUPIXENT,2,14,801,ECZEMA,SUBCUTANEOUS,Solution for injection,CARDIAC DISORDER,2
DUPIXENT,1,40,801,ECZEMA,SUBCUTANEOUS,Solution for injection,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,2
WEGOVY,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,CHOLECYSTECTOMY,1
LENALIDOMIDE,2,78,801,PLASMA CELL MYELOMA,ORAL,Capsule,DEMENTIA ALZHEIMER^S TYPE,1
LUMRYZ,2,,,,ORAL,Extended-Release Oral Suspension,TERMINAL INSOMNIA,2
LILETTA,2,48,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAUTERINE,,DEVICE EXPULSION,2
TECFIDERA,2,25,801,MULTIPLE SCLEROSIS,ORAL,Prolonged-release capsule,MULTIPLE SCLEROSIS RELAPSE,1
NEOSPORIN,2,,,,,"Eye drops, solution",DRUG HYPERSENSITIVITY,2
ACETAMINOPHEN\HYDROCODONE BITARTRATE,2,80,801,PRODUCT USED FOR UNKNOWN INDICATION,,,DEATH,1
HUMIRA,1,84,801,PRODUCT USED FOR UNKNOWN INDICATION,,,RETINAL TEAR,1
MOUNJARO,2,48,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,INCORRECT DOSE ADMINISTERED,2
INLYTA,1,67,801,RENAL CANCER,ORAL,,DEATH,1
METHOTREXATE SODIUM,2,48,801,ARTHRITIS,INTRA-ARTERIAL,,HEPATIC ENZYME INCREASED,2
OTEZLA,1,64,801,PSORIASIS,ORAL,Tablet,"SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE",2
ELIGARD,1,73,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,INTERCEPTED PRODUCT PREPARATION ERROR,2
SERTRALINE,2,36,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,POLYMENORRHOEA,1
TYLENOL,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,DRUG HYPERSENSITIVITY,2
SERTRALINE,1,44,801,ANXIETY,ORAL,Tablet,ABNORMAL DREAMS,1
PANZYGA,2,56,801,POLYMYOSITIS,,,RASH,1
DUPIXENT,1,75,801,DERMATITIS,SUBCUTANEOUS,Solution for injection,PRODUCT USE IN UNAPPROVED INDICATION,2
ORENCIA,2,56,801,POLYARTHRITIS,INTRAVENOUS,Solution for injection in pre-filled pen,DEVICE OPERATIONAL ISSUE,1
MOUNJARO,1,47,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INJECTION SITE PAIN,2
RHOPRESSA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,OPHTHALMIC,"Eye drops, solution",PRODUCT DOSE OMISSION ISSUE,2
XELJANZ XR,1,67,801,,ORAL,Prolonged-release tablet,ANXIETY,2
INLYTA,2,84,801,,ORAL,Film-coated tablet,CANDIDA INFECTION,2
ATORVASTATIN,2,74,801,HYPERCHOLESTEROLAEMIA,,Tablet,HYPERTRANSAMINASAEMIA,1
AVASTIN,2,,,OVARIAN CANCER,INTRAVENOUS,,DEATH,1
DUPIXENT,1,,,ECZEMA,SUBCUTANEOUS,Solution for injection,EYE PRURITUS,2
DUPIXENT,2,,,ASTHMA,SUBCUTANEOUS,Solution for injection,MEMORY IMPAIRMENT,2
DUPIXENT,2,6,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,2,15,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,1,34,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,SUPERFICIAL INJURY OF EYE,2
CARVYKTI,1,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Dispersion for infusion,ARTHRALGIA,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
OZEMPIC,2,,,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,ACUTE MACULAR NEURORETINOPATHY,1
DUPIXENT,2,60,801,ASTHMA,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,2,58,801,DERMATITIS,SUBCUTANEOUS,Solution for injection,EYE SWELLING,2
REVLIMID,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Capsule,DEATH,1
PADCEV,1,,,TRANSITIONAL CELL CARCINOMA METASTATIC,INTRAVENOUS,Infusion,ILEUS,1
REVLIMID,2,74,801,PLASMA CELL MYELOMA,ORAL,Capsule,NASOPHARYNGITIS,2
VEDOLIZUMAB,2,63,801,CROHN^S DISEASE,SUBCUTANEOUS,Powder for solution for infusion,CROHN^S DISEASE,1
TERIFLUNOMIDE,2,,,MULTIPLE SCLEROSIS,ORAL,Film-coated tablet,COGNITIVE DISORDER,1
VEDOLIZUMAB,1,,,COLITIS ULCERATIVE,SUBCUTANEOUS,Solution for injection,COLITIS ULCERATIVE,1
XOLAIR,2,32,801,CHRONIC SPONTANEOUS URTICARIA,SUBCUTANEOUS,Solution for injection in pre-filled syringe,ANAPHYLACTIC REACTION,1
KYLEENA,2,,,,INTRAUTERINE,Intrauterine delivery system,DEVICE EXPULSION,2
GAMMAGARD LIQUID,2,,,IMMUNODEFICIENCY COMMON VARIABLE,,Solution for infusion,COLITIS,1
ERIBULIN,2,46,801,BREAST NEOPLASM,,Solution for injection,WHITE BLOOD CELL COUNT DECREASED,1
INGREZZA,1,,,TARDIVE DYSKINESIA,ORAL,Capsule,DEPRESSION,2
DUPIXENT,1,,,ECZEMA,SUBCUTANEOUS,Solution for injection,ERYTHEMA,2
COMBIVENT RESPIMAT,1,79,801,PRODUCT USED FOR UNKNOWN INDICATION,RESPIRATORY (INHALATION),,OXYGEN THERAPY,1
ADBRY,1,66,801,DERMATITIS ATOPIC,SUBCUTANEOUS,,DERMATITIS ATOPIC,2
OSELTAMIVIR,2,3,801,TONSILLITIS,ORAL,Oral suspension,PRURITUS,1
XOLAIR PFS,2,,,PRURITUS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,OFF LABEL USE,2
OCRELIZUMAB,2,,,MULTIPLE SCLEROSIS,INTRAVENOUS,Infusion,ABORTION SPONTANEOUS,1
SERTRALINE,1,61,801,DEPRESSION,ORAL,,ABNORMAL DREAMS,1
SERTRALINE,2,36,801,ADVERSE DRUG REACTION,ORAL,,URINARY INCONTINENCE,1
ORENCIA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Injection,PRODUCT DOSE OMISSION IN ERROR,1
LEQVIO,2,71,801,HYPERLIPIDAEMIA,SUBCUTANEOUS,Solution for injection,LIVER FUNCTION TEST INCREASED,1
REVLIMID,2,62,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,HEADACHE,2
ERELZI,2,,,ANKYLOSING SPONDYLITIS,,Solution for injection,RADICULOTOMY,1
HUMIRA,2,32,801,HIDRADENITIS,,Solution for injection in pre-filled pen,INJECTION SITE HAEMORRHAGE,2
HUMIRA,2,,,PSORIASIS,,Solution for injection in pre-filled pen,BLINDNESS,1
EUTHYROX,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,DIABETES MELLITUS,1
FINASTERIDE,1,63,801,ALOPECIA,ORAL,Tablet,TESTICULAR PAIN,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,VISUAL IMPAIRMENT,2
GENOTROPIN,2,18,801,,,Solution for injection,DEVICE MALFUNCTION,2
SOFOSBUVIR\VELPATASVIR,2,,,HEPATITIS C,,Tablet,DEHYDRATION,1
TRASTUZUMAB,2,51,801,BREAST CANCER,INTRAVENOUS,Injection,WHITE BLOOD CELL COUNT DECREASED,1
VOTRIENT,2,61,801,BREAST CANCER,ORAL,Film-coated tablet,FRACTURE,1
RITUXIMAB,2,87,801,DIFFUSE LARGE B-CELL LYMPHOMA,INTRAVENOUS,,DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT,1
DUPIXENT,1,2,801,ECZEMA,SUBCUTANEOUS,Solution for injection,EAR INFECTION,2
LINACLOTIDE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,THERAPEUTIC PRODUCT EFFECT DECREASED,2
PAXLOVID,2,72,801,COVID-19 TREATMENT,,Tablet,COVID-19,2
ODEFSEY,1,56,801,HIV INFECTION,ORAL,,SEIZURE,1
BOTOX,2,,,PRODUCT USE IN UNAPPROVED INDICATION,INTRADERMAL,,OFF LABEL USE,2
VANFLYTA,2,,,ACUTE MYELOID LEUKAEMIA,ORAL,Tablet,NEUTROPENIA,1
KEPPRA,2,19,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,,BORDERLINE PERSONALITY DISORDER,1
PLEGRIDY,2,,,MULTIPLE SCLEROSIS,SUBCUTANEOUS,Unknown,FALL,2
GENOTROPIN,2,12,801,,,Solution for injection,DRUG DOSE OMISSION BY DEVICE,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
EUTHYROX,2,,,HYPOTHYROIDISM,ORAL,,HYPERTENSION,1
VENCLEXTA,2,69,801,PLASMA CELL MYELOMA,ORAL,Film-coated tablet,COLON CANCER,1
XELJANZ XR,1,52,801,,ORAL,Prolonged-release tablet,ILLNESS,2
LANTUS SOLOSTAR,2,44,801,BLOOD GLUCOSE INCREASED,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
DUPIXENT,2,35,801,SKIN DISORDER,SUBCUTANEOUS,Solution for injection,PRODUCT USE IN UNAPPROVED INDICATION,2
DUPIXENT,2,,,ECZEMA,SUBCUTANEOUS,Solution for injection,ACCIDENTAL EXPOSURE TO PRODUCT,2
ASENAPINE MALEATE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBLINGUAL,Tablet,SUICIDE ATTEMPT,1
CITALOPRAM,2,46,801,MAJOR DEPRESSION,ORAL,,MOOD SWINGS,2
OSELTAMIVIR PHOSPHATE,1,78,801,PYREXIA,ORAL,Capsule,HALLUCINATION,1
COSENTYX,1,68,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Injection,INFLUENZA,2
CIMZIA,2,31,801,RHEUMATOID ARTHRITIS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,RHEUMATOID ARTHRITIS,1
DUPIXENT,2,48,801,,SUBCUTANEOUS,,VISUAL IMPAIRMENT,1
ZIRABEV,1,59,801,,INTRAVENOUS,Solution for infusion,TERMINAL STATE,1
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,2,74,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,COMPLETED SUICIDE,1
XIFAXAN,1,72,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,DEATH,1
BRIGATINIB,1,66,801,LUNG NEOPLASM MALIGNANT,ORAL,Tablet,HEPATIC FUNCTION ABNORMAL,1
IMBRUVICA,2,75,801,CHRONIC LYMPHOCYTIC LEUKAEMIA,ORAL,Capsule,CARDIAC OPERATION,1
CILASTATIN SODIUM\IMIPENEM,1,33,801,INFECTION,,Injection,HAEMORRHAGE INTRACRANIAL,1
CEFIDEROCOL,1,73,801,BACTERAEMIA,,Intravenous infusion,BACTERAEMIA,1
ENTYVIO,2,,,COLITIS ULCERATIVE,SUBCUTANEOUS,Solution for injection,NO ADVERSE EVENT,2
MOUNJARO,2,56,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INCORRECT DOSE ADMINISTERED,2
HAEGARDA,2,37,801,HEREDITARY ANGIOEDEMA,,Injection,SENSITIVE SKIN,2
LYUMJEV KWIKPEN,1,24,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INJECTION SITE DISCOMFORT,2
DUPIXENT,1,19,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,INJECTION SITE PAIN,2
DUPIXENT,2,,,ASTHMA,SUBCUTANEOUS,Solution for injection,INFLUENZA,2
DUPIXENT,1,33,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DRUG INEFFECTIVE,2
KYLEENA,2,,,,INTRAUTERINE,Intrauterine delivery system,ACNE,2
CARBIDOPA\LEVODOPA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,,"Modified-release capsule, hard",ADVERSE DRUG REACTION,2
DUPIXENT,1,80,801,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,SUBCUTANEOUS,Solution for injection,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
DUPIXENT,1,2,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DYSPHEMIA,2
DUPIXENT,2,67,801,ASTHMA,SUBCUTANEOUS,Solution for injection,ARTHRALGIA,2
LANTUS SOLOSTAR,2,73,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,PRODUCT STORAGE ERROR,2
NUPLAZID,1,86,801,PARKINSON^S DISEASE,ORAL,Capsule,DEATH,1
DUPIXENT,2,45,801,ECZEMA,SUBCUTANEOUS,Solution for injection,INFLUENZA,1
ROSUVASTATIN,1,58,801,DYSLIPIDAEMIA,ORAL,Tablet,ERYTHEMA,1
ADVATE,1,9,801,FACTOR VIII DEFICIENCY,,,INTRA-ABDOMINAL HAEMORRHAGE,1
ISOVUE 300,2,32,801,COMPUTERISED TOMOGRAM ABDOMEN,INTRAVENOUS,Solution for injection,ANAPHYLACTIC REACTION,1
MYALEPT,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Powder for solution for injection,ILL-DEFINED DISORDER,1
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,SUICIDAL IDEATION,1
DUPIXENT,1,58,801,ASTHMA,SUBCUTANEOUS,Solution for injection,DYSPNOEA,2
DUPIXENT,2,12,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ECZEMA,2
TOUJEO MAX,1,66,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,BLOOD GLUCOSE DECREASED,2
DUPIXENT,2,16,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,1,40,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,INFLUENZA,2
DUPIXENT,2,33,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Solution for injection,PAIN,2
DUPIXENT,1,34,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,2,38,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
AVONEX,2,64,801,MULTIPLE SCLEROSIS,INTRAMUSCULAR,Solution for injection in pre-filled syringe,STRESS,2
MOUNJARO,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in cartridge,ANGIOEDEMA,1
FINASTERIDE,1,36,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ERECTILE DYSFUNCTION,1
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,SUICIDAL IDEATION,1
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,SUICIDAL IDEATION,1
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
PARAGARD T 380A,2,,,,INTRAUTERINE,Intrauterine,REPRODUCTIVE COMPLICATION ASSOCIATED WITH DEVICE,1
ALLOPURINOL,1,72,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
ZOLEDRONIC ACID,2,54,801,OSTEOPOROSIS,INTRAVENOUS,Solution for infusion,CHOLECYSTITIS,1
DUPIXENT,2,74,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PRURITUS,2
HYFTOR,2,17,801,TUBEROUS SCLEROSIS COMPLEX,TOPICAL,Jelly,DRY SKIN,2
MOUNJARO,2,72,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,PRODUCT DOSE OMISSION ISSUE,2
DEFINITY,2,53,801,STRESS ECHOCARDIOGRAM,INTRAVENOUS,"INJECTION, SUSPENSION",PAIN IN EXTREMITY,2
DEFINITY,2,52,801,ECHOCARDIOGRAM,INTRAVENOUS,"INJECTION, SUSPENSION",MUSCLE SPASMS,2
METFORMIN,2,51,801,DIABETES MELLITUS,ORAL,,WERNICKE-KORSAKOFF SYNDROME,1
NUPLAZID,1,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,HALLUCINATION,1
NEULASTA,2,77,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,DEVICE ADHESION ISSUE,2
CLENPIQ,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Oral solution,DRUG INEFFECTIVE,2
DUPIXENT,2,34,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
METFORMIN,2,66,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,COMPLETED SUICIDE,1
HUMIRA,1,,,CROHN^S DISEASE,,,OBSTRUCTION,1
DUPIXENT,1,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
VEOZAH,2,48,801,HOT FLUSH,ORAL,,WEIGHT INCREASED,1
EPIDIOLEX,2,11,801,LENNOX-GASTAUT SYNDROME,ORAL,Oral solution,DEATH,1
TAVALISSE,1,,,IMMUNE THROMBOCYTOPENIA,ORAL,Tablet,ATRIAL FIBRILLATION,1
CLOZARIL,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,LYMPHOMA,1
LANTUS SOLOSTAR,2,40,801,TYPE 1 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,PRODUCT DISPENSING ERROR,2
DUPIXENT,1,73,801,RHINITIS ALLERGIC,SUBCUTANEOUS,Solution for injection,COUGH,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DRUG INEFFECTIVE,2
DUPIXENT,2,87,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PRURITUS,2
VEDOLIZUMAB,2,,,CROHN^S DISEASE,SUBCUTANEOUS,Powder for solution for infusion,COVID-19,1
TEPEZZA,1,68,801,ENDOCRINE OPHTHALMOPATHY,INTRAVENOUS,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",INFLAMMATORY BOWEL DISEASE,1
NURTEC ODT,2,71,801,MIGRAINE,ORAL,Orodispersible tablet,TOE OPERATION,1
REVLIMID,1,63,801,PLASMA CELL MYELOMA,ORAL,Capsule,PRODUCT DOSE OMISSION ISSUE,2
CLOZARIL,1,,,SCHIZOPHRENIA,ORAL,,DEATH,1
KEPPRA,1,,,SEIZURE,INTRAVENOUS,Film-coated tablet,AFFECTIVE DISORDER,2
MOUNJARO,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,MATERNAL EXPOSURE DURING PREGNANCY,2
TOUJEO MAX,1,71,801,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,WRONG PRODUCT ADMINISTERED,2
PARAGARD T 380A,2,30,801,CONTRACEPTION,INTRAUTERINE,Intrauterine,REPRODUCTIVE COMPLICATION ASSOCIATED WITH DEVICE,1
DIANEAL FOR PERITONEAL DIALYSIS,2,,,,,Solution for peritoneal dialysis,DRUG INEFFECTIVE,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
DUPIXENT,2,91,801,ASTHMA,SUBCUTANEOUS,Solution for injection,ASTHMA,1
DUPIXENT,2,,,ASTHMA,SUBCUTANEOUS,Solution for injection,LUNG DISORDER,2
TAVNEOS,2,87,801,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS,ORAL,"Capsule, hard",IGA NEPHROPATHY,1
BOTOX COSMETIC,2,,,SKIN WRINKLING,INTRAMUSCULAR,,THERAPEUTIC RESPONSE SHORTENED,2
DUPIXENT,2,45,801,,SUBCUTANEOUS,,DIZZINESS,2
VIMPAT,2,,,SEIZURE,INTRAVENOUS,Oral solution,GENERALISED TONIC-CLONIC SEIZURE,1
GENOTROPIN,1,15,801,,,Solution for injection,DRUG DOSE OMISSION BY DEVICE,2
ERLEADA,1,81,801,PROSTATE CANCER METASTATIC,ORAL,Film-coated tablet,RASH,1
XELJANZ XR,2,38,801,RHEUMATOID ARTHRITIS,ORAL,Prolonged-release tablet,DRUG INEFFECTIVE,2
NEULASTA,2,77,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,INTERCEPTED PRODUCT PREPARATION ERROR,2
OXERVATE,2,86,801,NEUROTROPHIC KERATOPATHY,OPHTHALMIC,"Eye drops, solution",CEREBROVASCULAR ACCIDENT,1
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ACCIDENT,2
ERLEADA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Film-coated tablet,HOSPITALISATION,1
DOVATO,1,26,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Film-coated tablet,PRODUCT DOSE OMISSION ISSUE,2
PREVYMIS,1,59,801,,ORAL,Tablet,DEATH,1
DEFINITY,1,74,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,"INJECTION, SUSPENSION",LIQUID PRODUCT PHYSICAL ISSUE,2
TALTZ,2,65,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Solution for injection in pre-filled pen,PSORIATIC ARTHROPATHY,2
ARIKAYCE,2,76,801,MYCOBACTERIAL INFECTION,RESPIRATORY (INHALATION),Suspension,SYNCOPE,1
RYBELSUS,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,DEATH,1
TECENTRIQ,1,73,801,NON-SMALL CELL LUNG CANCER,INTRAVENOUS,,DEATH,1
ELIGARD,1,76,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,INTERCEPTED PRODUCT PREPARATION ERROR,2
OMNIPAQUE,2,48,801,DIAGNOSTIC PROCEDURE,INTRAVENOUS,Solution for injection,DYSPHAGIA,1
PARAGARD T 380A,2,,,,INTRAUTERINE,Intrauterine,INJURY ASSOCIATED WITH DEVICE,1
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DRUG INEFFECTIVE,2
VYEPTI,2,52,801,MIGRAINE,INTRAVENOUS,Solution for infusion,LOSS OF CONSCIOUSNESS,1
EPIDIOLEX,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Oral solution,HOSPITALISATION,1
UPTRAVI,2,76,801,PULMONARY ARTERIAL HYPERTENSION,ORAL,Tablet,FRACTURE,1
DUPIXENT,2,9,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DRY SKIN,2
ZOLEDRONIC ACID,2,80,801,OSTEOPOROSIS,INTRAVENOUS,,BLADDER CANCER,1
REVLIMID,2,62,801,PLASMA CELL MYELOMA,ORAL,Capsule,DIARRHOEA,2
AUVELITY,1,22,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,PAIN IN EXTREMITY,2
REFRESH TEARS PF,1,,,PRODUCT USED FOR UNKNOWN INDICATION,OPHTHALMIC,"Eye drops, solution",POOR QUALITY PRODUCT ADMINISTERED,2
PARAGARD T 380A,2,35,801,CONTRACEPTION,INTRAUTERINE,Intrauterine,UTERINE LEIOMYOMA,1
EYLEA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVITREAL,Injection,LASER SURGERY,1
RISPERDAL,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Film-coated tablet,OFF LABEL USE,2
ESCITALOPRAM,2,90,801,DEPRESSION,ORAL,,BIPOLAR I DISORDER,1
DOXORUBICIN,2,50,801,TRIPLE NEGATIVE BREAST CANCER,INTRAVENOUS,,METASTASES TO CENTRAL NERVOUS SYSTEM,1
MIRTAZAPINE,1,,,ANXIETY,ORAL,Film-coated tablet,SEROTONIN SYNDROME,1
HUMIRA,2,64,801,RHEUMATOID ARTHRITIS,,Injection,INFLUENZA,2
SOTYKTU,1,77,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,DRUG INEFFECTIVE,2
CLOZAPINE,1,41,801,SCHIZOAFFECTIVE DISORDER,ORAL,,MYOCARDIAL INFARCTION,1
CABENUVA,2,,,HIV INFECTION,,Suspension for injection,PRODUCT DOSE OMISSION ISSUE,2
CUVITRU,1,,,,,,MEDICAL PROCEDURE,1
TRASTUZUMAB,1,59,801,GASTRIC CANCER,INTRAVENOUS,Injection,MYELOSUPPRESSION,1
NIRSEVIMAB,1,4,803,ANTIVIRAL PROPHYLAXIS,INTRAMUSCULAR,,LETHARGY,1
REVLIMID,2,76,801,PLASMA CELL MYELOMA,ORAL,Capsule,PNEUMONIA,1
HUMIRA,2,75,801,RHEUMATOID ARTHRITIS,,Injection,MALAISE,2
GENOTROPIN,1,,,,,Solution for injection,PRODUCT COMMUNICATION ISSUE,2
DUPIXENT,2,72,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PRURITUS,2
KETOROLAC,1,6,800,CANCER PAIN,,,DRUG INEFFECTIVE,1
GENOTROPIN,1,15,801,HYPOPITUITARISM,,Solution for injection,INCORRECT DOSE ADMINISTERED BY DEVICE,2
RADICAVA ORS,1,77,801,AMYOTROPHIC LATERAL SCLEROSIS,,Oral suspension,GENERAL PHYSICAL HEALTH DETERIORATION,1
REVLIMID,1,65,801,PLASMA CELL MYELOMA IN REMISSION,ORAL,Capsule,THROMBOSIS,1
HUMIRA,2,,,RHEUMATOID ARTHRITIS,,Solution for injection in pre-filled pen,SPINAL OPERATION,1
MENS ROGAINE EXTRA STRENGTH,1,,,ANDROGENETIC ALOPECIA,,Cutaneous foam,SEBORRHOEA,2
VELSIPITY,1,53,801,,ORAL,Film-coated tablet,PNEUMONIA,1
CARBIDOPA\LEVODOPA,2,57,801,PARKINSON^S DISEASE,,Solution for infusion,RESPIRATORY TRACT INFECTION,1
LUMAKRAS,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown formulation,MUCOSAL INFLAMMATION,2
DUPIXENT,1,30,801,NASAL POLYPS,SUBCUTANEOUS,Solution for injection,RHINORRHOEA,2
DUPIXENT,1,40,801,NASAL POLYPS,SUBCUTANEOUS,Solution for injection,NASOPHARYNGITIS,2
FOSCARBIDOPA\FOSLEVODOPA,1,,,PARKINSON^S DISEASE,SUBCUTANEOUS,Infusion,ABSCESS,1
AMPHOTERICIN B,1,,,PNEUMONIA FUNGAL,INTRAVENOUS,Injection,OXYGEN SATURATION DECREASED,1
DUPIXENT,1,55,801,ECZEMA,SUBCUTANEOUS,Solution for injection,INJECTION SITE PAIN,2
OCRELIZUMAB,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,,NEUTROPENIA,1
ORENCIA,2,33,801,PSORIATIC ARTHROPATHY,INTRAVENOUS,Injection,MALAISE,2
HADLIMA,2,29,801,HIDRADENITIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,FEAR OF INJECTION,2
ROMOSOZUMAB,2,,,PRODUCT USED FOR UNKNOWN INDICATION,,,ACUTE CORONARY SYNDROME,1
BELSOMRA,2,85,801,INSOMNIA,ORAL,,HEADACHE,2
ELIGARD,1,,,PROSTATE CANCER,SUBCUTANEOUS,Injection,CHEST PAIN,1
MOUNJARO,2,61,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,BREAST CANCER,1
BUPRENORPHINE HYDROCHLORIDE\NALOXONE HYDROCHLORIDE,2,29,801,DRUG USE DISORDER,,,HEADACHE,1
OZEMPIC,1,,,CARDIAC FAILURE,SUBCUTANEOUS,Solution for injection,CARDIAC FAILURE CONGESTIVE,1
JARDIANCE,2,72,801,TYPE 2 DIABETES MELLITUS,ORAL,,DYSPNOEA,2
FRUQUINTINIB,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Capsule,OESOPHAGEAL CANDIDIASIS,1
RISPERDAL,1,25,801,DEPRESSION,ORAL,Unknown,TREATMENT NONCOMPLIANCE,2
HUMIRA,2,65,801,CROHN^S DISEASE,,,SPINAL STENOSIS,1
DUPIXENT,1,17,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,BLOOD CALCIUM DECREASED,2
IBRUTINIB,1,66,801,MANTLE CELL LYMPHOMA,ORAL,Tablet,DEATH,1
DUPIXENT,2,64,801,ASTHMA,SUBCUTANEOUS,Solution for injection,COUGH,2
FINGOLIMOD,1,48,801,MULTIPLE SCLEROSIS,ORAL,Unknown,LIVER DISORDER,1
MOUNJARO,1,35,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,ABDOMINAL PAIN,2
DUPIXENT,2,59,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PRURITUS,2
DUPIXENT,1,17,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
ATORVASTATIN,1,62,801,PRODUCT USED FOR UNKNOWN INDICATION,,,DRY MOUTH,1
NUBEQA,1,56,801,PROSTATE CANCER,ORAL,,PYREXIA,1
DUPIXENT,2,64,801,CHRONIC SINUSITIS,SUBCUTANEOUS,Solution for injection,ASTHMA,2
DUPIXENT,2,66,801,ASTHMA,SUBCUTANEOUS,Solution for injection,ILLNESS,2
DUPIXENT,1,78,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,CYST,2
SUTENT,1,65,801,RENAL CANCER,ORAL,"Capsule, hard",HAEMATOCHEZIA,1
HUMIRA,2,63,801,RHEUMATOID ARTHRITIS,,,OVARIAN NEOPLASM,1
REVLIMID,2,88,801,PLASMA CELL MYELOMA,ORAL,,FATIGUE,2
DUPIXENT,2,51,801,DERMATITIS CONTACT,SUBCUTANEOUS,Solution for injection,BLINDNESS UNILATERAL,1
ORENCIA,2,56,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Solution for injection,RHEUMATOID ARTHRITIS,2
LENALIDOMIDE,1,85,801,PLASMA CELL MYELOMA IN REMISSION,ORAL,Capsule,FATIGUE,2
DUPIXENT,1,16,801,ECZEMA,SUBCUTANEOUS,Solution for injection,INCORRECT DOSE ADMINISTERED,2
PATADAY ONCE DAILY RELIEF,2,,,EYE PRURITUS,OPHTHALMIC,"Eye drops, solution",EYE IRRITATION,2
ELIGARD,1,91,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,INJECTION SITE PAIN,2
ZOMETA,2,43,801,PRODUCT USED FOR UNKNOWN INDICATION,,Concentrate for solution for infusion,HYPERVENTILATION,1
LEQEMBI,2,74,801,DEMENTIA ALZHEIMER^S TYPE,INTRAVENOUS,Infusion,AMYLOID RELATED IMAGING ABNORMALITY-OEDEMA/EFFUSION,1
TRIPTORELIN,1,,,PROSTATE CANCER,,,MALIGNANT NEOPLASM PROGRESSION,1
MEKINIST,1,,,MALIGNANT MELANOMA,ORAL,Film-coated tablet,DEPRESSED LEVEL OF CONSCIOUSNESS,1
DUPIXENT,2,7,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DRY SKIN,2
PARAGARD T 380A,2,,,CONTRACEPTION,INTRAUTERINE,Intrauterine,ADNEXAL TORSION,1
OPSUMIT,1,63,801,PULMONARY ARTERIAL HYPERTENSION,ORAL,,INFLUENZA,1
LUMAKRAS,1,,,NON-SMALL CELL LUNG CANCER,ORAL,Tablet,NON-SMALL CELL LUNG CANCER,1
BRINZOLAMIDE,2,,,DRY EYE,OPHTHALMIC,Eye drops,BLINDNESS TRANSIENT,1
ULTRAVIST,1,71,801,COMPUTERISED TOMOGRAM ABDOMEN,INTRA-ARTERIAL,Solution for injection,LOSS OF CONSCIOUSNESS,1
TOSYMRA,2,36,801,MIGRAINE,NASAL,Nasal spray,PAIN,2
LEQVIO,2,64,801,HYPERCHOLESTEROLAEMIA,SUBCUTANEOUS,Solution for injection in pre-filled syringe,AMNESTIC DISORDER,1
MOUNJARO,2,,,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,NAUSEA,2
DUPIXENT,2,20,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,2,,,SECONDARY IMMUNODEFICIENCY,,,DRUG HYPERSENSITIVITY,2
TOFACITINIB CITRATE,2,78,801,RHEUMATOID ARTHRITIS,,Film-coated tablet,EMBOLIC STROKE,1
LUCENTIS,1,,,DIABETIC RETINAL OEDEMA,INTRAVITREAL,,CATARACT,1
HUMIRA,2,,,PSORIATIC ARTHROPATHY,,,RASH,2
RISANKIZUMAB,2,68,801,PSORIATIC ARTHROPATHY,,,BREAST CANCER,1
MOUNJARO,2,60,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,PRODUCT DOSE OMISSION ISSUE,2
ADEMPAS,1,78,801,PULMONARY ARTERIAL HYPERTENSION,ORAL,,DEATH,1
ORENCIA,2,52,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Solution for injection in pre-filled syringe,RHEUMATOID ARTHRITIS,2
DABRAFENIB,2,26,801,MALIGNANT MELANOMA,ORAL,,RELAPSING FEVER,1
OPDUALAG,2,57,801,METASTATIC MALIGNANT MELANOMA,INTRAVENOUS,,IMMUNE-MEDIATED GASTROINTESTINAL DISORDER,1
DUPIXENT,2,24,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PARANASAL SINUS DISCOMFORT,2
ELIGARD,1,79,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,INJECTION SITE PAIN,2
DUPIXENT,2,45,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,CHOKING SENSATION,2
DUPIXENT,2,25,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ARTHRALGIA,2
WEGOVY,2,56,801,,SUBCUTANEOUS,Solution for injection,SURGERY,1
INVANZ,2,95,801,SYMPTOMATIC TREATMENT,INTRAMUSCULAR,Powder for injection,TOXIC ENCEPHALOPATHY,1
KISUNLA,2,77,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Solution for infusion,CEREBRAL HAEMORRHAGE,1
KISQALI,2,60,801,BREAST CANCER,ORAL,Tablet,ACUTE KIDNEY INJURY,1
HIZENTRA,2,,,SECONDARY IMMUNODEFICIENCY,,Injection,DEATH,1
WOMENS ROGAINE UNSCENTED,2,,,ALOPECIA,TOPICAL,Cutaneous foam,ALOPECIA,2
VASCEPA,1,76,801,TYPE 2 DIABETES MELLITUS,ORAL,Capsule,POOR QUALITY PRODUCT ADMINISTERED,2
NEXVIAZYME,2,,,GLYCOGEN STORAGE DISEASE TYPE II,INTRAVENOUS,,INFUSION RELATED REACTION,2
AMIODARONE,1,86,801,SUPRAVENTRICULAR TACHYCARDIA,,,HYPOTHYROIDISM,1
DUPIXENT,1,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION,2
HADLIMA,2,63,801,RHEUMATOID ARTHRITIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,INJECTION SITE BRUISING,2
DUPIXENT,1,42,801,ECZEMA,SUBCUTANEOUS,Solution for injection,RASH,2
ALTUVIIIO,1,12,801,FACTOR VIII DEFICIENCY,,Powder and solvent for solution for injection,NASOPHARYNGITIS,2
DUPIXENT,2,49,801,NASAL POLYPS,SUBCUTANEOUS,Solution for injection,PSORIASIS,2
DUPIXENT,2,22,801,,SUBCUTANEOUS,Solution for injection,ACCIDENTAL EXPOSURE TO PRODUCT,2
"COAGULATION FACTOR IX (RECOMBINANT), GLYCOPEGYLATED",1,,,FACTOR IX DEFICIENCY,,Powder and solvent for solution for injection,LIVER FUNCTION TEST ABNORMAL,1
REVLIMID,2,84,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Capsule,PERIPHERAL SWELLING,2
HUMIRA,1,,,ANKYLOSING SPONDYLITIS,,Solution for injection in pre-filled pen,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
XOLAIR PFS,2,64,801,IDIOPATHIC URTICARIA,SUBCUTANEOUS,Solution for injection in pre-filled syringe,PRURITUS,2
TECFIDERA,2,,,MULTIPLE SCLEROSIS,ORAL,Prolonged-release capsule,DRUG INEFFECTIVE,2
CIMZIA,2,56,801,RHEUMATOID ARTHRITIS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,RHEUMATOID ARTHRITIS,1
GLATOPA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,PRODUCT KNOWLEDGE DEFICIT,2
LUPRON,1,60,801,PROSTATE CANCER,,Powder and solvent for suspension for injection in,DEATH,1
AMPICILLIN TRIHYDRATE,2,,,ANTIBIOTIC PROPHYLAXIS,,Unknown,AMNIOTIC CAVITY INFECTION,1
ZURZUVAE,2,22,801,PERINATAL DEPRESSION,ORAL,,TREMOR,2
CORTICOTROPIN,2,64,801,RHEUMATOID ARTHRITIS,,Gel,INJECTION SITE RASH,2
TNKASE,1,,,ISCHAEMIC STROKE,,,VASCULAR ACCESS SITE EXTRAVASATION,2
OPSUMIT,2,,,PULMONARY ARTERIAL HYPERTENSION,ORAL,,RENAL PAIN,1
KOVALTRY,1,62,801,,,Powder and solvent for solution for injection,TRAUMATIC PAIN,1
MOUNJARO,1,54,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,INCORRECT DOSE ADMINISTERED,2
TECVAYLI,2,73,801,PLASMA CELL MYELOMA,SUBCUTANEOUS,Solution for injection,DEATH,1
NEORAL,2,29,801,URTICARIA CHRONIC,ORAL,,GESTATIONAL HYPERTENSION,1
DUPIXENT,2,57,801,ASTHMA,SUBCUTANEOUS,Solution for injection,ASTHMA,2
SERTRALINE,2,28,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Film-coated tablet,GINGIVAL DISORDER,1
LENALIDOMIDE,2,65,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,"Capsule, hard",MUSCULOSKELETAL STIFFNESS,2
TYSABRI,1,,,MULTIPLE SCLEROSIS,INTRAVENOUS,Unknown,MULTIPLE SCLEROSIS RELAPSE,1
CIMZIA,2,31,801,ANKYLOSING SPONDYLITIS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,ANKYLOSING SPONDYLITIS,1
GAMUNEX-C,1,68,801,,,,BLOOD PRESSURE INCREASED,2
TRAMETINIB,2,77,801,LUNG ADENOCARCINOMA,ORAL,Film-coated tablet,PLATELET COUNT DECREASED,1
DUPIXENT,1,75,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
HYDROXYCHLOROQUINE,2,36,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
EMPAGLIFLOZIN\METFORMIN HYDROCHLORIDE,2,66,801,TYPE 2 DIABETES MELLITUS,,,VENTRICULAR EXTRASYSTOLES,1
ORENCIA,2,63,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Solution for injection,DRUG INEFFECTIVE,2
COSENTYX,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,PRODUCT STORAGE ERROR,2
CLOZAPINE,1,30,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,HOSPITALISATION,1
RILPIVIRINE,2,65,801,HIV INFECTION,,Unknown,HEPATITIS B,1
KISQALI,2,,,HORMONE RECEPTOR POSITIVE HER2 NEGATIVE BREAST CANCER,ORAL,Film-coated tablet,NEUTROPENIA,1
OZEMPIC,2,70,801,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,KNEE ARTHROPLASTY,1
VERZENIO,2,64,801,BREAST CANCER FEMALE,ORAL,Tablet,DIARRHOEA,2
DUPIXENT,2,65,801,NEURODERMATITIS,SUBCUTANEOUS,Solution for injection,PRURITUS,2
GENOTROPIN,1,6,801,SHORT STATURE,,Solution for injection,URINARY TRACT INFECTION,1
PANTOPRAZOLE,2,70,801,GASTROOESOPHAGEAL REFLUX DISEASE,ORAL,,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
GOLD BOND MEDICATED ORIGINAL STRENGTH BODY,2,44,801,PRODUCT USED FOR UNKNOWN INDICATION,TOPICAL,,PERITONEAL MESOTHELIOMA MALIGNANT,1
XIFAXAN,1,79,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,DEATH,1
TRIKAFTA,2,0,801,CYSTIC FIBROSIS,,Film-coated tablet,CONGENITAL MULTIPLEX ARTHROGRYPOSIS,1
ELIGARD,1,,,PROSTATE CANCER,SUBCUTANEOUS,Injection,METASTASES TO ABDOMINAL WALL,1
ELIGARD,1,83,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,INTERCEPTED PRODUCT PREPARATION ERROR,2
KETAMINE HYDROCHLORIDE,1,37,801,MAJOR DEPRESSION,INTRAMUSCULAR,,HYPOXIA,1
DUPIXENT,1,82,801,ECZEMA,SUBCUTANEOUS,Solution for injection,MYALGIA,2
DUPIXENT,2,18,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
BASAGLAR,2,82,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Injection,INCORRECT DOSE ADMINISTERED,2
PALFORZIA,2,6,801,FOOD ALLERGY,,Capsule,PROCEDURAL ANXIETY,2
SEVELAMER,1,70,801,END STAGE RENAL DISEASE,,,LARGE INTESTINE POLYP,2
ARANESP,1,,,NEPHROGENIC ANAEMIA,INTRAVENOUS,Solution for injection,PARVOVIRUS INFECTION,1
LEVOFLOXACIN,2,80,801,TONSILLITIS,INTRAVENOUS,,LARYNGEAL OEDEMA,1
NUPLAZID,2,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,LIVING IN RESIDENTIAL INSTITUTION,2
ORENCIA,2,70,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Solution for injection,JOINT SWELLING,2
DUPIXENT,2,51,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PRURITUS,2
DUPIXENT,2,38,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,INCORRECT DOSE ADMINISTERED,2
CLOZAPINE,1,27,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,HOSPITALISATION,1
ZYRTEC,1,,,NASAL CONGESTION,ORAL,Tablet,OVERDOSE,2
ORENCIA,2,45,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Solution for injection,RHEUMATOID ARTHRITIS,2
DUPIXENT,1,8,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,INJECTION SITE URTICARIA,2
VOQUEZNA,2,38,801,,ORAL,Tablet,DRUG INEFFECTIVE,2
LEQEMBI,1,75,801,DEMENTIA ALZHEIMER^S TYPE,INTRAVENOUS,Infusion,INFUSION RELATED REACTION,1
DUPIXENT,1,7,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,PNEUMONIA,1
VEVYE,2,66,801,PRODUCT USED FOR UNKNOWN INDICATION,OPHTHALMIC,"Eye drops, solution",DRUG HYPERSENSITIVITY,2
GENOTROPIN,1,13,801,,,Solution for injection,PRODUCT STORAGE ERROR,2
DUPIXENT,2,67,801,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,SUBCUTANEOUS,Solution for injection,ACCIDENTAL EXPOSURE TO PRODUCT,2
GLATOPA,2,36,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,INJECTION SITE MASS,2
DUPIXENT,2,71,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,PRURITUS,2
LENALIDOMIDE,2,80,801,PLASMA CELL MYELOMA,ORAL,Capsule,HOSPITALISATION,1
REVLIMID,2,67,801,PLASMA CELL MYELOMA,ORAL,Capsule,CYTOMEGALOVIRUS INFECTION,1
DUPIXENT,2,77,801,ASTHMA,SUBCUTANEOUS,Solution for injection,INJECTION SITE PAIN,2
OTEZLA,2,,,PSORIASIS,ORAL,Tablet,THERAPY NON-RESPONDER,2
BELINOSTAT,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,,FEBRILE BONE MARROW APLASIA,1
TEPEZZA,1,47,801,ENDOCRINE OPHTHALMOPATHY,INTRAVENOUS,Solution for injection,ACUTE KIDNEY INJURY,1
DUPIXENT,2,16,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,MENSTRUAL DISORDER,2
COSENTYX,2,,,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,,BELL^S PALSY,1
PROCYSBI,2,5,801,CYSTINOSIS,ORAL,"CAPSULE, DELAYED RELEASE",LABORATORY TEST ABNORMAL,1
SARCLISA,1,71,801,PLASMA CELL MYELOMA,INTRAVENOUS,Concentrate for solution for infusion,HYPOTENSION,1
GENOTROPIN,1,11,801,SHORT STATURE,,Solution for injection,NEEDLE ISSUE,2
VELTASSA,1,76,801,RENIN-ANGIOTENSIN SYSTEM INHIBITION,ORAL,Powder for oral suspension,DEVICE RELATED INFECTION,1
OCREVUS,2,,,RELAPSING-REMITTING MULTIPLE SCLEROSIS,INTRAVENOUS,Solution for infusion,URINARY TRACT INFECTION,2
MOUNJARO,2,43,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INCORRECT DOSE ADMINISTERED,2
OZEMPIC,1,,,,SUBCUTANEOUS,Solution for injection,PROSTATE CANCER,1
XOLAIR,2,,,IDIOPATHIC URTICARIA,SUBCUTANEOUS,Direct auto-injector,ALOPECIA,2
VYVANSE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,INSURANCE ISSUE,2
DUPIXENT,1,89,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,CORONAVIRUS INFECTION,1
DUPIXENT,2,82,801,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,SUBCUTANEOUS,Solution for injection,ACCIDENTAL EXPOSURE TO PRODUCT,2
LANTUS SOLOSTAR,2,,,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,PRODUCT STORAGE ERROR,2
OLUMIANT,2,60,801,ALOPECIA AREATA,ORAL,Tablet,WEIGHT INCREASED,2
TEPEZZA,2,54,801,ENDOCRINE OPHTHALMOPATHY,INTRAVENOUS,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",THERAPY NON-RESPONDER,2
OZEMPIC,2,41,801,ANOREXIA NERVOSA,SUBCUTANEOUS,Solution for injection,TREMOR,1
TRODELVY,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Powder for concentrate for solution for infusion,DISEASE PROGRESSION,1
AIMOVIG,1,54,801,MIGRAINE,SUBCUTANEOUS,,MYOCARDIAL INFARCTION,1
XELJANZ XR,2,67,801,,ORAL,Prolonged-release tablet,CARPAL TUNNEL SYNDROME,1
COSENTYX,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,DRUG INEFFECTIVE,2
VOSEVI,1,39,801,HEPATITIS C,ORAL,Tablet,DRUG RESISTANCE,2
SAFINAMIDE,1,,,PARKINSON^S DISEASE,,Tablet,OXYGEN SATURATION DECREASED,1
ALECENSA,2,76,801,LUNG ADENOCARCINOMA,ORAL,Capsule,NEOPLASM PROGRESSION,1
ACTEMRA ACTPEN,2,,,GIANT CELL ARTERITIS,SUBCUTANEOUS,Direct auto-injector,WHITE BLOOD CELL COUNT DECREASED,2
NUPLAZID,2,,,PARKINSON^S DISEASE,ORAL,Tablet,TRISMUS,2
VELPHORO,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Chewable tablet,DEATH,1
ESCITALOPRAM,2,45,801,DEPRESSION,ORAL,Tablet,SUICIDAL IDEATION,1
OMNITROPE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Unknown,INCORRECT DOSE ADMINISTERED,2
DOXORUBICIN,2,68,801,UTERINE CANCER,INTRAVENOUS,Infusion,CONSTIPATION,1
VYVANSE,1,,,ATTENTION DEFICIT HYPERACTIVITY DISORDER,ORAL,Capsule,INCORRECT DOSE ADMINISTERED,2
COSENTYX,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,DEATH,1
OMNITROPE,1,,,SHORT STATURE,SUBCUTANEOUS,Powder and solvent for solution for injection,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,2
OZEMPIC,2,68,801,,SUBCUTANEOUS,,PRODUCT SUBSTITUTION ISSUE,1
GOLD BOND ORIGINAL STRENGTH,2,,,PRODUCT USED FOR UNKNOWN INDICATION,,Powder,MESOTHELIOMA,1
FENTANYL,1,32,801,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,,DRUG ABUSE,1
PAXLOVID,2,71,801,COVID-19 TREATMENT,,Tablet,COVID-19,2
DUPIXENT,2,45,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,RASH MACULAR,2
HAEMOCOMPLETTAN P,2,,,FACTOR I DEFICIENCY,,Infusion,HEPATITIS C,1
RISPERDAL CONSTA,2,63,801,BIPOLAR DISORDER,,Prolonged-release suspension for injection,HIP FRACTURE,1
SACITUZUMAB GOVITECAN-HZIY,2,,,BREAST CANCER,,Powder for concentrate for solution for infusion,LYMPHADENOPATHY,1
CABOMETYX,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,BLOOD PRESSURE INCREASED,2
CABOMETYX,2,,,HEPATOCELLULAR CARCINOMA,ORAL,Tablet,BLISTER,2
CABOMETYX,2,,,RENAL CANCER,ORAL,Tablet,FLATULENCE,2
ADBRY,1,63,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Injection,INJECTION SITE RASH,2
AYVAKIT,1,43,801,SYSTEMIC MASTOCYTOSIS,ORAL,Unknown,SINUS DISORDER,2
VISMODEGIB,1,,,PROSTATE CANCER,ORAL,,DEATH,1
NUPLAZID,1,82,801,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,DEATH,1
CABOMETYX,1,,,RENAL CANCER,ORAL,Tablet,HAIR COLOUR CHANGES,2
DUPIXENT,2,,,,SUBCUTANEOUS,Solution for injection,ACCIDENTAL EXPOSURE TO PRODUCT,2
WOMENS ROGAINE UNSCENTED,2,75,801,ALOPECIA,TOPICAL,Cutaneous foam,PRODUCT LOT NUMBER ISSUE,2
ERTAPENEM SODIUM,2,68,801,ENTEROBACTER INFECTION,INTRAMUSCULAR,Powder for injection,CONFUSIONAL STATE,1
LUPKYNIS,2,,,LUPUS NEPHRITIS,ORAL,Softgel capsule,PROTEIN URINE PRESENT,2
LUPKYNIS,2,,,LUPUS NEPHRITIS,ORAL,Softgel capsule,THERAPY INTERRUPTED,2
CABOMETYX,1,,,MALIGNANT NEOPLASM OF RENAL PELVIS,ORAL,Tablet,OFF LABEL USE,2
FINTEPLA,2,16,801,EPILEPSY,ORAL,Oral solution,TRICUSPID VALVE INCOMPETENCE,1
PALFORZIA,2,,,FOOD ALLERGY,,Oral powder,ILLNESS,2
ETONOGESTREL,2,29,801,CONTRACEPTION,SUBCUTANEOUS,Implant,PREGNANCY WITH IMPLANT CONTRACEPTIVE,1
NGENLA,2,8,801,,SUBCUTANEOUS,Solution for injection in pre-filled pen,INJECTION SITE PAIN,2
MOUNJARO,2,69,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,DEMENTIA,1
TARCEVA,1,70,801,NON-SMALL CELL LUNG CANCER,ORAL,,FALL,1
BOTOX,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRADERMAL,,FACIAL PARESIS,2
REVLIMID,2,68,801,PLASMA CELL MYELOMA,ORAL,Capsule,FRACTURE,1
COSENTYX,2,,,HIDRADENITIS,SUBCUTANEOUS,,MATERNAL EXPOSURE DURING PREGNANCY,2
GAVRETO,1,,,THYROID CANCER,ORAL,Capsule,BRAIN NEOPLASM,1
LANTUS SOLOSTAR,1,80,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,HEADACHE,2
REVLIMID,1,64,801,PLASMA CELL MYELOMA,ORAL,Capsule,PRODUCT DOSE OMISSION IN ERROR,2
TEDUGLUTIDE,1,29,801,SHORT-BOWEL SYNDROME,SUBCUTANEOUS,Solution for injection,SUICIDAL IDEATION,1
GLASSIA,1,77,801,,,,PULMONARY HYPERTENSION,1
LENALIDOMIDE,1,81,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Capsule,HYPOACUSIS,2
NEULASTA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,INSOMNIA,2
GAMUNEX-C,2,57,801,IMMUNODEFICIENCY COMMON VARIABLE,,Solution for injection,FALL,1
SIMPONI ARIA,2,,,RHEUMATOID ARTHRITIS,INTRAVENOUS,Solution for infusion,HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL,1
VEDOLIZUMAB,1,,,COLITIS ULCERATIVE,SUBCUTANEOUS,Powder for solution for infusion,COLITIS ULCERATIVE,1
CLARAVIS,1,29,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Capsule,DEPRESSION,1
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,HYPERHIDROSIS,2
DUPIXENT,1,54,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ALOPECIA,2
BOTOX,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRADERMAL,,JAW OPERATION,1
DUPIXENT,2,13,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
TALTZ,2,54,801,PSORIASIS,SUBCUTANEOUS,Injection,BREAST CANCER,2
POLATUZUMAB VEDOTIN,2,,,DIFFUSE LARGE B-CELL LYMPHOMA,INTRAVENOUS,,DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT,1
TAMOXIFEN,2,64,801,MESENTERIC PANNICULITIS,,,EMBOLISM VENOUS,1
OXYCONTIN,1,71,801,CANCER PAIN,ORAL,Prolonged-release tablet,HYPOXIA,1
MAYZENT,2,,,MULTIPLE SCLEROSIS,ORAL,,LOWER RESPIRATORY TRACT INFECTION,1
EPKINLY,1,79,801,DIFFUSE LARGE B-CELL LYMPHOMA,SUBCUTANEOUS,Injection,IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME,1
FENTANYL,1,39,801,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,,DRUG ABUSE,1
ALPHAGAN P,2,,,GLAUCOMA,OPHTHALMIC,,MYDRIASIS,2
DEXTROMETHORPHAN HYDROBROMIDE,1,32,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,TOXICITY TO VARIOUS AGENTS,1
INQOVI,2,69,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,CYTOPENIA,1
WOMENS ROGAINE UNSCENTED,2,,,PRODUCT USED FOR UNKNOWN INDICATION,TOPICAL,Cutaneous foam,APPLICATION SITE PRURITUS,2
VEOZAH,2,,,MENOPAUSAL SYMPTOMS,ORAL,Tablet,THERAPEUTIC RESPONSE SHORTENED,2
CABOTEGRAVIR,1,,,PRODUCT USED FOR UNKNOWN INDICATION,,Suspension for injection,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,2
SERTRALINE,2,58,801,DEPRESSION,ORAL,Tablet,ABNORMAL DREAMS,1
EPIDIOLEX,1,,,SEIZURE,ORAL,Oral solution,SEIZURE,1
LEQVIO,2,,,HYPERLIPIDAEMIA,SUBCUTANEOUS,Solution for injection,ALOPECIA,2
MOUNJARO,1,71,801,WEIGHT CONTROL,SUBCUTANEOUS,Solution for injection in cartridge,DYSPNOEA,1
LEVOFLOXACIN,2,26,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,,ANAEMIA,1
PAXLOVID,2,71,801,COVID-19 TREATMENT,,Tablet,COVID-19,2
DUPIXENT,1,31,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
TRESIBA,1,20,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,KETOACIDOSIS,1
REVLIMID,2,79,801,MYELODYSPLASTIC SYNDROME,ORAL,Capsule,DIARRHOEA,2
DUPIXENT,1,34,801,DERMATITIS,SUBCUTANEOUS,Solution for injection,RASH ERYTHEMATOUS,2
DUPIXENT,2,67,801,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,SUBCUTANEOUS,Solution for injection,INJECTION SITE DISCOMFORT,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION,2
QUTENZA,1,,,DIABETIC NEUROPATHY,,Cutaneous patch,FEELING COLD,2
DUPIXENT,2,,,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,2
VOQUEZNA,2,55,801,GASTROOESOPHAGEAL REFLUX DISEASE,ORAL,Tablet,GASTROOESOPHAGEAL REFLUX DISEASE,2
LOSARTAN,1,57,801,HYPERTENSION,ORAL,Film-coated tablet,ABNORMAL WEIGHT GAIN,1
MOUNJARO,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INJECTION SITE PAIN,2
STIVARGA,2,70,801,COLORECTAL CANCER,ORAL,Film-coated tablet,COUGH,1
SUTAB,2,27,801,COLONOSCOPY,ORAL,Tablet,HYPERSENSITIVITY,1
DUPIXENT,1,81,801,NEURODERMATITIS,SUBCUTANEOUS,Solution for injection,INJECTION SITE BRUISING,2
FENTANYL,2,36,801,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,,DRUG ABUSE,1
DUPIXENT,2,52,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,INJECTION SITE RASH,2
XIIDRA,2,71,801,PRODUCT USED FOR UNKNOWN INDICATION,OPHTHALMIC,"Eye drops, solution",DRUG INEFFECTIVE,2
TARPEYO,2,65,801,IGA NEPHROPATHY,ORAL,Prolonged-release capsule,COVID-19,2
VERZENIO,2,49,801,BREAST CANCER,ORAL,Tablet,VERTIGO,2
LINAGLIPTIN,2,81,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,DERMATITIS BULLOUS,1
DEPO-PROVERA,2,48,801,,INTRAMUSCULAR,Suspension for injection,BONE DENSITY DECREASED,1
BESREMI,1,35,801,POLYCYTHAEMIA VERA,SUBCUTANEOUS,Prefilled Pen,ERECTILE DYSFUNCTION,1
MOUNJARO,2,58,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,INCORRECT DOSE ADMINISTERED,2
VEDOLIZUMAB,2,92,801,COLITIS ULCERATIVE,SUBCUTANEOUS,Solution for injection,MALAISE,1
SEVELAMER,1,37,801,ACUTE KIDNEY INJURY,,,MELAENA,1
ADSTILADRIN,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVESICAL,Intravesical suspension,THERAPEUTIC PRODUCT EFFECT INCOMPLETE,2
DUPIXENT,2,33,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,VIRAL INFECTION,2
ADSTILADRIN,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVESICAL,Intravesical suspension,DYSURIA,2
HUMIRA,2,,,COLITIS ULCERATIVE,,,MALAISE,2
DUPIXENT,2,,,,SUBCUTANEOUS,Solution for injection,ACCIDENTAL EXPOSURE TO PRODUCT,2
DUPIXENT,1,,,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,DIARRHOEA,2
CLOZAPINE,1,34,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,PRODUCT DOSE OMISSION ISSUE,2
TRODELVY,2,47,801,BREAST CANCER METASTATIC,INTRAVENOUS,Powder for concentrate for solution for infusion,HEPATIC CYTOLYSIS,1
OMEGA-3-ACID ETHYL ESTER,2,65,801,BLOOD TRIGLYCERIDES INCREASED,ORAL,Capsule,HEADACHE,2
METHYLPREDNISOLONE ACETATE,1,,,APLASTIC ANAEMIA,INTRA-ARTICULAR,,FEBRILE NEUTROPENIA,1
HUMIRA,2,81,801,CROHN^S DISEASE,,Injection,DEATH,1
ORENCIA,2,86,801,PSORIATIC ARTHROPATHY,INTRAVENOUS,Injection,ASTHMA,2
REVLIMID,1,62,801,PLASMA CELL MYELOMA,ORAL,Capsule,PRODUCT DOSE OMISSION ISSUE,2
SIMPONI,1,73,801,ANKYLOSING SPONDYLITIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,PNEUMONIA,1
DUPIXENT,1,46,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
FINASTERIDE,1,33,801,ALOPECIA,ORAL,,ERECTILE DYSFUNCTION,1
VASCEPA,2,72,801,DYSLIPIDAEMIA,ORAL,Capsule,OFF LABEL USE,2
METHOTREXATE SODIUM,2,61,801,CROHN^S DISEASE,INTRA-ARTERIAL,,HEPATIC CIRRHOSIS,1
PARAGARD T 380A,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAUTERINE,Intrauterine,DEVICE BREAKAGE,1
PARAGARD T 380A,2,40,801,CONTRACEPTION,INTRAUTERINE,Intrauterine,COMPLICATION OF DEVICE INSERTION,2
PARAGARD T 380A,2,20,801,CONTRACEPTION,INTRAUTERINE,Intrauterine,COMPLICATION OF DEVICE INSERTION,2
DUPIXENT,2,60,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DRY EYE,2
HUMIRA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,,,NEPHROLITHIASIS,1
DUPIXENT,1,60,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ARTHRALGIA,2
ELMIRON,2,,,CYSTITIS INTERSTITIAL,ORAL,"Capsule, hard",VISUAL IMPAIRMENT,2
AVASTIN,1,80,801,NON-SMALL CELL LUNG CANCER,INTRAVENOUS,,NON-SMALL CELL LUNG CANCER,1
ELIGARD,1,,,PROSTATE CANCER,SUBCUTANEOUS,Injection,URINARY TRACT INFECTION,2
RITUXIMAB,1,10,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,,DRUG HYPERSENSITIVITY,2
XEMBIFY,2,75,801,IMMUNODEFICIENCY COMMON VARIABLE,,,INFUSION SITE PAIN,1
DUPIXENT,1,49,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS EXFOLIATIVE GENERALISED,1
NEULASTA,2,76,801,PANCREATIC CARCINOMA,SUBCUTANEOUS,Solution for injection,DEVICE OCCLUSION,2
LENALIDOMIDE,2,78,801,PLASMA CELL MYELOMA IN REMISSION,ORAL,Capsule,DIARRHOEA,2
DUPIXENT,1,30,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,2,,,ECZEMA INFANTILE,SUBCUTANEOUS,Solution for injection,SINUSITIS,2
SCEMBLIX,2,,,CHRONIC MYELOID LEUKAEMIA,ORAL,,DEATH,2
DUPIXENT,1,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
VEOZAH,2,62,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,INSOMNIA,2
LEQEMBI,1,75,801,DEMENTIA ALZHEIMER^S TYPE,INTRAVENOUS,Infusion,CATARACT,1
PULMOZYME,2,4,801,PRODUCT USED FOR UNKNOWN INDICATION,RESPIRATORY (INHALATION),,DEATH,1
CIMZIA,2,29,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Solution for injection in pre-filled syringe,PSORIATIC ARTHROPATHY,1
LEQVIO,1,72,801,BLOOD CHOLESTEROL ABNORMAL,SUBCUTANEOUS,,ARTHRALGIA,1
SOLUPREP,1,50,801,PREOPERATIVE CARE,,,SKIN IRRITATION,1
TREPROSTINIL SODIUM,1,,,PULMONARY ARTERIAL HYPERTENSION,,,UNRESPONSIVE TO STIMULI,1
HIZENTRA,1,69,801,PRIMARY IMMUNODEFICIENCY SYNDROME,,Injection,INFUSION SITE NODULE,2
GLASSIA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,,Solution for infusion,NO ADVERSE EVENT,2
ORENCIA,2,59,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Solution for injection,JOINT SWELLING,2
RILPIVIRINE,2,61,801,PRODUCT USED FOR UNKNOWN INDICATION,,Prolonged-release suspension for injection,PRODUCT DOSE OMISSION ISSUE,2
IDHIFA,1,58,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,PANNICULITIS,1
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
"DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE",2,,,PRODUCT USED FOR UNKNOWN INDICATION,,Extended-Release Capsules,ABDOMINAL DISCOMFORT,2
CARBIDOPA\LEVODOPA,1,67,801,PARKINSON^S DISEASE,,Intestinal gel,STAPHYLOCOCCUS TEST POSITIVE,1
DUPIXENT,1,85,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,2,74,801,ASTHMA,SUBCUTANEOUS,Solution for injection,ASTHMA,2
LANTUS SOLOSTAR,2,19,801,TYPE 1 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
DUPIXENT,1,19,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,THROAT IRRITATION,2
OCREVUS,2,58,801,MULTIPLE SCLEROSIS,INTRAVENOUS,Infusion,DRUG ERUPTION,2
OCREVUS,2,62,801,RELAPSING-REMITTING MULTIPLE SCLEROSIS,INTRAVENOUS,,CHEST DISCOMFORT,2
DAYVIGO,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Film-coated tablet,DRUG INEFFECTIVE,2
JARDIANCE,1,56,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,DIABETIC KETOACIDOSIS,1
NEXPLANON,2,19,801,CONTRACEPTION,SUBCUTANEOUS,Implant,MENOMETRORRHAGIA,1
RISANKIZUMAB,2,,,PSORIASIS,,Solution for injection,CLUSTER HEADACHE,1
MVASI,1,55,801,COLON CANCER,INTRAVENOUS,Solution for injection,HYPOKALAEMIA,1
DUPIXENT,1,49,801,DERMATITIS ALLERGIC,SUBCUTANEOUS,Solution for injection,INJECTION SITE SWELLING,2
COMETRIQ,1,,,MALIGNANT MELANOMA,ORAL,Capsule,OFF LABEL USE,2
CABOMETYX,2,,,RENAL CANCER,ORAL,Tablet,BLOOD PRESSURE INCREASED,2
CABOMETYX,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE REACTION,2
CABOMETYX,2,,,RENAL CANCER,ORAL,Tablet,TOOTH DISORDER,2
CABOMETYX,1,69,801,RENAL CELL CARCINOMA,ORAL,Tablet,MALIGNANT NEOPLASM PROGRESSION,1
CABOMETYX,1,,,RENAL CANCER,ORAL,Tablet,MALIGNANT NEOPLASM PROGRESSION,1
CABOMETYX,1,72,801,HEPATOCELLULAR CARCINOMA,ORAL,Tablet,MALIGNANT NEOPLASM PROGRESSION,1
CABOTEGRAVIR,1,27,801,PRODUCT USED FOR UNKNOWN INDICATION,,Suspension for injection,PRODUCT DOSE OMISSION ISSUE,2
OCREVUS,2,51,801,RELAPSING-REMITTING MULTIPLE SCLEROSIS,INTRAVENOUS,Solution for infusion,INFLUENZA,2
SIMPONI,1,66,801,ANKYLOSING SPONDYLITIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,PROSTATIC OPERATION,1
ABRILADA,2,65,801,CROHN^S DISEASE,,Solution for injection in pre-filled pen,ILEOSTOMY,1
MIRENA,2,31,801,CONTRACEPTION,INTRAUTERINE,Intrauterine delivery system,DEVICE EXPULSION,2
PARAGARD T 380A,2,33,801,,INTRAUTERINE,Intrauterine,REPRODUCTIVE COMPLICATION ASSOCIATED WITH DEVICE,1
DUPIXENT,1,61,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
HUMIRA,2,49,801,,,,SKIN CANCER,1
FINASTERIDE,1,,,ALOPECIA,ORAL,Tablet,HEADACHE,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,SUICIDAL IDEATION,1
ACARBOSE,1,38,801,TYPE 2 DIABETES MELLITUS,ORAL,Unknown,DIABETIC KETOSIS,1
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,MENTAL DISORDER,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
LAMPRENE,1,68,801,MYCOBACTERIUM AVIUM COMPLEX INFECTION,,Capsule,PNEUMOTHORAX,1
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
DUPIXENT,2,53,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,JOINT DISLOCATION,1
TRIUMEQ,1,2,801,HIV INFECTION,ORAL,Dispersible tablet,PRODUCT STORAGE ERROR,2
NUPLAZID,1,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,DEMENTIA,1
COSENTYX,2,56,801,HIDRADENITIS,SUBCUTANEOUS,,IMMUNODEFICIENCY,1
SUGAMMADEX,2,,,,INTRAVENOUS,,BRONCHOSPASM,1
ISONIAZID,2,39,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,ACUTE HEPATIC FAILURE,1
CLOZAPINE,1,48,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,HOSPITALISATION,1
DUPIXENT,2,73,801,PSORIASIS,SUBCUTANEOUS,Solution for injection,RASH ERYTHEMATOUS,2
CAPLYTA,1,25,801,BIPOLAR II DISORDER,ORAL,Capsule,MIGRAINE,2
CAPLYTA,2,53,801,BIPOLAR DISORDER,ORAL,Capsule,TONGUE DISCOMFORT,2
MEKINIST,2,54,801,OVARIAN CANCER,ORAL,,TREMOR,1
OCREVUS,2,,,RELAPSING-REMITTING MULTIPLE SCLEROSIS,INTRAVENOUS,Solution for infusion,RESPIRATORY SYNCYTIAL VIRUS INFECTION,2
DUPIXENT,2,51,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PRURITUS,2
OXALIPLATIN,1,44,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Unknown,SWELLING,1
XTANDI,1,9,800,PROSTATE CANCER,ORAL,Tablet,COVID-19,1
DIOVAN,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,KELOID SCAR,2
XOLAIR,2,62,801,URTICARIA,SUBCUTANEOUS,,URTICARIA,2
BENLYSTA,2,52,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,PRODUCT DOSE OMISSION ISSUE,2
KESIMPTA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,PRODUCT STORAGE ERROR,2
CARBIDOPA\LEVODOPA,2,,,PARKINSON^S DISEASE,,"Modified-release capsule, hard",PRURITUS,2
ELIGARD,1,81,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,INTERCEPTED PRODUCT PREPARATION ERROR,2
SIMLANDI,2,49,801,MYOSITIS,SUBCUTANEOUS,Solution,SKIN CANCER,1
REVLIMID,2,79,801,PLASMA CELL MYELOMA,ORAL,Capsule,ALOPECIA,2
CABOMETYX,1,,,CARCINOID TUMOUR,ORAL,Tablet,ABDOMINAL DISCOMFORT,2
CABOMETYX,1,,,RENAL CANCER,ORAL,Tablet,BLOOD PRESSURE INCREASED,2
FABRAZYME,2,,,FABRY^S DISEASE,INTRAVENOUS,Powder for concentrate for solution for infusion,ALOPECIA,2
USTEKINUMAB,2,43,801,PSORIASIS,SUBCUTANEOUS,Solution for injection,CEREBROVASCULAR ACCIDENT,1
ARANESP,2,60,801,IRON DEFICIENCY ANAEMIA,INTRAVENOUS,,PNEUMONIA,1
AYVAKIT,1,48,801,MALIGNANT CONNECTIVE TISSUE NEOPLASM,ORAL,Tablet,SPINAL OPERATION,1
RUXIENCE,2,78,801,PEMPHIGUS,INTRAVENOUS,Solution for infusion,HYSTERECTOMY,1
SLYND,2,,,CONTRACEPTION,,Tablet,AMENORRHOEA,2
XOLAIR,2,12,801,IDIOPATHIC URTICARIA,SUBCUTANEOUS,Direct auto-injector,OFF LABEL USE,2
LEQEMBI,2,78,801,COGNITIVE DISORDER,INTRAVENOUS,Infusion,AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS,1
BOTOX,2,73,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRADERMAL,,HYPOTENSION,2
CIMZIA,2,,,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,NEPHROLITHIASIS,1
MOUNJARO,1,73,801,WEIGHT CONTROL,SUBCUTANEOUS,Solution for injection in pre-filled pen,OFF LABEL USE,2
NUPLAZID,2,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,SPINAL CORD DISORDER,1
SAXENDA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,PANCREATITIS,1
RECLAST,2,72,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Unknown,MUSCULOSKELETAL STIFFNESS,2
DUPIXENT,1,69,801,ECZEMA,SUBCUTANEOUS,Solution for injection,RENAL DISORDER,1
DUPIXENT,2,35,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,2
DUPIXENT,1,56,801,NEURODERMATITIS,SUBCUTANEOUS,Solution for injection,HAIR COLOUR CHANGES,2
DUPIXENT,2,21,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ARTHRALGIA,2
DUPIXENT,2,48,801,,SUBCUTANEOUS,Solution for injection,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
CARAFATE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,ENDOMETRIOSIS,2
BENLYSTA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,PRODUCT DOSE OMISSION ISSUE,2
TARPEYO,1,40,801,IGA NEPHROPATHY,ORAL,Prolonged-release capsule,RASH MACULAR,2
VELSIPITY,2,52,801,,ORAL,Film-coated tablet,DRUG INEFFECTIVE,2
DUPIXENT,1,33,801,DERMATITIS,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
LANTUS SOLOSTAR,1,70,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,BLOOD GLUCOSE INCREASED,2
CLOZARIL,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,LUNG NEOPLASM MALIGNANT,1
PREDNISOLONE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,DEATH,1
COSENTYX,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,PRODUCT DOSE OMISSION ISSUE,2
OMALIZUMAB,2,16,801,CHRONIC SPONTANEOUS URTICARIA,SUBCUTANEOUS,,ANAEMIA,1
OTEZLA,2,,,PSORIASIS,ORAL,Tablet,TREATMENT FAILURE,2
INVEGA TRINZA,1,47,801,SCHIZOPHRENIA,INTRAMUSCULAR,Suspension for injection,SCHIZOPHRENIA,1
DOTAREM,1,51,801,MAGNETIC RESONANCE IMAGING,INTRAVENOUS,Solution for injection,PALLOR,1
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,WEIGHT INCREASED,2
DUPIXENT,2,18,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DIOVAN,2,66,801,BLOOD PRESSURE DECREASED,ORAL,"Capsule, hard",GASTRITIS HAEMORRHAGIC,1
XOLAIR,2,66,801,URTICARIA,SUBCUTANEOUS,,PRURITUS,2
ETONOGESTREL,2,,,CONTRACEPTION,SUBCUTANEOUS,Implant,HEAVY MENSTRUAL BLEEDING,1
LENALIDOMIDE,2,73,801,PLASMA CELL MYELOMA,ORAL,Capsule,RASH,2
TYSABRI,2,,,MULTIPLE SCLEROSIS,INTRAVENOUS,Concentrate for solution for infusion,CELLULITIS,1
IMIGLUCERASE,2,20,801,GAUCHER^S DISEASE TYPE III,INTRAVENOUS,Powder for concentrate for solution for infusion,ARTHRALGIA,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ACCIDENTAL EXPOSURE TO PRODUCT,2
XELJANZ XR,2,38,801,,ORAL,Prolonged-release tablet,ANXIETY,2
REVLIMID,2,74,801,PLASMACYTOSIS,ORAL,Capsule,PLATELET COUNT DECREASED,2
DUPIXENT,2,18,801,DERMATITIS,SUBCUTANEOUS,Solution for injection,MENSTRUAL DISORDER,2
ELIGARD,1,73,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
GENOTROPIN,1,11,801,BLOOD GROWTH HORMONE ABNORMAL,,Solution for injection,DRUG DOSE OMISSION BY DEVICE,2
CABOMETYX,2,,,RENAL CANCER,ORAL,Tablet,HYPOACUSIS,2
CABOMETYX,1,,,RENAL CANCER,ORAL,Tablet,ABDOMINAL DISCOMFORT,2
KISQALI,2,,,BREAST CANCER METASTATIC,ORAL,,DEATH,1
CABOMETYX,1,6,800,HEPATOCELLULAR CARCINOMA,ORAL,Tablet,PROTEINURIA,2
TEPEZZA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Unknown formulation,EYE DISORDER,2
MEKINIST,2,14,801,BRAIN NEOPLASM MALIGNANT,ORAL,,RASH,2
KESIMPTA,2,59,801,RELAPSING-REMITTING MULTIPLE SCLEROSIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,LOWER RESPIRATORY TRACT INFECTION,1
HUMIRA,1,,,RHEUMATOID ARTHRITIS,,,DEMENTIA,2
DUPIXENT,2,52,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,2,77,801,NEURODERMATITIS,SUBCUTANEOUS,Solution for injection,NEURODERMATITIS,2
TIVDAK,2,63,801,,INTRAVENOUS,Powder for solution for injection,DEATH,1
METHOTREXATE SODIUM,2,78,801,,INTRA-ARTERIAL,,GAIT INABILITY,2
ANAVIP,1,89,801,SNAKE BITE,,,PRURITUS,1
LUPKYNIS,2,,,LUPUS NEPHRITIS,ORAL,Softgel capsule,SWELLING,2
LUPKYNIS,2,,,LUPUS NEPHRITIS,ORAL,Softgel capsule,ANAEMIA,1
LUPKYNIS,1,,,LUPUS NEPHRITIS,ORAL,Softgel capsule,THERAPY INTERRUPTED,2
LUPKYNIS,2,,,LUPUS NEPHRITIS,ORAL,Softgel capsule,PALPITATIONS,2
CABOMETYX,2,,,PANCREATIC CARCINOMA,ORAL,Tablet,FLUID RETENTION,2
VERZENIO,2,59,801,BREAST CANCER FEMALE,ORAL,Tablet,DIARRHOEA,2
CABOMETYX,1,58,801,RENAL CELL CARCINOMA,ORAL,Tablet,RENAL CELL CARCINOMA,1
CABOMETYX,1,81,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
CABOMETYX,1,59,801,RENAL CELL CARCINOMA,ORAL,Tablet,PRODUCT DOSE OMISSION ISSUE,2
CLOZAPINE,2,16,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,FULL BLOOD COUNT INCREASED,2
SERTRALINE,1,27,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,ERECTILE DYSFUNCTION,1
ABILIFY MAINTENA,2,,,SCHIZOPHRENIA,,Suspension for injection,WEIGHT INCREASED,2
LENALIDOMIDE,1,72,801,PLASMA CELL MYELOMA,ORAL,Capsule,GOUT,2
VERZENIO,2,56,801,MENOPAUSAL DISORDER,ORAL,Tablet,OFF LABEL USE,2
KESIMPTA,2,,,RELAPSING-REMITTING MULTIPLE SCLEROSIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,KIDNEY INFECTION,1
VYZULTA,1,50,801,PRODUCT USED FOR UNKNOWN INDICATION,OPHTHALMIC,"Eye drops, solution",CORNEAL IRRITATION,1
JAVYGTOR,1,,,PHENYLKETONURIA,ORAL,Tablet,ACNE,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ANXIETY,2
SERTRALINE,2,26,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Film-coated tablet,URINARY RETENTION,1
LEVOFLOXACIN,2,,,URINARY TRACT INFECTION,INTRAVENOUS,,FEELING HOT,1
MIRENA,2,38,801,HEAVY MENSTRUAL BLEEDING,INTRAUTERINE,Intrauterine delivery system,DEVICE EXPULSION,2
CAPLYTA,2,,,BIPOLAR DISORDER,ORAL,Capsule,TARDIVE DYSKINESIA,1
IDECABTAGENE VICLEUCEL,1,,,PLASMA CELL MYELOMA REFRACTORY,INTRAVENOUS,Injection for infusion,ANAEMIA,1
VERZENIO,2,40,801,BREAST CANCER FEMALE,ORAL,Tablet,RECTAL HAEMORRHAGE,2
DUPIXENT,2,36,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PRURITUS,2
TYLENOL 8 HR ARTHRITIS PAIN,2,74,801,PAIN,ORAL,Tablet,DIZZINESS,2
SAXENDA,2,28,801,WEIGHT CONTROL,SUBCUTANEOUS,Solution for injection,ABORTION SPONTANEOUS,1
PLUVICTO,1,68,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Solution for injection/infusion,ABDOMINAL PAIN,1
POLIVY,2,62,801,DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV,INTRAVENOUS,Infusion,NEOPLASM MALIGNANT,1
AUSTEDO,1,76,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,DEATH,1
HUMIRA,1,62,801,RHEUMATOID ARTHRITIS,,Solution for injection in pre-filled pen,KNEE ARTHROPLASTY,1
DUVYZAT,1,,,DUCHENNE MUSCULAR DYSTROPHY,ORAL,,ABDOMINAL PAIN,2
IMBRUVICA,2,75,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Capsule,LIVING IN RESIDENTIAL INSTITUTION,1
DUPIXENT,2,41,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ALOPECIA,2
PANTOPRAZOLE,2,,,GASTRIC HAEMORRHAGE,ORAL,,GASTRIC HAEMORRHAGE,1
FEZOLINETANT,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,2
TAXOTERE,2,,,,,Concentrate for solution for infusion,LACRIMATION INCREASED,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,1,23,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,VISION BLURRED,2
DUPIXENT,2,37,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,1,76,801,ASTHMA,SUBCUTANEOUS,Solution for injection,ASTHMA,2
VYALEV,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Injection,INFUSION SITE CELLULITIS,1
VENCLEXTA,2,77,801,MYELODYSPLASTIC SYNDROME,ORAL,Tablet,HOSPICE CARE,1
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
DUPIXENT,2,55,801,,SUBCUTANEOUS,Solution for injection,INJECTION SITE ERYTHEMA,2
TRIKAFTA,1,,,CYSTIC FIBROSIS,,Film-coated tablet,HOSPITALISATION,1
VENLAFAXINE,2,20,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,HAEMATOMA,1
DUPIXENT,2,23,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,2
DUPIXENT,1,,,ECZEMA,SUBCUTANEOUS,Solution for injection,ECZEMA,2
TRODELVY,2,28,801,METASTASES TO LUNG,INTRAVENOUS,Powder for concentrate for solution for infusion,DISEASE PROGRESSION,1
ACTEMRA ACTPEN,2,74,801,RHEUMATOID ARTHRITIS,SUBCUTANEOUS,Direct auto-injector,HEADACHE,2
BASAGLAR,1,74,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Injection,ACCIDENTAL UNDERDOSE,2
MOUNJARO,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,NAUSEA,2
PAXLOVID,1,70,801,COVID-19 TREATMENT,,Tablet,PRODUCT QUALITY ISSUE,2
FINGOLIMOD,2,,,RELAPSING MULTIPLE SCLEROSIS,ORAL,,RELAPSING MULTIPLE SCLEROSIS,1
LANTUS SOLOSTAR,1,,,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,OCULAR HYPERAEMIA,2
VYLEESI,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Injection,NAUSEA,2
ATOGEPANT,2,,,MIGRAINE PROPHYLAXIS,ORAL,,CONSTIPATION,2
REVLIMID,1,35,801,PLASMA CELL MYELOMA,ORAL,Capsule,CONTUSION,2
METHOTREXATE SODIUM,2,75,801,RHEUMATOID ARTHRITIS,INTRA-ARTERIAL,,RETINAL ARTERY STENOSIS,1
HUMIRA,2,,,CROHN^S DISEASE,,Solution for injection in pre-filled pen,CYST,1
FENTANYL,1,37,801,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,,DRUG ABUSE,1
EPIDIOLEX,2,,,IDIOPATHIC GENERALISED EPILEPSY,ORAL,Oral solution,HOSPITALISATION,1
FENTANYL,1,42,801,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,,DRUG ABUSE,1
TECENTRIQ,1,67,801,HEPATOCELLULAR CARCINOMA,INTRAVENOUS,Infusion,DISEASE PROGRESSION,1
OTEZLA,2,54,801,PSORIATIC ARTHROPATHY,ORAL,Tablet,PSORIATIC ARTHROPATHY,1
OZEMPIC,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,COVID-19,1
ZYVOX,2,89,801,PNEUMONIA,INTRAVENOUS,Film-coated tablet,DELIRIUM,1
XIFAXAN,1,70,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,DEATH,1
XOLAIR,2,,,ASTHMA,SUBCUTANEOUS,Direct auto-injector,DEATH,1
HUMIRA,2,74,801,RHEUMATOID ARTHRITIS,,,DEATH,1
CARBIDOPA\LEVODOPA,1,74,801,PARKINSON^S DISEASE,,Intestinal gel,FEMORAL NECK FRACTURE,1
VENCLEXTA,1,83,801,CHRONIC LYMPHOCYTIC LEUKAEMIA,ORAL,Tablet,CARDIAC PACEMAKER INSERTION,1
FEZOLINETANT,2,,,GYNAECOLOGICAL EXAMINATION,ORAL,Tablet,OFF LABEL USE,2
SUTAB,1,,,COLONOSCOPY,ORAL,Tablet,VOMITING,2
OTEZLA,2,,,PSORIATIC ARTHROPATHY,ORAL,Tablet,ARTHRALGIA,2
IMATINIB,1,55,801,GASTROINTESTINAL STROMAL TUMOUR,ORAL,Film-coated tablet,MALIGNANT NEOPLASM PROGRESSION,1
METFORMIN,1,74,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,ADVERSE DRUG REACTION,1
BUPRENORPHINE\NALOXONE,1,29,801,PRODUCT USED FOR UNKNOWN INDICATION,,,DRUG ABUSE,1
DULOXETINE HYDROCHLORIDE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Capsule,DRUG INTOLERANCE,2
GENOTROPIN,1,7,801,SHORT STATURE,,Solution for injection,DEVICE LEAKAGE,2
SKYCLARYS,2,,,FRIEDREICH^S ATAXIA,ORAL,Capsule,CONFUSIONAL STATE,2
VERZENIO,2,48,801,BREAST CANCER FEMALE,ORAL,Tablet,MOUTH ULCERATION,2
DUPIXENT,1,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ALOPECIA,2
AGALSIDASE BETA,2,32,801,FABRY^S DISEASE,INTRAVENOUS,Powder for concentrate for solution for infusion,BRAIN OEDEMA,1
DUPIXENT,2,60,801,NASAL POLYPS,SUBCUTANEOUS,Solution for injection,INFLUENZA,2
BENLYSTA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Powder for solution for infusion,MALAISE,2
DUPIXENT,2,47,801,ASTHMA,SUBCUTANEOUS,Solution for injection,LICHEN PLANUS,1
DUPIXENT,1,50,801,DERMATITIS ALLERGIC,SUBCUTANEOUS,Solution for injection,LOCALISED INFECTION,1
JAKAFI,1,68,801,,ORAL,,MALAISE,2
MIRTAZAPINE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,HYPERHIDROSIS,1
REVLIMID,1,87,801,MYELODYSPLASTIC SYNDROME,ORAL,,COVID-19,2
DUPIXENT,2,55,801,URTICARIA,SUBCUTANEOUS,Solution for injection,URTICARIA,2
AUSTEDO,1,65,801,DYSKINESIA,ORAL,Tablet,PRODUCT USE IN UNAPPROVED INDICATION,2
ELIGARD,1,71,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,INTERCEPTED PRODUCT PREPARATION ERROR,2
NUPLAZID,1,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,HALLUCINATION,1
LANTUS,2,72,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
VENETOCLAX,1,100,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,DEATH,1
CLOZAPINE,1,67,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,NEUTROPENIA,1
TRAVOPROST,2,81,801,GLAUCOMA,OPHTHALMIC,"Eye drops, solution",EYE IRRITATION,2
LISDEXAMFETAMINE DIMESYLATE,2,,,ATTENTION DEFICIT HYPERACTIVITY DISORDER,ORAL,Capsule,ADVERSE EVENT,2
MARIBAVIR,2,,,CYTOMEGALOVIRUS INFECTION,ORAL,Tablet,LEUKOPENIA,1
ELIGARD,1,70,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,CEREBROVASCULAR ACCIDENT,1
TAVNEOS,2,37,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,"Capsule, hard",BLOOD CREATININE INCREASED,1
BELSOMRA,2,62,801,INSOMNIA,ORAL,Tablet,DRUG INEFFECTIVE,2
PARAGARD T 380A,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAUTERINE,Intrauterine,MENSTRUATION IRREGULAR,2
PARAGARD T 380A,2,28,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAUTERINE,Intrauterine,COMPLICATION OF DEVICE INSERTION,2
PARAGARD T 380A,2,45,801,CONTRACEPTION,INTRAUTERINE,Intrauterine,DEVICE BREAKAGE,1
ELIGARD,1,,,PROSTATE CANCER,SUBCUTANEOUS,Injection,FATIGUE,2
BASAGLAR,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Injection,ACCIDENTAL UNDERDOSE,2
CLOZAPINE,1,28,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,IMPRISONMENT,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,ADVERSE EVENT,2
FLONASE SENSIMIST ALLERGY RELIEF,2,,,HYPERSENSITIVITY,NASAL,SPRAY,DRUG EFFECT LESS THAN EXPECTED,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,ADVERSE EVENT,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,ADVERSE EVENT,2
DUPIXENT,2,15,801,ASTHMA,SUBCUTANEOUS,Solution for injection,DYSPNOEA,2
DUPIXENT,2,66,801,NASAL POLYPS,SUBCUTANEOUS,Solution for injection,DRUG INEFFECTIVE,2
CLOZARIL,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,THERAPY INTERRUPTED,1
SOMATROPIN,2,,,,SUBCUTANEOUS,,MUSCLE DISORDER,1
ORENCIA,2,64,801,CONSTIPATION,INTRAVENOUS,Solution for injection,HEADACHE,2
CLOZAPINE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,METABOLIC SYNDROME,2
ELIGARD,1,75,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,INTERCEPTED PRODUCT PREPARATION ERROR,2
XULTOPHY 100/3.6,1,82,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,EATING DISORDER,1
VENCLEXTA,1,,,CHRONIC LYMPHOCYTIC LEUKAEMIA,ORAL,,CARDIAC HYPERTROPHY,2
IBRUTINIB,2,62,801,MANTLE CELL LYMPHOMA,ORAL,Capsule,DISEASE PROGRESSION,1
EPIDIOLEX,1,,,LENNOX-GASTAUT SYNDROME,ORAL,Oral solution,HOSPITALISATION,1
OXALIPLATIN,2,72,801,ADENOCARCINOMA OF COLON,INTRAVENOUS,,DIARRHOEA,1
MOUNJARO,1,52,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,EYE INFECTION FUNGAL,2
DUPIXENT,2,12,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ALOPECIA,2
CLOZAPINE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,THERAPY INTERRUPTED,2
IMATINIB,1,68,801,GASTROINTESTINAL STROMAL TUMOUR,ORAL,,INTERSTITIAL LUNG DISEASE,1
MOUNJARO,2,60,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,DIARRHOEA,2
XELJANZ XR,2,59,801,PSORIATIC ARTHROPATHY,ORAL,Prolonged-release tablet,BASAL CELL CARCINOMA,1
XOLAIR,2,,,ASTHMA,SUBCUTANEOUS,Solution for injection in pre-filled syringe,BONE CANCER,1
ATEZOLIZUMAB,1,,,HEPATOCELLULAR CARCINOMA,INTRAVENOUS,,DEATH,1
DUPIXENT,2,57,801,NEURODERMATITIS,SUBCUTANEOUS,Solution for injection,DRY MOUTH,2
VOQUEZNA,1,50,801,,ORAL,Tablet,DRUG INEFFECTIVE,2
CARBIDOPA\LEVODOPA,1,64,801,PARKINSON^S DISEASE,,Solution for infusion,LOSS OF CONSCIOUSNESS,1
DUPILUMAB,1,82,801,IMMUNOSUPPRESSION,SUBCUTANEOUS,Solution for injection,SKIN LESION,1
TALTZ,2,8,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled syringe,INTERCEPTED PRODUCT DISPENSING ERROR,2
CYCLOSPORINE,1,,,DRY EYE,ORAL,,EYE IRRITATION,2
AVONEX,1,,,MULTIPLE SCLEROSIS,INTRAMUSCULAR,Solution for injection in pre-filled pen,NERVOUSNESS,2
CABOMETYX,2,,,RENAL CANCER,ORAL,Tablet,NEUROPATHY PERIPHERAL,1
DUPIXENT,2,8,801,ECZEMA,SUBCUTANEOUS,Solution for injection,FATIGUE,2
DUPIXENT,2,61,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ACCIDENTAL EXPOSURE TO PRODUCT,2
DUPIXENT,1,2,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,RASH,2
ADVATE,1,16,801,FACTOR VIII DEFICIENCY,,Powder and solvent for solution for infusion,HAEMARTHROSIS,1
REVLIMID,2,61,801,PLASMA CELL MYELOMA,ORAL,Capsule,PRODUCT DOSE OMISSION ISSUE,2
AMLODIPINE,2,61,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,CARDIAC ARREST,1
RISANKIZUMAB,2,,,PSORIATIC ARTHROPATHY,,,DIABETES MELLITUS,2
ZEPOSIA,1,22,801,COLITIS ULCERATIVE,ORAL,Capsule,PRODUCT USE ISSUE,2
GENOTROPIN,1,16,801,HYPOPITUITARISM,,Solution for injection,DRUG DOSE OMISSION BY DEVICE,2
GENOTROPIN,1,15,801,,,Solution for injection,DEVICE ISSUE,2
VENCLEXTA,2,,,ACUTE MYELOID LEUKAEMIA,ORAL,,DYSPNOEA,1
MOUNJARO,1,44,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INCORRECT DOSE ADMINISTERED,2
OZEMPIC,1,,,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,SURGERY,1
ESLICARBAZEPINE,2,2,801,FOCAL DYSCOGNITIVE SEIZURES,,Unknown,SEIZURE,1
NUPLAZID,1,70,801,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,DEATH,1
TIBSOVO,1,46,801,ASTROCYTOMA,ORAL,,SEIZURE,1
FABRAZYME,1,57,801,FABRY^S DISEASE,INTRAVENOUS,Powder for concentrate for solution for infusion,DEPRESSED MOOD,2
DIANEAL PD-2 PERITONEAL DIALYSIS SOLUTION WITH DEXTROSE,1,81,801,RENAL FAILURE,,Solution for peritoneal dialysis,ULTRAFILTRATION FAILURE,1
REVLIMID,1,51,801,PLASMA CELL MYELOMA,ORAL,Capsule,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,2
NUPLAZID,2,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,HYPOACUSIS,2
REVLIMID,2,88,801,PLASMA CELL MYELOMA,ORAL,Capsule,HAEMOGLOBIN DECREASED,1
LANTUS SOLOSTAR,2,81,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,MYALGIA,2
DUPIXENT,2,63,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,2,35,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
MOUNJARO,2,54,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in cartridge,DIARRHOEA HAEMORRHAGIC,1
HADLIMA,1,65,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,VASCULITIC RASH,2
STELARA,1,,,CROHN^S DISEASE,INTRAVENOUS,Solution for infusion,UPPER RESPIRATORY TRACT INFECTION,2
SACUBITRIL\VALSARTAN,1,83,801,HYPERTENSION,,Film-coated tablet,HYPOTENSION,1
GENOTROPIN,1,12,801,,,Solution for injection,PRODUCT STORAGE ERROR,2
DUPIXENT,2,25,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
LUMIFY,2,75,801,OCULAR HYPERAEMIA,,"Eye drops, solution",DISCOMFORT,2
DUPIXENT,2,55,801,ASTHMA,SUBCUTANEOUS,Solution for injection,INJECTION SITE PAIN,2
SERTRALINE,2,31,801,DEPRESSION,ORAL,,SELF-INJURIOUS IDEATION,1
METHOTREXATE SODIUM,2,64,801,RHEUMATOID ARTHRITIS,INTRA-ARTERIAL,Tablet,NEUTROPENIA,1
LENALIDOMIDE,2,49,801,PLASMA CELL MYELOMA,ORAL,Capsule,HUMAN CHORIONIC GONADOTROPIN INCREASED,2
ALECTINIB,2,81,801,LUNG NEOPLASM MALIGNANT,,,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
DUPIXENT,1,40,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,COVID-19,2
GLIFAGE,2,74,801,TYPE 2 DIABETES MELLITUS,,,GASTROINTESTINAL CARCINOMA,1
SEVELAMER CARBONATE,1,81,801,HYPERPHOSPHATAEMIA,ORAL,,ABDOMINAL DISCOMFORT,1
EYLEA,1,,,RETINAL VEIN OCCLUSION,INTRAVITREAL,Injection,DEATH,1
VYALEV,1,,,PARKINSON^S DISEASE,SUBCUTANEOUS,,SKIN MASS,2
GENOTROPIN,1,3,801,PRADER-WILLI SYNDROME,,Solution for injection,DEVICE POWER SOURCE ISSUE,2
TECENTRIQ,1,58,801,LUNG ADENOCARCINOMA,INTRAVENOUS,Infusion,DECREASED APPETITE,1
AYVAKIT,2,39,801,HAEMATOPOIETIC NEOPLASM,ORAL,Unknown,FATIGUE,2
SERTRALINE,2,31,801,DEPRESSION,ORAL,Film-coated tablet,DRUG INTERACTION,1
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,GROIN PAIN,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
DUPIXENT,2,42,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
ELIGARD,1,68,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,INTERCEPTED PRODUCT PREPARATION ERROR,2
ADBRY,1,60,801,DERMATITIS ATOPIC,SUBCUTANEOUS,,DRUG INEFFECTIVE,2
CARBIDOPA\LEVODOPA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,,"Modified-release capsule, hard",DRUG INTOLERANCE,2
ERTAPENEM,2,65,801,PANCREATITIS ACUTE,INTRAMUSCULAR,,DRUG HYPERSENSITIVITY,1
SIMPONI,2,75,801,RHEUMATOID ARTHRITIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,HIP FRACTURE,1
METHOTREXATE SODIUM,1,72,801,PAIN,INTRA-ARTERIAL,,ACCIDENTAL POISONING,1
CLOZARIL,1,,,MAJOR DEPRESSION,ORAL,Tablet,HOSPITALISATION,1
NEULASTA,2,45,801,PROPHYLAXIS,SUBCUTANEOUS,Solution for injection,DEVICE ADHESION ISSUE,2
GLIVEC,1,44,801,CHRONIC MYELOID LEUKAEMIA,,Tablet,CYTOGENETIC ANALYSIS ABNORMAL,2
AURYXIA,2,,,HYPERPHOSPHATAEMIA,ORAL,Tablet,DEMENTIA,1
OCREVUS,1,32,801,MULTIPLE SCLEROSIS,INTRAVENOUS,Solution for infusion,URINARY INCONTINENCE,1
REVLIMID,1,68,801,PLASMA CELL MYELOMA,ORAL,,DIARRHOEA,2
ZENATANE,2,23,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Capsule,ADVERSE DRUG REACTION,2
CIMZIA,2,30,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Solution for injection in pre-filled syringe,PSORIATIC ARTHROPATHY,1
AIMOVIG,2,56,801,MIGRAINE,SUBCUTANEOUS,Solution for injection,THERAPY INTERRUPTED,2
DUPIXENT,1,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,SENSITIVE SKIN,2
VERZENIO,2,39,801,BREAST CANCER FEMALE,ORAL,Tablet,PRODUCT DOSE OMISSION ISSUE,2
DUPIXENT,2,56,801,ASTHMA,SUBCUTANEOUS,Solution for injection,SUICIDAL IDEATION,1
DUPIXENT,2,52,801,ECZEMA,SUBCUTANEOUS,Solution for injection,DRY SKIN,2
MOUNJARO,2,87,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,PRODUCT DOSE OMISSION ISSUE,2
HAEGARDA,2,53,801,HEREDITARY ANGIOEDEMA,,Injection,HEREDITARY ANGIOEDEMA,1
NEULASTA,2,58,801,PROPHYLAXIS,SUBCUTANEOUS,Solution for injection,DEVICE DEPLOYMENT ISSUE,2
XELJANZ,1,47,801,COLITIS ULCERATIVE,ORAL,Tablet,DIARRHOEA,2
FINTEPLA,1,,,LENNOX-GASTAUT SYNDROME,ORAL,Oral solution,HOSPITALISATION,1
VELSIPITY,1,36,801,INFLAMMATORY BOWEL DISEASE,ORAL,Film-coated tablet,SINUSITIS,2
REVLIMID,1,74,801,MYELODYSPLASTIC SYNDROME,ORAL,Capsule,BONE MARROW FAILURE,1
DARATUMUMAB,1,61,801,PLASMA CELL MYELOMA REFRACTORY,INTRAVENOUS,Concentrate for solution for infusion,PLASMA CELL MYELOMA,1
TALTZ,1,61,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,DRUG INEFFECTIVE,2
SUCCINYLCHOLINE CHLORIDE,2,41,801,NEUROMUSCULAR BLOCKING THERAPY,INTRAMUSCULAR,Unknown,MYASTHENIA GRAVIS CRISIS,1
HUMIRA,2,73,801,RHEUMATOID ARTHRITIS,,Solution for injection in pre-filled syringe,CARDIAC ARREST,1
XELJANZ XR,2,37,801,,ORAL,Prolonged-release tablet,DRUG INEFFECTIVE,2
RILPIVIRINE,2,,,HIV INFECTION,,Prolonged-release suspension for injection,PAIN,2
NEULASTA,2,65,801,PROPHYLAXIS,SUBCUTANEOUS,Solution for injection,DEVICE OCCLUSION,2
TECFIDERA,2,,,MULTIPLE SCLEROSIS,ORAL,Prolonged-release capsule,GASTROINTESTINAL DISORDER,2
DUPIXENT,1,54,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
XELJANZ,1,25,801,ALOPECIA,ORAL,Tablet,COVID-19,2
CLOZARIL,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,INTESTINAL OBSTRUCTION,1
DUPIXENT,1,16,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,LOSS OF CONSCIOUSNESS,1
DUPIXENT,2,,,NEURODERMATITIS,SUBCUTANEOUS,Solution for injection,INJECTION SITE WARMTH,2
KRYSTEXXA,1,68,801,GOUTY TOPHUS,INTRAVENOUS,Solution for infusion,THERAPEUTIC PRODUCT EFFECT DECREASED,2
VEVYE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,OPHTHALMIC,"Eye drops, solution",LACRIMATION INCREASED,2
MOUNJARO,2,62,801,WEIGHT CONTROL,SUBCUTANEOUS,Solution for injection in cartridge,HYPERSENSITIVITY,1
MOUNJARO,2,64,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INCORRECT DOSE ADMINISTERED,2
HEMLIBRA,1,,,FACTOR VIII DEFICIENCY,SUBCUTANEOUS,,INTENTIONAL PRODUCT MISUSE,2
ELIGARD,1,,,PROSTATE CANCER,SUBCUTANEOUS,Injection,ACNE,2
GENOTROPIN,1,13,801,,,Solution for injection,DEVICE LEAKAGE,2
SELADELPAR,2,,,PRIMARY BILIARY CHOLANGITIS,,Capsule,WEIGHT INCREASED,1
LANTUS SOLOSTAR,1,73,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,BLOOD GLUCOSE INCREASED,2
PALFORZIA,1,6,801,FOOD ALLERGY,,Capsule,NAUSEA,2
LANTUS SOLOSTAR,1,78,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
ARIMIDEX,2,49,801,BREAST CANCER,ORAL,Tablet,DIPLOPIA,1
LEQEMBI,1,83,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Solution for infusion,AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS,2
MOUNJARO,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in cartridge,DEPRESSED MOOD,1
XIFAXAN,1,71,801,LIVER DISORDER,ORAL,Tablet,PLEURAL EFFUSION,1
FINGOLIMOD HYDROCHLORIDE,2,,,RELAPSING-REMITTING MULTIPLE SCLEROSIS,ORAL,,HAND FRACTURE,1
KRYSTEXXA,1,89,801,GOUTY TOPHUS,INTRAVENOUS,Solution for infusion,DEATH,1
HUMIRA,2,16,801,CROHN^S DISEASE,,Solution for injection in pre-filled pen,INFLAMMATION,1
ELIGARD,1,70,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,INTENTIONAL PRODUCT USE ISSUE,2
TAFINLAR,2,32,801,BRAF V600E MUTATION POSITIVE,ORAL,"Capsule, hard",PANNICULITIS,1
CONCERTA,2,14,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Prolonged-release tablet,INTENTIONAL SELF-INJURY,1
CLOZAPINE,1,55,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,HOSPITALISATION,1
EYLEA HD,2,86,801,DIABETIC RETINAL OEDEMA,INTRAVITREAL,Solution for injection,TOXIC ANTERIOR SEGMENT SYNDROME,1
MYSOLINE,2,76,801,SEIZURE,ORAL,Tablet,CATARACT,1
COSENTYX,2,37,801,HIDRADENITIS,SUBCUTANEOUS,Injection,COVID-19,2
XTANDI,1,62,801,PROSTATE CANCER,ORAL,Unknown,SYSTEMIC SCLERODERMA,1
MAVENCLAD,2,43,801,MULTIPLE SCLEROSIS,ORAL,,CHOKING,1
TYSABRI,2,50,801,MULTIPLE SCLEROSIS,INTRAVENOUS,Concentrate for solution for infusion,OPTIC NEURITIS,1
DUPIXENT,1,55,801,NASAL POLYPS,SUBCUTANEOUS,Solution for injection,GAIT DISTURBANCE,2
DUPIXENT,1,24,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ECZEMA,2
FENTANYL,1,33,801,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,,DRUG ABUSE,1
MOUNJARO,2,52,801,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,INCORRECT DOSE ADMINISTERED,2
NEULASTA,2,63,801,PROPHYLAXIS,SUBCUTANEOUS,Solution for injection,DEVICE ADHESION ISSUE,2
DARZALEX,1,62,801,WARM AUTOIMMUNE HAEMOLYTIC ANAEMIA,INTRAVENOUS,Solution for injection,SHOCK HAEMORRHAGIC,1
TECENTRIQ,1,54,801,HEPATOCELLULAR CARCINOMA,INTRAVENOUS,,MOUTH ULCERATION,1
VELSIPITY,1,,,COLITIS ULCERATIVE,ORAL,Film-coated tablet,ABDOMINAL PAIN UPPER,2
XELJANZ XR,1,73,801,,ORAL,Prolonged-release tablet,THROMBOSIS,1
DUPIXENT,1,,,ECZEMA,SUBCUTANEOUS,Solution for injection,CYST,2
CABENUVA,1,,,HIV INFECTION,,Prolonged-release suspension for injection,HEPATITIS B,1
VEDOLIZUMAB,2,,,CROHN^S DISEASE,SUBCUTANEOUS,Infusion,RETINAL DETACHMENT,1
HYDROXYCHLOROQUINE,1,71,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
VEKLURY,1,93,801,COVID-19,INTRAVENOUS,Injection,DEATH,1
MOUNJARO,1,57,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,BLOOD GLUCOSE INCREASED,2
NUPLAZID,1,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,HALLUCINATION,1
STIVARGA,1,54,801,COLON CANCER,ORAL,Film-coated tablet,OESOPHAGEAL VARICES HAEMORRHAGE,1
HUMIRA,2,77,801,COLITIS ULCERATIVE,,Solution for injection in pre-filled pen,DEATH,1
DUPIXENT,2,69,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,BLEPHAROSPASM,2
TRASTUZUMAB DERUXTECAN,2,,,GASTRIC CANCER,,"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",MYELOSUPPRESSION,1
ZOLEDRONIC ACID,1,75,801,PLASMA CELL MYELOMA,INTRAVENOUS,Unknown,OSTEONECROSIS OF JAW,1
FINGOLIMOD,1,43,801,RELAPSING-REMITTING MULTIPLE SCLEROSIS,ORAL,Unknown,DURAL ARTERIOVENOUS FISTULA,1
TRINTELLIX,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ANXIETY,2
ARIKAYCE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,RESPIRATORY (INHALATION),Suspension,HOSPITALISATION,1
RUXIENCE,1,72,801,DIFFUSE LARGE B-CELL LYMPHOMA,INTRAVENOUS,Solution for infusion,WEIGHT INCREASED,1
DUPIXENT,1,7,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DRY SKIN,2
ADBRY,1,77,801,ASTHMA,SUBCUTANEOUS,,ADVERSE EVENT,2
JANUVIA,1,,,,ORAL,Film-coated tablet,BLOOD GLUCOSE INCREASED,2
TRAMADOL,2,21,801,PRODUCT USED FOR UNKNOWN INDICATION,,,DRUG USE DISORDER,1
VENOFER,2,80,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Injection,DRUG HYPERSENSITIVITY,1
NUPLAZID,1,71,801,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,DEATH,1
ERIBULIN,2,49,801,BREAST CANCER,,Solution for injection,WHITE BLOOD CELL COUNT DECREASED,1
DUPIXENT,1,76,801,NEURODERMATITIS,SUBCUTANEOUS,Solution for injection,INJECTION SITE PAIN,2
DUPIXENT,2,18,801,ASTHMA,SUBCUTANEOUS,Solution for injection,PRURITUS,2
AMOXICILLIN\CLAVULANATE POTASSIUM,2,,,LOWER RESPIRATORY TRACT INFECTION,,Film-coated tablet,SWOLLEN TONGUE,1
FLUOXETINE,2,43,801,DEPRESSION,ORAL,,HEPATITIS,1
ACTEMRA,2,,,RHEUMATOID ARTHRITIS,INTRAVENOUS,Direct auto-injector,PAIN,2
MAVENCLAD,2,,,MULTIPLE SCLEROSIS,ORAL,,DERMATITIS ALLERGIC,1
NEXPLANON,2,,,,SUBCUTANEOUS,Implant,HEAVY MENSTRUAL BLEEDING,1
DUPIXENT,1,19,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,CONSTIPATION,2
CABOTEGRAVIR,1,,,PRODUCT USED FOR UNKNOWN INDICATION,,Suspension for injection,PRODUCT DOSE OMISSION ISSUE,2
CARBIDOPA\LEVODOPA,2,,,PARKINSON^S DISEASE,,Intestinal gel,PARKINSON^S DISEASE,1
MOUNJARO,2,52,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,EXTRA DOSE ADMINISTERED,2
MICAFUNGIN SODIUM,2,70,801,CANDIDA INFECTION,INTRAVENOUS,,PAIN,1
ELIGARD,1,74,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,INJECTION SITE ERYTHEMA,2
IBUPROFEN AND DIPHENHYDRAMINE CITRATE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,VOMITING,2
DUPIXENT,2,,,ASTHMA,SUBCUTANEOUS,Solution for injection,RHINORRHOEA,2
DUPIXENT,2,8,801,ECZEMA,SUBCUTANEOUS,Solution for injection,DRY SKIN,2
DUPIXENT,1,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DRUG INEFFECTIVE,2
LENALIDOMIDE,2,77,801,PLASMA CELL MYELOMA,ORAL,,DEATH,1
DUPIXENT,1,6,801,DERMATITIS,SUBCUTANEOUS,Solution for injection,INJECTION SITE SWELLING,2
HUMIRA,1,61,801,PSORIATIC ARTHROPATHY,,,FATIGUE,1
ACTEMRA,1,88,801,GIANT CELL ARTERITIS,INTRAVENOUS,Solution for injection in pre-filled syringe,PNEUMONIA,1
UPTRAVI,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,SUICIDAL IDEATION,1
MOUNJARO,1,55,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,FALL,2
NUPLAZID,2,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,PRODUCT USE ISSUE,2
AVONEX,2,,,RELAPSING-REMITTING MULTIPLE SCLEROSIS,INTRAMUSCULAR,Unknown,TREATMENT FAILURE,2
NUPLAZID,1,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,DRUG INEFFECTIVE,2
XIFAXAN,2,51,801,HEPATIC ENCEPHALOPATHY,ORAL,Tablet,DEATH,1
AZITHROMYCIN ANHYDROUS,2,76,801,BRONCHITIS,,,GASTROINTESTINAL PAIN,2
EMPAGLIFLOZIN,1,60,801,DIABETES MELLITUS,ORAL,,FOURNIER^S GANGRENE,1
ELREXFIO,2,84,801,PLASMA CELL MYELOMA REFRACTORY,SUBCUTANEOUS,Solution for injection,INJECTION SITE RASH,2
TUBERSOL,2,19,801,TUBERCULIN TEST,INTRADERMAL,Solution for injection,INCORRECT DOSE ADMINISTERED,2
ETONOGESTREL,2,29,801,,SUBCUTANEOUS,Implant,ABNORMAL UTERINE BLEEDING,1
RISPERDAL,1,,,AFFECTIVE DISORDER,ORAL,Film-coated tablet,OFF LABEL USE,2
COSENTYX,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,DRUG INEFFECTIVE,2
CABOMETYX,1,,,RENAL CANCER,ORAL,Tablet,ADVERSE DRUG REACTION,2
CABOMETYX,2,,,RENAL CELL CARCINOMA,ORAL,Tablet,OFF LABEL USE,2
ZENATANE,2,16,801,ACNE,ORAL,Capsule,PRODUCT PRESCRIBING ERROR,2
MOUNJARO,1,67,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INCORRECT DOSE ADMINISTERED,2
NUPLAZID,1,77,801,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,PARKINSON^S DISEASE,1
OMNITROPE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,2
ROZLYTREK,2,,,LUNG NEOPLASM MALIGNANT,ORAL,,DRY EYE,2
VYEPTI,2,36,801,MIGRAINE,INTRAVENOUS,Solution for infusion,INFLUENZA,2
OMNITROPE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,DEVICE BREAKAGE,2
BENLYSTA,2,,,SYSTEMIC LUPUS ERYTHEMATOSUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,EXPOSURE VIA SKIN CONTACT,2
VENCLEXTA,2,80,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,DEATH,1
EGRIFTA,1,68,801,HIV INFECTION,,,NEOPLASM MALIGNANT,1
TAVNEOS,2,68,801,,ORAL,,MENINGITIS,1
HUMIRA,1,61,801,PSORIASIS,,Injection,NASOPHARYNGITIS,2
EVENITY,2,61,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,INJECTION SITE RASH,2
CABOMETYX,1,68,801,RENAL CANCER,ORAL,Tablet,ABDOMINAL DISCOMFORT,2
CABOMETYX,1,,,RENAL CANCER,ORAL,Tablet,SKIN ULCER,2
REVLIMID,1,75,801,PLASMA CELL MYELOMA,ORAL,Capsule,DIARRHOEA,2
DUPIXENT,1,69,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,RASH ERYTHEMATOUS,2
BOTOX,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRADERMAL,,THERAPEUTIC RESPONSE SHORTENED,2
TALTZ,1,59,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,PRODUCT DOSE OMISSION ISSUE,2
JARDIANCE,2,55,801,DIABETES MELLITUS,ORAL,,ANAL ABSCESS,1
ISAVUCONAZOLE,1,75,801,BRONCHOPULMONARY ASPERGILLOSIS,,Concentrate for solution for infusion,VENTRICULAR FIBRILLATION,1
LUPKYNIS,2,,,LUPUS NEPHRITIS,ORAL,Softgel capsule,BLOOD PRESSURE INCREASED,2
LUPKYNIS,2,17,801,LUPUS NEPHRITIS,ORAL,Softgel capsule,THERAPY INTERRUPTED,2
LUPKYNIS,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Softgel capsule,ROAD TRAFFIC ACCIDENT,2
CABOMETYX,2,36,801,ADRENOCORTICAL CARCINOMA,ORAL,Tablet,OFF LABEL USE,2
CABOMETYX,1,,,RENAL CANCER,ORAL,Tablet,HAIR COLOUR CHANGES,2
CABOMETYX,1,,,RENAL CANCER,ORAL,Tablet,SKIN ULCER,2
PONATINIB,2,49,801,PHILADELPHIA POSITIVE ACUTE LYMPHOCYTIC LEUKAEMIA,,Tablet,PHILADELPHIA CHROMOSOME POSITIVE,1
CABOMETYX,1,69,801,HEPATOCELLULAR CARCINOMA,ORAL,Tablet,LETHARGY,2
VEOZAH,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,TRANSAMINASES INCREASED,2
AYVAKIT,1,56,801,MASTOCYTOMA,ORAL,Tablet,NASOPHARYNGITIS,2
DUPIXENT,2,40,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,RASH,2
XARELTO,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Film-coated tablet,DEATH,1
CABOMETYX,1,35,801,RENAL CANCER,ORAL,Tablet,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
UBRELVY,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,DEATH,1
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,BRAIN FOG,2
DUPIXENT,2,17,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ASTHMA,2
ATOMOXETINE HYDROCHLORIDE,2,38,801,ATTENTION DEFICIT HYPERACTIVITY DISORDER,ORAL,,CARDIAC FLUTTER,1
STELARA,2,64,801,PSORIATIC ARTHROPATHY,INTRAVENOUS,Solution for injection in pre-filled syringe,RASH PRURITIC,2
METHOTREXATE SODIUM,2,67,801,,INTRA-ARTERIAL,,RENAL FAILURE,1
TYMLOS,2,71,801,OSTEOPOROSIS,SUBCUTANEOUS,Sub-cutaneous injection,PNEUMONIA,1
ZYRTEC,1,,,PARAESTHESIA,ORAL,Tablet,SOMNOLENCE,2
MAVENCLAD,2,,,MULTIPLE SCLEROSIS,ORAL,,PNEUMONIA,1
HIZENTRA,2,40,801,CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY,,Injection,LOSS OF CONSCIOUSNESS,1
HUMIRA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,,Solution for injection in pre-filled pen,WEIGHT DECREASED,1
SEVELAMER CARBONATE,1,65,801,HYPOPHOSPHATAEMIA,ORAL,Tablet,PRODUCT USE IN UNAPPROVED INDICATION,2
HUMIRA,2,60,801,HIDRADENITIS,,,DEATH,1
CAPLYTA,2,,,BIPOLAR I DISORDER,ORAL,Capsule,ANXIETY,2
RILUZOLE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,ILLNESS,1
DUPIXENT,1,47,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,INJECTION SITE PAIN,2
IMBRUVICA,1,,,CHRONIC LYMPHOCYTIC LEUKAEMIA,ORAL,Unknown,NASOPHARYNGITIS,2
LANTUS SOLOSTAR,2,79,801,TYPE 1 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,DRUG INEFFECTIVE,2
DUPIXENT,2,38,801,ECZEMA,SUBCUTANEOUS,Solution for injection,EXPOSURE VIA SKIN CONTACT,2
STELARA,2,10,801,PSORIASIS,INTRAVENOUS,Solution for injection in pre-filled syringe,INCORRECT DOSE ADMINISTERED,2
ALECENSA,1,77,801,LUNG NEOPLASM MALIGNANT,ORAL,Capsule,BLADDER CANCER,1
CLARAVIS,2,28,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,UNINTENDED PREGNANCY,1
EVENITY,2,77,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,CARDIAC DISORDER,2
LEVOTHYROXINE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,LETHARGY,2
TUKYSA,2,65,801,,ORAL,Film-coated tablet,DRUG INTERACTION,2
WOMENS ROGAINE UNSCENTED,2,,,ACCIDENTAL EXPOSURE TO PRODUCT,TOPICAL,Cutaneous foam,HAIR GROWTH ABNORMAL,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
ADBRY,2,15,801,DERMATITIS ATOPIC,SUBCUTANEOUS,,INJECTION SITE REACTION,2
DUPIXENT,1,73,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,MOVEMENT DISORDER,1
DUPIXENT,1,48,801,NEURODERMATITIS,SUBCUTANEOUS,Suspension for injection in pre-filled syringe,ANGINA PECTORIS,1
XOLAIR,2,46,801,ASTHMA,SUBCUTANEOUS,Direct auto-injector,OFF LABEL USE,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,SUICIDAL IDEATION,1
EZETIMIBE,1,67,801,BLOOD CHOLESTEROL DECREASED,ORAL,Unknown,MUSCLE SPASMS,2
IMBRUVICA,2,85,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,DEATH,1
FILSPARI,1,43,801,IGA NEPHROPATHY,ORAL,Tablet,BLOOD PRESSURE DECREASED,2
TALTZ,2,59,801,PSORIASIS,SUBCUTANEOUS,,INFLUENZA,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
COSENTYX,1,66,801,PSORIASIS,SUBCUTANEOUS,,HALLUCINATION,1
ALPROLIX,1,59,801,HAEMORRHAGE PROPHYLAXIS,,Powder and solvent for solution for injection,CATHETERISATION CARDIAC,1
FINASTERIDE,1,,,ALOPECIA,ORAL,Tablet,ANGIOEDEMA,1
STIVARGA,2,,,HEPATOCELLULAR CARCINOMA,ORAL,Film-coated tablet,DEATH,1
STIVARGA,1,59,801,HEPATIC CANCER,ORAL,Film-coated tablet,MYELOSUPPRESSION,1
HUMIRA,2,58,801,PSORIASIS,,Injection,INJECTION SITE INFECTION,2
CAPLYTA,2,,,BIPOLAR DISORDER,ORAL,Capsule,DRUG INEFFECTIVE,2
CAPLYTA,2,,,BIPOLAR DISORDER,ORAL,Capsule,COLD SWEAT,2
ELOCTATE,1,18,801,,,Powder and solvent for solution for injection,PANIC ATTACK,2
KEPPRA,1,58,801,SEIZURE,INTRAVENOUS,,RENAL TUBULAR NECROSIS,1
BOTOX,2,,,MUSCLE HYPERTROPHY,INTRADERMAL,,OFF LABEL USE,2
AVONEX,2,,,MULTIPLE SCLEROSIS,INTRAMUSCULAR,Unknown,CEREBROVASCULAR ACCIDENT,1
ORENCIA,1,71,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Solution for injection,RHEUMATOID ARTHRITIS,2
OMNIPAQUE,2,65,801,DIAGNOSTIC PROCEDURE,INTRAVENOUS,Solution for injection,URTICARIA,2
TOCILIZUMAB,1,36,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,,LOCALISED OEDEMA,1
JARDIANCE,1,71,801,TYPE 2 DIABETES MELLITUS,ORAL,Tablet,FUNGAL INFECTION,2
DUPIXENT,1,80,801,,SUBCUTANEOUS,Solution for injection,SKIN EXFOLIATION,2
MOUNJARO,1,54,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in cartridge,EMBOLIC STROKE,1
ELAHERE,2,,,OVARIAN CANCER,INTRAVENOUS,Intravenous infusion,OCULAR TOXICITY,2
OCREVUS,2,57,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,,JC VIRUS INFECTION,2
DUPIXENT,1,58,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
NUCYNTA,2,71,801,COLON CANCER,ORAL,Tablet,DELIRIUM,1
AMLODIPINE,2,23,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,COMPLETED SUICIDE,1
DEXAMETHASONE\NEOMYCIN\POLYMYXIN B SULFATE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,,"Eye drops, suspension",EYE IRRITATION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
ETONOGESTREL,2,,,,SUBCUTANEOUS,Implant,UTERINE HAEMORRHAGE,1
VEDOLIZUMAB,2,,,COLITIS ULCERATIVE,SUBCUTANEOUS,Solution for injection,PARKINSON^S DISEASE,1
SIMPONI,1,,,ANKYLOSING SPONDYLITIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,LOWER RESPIRATORY TRACT INFECTION,1
TISSUEBLUE,2,68,801,MACULAR HOLE,INTRAOCULAR,,RETINAL DISORDER,1
ORENCIA,2,35,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Solution for injection,DEVICE DELIVERY SYSTEM ISSUE,2
PRALUENT,2,,,HYPERCHOLESTEROLAEMIA,SUBCUTANEOUS,Injection,ARTHROPATHY,1
RHOPRESSA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,OPHTHALMIC,"Eye drops, solution",OVERDOSE,2
XIIDRA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,OPHTHALMIC,"Eye drops, solution",DRY EYE,2
AMLODIPINE,2,72,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,COMPLETED SUICIDE,1
MENS ROGAINE EXTRA STRENGTH,1,6,800,ALOPECIA,,Cutaneous foam,INCORRECT DOSE ADMINISTERED,2
ESBRIET,1,78,801,IDIOPATHIC PULMONARY FIBROSIS,ORAL,Tablet,HEPATIC ENZYME INCREASED,2
KYLEENA,2,,,,INTRAUTERINE,Intrauterine delivery system,ECTOPIC PREGNANCY WITH CONTRACEPTIVE DEVICE,1
GENOTROPIN,2,,,,,Solution for injection,DEVICE MECHANICAL ISSUE,2
ACTEMRA,1,,,RHEUMATOID ARTHRITIS,INTRAVENOUS,,WHITE BLOOD CELL COUNT DECREASED,2
LENALIDOMIDE,1,73,801,PLASMA CELL MYELOMA,ORAL,,SYNCOPE,1
EUCRISA,1,30,801,DERMATITIS ATOPIC,TOPICAL,Ointment,THERAPEUTIC PRODUCT EFFECT INCOMPLETE,2
MOUNJARO,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,EYELID DISORDER,2
VYEPTI,2,59,801,MIGRAINE,INTRAVENOUS,Solution for infusion,GRANULOMATOSIS WITH POLYANGIITIS,1
TALTZ,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,SUICIDAL IDEATION,1
CARBIDOPA\LEVODOPA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,,"Modified-release capsule, hard",TREMOR,2
DOVATO,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Film-coated tablet,PRODUCT DOSE OMISSION ISSUE,2
DOPTELET,2,65,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,HAEMOLYTIC ANAEMIA,1
OTEZLA,1,,,PSORIASIS,ORAL,Tablet,HEPATOMEGALY,2
TYSABRI,1,,,MULTIPLE SCLEROSIS,INTRAVENOUS,Unknown,MENTAL IMPAIRMENT,2
ZOLOFT,2,15,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,EPILEPSY,1
XELJANZ,2,45,801,,ORAL,,ARTHRITIS,2
ENTYVIO,1,37,801,CROHN^S DISEASE,SUBCUTANEOUS,,HEADACHE,1
SKYLA,2,28,801,,INTRAUTERINE,Intrauterine delivery system,EXPIRED DEVICE USED,2
LENALIDOMIDE,1,73,801,PLASMA CELL MYELOMA,ORAL,Capsule,THROMBOSIS,1
BRIGATINIB,2,,,NON-SMALL CELL LUNG CANCER,ORAL,Tablet,PYELONEPHRITIS,1
NUPLAZID,1,,,PARKINSON^S DISEASE,ORAL,Capsule,HALLUCINATION,1
TAVNEOS,1,36,801,,ORAL,,HOSPITALISATION,1
XELJANZ,2,63,801,,ORAL,Tablet,PNEUMONIA,1
DULOXETINE,2,69,801,BACK PAIN,ORAL,Unknown,PARANOIA,1
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,ADVERSE EVENT,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
CARVYKTI,1,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Dispersion for infusion,FACIAL PARALYSIS,1
MOUNJARO,1,77,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,MUSCLE SPASMS,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,ADVERSE EVENT,2
NUPLAZID,1,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,HALLUCINATION,1
DEPO-PROVERA,2,22,801,CONTRACEPTION,INTRAMUSCULAR,Suspension for injection,DRUG DOSE OMISSION BY DEVICE,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ABDOMINAL DISTENSION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,ADVERSE EVENT,2
XIFAXAN,1,82,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,DEATH,1
CARBIDOPA\LEVODOPA,2,74,801,PARKINSON^S DISEASE,,Intestinal gel,BLADDER OPERATION,1
OTEZLA,1,,,PSORIATIC ARTHROPATHY,ORAL,Tablet,HOSPITALISATION,1
MOUNJARO,2,,,WEIGHT CONTROL,SUBCUTANEOUS,Solution for injection in cartridge,VAGINAL HAEMORRHAGE,1
ELREXFIO,2,,,PLASMA CELL MYELOMA REFRACTORY,SUBCUTANEOUS,Solution for injection,VIRAL INFECTION,2
DOVATO,1,67,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Film-coated tablet,PRODUCT DOSE OMISSION ISSUE,2
SERTRALINE,1,56,801,DEPRESSED MOOD,ORAL,,ABNORMAL DREAMS,1
CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE,2,77,801,PRODUCT USED FOR UNKNOWN INDICATION,,Tablet,FALL,1
BOTOX,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRADERMAL,,OFF LABEL USE,2
RISANKIZUMAB,1,,,PRODUCT USED FOR UNKNOWN INDICATION,,,ADVERSE EVENT,2
GILTERITINIB,1,18,801,FLT3 GENE MUTATION,ORAL,Unknown,DEATH,1
ATORVASTATIN,1,,,PRODUCT USED FOR UNKNOWN INDICATION,,Tablet,PRODUCT USE COMPLAINT,2
TRIUMEQ,2,59,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Film-coated tablet,PRODUCT DOSE OMISSION ISSUE,2
LEVULAN KERASTICK,2,60,801,PHOTODYNAMIC THERAPY,,Cutaneous solution,DRUG INEFFECTIVE,2
ELIGARD,1,,,PROSTATE CANCER,SUBCUTANEOUS,Injection,DEATH,1
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Unknown,ADVERSE EVENT,2
DARZALEX FASPRO,2,90,801,PLASMA CELL MYELOMA,SUBCUTANEOUS,Solution for injection,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
BRIVARACETAM,2,72,801,SEIZURE,ORAL,Film-coated tablet,PARTIAL SEIZURES,1
RUKOBIA,1,,,HIV INFECTION,ORAL,Prolonged-release tablet,PRODUCT DOSE OMISSION ISSUE,2
ELIGARD,1,72,801,PROSTATE CANCER,SUBCUTANEOUS,Injection,INTENTIONAL PRODUCT USE ISSUE,2
MIRENA,2,18,801,INTRAUTERINE CONTRACEPTION,INTRAUTERINE,Intrauterine delivery system,ADENOMYOSIS,2
REVLIMID,2,47,801,PLASMA CELL MYELOMA,ORAL,Capsule,THERAPY INTERRUPTED,1
CLOZAPINE,2,75,801,MIXED ANXIETY AND DEPRESSIVE DISORDER,ORAL,Unknown,HYPERTHERMIA,1
VEKLURY,1,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Injection,DEATH,1
VERZENIO,2,55,801,BREAST CANCER FEMALE,ORAL,Tablet,HEPATIC ENZYME INCREASED,2
INBRIJA,1,,,PARKINSON^S DISEASE,RESPIRATORY (INHALATION),Inhalation powder,RESPIRATORY TRACT IRRITATION,2
DUPIXENT,1,,,ASTHMA,SUBCUTANEOUS,Solution for injection,OPTIC NEURITIS,1
OMNITROPE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,INCORRECT DOSE ADMINISTERED BY DEVICE,2
HUMIRA,2,,,CROHN^S DISEASE,,Solution for injection in pre-filled pen,DYSPHAGIA,1
TRESIBA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,INTESTINAL OBSTRUCTION,1
VEDOLIZUMAB,2,40,801,COLITIS ULCERATIVE,SUBCUTANEOUS,Powder for solution for infusion,RECTAL HAEMORRHAGE,1
METFORMIN,1,71,801,TYPE 2 DIABETES MELLITUS,ORAL,,LACTIC ACIDOSIS,1
COTELLIC,2,59,801,PANCREATIC CARCINOMA,ORAL,Tablet,OFF LABEL USE,2
MOXIFLOXACIN,2,77,801,DEVICE RELATED INFECTION,INTRAVENOUS,,NEURALGIA,1
CLOZAPINE,1,50,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,METABOLIC ENCEPHALOPATHY,1
CELEXA,1,40,801,,ORAL,,NAUSEA,1
BRINTELLIX,2,28,801,DEPRESSION,,Film-coated tablet,TRIGGER POINTS,1
MEDROL,2,64,801,,ORAL,Tablet,PYELONEPHRITIS,1
VENCLEXTA,2,90,801,ACUTE MYELOID LEUKAEMIA,ORAL,Tablet,CEREBRAL HAEMORRHAGE,1
OMALIZUMAB,1,55,801,ASTHMA,SUBCUTANEOUS,Capsule,ASTHENIA,1
NUZYRA,1,73,801,PNEUMONIA,INTRAVENOUS,Injection,ELECTROCARDIOGRAM QT PROLONGED,1
MOUNJARO,1,45,801,GLUCOSE TOLERANCE IMPAIRED,SUBCUTANEOUS,Solution for injection in pre-filled pen,OFF LABEL USE,2
OZEMPIC,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,PULMONARY EMBOLISM,1
HUMALOG MIX75/25,2,86,801,DIABETES MELLITUS,SUBCUTANEOUS,Injection,DEMENTIA,1
NUBEQA,1,88,801,HORMONE-REFRACTORY PROSTATE CANCER,ORAL,Film-coated tablet,RENAL INJURY,1
ELIGARD,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Injection,PRODUCT PREPARATION ERROR,2
DARATUMUMAB\HYALURONIDASE-FIHJ,2,76,801,,,,DIZZINESS,1
TALTZ,2,59,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Solution for injection in pre-filled pen,PYREXIA,1
ZOMETA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,,,INJECTION SITE ERYTHEMA,2
KESIMPTA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,HERPES ZOSTER,2
ENTYVIO,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,NO ADVERSE EVENT,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,WHEEZING,2
DUPIXENT,2,3,801,ECZEMA,SUBCUTANEOUS,Solution for injection,DRY SKIN,2
DUPIXENT,1,,,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,2
DUPIXENT,1,38,801,ECZEMA,SUBCUTANEOUS,Solution for injection,DISCOMFORT,2
ACTEMRA ACTPEN,1,83,801,GIANT CELL ARTERITIS,SUBCUTANEOUS,Direct auto-injector,OFF LABEL USE,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,2,,,ASTHMA,SUBCUTANEOUS,Solution for injection,INJECTION SITE REACTION,2
COSENTYX,2,62,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,FEELING ABNORMAL,2
DUPIXENT,2,2,801,ECZEMA,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
ENTYVIO,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,,HAEMATOCHEZIA,1
GENOTROPIN,1,,,,,Solution for injection,DEVICE LEAKAGE,2
DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE SULFATE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,,Capsule,DEATH,1
DEFINITY,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,"INJECTION, SUSPENSION",OROPHARYNGEAL DISCOMFORT,2
DEFINITY,1,,,ECHOCARDIOGRAM,INTRAVENOUS,"INJECTION, SUSPENSION",PAIN IN JAW,2
ADBRY,1,78,801,DERMATITIS ATOPIC,SUBCUTANEOUS,,RASH,2
M-M-RVAXPRO,1,17,802,IMMUNISATION,,,SLEEP DISORDER,1
NICOTINIC ACID,1,80,801,PRODUCT USED FOR UNKNOWN INDICATION,,,HEPATIC ENCEPHALOPATHY,1
OCREVUS,2,,,RELAPSING-REMITTING MULTIPLE SCLEROSIS,INTRAVENOUS,Solution for infusion,INFLUENZA,2
DOSTINEX,2,21,801,HYPERPROLACTINAEMIA,,Tablet,VISUAL IMPAIRMENT,1
RUXIENCE,2,45,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Solution for infusion,SINUS OPERATION,1
LIALDA,1,41,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,HAEMATOCHEZIA,1
ALECENSA,1,56,801,LUNG NEOPLASM MALIGNANT,ORAL,Capsule,DEATH,1
XOLAIR PFS,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Direct auto-injector,INCORRECT DOSE ADMINISTERED,2
ACTEMRA,2,40,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Solution for injection in pre-filled syringe,OFF LABEL USE,2
LUMRYZ,2,67,801,,ORAL,Extended-Release Oral Suspension,INITIAL INSOMNIA,2
HUMIRA,2,40,801,RHEUMATOID ARTHRITIS,,Injection,ILLNESS,2
OCREVUS,2,,,RELAPSING-REMITTING MULTIPLE SCLEROSIS,INTRAVENOUS,Solution for infusion,ORAL HERPES,2
CLOZAPINE,1,58,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ADVERSE DRUG REACTION,1
OZEMPIC,2,67,801,,SUBCUTANEOUS,Solution for injection,LUNG DISORDER,1
MOUNJARO,2,70,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INCORRECT DOSE ADMINISTERED,2
VERAPAMIL,2,27,801,PRODUCT USED FOR UNKNOWN INDICATION,,Modified-release tablet,TOXICITY TO VARIOUS AGENTS,1
LUMRYZ,2,20,801,,ORAL,Extended-Release Oral Suspension,NAUSEA,2
MOUNJARO,2,62,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,DEPRESSION,2
PONATINIB,1,41,801,ACUTE LYMPHOCYTIC LEUKAEMIA,,Tablet,DECREASED IMMUNE RESPONSIVENESS,1
OZEMPIC,2,65,801,GLUCOSE TOLERANCE IMPAIRED,SUBCUTANEOUS,Solution for injection,LIMB INJURY,1
NUPLAZID,2,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,FEELING ABNORMAL,2
VELAGLUCERASE ALFA,1,,,GAUCHER^S DISEASE,INTRAVENOUS,Concentrate for solution for infusion,GALLBLADDER RUPTURE,1
DUPIXENT,1,,,ASTHMA,SUBCUTANEOUS,Solution for injection,URTICARIA,2
TEDUGLUTIDE,1,,,SHORT-BOWEL SYNDROME,SUBCUTANEOUS,Solution for injection,JOINT SWELLING,1
ESCITALOPRAM,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,ACNE CYSTIC,1
VALSARTAN,2,3,804,HYPERTENSION,ORAL,,COARCTATION OF THE AORTA,1
DUPIXENT,1,47,801,ASTHMA,SUBCUTANEOUS,Solution for injection,INJECTION SITE LACERATION,2
DUPIXENT,2,,,,SUBCUTANEOUS,Solution for injection,ACCIDENTAL EXPOSURE TO PRODUCT,2
SERTRALINE,2,16,801,OBSESSIVE-COMPULSIVE DISORDER,ORAL,,CHILLS,1
MOUNJARO,2,23,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in cartridge,PAIN IN EXTREMITY,1
ELREXFIO,2,72,801,PLASMA CELL MYELOMA,SUBCUTANEOUS,Solution for injection,FATIGUE,2
DUPIXENT,2,47,801,ASTHMA,SUBCUTANEOUS,Solution for injection,NOROVIRUS INFECTION,1
LANTUS SOLOSTAR,2,,,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
SITAGLIPTIN,2,79,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,DYSPNOEA AT REST,1
ELFABRIO,1,29,801,FABRY^S DISEASE,INTRAVENOUS,Solution for infusion,RHINORRHOEA,2
AUSTEDO,1,43,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,DROOLING,2
CANDESARTAN CILEXETIL,2,54,801,HYPERTENSION,ORAL,Tablet,DIARRHOEA,1
XELJANZ,2,75,801,,ORAL,,URTICARIA,2
DUPIXENT,2,36,801,NASAL POLYPS,SUBCUTANEOUS,Solution for injection,ARTHRALGIA,2
JIVI,1,53,801,FACTOR VIII DEFICIENCY,,Powder and solvent for solution for infusion,HAEMORRHAGE,1
DUPIXENT,1,82,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,FALL,1
IMBRUVICA,1,,,CHRONIC LYMPHOCYTIC LEUKAEMIA,ORAL,,CANCER SURGERY,1
TECARTUS,1,63,801,ACUTE LYMPHOCYTIC LEUKAEMIA,INTRAVENOUS,Suspension,DEATH,1
FRUQUINTINIB,1,,,COLORECTAL CANCER METASTATIC,ORAL,Capsule,COLORECTAL CANCER METASTATIC,1
EYLEA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVITREAL,Injection,HOSPITALISATION,1
METHOTREXATE SODIUM,2,88,801,,INTRA-ARTERIAL,,LYMPHOPROLIFERATIVE DISORDER,1
NUBEQA,1,,,HORMONE-DEPENDENT PROSTATE CANCER,ORAL,Film-coated tablet,DEATH,1
COSENTYX,1,,,ANKYLOSING SPONDYLITIS,SUBCUTANEOUS,Solution for injection,LOWER RESPIRATORY TRACT INFECTION,1
DUVYZAT,1,,,,ORAL,,THROMBOCYTOPENIA,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,SWELLING,2
DUPIXENT,2,66,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ECZEMA,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PRURITUS,2
HUMIRA,2,74,801,COLITIS ULCERATIVE,,,RECTAL CANCER,1
IBRUTINIB,1,73,801,CHRONIC LYMPHOCYTIC LEUKAEMIA,ORAL,Tablet,ATRIAL FIBRILLATION,1
RYLAZE,2,2,801,ACUTE LYMPHOCYTIC LEUKAEMIA,INTRAMUSCULAR,UNK,PARTIAL SEIZURES,1
ZOMETA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,,,PYREXIA,2
ZOLPIDEM,1,82,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Film-coated tablet,DRUG USE DISORDER,1
LANTUS SOLOSTAR,1,78,801,,SUBCUTANEOUS,,INCORRECT DOSE ADMINISTERED,1
SAXENDA,2,34,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,WEIGHT INCREASED,2
ACTEMRA,2,,,RHEUMATOID ARTHRITIS,INTRAVENOUS,,PAIN,2
DUPIXENT,1,73,801,NEURODERMATITIS,SUBCUTANEOUS,Solution for injection,VEIN DISCOLOURATION,2
TALTZ,1,66,801,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,CHILLS,2
FEXOFENADINE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,,,URTICARIA,1
ETONOGESTREL,2,,,,SUBCUTANEOUS,Implant,UTERINE LEIOMYOMA,1
ATORVASTATIN,1,44,801,ADVERSE DRUG REACTION,,,DRY SKIN,1
LYUMJEV KWIKPEN,2,75,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,INJECTION SITE HAEMORRHAGE,2
RITUXIMAB,1,75,801,SPLENIC MARGINAL ZONE LYMPHOMA,INTRAVENOUS,,ATRIAL FIBRILLATION,1
OCREVUS,2,56,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Infusion,NEURALGIA,2
PALIVIZUMAB,1,8,802,PRODUCT USED FOR UNKNOWN INDICATION,INTRAMUSCULAR,Injection,INFECTION,1
ORENCIA,2,39,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Solution for injection,NODULE,2
CYRAMZA,1,67,801,NON-SMALL CELL LUNG CANCER,INTRAVENOUS,Injection,DERMATITIS ACNEIFORM,1
NEXPLANON,2,42,801,CONTRACEPTION,SUBCUTANEOUS,Implant,PREGNANCY WITH IMPLANT CONTRACEPTIVE,1
XELJANZ,2,56,801,,ORAL,,ACNE,2
DUPIXENT,2,37,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,REBOUND ATOPIC DERMATITIS,2
DUPIXENT,2,29,801,ASTHMA,SUBCUTANEOUS,Solution for injection,INJECTION SITE ERYTHEMA,2
DESMOPRESSIN,1,27,801,DIABETES INSIPIDUS,,Tablet,CHILLS,1
TRASTUZUMAB,2,,,UTERINE CANCER,INTRAVENOUS,Unknown formulation,UTERINE CANCER,1
ELIGARD,2,,,PRECOCIOUS PUBERTY,SUBCUTANEOUS,Injection,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,2
DUPIXENT,2,63,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ENCEPHALOPATHY,1
LANTUS SOLOSTAR,1,,,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
DUPIXENT,2,,,,SUBCUTANEOUS,Solution for injection,LUNG DISORDER,2
DUPIXENT,1,65,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DRUG INEFFECTIVE,2
DUPIXENT,2,,,ASTHMA,SUBCUTANEOUS,Solution for injection,ILLNESS,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,FATIGUE,2
IMBRUVICA,2,,,CHRONIC LYMPHOCYTIC LEUKAEMIA,ORAL,Tablet,RESPIRATORY DISORDER,1
DUPIXENT,2,7,801,ASTHMA,SUBCUTANEOUS,Solution for injection,FATIGUE,2
DUPIXENT,1,53,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
DUPIXENT,2,77,801,ASTHMA,SUBCUTANEOUS,Solution for injection,HIP FRACTURE,1
MOUNJARO,1,63,801,WEIGHT CONTROL,SUBCUTANEOUS,Solution for injection in pre-filled pen,PRODUCT DOSE OMISSION ISSUE,2
CLOZARIL,1,,,SCHIZOPHRENIA,ORAL,,HOSPITALISATION,1
DUPIXENT,1,83,801,PEMPHIGOID,SUBCUTANEOUS,Solution for injection,DEATH,1
ELREXFIO,2,,,,SUBCUTANEOUS,Solution for injection,HAEMATOMA,1
DUPIXENT,1,,,,SUBCUTANEOUS,Solution for injection,TUNNEL VISION,1
DUPIXENT,2,61,801,,SUBCUTANEOUS,Solution for injection,COVID-19,2
DUPIXENT,2,52,801,NASAL POLYPS,SUBCUTANEOUS,Solution for injection,UTERINE POLYP,2
BOTOX,2,,,SKIN COSMETIC PROCEDURE,INTRADERMAL,,BOTULISM,1
FULVESTRANT,2,,,BREAST CANCER METASTATIC,INTRAMUSCULAR,,MYOCARDIAL INFARCTION,1
VERZENIO,2,60,801,MALIGNANT NIPPLE NEOPLASM FEMALE,ORAL,Tablet,DEHYDRATION,2
FINASTERIDE,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,ERECTILE DYSFUNCTION,1
FENTANYL,1,37,801,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,,DRUG ABUSE,1
HUMIRA,1,37,801,HIDRADENITIS,,Solution for injection,DEATH,1
REVLIMID,1,82,801,PLASMA CELL MYELOMA,ORAL,Capsule,GOUT,1
ONUREG,1,65,801,ACUTE MYELOID LEUKAEMIA,ORAL,Tablet,OFF LABEL USE,2
ADBRY,2,32,801,ECZEMA,SUBCUTANEOUS,,EYELIDS PRURITUS,2
HEPARIN,2,32,801,BUDD-CHIARI SYNDROME,,Unknown,DRUG INEFFECTIVE,1
VERZENIO,2,53,801,BREAST CANCER,ORAL,Tablet,PAIN,2
KERENDIA,2,62,801,DRUG THERAPY,ORAL,Film-coated tablet,RENAL FAILURE,1
MACI,2,54,801,CHONDROPATHY,INTRA-ARTICULAR,Implant - LIVING TISSUE EQUIVALENT,PRODUCT PHYSICAL ISSUE,2
KISQALI,2,69,801,BREAST CANCER,ORAL,Tablet,DEATH,1
INLYTA,1,64,801,,ORAL,Film-coated tablet,ARTHRALGIA,2
VALIUM,1,53,801,INSOMNIA,ORAL,Unknown,TOXICITY TO VARIOUS AGENTS,1
MOUNJARO,2,54,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,EXTRA DOSE ADMINISTERED,2
ELOCTATE,1,17,801,FACTOR VIII DEFICIENCY,,Powder and solvent for solution for injection,CHEST PAIN,2
DEPO-PROVERA,2,,,,INTRAMUSCULAR,Suspension for injection,INCORRECT DOSE ADMINISTERED BY DEVICE,2
FOSCARBIDOPA\FOSLEVODOPA,1,70,801,PARKINSON^S DISEASE,SUBCUTANEOUS,Solution for infusion,SKIN CANCER,1
LANTUS SOLOSTAR,2,63,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,COVID-19,1
OXALIPLATIN,2,75,801,COLORECTAL ADENOMA,INTRAVENOUS,Injection,FEAR OF DEATH,1
STELARA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Solution for injection in pre-filled syringe,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,2
XPHOZAH,1,,,CHRONIC KIDNEY DISEASE,,Tablet,CARDIAC ARREST,1
TERIFLUNOMIDE,2,46,801,MULTIPLE SCLEROSIS,ORAL,,MUSCULAR WEAKNESS,1
PAXLOVID,1,24,801,COVID-19 TREATMENT,,Tablet,COVID-19,2
XELJANZ XR,2,74,801,,ORAL,Prolonged-release tablet,DRUG INEFFECTIVE,2
CEFDINIR,2,18,802,EAR INFECTION,ORAL,Oral suspension,PRODUCT STORAGE ERROR,2
MOUNJARO,2,,,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,INCORRECT DOSE ADMINISTERED,2
TYSABRI,2,,,MULTIPLE SCLEROSIS,INTRAVENOUS,Concentrate for solution for infusion,COVID-19,1
REVLIMID,1,82,801,PLASMA CELL MYELOMA IN REMISSION,ORAL,Capsule,SKIN CANCER,1
AVASTIN,1,51,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,,HEPATOCELLULAR CARCINOMA,1
CABOTEGRAVIR,1,,,PRODUCT USED FOR UNKNOWN INDICATION,,Suspension for injection,OCCUPATIONAL EXPOSURE TO PRODUCT,2
REZAFUNGIN ACETATE,1,57,801,FUNGAEMIA,,Powder for concentrate for solution for infusion,SEPSIS,1
LISDEXAMFETAMINE DIMESYLATE,1,17,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Capsule,INTENTIONAL OVERDOSE,1
ARMOUR THYROID,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,BLOOD THYROID STIMULATING HORMONE ABNORMAL,2
TRIUMEQ,1,58,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Film-coated tablet,PRODUCT DOSE OMISSION ISSUE,2
ORENCIA,2,60,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Injection,BRONCHITIS,2
HUMIRA,2,70,801,RHEUMATOID ARTHRITIS,,Solution for injection in pre-filled pen,AORTIC ANEURYSM,1
ACTEMRA ACTPEN,1,86,801,GIANT CELL ARTERITIS,SUBCUTANEOUS,Direct auto-injector,CHILLS,2
ESLICARBAZEPINE,2,1,801,FOCAL DYSCOGNITIVE SEIZURES,,Unknown,DIZZINESS,2
ZILBRYSQ,1,,,MYASTHENIA GRAVIS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,MUSCULAR WEAKNESS,2
HUMIRA,2,,,CROHN^S DISEASE,,,MATERNAL EXPOSURE DURING PREGNANCY,2
ERLEADA,1,75,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Film-coated tablet,URINARY INCONTINENCE,2
ORENCIA,2,64,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Solution for injection,JOINT SWELLING,2
DUPIXENT,2,82,801,ASTHMA,SUBCUTANEOUS,Solution for injection,DYSPNOEA,2
DIANEAL FOR PERITONEAL DIALYSIS,1,,,,,Solution for peritoneal dialysis,DRUG INEFFECTIVE,2
PALFORZIA,1,9,801,FOOD ALLERGY,,Capsule,ERYTHEMA,2
PANTOPRAZOLE,2,67,801,DUODENAL ULCER HAEMORRHAGE,ORAL,,"HALLUCINATION, VISUAL",1
DAPTOMYCIN,1,67,801,ENDOCARDITIS STAPHYLOCOCCAL,INTRAVENOUS,,EOSINOPHILIC PNEUMONIA,1
HUMIRA,2,,,PRODUCT USED FOR UNKNOWN INDICATION,,,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
XDEMVY,2,,,DEMODEX BLEPHARITIS,OPHTHALMIC,Ophthalmic Solution,VISION BLURRED,2
CABOTEGRAVIR,1,21,801,PRODUCT USED FOR UNKNOWN INDICATION,,Suspension for injection,HYPOAESTHESIA,2
REVLIMID,2,84,801,MYELODYSPLASTIC SYNDROME,ORAL,Capsule,DIZZINESS POSTURAL,2
EPIDIOLEX,2,4,801,EPILEPSY,ORAL,,DIARRHOEA,1
CARBIDOPA\LEVODOPA,2,77,801,PARKINSON^S DISEASE,,Intestinal gel,FEMORAL NECK FRACTURE,1
LUMRYZ,1,,,,ORAL,Extended-Release Oral Suspension,SOMNOLENCE,2
ROSUVASTATIN,1,60,801,CAROTID ARTERY DISEASE,ORAL,Tablet,PERIARTHRITIS,1
ADCETRIS,2,66,801,T-CELL LYMPHOMA,INTRAVENOUS,Powder for solution for injection,CHEST DISCOMFORT,1
DUPIXENT,1,28,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,PRODUCT DOSE OMISSION IN ERROR,2
IMRALDI,1,48,801,CROHN^S DISEASE,,Solution for injection in pre-filled pen,IMMUNODEFICIENCY,1
DUPIXENT,1,24,801,ECZEMA INFANTILE,SUBCUTANEOUS,Solution for injection,SKIN FISSURES,2
LUPRON,1,60,801,PROSTATE CANCER,,Injection,CEREBROVASCULAR ACCIDENT,1
DUPIXENT,2,,,,SUBCUTANEOUS,Solution for injection,INJECTION SITE PAIN,2
DEPO-PROVERA,2,,,CONTRACEPTION,INTRAMUSCULAR,Suspension for injection,MENINGIOMA,1
AVEED,1,65,801,TESTICULAR FAILURE,INTRAMUSCULAR,Injection,PROCTECTOMY,1
MIRCERA,1,69,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Solution for injection in pre-filled syringe,DEATH,1
TECFIDERA,1,,,MULTIPLE SCLEROSIS,ORAL,Prolonged-release capsule,GASTROINTESTINAL DISORDER,2
ORENCIA,2,76,801,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Solution for injection,CORTISOL DECREASED,2
CABOMETYX,1,,,RENAL CANCER,ORAL,Tablet,PRODUCT DOSE OMISSION ISSUE,2
FENTANYL,1,26,801,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,,DRUG ABUSE,1
ZEPOSIA,2,62,801,MULTIPLE SCLEROSIS,ORAL,,PRODUCT USE ISSUE,2
BOTOX,2,,,MIGRAINE,INTRADERMAL,,NEOPLASM MALIGNANT,1
REVLIMID,1,55,801,PLASMA CELL MYELOMA,ORAL,Capsule,NEUROPATHY PERIPHERAL,1
COSENTYX,2,48,801,HIDRADENITIS,SUBCUTANEOUS,Injection,BRAIN OPERATION,2
DUPIXENT,1,50,801,ASTHMA,SUBCUTANEOUS,Solution for injection,INJECTION SITE PAIN,2
DUPIXENT,2,,,ASTHMA,SUBCUTANEOUS,Solution for injection,ASTHMA,2
DUPIXENT,2,64,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ACCIDENTAL EXPOSURE TO PRODUCT,2
DUPIXENT,1,,,ASTHMA,SUBCUTANEOUS,Solution for injection,COUGH,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
MAVENCLAD,2,43,801,MULTIPLE SCLEROSIS,ORAL,,LOWER RESPIRATORY TRACT INFECTION,1
LUPKYNIS,1,,,LUPUS NEPHRITIS,ORAL,Softgel capsule,INCORRECT DOSE ADMINISTERED,2
LUPKYNIS,1,,,LUPUS NEPHRITIS,ORAL,Softgel capsule,ARTHRALGIA,2
LUPKYNIS,1,41,801,LUPUS NEPHRITIS,ORAL,Softgel capsule,VOMITING,2
MOUNJARO,1,,,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,ABDOMINAL PAIN UPPER,2
TESTOSTERONE\TRIAMCINOLONE ACETONIDE,2,48,801,MENOPAUSAL SYMPTOMS,,,IMPLANT SITE ABSCESS,1
LENALIDOMIDE,1,68,801,PLASMA CELL MYELOMA,ORAL,,PAIN,2
GENOTROPIN,2,10,801,TURNER^S SYNDROME,,Solution for injection,TONSILLAR DISORDER,1
CALCITONIN SALMON,2,,,PRODUCT USED FOR UNKNOWN INDICATION,NASAL,"Nasal spray, solution",OROPHARYNGEAL PAIN,2
MEKTOVI,2,72,801,BREAST CANCER METASTATIC,ORAL,Film-coated tablet,LYMPHOEDEMA,2
ADEMPAS,2,,,PULMONARY ARTERIAL HYPERTENSION,ORAL,,INTERNATIONAL NORMALISED RATIO INCREASED,1
MOUNJARO,2,66,801,GLYCOSYLATED HAEMOGLOBIN ABNORMAL,SUBCUTANEOUS,Solution for injection in pre-filled pen,DELIRIUM,2
PALFORZIA,2,9,801,FOOD ALLERGY,,Capsule,PYREXIA,2
CLOZAPINE,2,27,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,ADVERSE EVENT,1
HIZENTRA,1,,,PRIMARY IMMUNODEFICIENCY SYNDROME,,Injection,PALLIATIVE CARE,1
DUPIXENT,2,47,801,EOSINOPHILIC OESOPHAGITIS,SUBCUTANEOUS,Solution for injection,INJECTION SITE PAIN,2
DUPIXENT,2,77,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,RASH MACULAR,2
VEDOLIZUMAB,2,,,CROHN^S DISEASE,SUBCUTANEOUS,Powder for solution for infusion,PNEUMONIA,1
REVLIMID,2,55,801,PLASMA CELL MYELOMA,ORAL,Capsule,NEUROPATHY PERIPHERAL,1
DUPIXENT,1,9,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,RASH PRURITIC,2
RECLAST,2,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,Solution for infusion,CONJUNCTIVITIS,2
AVONEX,2,45,801,MULTIPLE SCLEROSIS,INTRAMUSCULAR,Solution for injection in pre-filled pen,BREAST MASS,1
NUPLAZID,1,,,PARKINSON^S DISEASE PSYCHOSIS,ORAL,Capsule,MEMORY IMPAIRMENT,2
DUPIXENT,2,19,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
OMNITROPE,1,,,SHORT STATURE,SUBCUTANEOUS,Solution for injection,INJECTION SITE PAIN,2
DUPIXENT,2,42,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,LACRIMATION INCREASED,2
RIVFLOZA,1,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection,RASH,2
XOSPATA,1,7,800,ACUTE MYELOID LEUKAEMIA,ORAL,Tablet,ACUTE MYELOID LEUKAEMIA,1
DUPIXENT,2,44,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DERMATITIS ATOPIC,2
BUTORPHANOL TARTRATE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,NASAL,Nasal drops,CRANIOCEREBRAL INJURY,1
ORENCIA,2,75,801,RHEUMATOID ARTHRITIS,INTRAVENOUS,Solution for injection,JOINT SWELLING,2
ESTRADIOL TRANSDERMAL SYSTEM,2,48,801,MENOPAUSE,TRANSDERMAL,Transdermal patch,APPLICATION SITE PRURITUS,2
XELJANZ,1,52,801,COLITIS ULCERATIVE,ORAL,,HAEMATOCHEZIA,1
TRIKAFTA,1,,,CYSTIC FIBROSIS,,Film-coated tablet,BEHAVIOUR DISORDER,2
DOVATO,1,36,801,HIV CARRIER,ORAL,Film-coated tablet,PRODUCT DOSE OMISSION ISSUE,2
OCREVUS,1,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,,URINARY TRACT INFECTION,1
PAXLOVID,2,,,,,Tablet,COVID-19,2
DUPIXENT,1,60,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PRURITUS,2
GENOTROPIN,1,8,801,,,Solution for injection,DEVICE DEFECTIVE,2
HEMLIBRA,1,22,801,FACTOR VIII DEFICIENCY,SUBCUTANEOUS,,HAEMORRHAGE,2
FENTANYL,1,35,801,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,,DRUG ABUSE,1
DUPIXENT,1,65,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,DRY SKIN,2
AMIFAMPRIDINE,2,12,801,MYASTHENIA GRAVIS,,Tablet,MYASTHENIA GRAVIS,1
MIRALAX,1,83,801,GASTROINTESTINAL DISORDER,ORAL,Powder for oral solution,PRODUCT PRESCRIBING ISSUE,2
FENTANYL,1,48,801,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,,DRUG ABUSE,1
FENTANYL,1,50,801,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,,DRUG ABUSE,1
OTEZLA,2,,,PSORIATIC ARTHROPATHY,ORAL,Tablet,THERAPEUTIC PRODUCT EFFECT INCOMPLETE,2
DUPIXENT,1,40,801,ASTHMA,SUBCUTANEOUS,Solution for injection,ASTHMA,2
DUPIXENT,1,1,801,ECZEMA,SUBCUTANEOUS,Solution for injection,SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION,2
NUPLAZID,2,73,801,PARKINSON^S DISEASE,ORAL,Capsule,HALLUCINATION,1
XOLAIR,2,,,ASTHMA,SUBCUTANEOUS,Solution for injection in pre-filled syringe,OFF LABEL USE,2
FENTANYL,1,43,801,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,,DRUG ABUSE,1
REVLIMID,2,63,801,PLASMA CELL MYELOMA,ORAL,Capsule,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,2
ACCUTANE,1,18,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Capsule,ILLNESS,2
ADBRY,2,45,801,DERMATITIS ATOPIC,SUBCUTANEOUS,,INJECTION SITE PAIN,2
GONAL-F,2,30,801,OVULATION INDUCTION,SUBCUTANEOUS,,DYSPNOEA,1
OLUMIANT,2,26,801,ALOPECIA AREATA,ORAL,Tablet,MUSCLE SPASMS,2
UBLITUXIMAB,2,43,801,MULTIPLE SCLEROSIS,INTRAVENOUS,Concentrate for solution for infusion,INFUSION RELATED REACTION,2
AYVAKIT,2,78,801,INDOLENT SYSTEMIC MASTOCYTOSIS,ORAL,Unknown,NEPHROLITHIASIS,1
MOUNJARO,1,60,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Solution for injection in pre-filled pen,FATIGUE,2
CLOZAPINE,1,59,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,PRODUCT DOSE OMISSION ISSUE,2
HYRIMOZ,2,56,801,RHEUMATOID ARTHRITIS,SUBCUTANEOUS,Unknown,DRUG INEFFECTIVE,2
ERIVEDGE,2,83,801,BASAL CELL CARCINOMA,ORAL,,DEATH,1
COSENTYX,2,35,801,PSORIATIC ARTHROPATHY,SUBCUTANEOUS,Injection,ILLNESS,2
OXYBUTYNIN,2,19,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,POISONING DELIBERATE,1
HUMIRA,2,,,PSORIASIS,,,UNEVALUABLE EVENT,1
FULVESTRANT,2,,,BREAST CANCER METASTATIC,INTRAMUSCULAR,,PNEUMONIA,1
HALOPERIDOL,2,37,801,AGITATION,ORAL,Solution for injection,CATATONIA,1
VEDOLIZUMAB,1,75,801,COLITIS ULCERATIVE,SUBCUTANEOUS,Powder for solution for infusion,BILIARY OBSTRUCTION,1
VEVYE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,OPHTHALMIC,"Eye drops, solution",EYE PAIN,2
INLYTA,2,,,,ORAL,,LIVER INJURY,1
ELIGARD,1,,,PROSTATE CANCER,SUBCUTANEOUS,Injection,INJECTION SITE MASS,2
LUMASON,2,,,ECHOCARDIOGRAM,INTRAVENOUS,Solution for injection,CARDIO-RESPIRATORY ARREST,1
DUPIXENT,1,8,801,ASTHMA,SUBCUTANEOUS,Solution for injection,INJECTION SITE PAIN,2
OZEMPIC,2,21,801,POLYCYSTIC OVARIAN SYNDROME,SUBCUTANEOUS,Solution for injection,DEHYDRATION,1
TYSABRI,2,,,MULTIPLE SCLEROSIS,INTRAVENOUS,Unknown,INFLUENZA,2
DUPIXENT,2,56,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,SYSTEMIC LUPUS ERYTHEMATOSUS,1
TAVNEOS,1,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,"Capsule, hard",NEUTROPENIA,1
DUPIXENT,2,55,801,ASTHMA,SUBCUTANEOUS,Solution for injection,ASTHMA,2
DUPIXENT,2,24,801,DERMATITIS,SUBCUTANEOUS,Solution for injection,EYE PRURITUS,2
NEUPRO,2,61,801,RESTLESS LEGS SYNDROME,TRANSDERMAL,Transdermal patch,PRODUCT ADHESION ISSUE,2
REVLIMID,1,78,801,PLASMA CELL MYELOMA,ORAL,,SPINAL FRACTURE,1
VEDOLIZUMAB,1,72,801,COLITIS ULCERATIVE,SUBCUTANEOUS,Powder for solution for infusion,TRANSIENT ISCHAEMIC ATTACK,1
VEVYE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,OPHTHALMIC,"Eye drops, solution",EYE IRRITATION,2
DUPIXENT,2,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ERYTHEMA,2
DUPIXENT,1,4,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,PNEUMONIA,1
AMOXICILLIN\CLAVULANIC ACID,2,40,801,DENTAL OPERATION,,,PRURITUS,1
SOTYKTU,2,74,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,DRUG INEFFECTIVE,2
DUPIXENT,1,11,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,INJECTION SITE BRUISING,2
DUPIXENT,1,14,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,2
DUPIXENT,1,65,801,ASTHMA,SUBCUTANEOUS,Solution for injection,INJECTION SITE URTICARIA,2
LANTUS SOLOSTAR,1,70,801,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,ADMINISTRATION SITE PAIN,2
CLOZAPINE,1,44,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,Tablet,WITHDRAWAL SYNDROME,2
STELARA,2,6,800,COLITIS ULCERATIVE,INTRAVENOUS,Solution for injection in pre-filled syringe,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION,1
PARAGARD T 380A,2,,,,INTRAUTERINE,Intrauterine,INJURY,1
AVASTIN,1,79,801,COLORECTAL CANCER METASTATIC,INTRAVENOUS,,DEATH,1
OZEMPIC,2,55,801,OBESITY,SUBCUTANEOUS,Solution for injection,IMPAIRED GASTRIC EMPTYING,1
DAPTOMYCIN,1,,,PRODUCT USED FOR UNKNOWN INDICATION,INTRAVENOUS,,RESPIRATORY FAILURE,1
DUPIXENT,1,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ECZEMA HERPETICUM,1
VRAYLAR,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,DISABILITY,1
PARAGARD T 380A,2,,,,INTRAUTERINE,Intrauterine,DEFORMITY,1
PARAGARD T 380A,1,,,,INTRAUTERINE,Intrauterine,INJURY,1
LANTUS,2,62,801,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,PRODUCT STORAGE ERROR,2
HUMIRA,2,78,801,PSORIASIS,,Injection,SINUS DISORDER,2
GENOTROPIN,1,11,801,GROWTH DISORDER,,Solution for injection,DRUG DOSE OMISSION BY DEVICE,2
OMNITROPE,1,13,801,HYPOPITUITARISM,SUBCUTANEOUS,Solution for injection,INCORRECT DOSE ADMINISTERED BY DEVICE,2
PARAGARD T 380A,2,,,CONTRACEPTION,INTRAUTERINE,Intrauterine,INTERMENSTRUAL BLEEDING,2
CLOZAPINE,1,38,801,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,PSYCHIATRIC DECOMPENSATION,2
DUPIXENT,2,52,801,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,LIMB INJURY,2
DUPIXENT,2,55,801,,SUBCUTANEOUS,Solution for injection,FALL,2
HUMIRA,2,50,801,HIDRADENITIS,,Injection,DIVERTICULITIS,2
TYSABRI,2,61,801,MULTIPLE SCLEROSIS,INTRAVENOUS,Infusion,PRESCRIBED UNDERDOSE,2
NOVOEIGHT,1,,,FACTOR VIII DEFICIENCY,,,CEREBRAL HAEMORRHAGE,1
PROCTOFOAM HC,1,,,PRODUCT USED FOR UNKNOWN INDICATION,TOPICAL,Rectal foam,OFF LABEL USE,2
DUPIXENT,1,,,DERMATITIS ATOPIC,SUBCUTANEOUS,Solution for injection,ECZEMA,2
LANTUS SOLOSTAR,2,72,801,DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection,PRODUCT STORAGE ERROR,2
TIVICAY,2,,,SEXUAL ABUSE,ORAL,Film-coated tablet,OFF LABEL USE,2
FULVESTRANT,2,,,HORMONE RECEPTOR POSITIVE BREAST CANCER,INTRAMUSCULAR,Unknown,OSTEONECROSIS,1
FILSPARI,2,50,801,IGA NEPHROPATHY,ORAL,Tablet,DIZZINESS,2
SERTRALINE,2,,,PRODUCT USED FOR UNKNOWN INDICATION,ORAL,,CONTUSION,1
LEVOXYL,2,85,801,,ORAL,Tablet,SWOLLEN TONGUE,2
NGENLA,1,13,801,,SUBCUTANEOUS,Solution for injection in pre-filled pen,INJECTION SITE PAIN,2
OCREVUS,1,,,MULTIPLE SCLEROSIS,INTRAVENOUS,,COVID-19,2
ELAHERE,2,,,OVARIAN CANCER,INTRAVENOUS,Intravenous infusion,PNEUMONITIS,2
VEDOLIZUMAB,2,,,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Powder for solution for infusion,CROHN^S DISEASE,1
CIMZIA,2,,,ANKYLOSING SPONDYLITIS,SUBCUTANEOUS,Solution for injection in pre-filled syringe,ANKYLOSING SPONDYLITIS,1
MOUNJARO,1,54,801,TYPE 2 DIABETES MELLITUS,SUBCUTANEOUS,Solution for injection in pre-filled pen,BLOOD GLUCOSE ABNORMAL,2
DUPIXENT,2,6,801,ASTHMA,SUBCUTANEOUS,Solution for injection,OFF LABEL USE,2
BASAGLAR,1,77,801,PRODUCT USED FOR UNKNOWN INDICATION,SUBCUTANEOUS,Injection,DEATH,1
KYLEENA,2,25,801,POLYCYSTIC OVARIAN SYNDROME,INTRAUTERINE,Intrauterine delivery system,COMPLICATION ASSOCIATED WITH DEVICE,2
MIRENA,2,,,INTRAUTERINE CONTRACEPTION,INTRAUTERINE,Intrauterine delivery system,SMEAR CERVIX ABNORMAL,2
ESTRADIOL TRANSDERMAL SYSTEM,2,,,PRODUCT USED FOR UNKNOWN INDICATION,TRANSDERMAL,Transdermal patch,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
REVLIMID,1,78,801,PLASMA CELL MYELOMA,ORAL,Capsule,ILLNESS,1
ALTUVIIIO,1,12,801,FACTOR VIII DEFICIENCY,,LYOPHILISATE FOR SUSPENSION FOR INJECTION,HAEMARTHROSIS,1
PRALUENT,2,,,HYPERCHOLESTEROLAEMIA,SUBCUTANEOUS,Injection,URINARY TRACT INFECTION,1
CARBIDOPA\LEVODOPA,2,78,801,PRODUCT USED FOR UNKNOWN INDICATION,,,DEATH,1
AMOXICILLIN\CLAVULANATE POTASSIUM,2,60,801,CARBUNCLE,,Film-coated tablet,SWELLING FACE,1
CITALOPRAM HYDROBROMIDE,1,,,MATERNAL EXPOSURE TIMING UNSPECIFIED,ORAL,,SMALL FOR DATES BABY,1
ACTEMRA,2,,,GIANT CELL ARTERITIS,INTRAVENOUS,Direct auto-injector,OSTEOPOROSIS,2
STELARA,2,47,801,CROHN^S DISEASE,INTRAVENOUS,,CROHN^S DISEASE,1
CABENUVA,1,45,801,HIV INFECTION,,Suspension for injection,INFLUENZA LIKE ILLNESS,2
COSENTYX,2,,,PSORIASIS,SUBCUTANEOUS,Solution for injection in pre-filled pen,LOWER RESPIRATORY TRACT INFECTION,1
